carbapenems has been researched along with Infections, Klebsiella in 1038 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (0.29) | 18.2507 |
| 2000's | 68 (6.55) | 29.6817 |
| 2010's | 587 (56.55) | 24.3611 |
| 2020's | 380 (36.61) | 2.80 |
| Authors | Studies |
|---|---|
| Ding, M; Hu, R; Li, Q; Liu, J; Zhang, F; Zhou, Y | 1 |
| Li, M; Li, S; Xu, L; Yang, P | 1 |
| Adhikari, B; Adhikari, N; Banjara, MR; Dhungel, B; Ghimire, P; Lamichhane, I; Rijal, KR; Shah, AK; Shrestha, UT; Thapa, S | 1 |
| Bozdogan, B; Guney, M; Guney-Kaya, K; Hosbul, T; Oryasin, E; Sakarya, S | 1 |
| Chen, Y; He, J; Hua, L; Huang, W; Li, D; Li, S; Li, W; Liu, Q; Ma, Y; Qi, J; Ren, Z; Yang, Y; Yang, Z; Ye, C; Zhang, Y; Zheng, P; Zheng, X | 1 |
| Kwan, S; Magallon, J; Oakley-Havens, CL; Phan, K; Ramirez, MS; Reeves, C; Tolmasky, ME; Vu, P | 1 |
| Anbarasu, A; Basu, S; Lal, B; Mathur, P; Ramaiah, S; Shankar, C; Shanmugam, S; Vasudevan, K; Veeraraghavan, B | 1 |
| Chen, W; Huang, Y; Jiang, X; Li, M; Sheng, Z; Tian, D; Wang, W; Zhou, Y | 1 |
| Ko, WC; Lee, NY; Lo, CL; Syue, LS; Tsai, WC | 1 |
| Arena, F; Coda, ARD; Liso, A; Meschini, V; Verzicco, R | 1 |
| Badmasti, F; Bolourchi, N; Giske, CG; Nematzadeh, S; Noori Goodarzi, N; Shahcheraghi, F; Solgi, H | 1 |
| Hagimoto, A; Nakaminami, H; Sugawara, T; Tanaka, E; Umeda, Y; Wajima, T | 1 |
| Chen, Y; Ding, H; Lan, T; Liao, G; Pan, J; Yang, J; Zhang, F; Zhong, J | 1 |
| Liao, X; Ling, Z; Liu, M; Rui, D; Su, R; Tang, Z; Wen, Z | 1 |
| Abril, D; Corredor Rozo, ZL; Cortés, JA; De La Rosa, Z; Escobar-Perez, J; Leal, AL; Madroñero, J; Marquez-Ortiz, RA; Nieto, CA; Palacios, D; Vanegas, N; Vergara, E | 1 |
| Fang, H; Feng, J; Hu, J; Jia, R; Li, C; Song, Y; Tang, N; Wang, C; Wei, D; Zhang, G; Zhao, Y | 1 |
| Bastos Leite, R; Bispo, S; Costa, J; Faria, NA; Miragaia, M; Palos, C; Peres Ladeiro, S; Sá-Leão, R; Serrano, M; Simões, AS; Touret, T | 1 |
| Costa, SF; Deo, B; Farrel Côrtes, M; Perdigão, L; Rizek, C; Rodrigues Pires de Campos, L; Santos, S | 1 |
| Holt, K; Wyres, K | 1 |
| Arias, CA; Arias, R; Baum, K; Bonomo, RA; Chambers, HF; Chen, L; Cober, E; Doi, Y; Earley, M; Evans, S; Fowler, VG; Fries, BC; Gao, H; Hanson, BM; Hill, C; Kanj, SS; Komarow, L; Kreiswirth, BN; Li, L; Liu, Z; Luterbach, C; Manca, C; Marimuthu, K; Marshall, SH; Munita, JM; Ordoñez, K; Patel, R; Paterson, DL; Reyes, J; Rudin, SD; Salcedo, S; Satlin, MJ; Stryjewski, ME; Valderrama-Beltrán, SL; van Duin, D; Villegas, MV; Wang, M; Weston, G; Yu, Y | 1 |
| Abu-Sayedahmed, SH; Ahmed El-Domany, R; El-Banna, T; Sonbol, F | 1 |
| Berglund, B; Bornefall, E; Dien, TM; Hanberger, H; Hoang, NTB; Khu, DTK; Larsson, M; Le, HT; Le, NK; Lundberg, L; Nilsson, LE; Nilsson, M; Olson, L; Tärnberg, M; Welander, J | 1 |
| Baier, C; Bange, FC; Chhatwal, P; Ebadi, E; Gerbel, S; Schlüter, D; Schwab, F; Simon, N; Vonberg, RP; Ziesing, S | 1 |
| Jiang, X; Li, G; Shen, P; Tang, Y; Zhang, Y | 1 |
| Aanensen, DM; Abrudan, M; Akshata, KP; Argimón, S; Govindan, V; Kekre, M; Nagaraj, G; Ravikumar, KL; Rose, S; Shamanna, V; Shincy, MR; Sravani, D; Underwood, A; Venkatesha, VT | 1 |
| Aanensen, DM; Abrudan, M; Arévalo, SA; Argimón, S; Bernal, JF; Donado-Godoy, P; Duarte, C; García-Vega, ÁS; Hidalgo, AM; Kekre, M; Montilla-Escudero, E; Moreno, J; Prada, DA; Saavedra, SY; Underwood, A; Valencia, MF | 1 |
| Feng, Y; Hu, Y; Long, H; McNally, A; Yang, J; Zong, Z | 1 |
| Bao, R; Hu, B; Li, N; Tan, D; Zeng, Y; Zhu, T | 1 |
| Cao, J; Chen, L; Chen, T; Huang, N; Liao, W; Sun, Y; Wen, H; Zeng, W; Zhang, Y; Zhou, T | 1 |
| Ke, H; Li, X; Tu, Y; Wu, W; Yu, Y; Zhou, H | 1 |
| Iosifidis, E; Karampatakis, T; Papa, A; Pappa, S; Roilides, E; Vagdatli, E; Zarras, C | 1 |
| Feng, Y; Qiao, F; Wei, L; Wen, H; Ya, H; Zong, Z | 1 |
| Bai, Y; Hao, Y; Jin, Y; Shao, C; Wang, Y | 1 |
| Cai, X; Hu, YB; Jin, MM; Li, RY; Liu, C; Liu, L; Wan, L; Wu, XJ; Zhang, HY | 1 |
| Ahmed, MAEE; Chen, P; Deng, B; Hassan, RM; He, R; Huang, X; Liang, X; Qin, M; Tian, GB; Wen, W; Wu, Y; Xu, L; Yang, Y; Zhong, LL | 1 |
| Han, D; Pan, F; Shi, Y; Sun, Y; Wang, B; Wang, C; Zhang, H; Zhang, T; Zhao, W | 1 |
| Fang, Q; Feng, Y; McNally, A; Zong, Z | 1 |
| Bhatia, M; Chakraborty, D; Gupta, P; Nagaraj, G; Omar, BJ; Ravikumar, KL; Shamanna, V; Sravani, D | 1 |
| Hoffman, S; Lapp, Z; Snitkin, ES; Wang, J | 1 |
| Ke, J; Liu, J; Min, L; Peng, J; Zeng, L; Zhao, Z; Zhou, S; Zhou, Y | 1 |
| Hu, K; Huang, W; Li, J; Li, X; Liu, B; Wang, J; Yang, C; Yin, L; Zeng, L; Zhang, J; Zhang, X | 1 |
| Bu, S; Chen, F; Chen, J; Li, L; Wang, F; Yang, Y; Yao, H | 1 |
| Chan, EWC; Chen, S; Dong, N; Liu, C; Zhang, R | 1 |
| Gu, B; Liu, QH; Liu, W; Lyu, JW; Pan, YC; Shi, XY; Tang, JW; Wang, JJ; Wang, L; Zhang, X | 1 |
| Feng, J; Li, J; Song, Y; Wang, C; Wei, DW; Wong, NK; Zhang, G | 1 |
| Hu, K; Huang, W; Li, J; Wang, J; Yang, C; Yin, L; Zeng, L; Zhang, J; Zhang, X | 1 |
| Fernández Do Porto, D; Nicolás, MF; Palomino, MM; Pardo, AM; Ramos, PIP; Serral, F; Sosa, E; Turjanski, AG | 1 |
| Akova, M; Aslan, AT; Bıçakcıgil, A; Dağ, O; Gürsoy, NC; Güven, GS; Hazırolan, G; Kırbaş, E; Liste, Ü; Otlu, B; Sancak, B; Tanrıverdi, ES; Tozluyurt, A; Yılmaz, YA | 1 |
| Chu, Y; Huang, X; Liu, X; Yue, H; Zhou, G | 1 |
| Cai, W; Chen, J; Ye, J; Ye, Y; Ying, P | 1 |
| Feng, X; Hu, Z; Jiang, J; Liao, C; Lu, X; Shang, M; Xu, X; Yan, J; Ye, M; Zhang, Y; Zhou, P; Zou, D | 1 |
| Bakhtiar, A; Chong, CW; Khalid, KE; Khan, RA; Tan, SY | 1 |
| Du, X; He, J; Hua, X; Moran, RA; van Schaik, W; Yu, Y; Zeng, X; Zhang, J; Zou, Q | 1 |
| Ai, W; Chen, L; Cienfuegos-Gallet, AV; Kreiswirth, BN; Yu, F; Zhou, Y | 1 |
| Bicout, DJ; Changruenngam, S; Modchang, C | 1 |
| Cremanns, M; Gatermann, SG; Lange, F; Pfennigwerth, N | 1 |
| Chan, EW; Chen, K; Chen, S; Dong, N; Xie, M; Xu, Q; Zhang, R | 1 |
| Akgül, M; Aypak, C; Bayram, Y; Güdücüoğlu, H; Karaşin, G; Parlak, M | 1 |
| Ding, H; Liao, G; Zhang, F; Zhong, J | 1 |
| Du, X; Han, X; Hu, H; Jiang, Y; Lan, P; Lou, T; Shi, Q; Wang, Y; Wu, X; Yan, R; Yu, Y; Zhang, P | 1 |
| Akalin, H; Akova, M; Arabacı, Ç; Aslan, AT; Aydın, M; Azap, A; Azap, Ö; Bakır, VO; Balkan, İİ; Can, F; Chatfield, MD; Çınar, G; Demir, SK; Demirkaya, H; Doğan, Ö; Dolapçı, İ; Ergönül, Ö; Falconer, C; Forde, B; Gönen, M; Hazırolan, G; Isler, B; Kapmaz, M; Keske, Ş; Menekşe, Ş; Özer, B; Paterson, DL; Saltoğlu, N; Şimşek, F; Tigen, ET; Tülek, N; Vatansever, C; Yağcı, S | 1 |
| Akcan, RE; Akyol, M; Barçın, E; Can, F; Demirlenk, YM; Ergönül, Ö; Gönen, M; Gücer, LS; Kalay, Z; Tanrıöver, C; Uçku, D | 1 |
| Alekseeva, AE; Brusnigina, NF; Gordinskaya, NA; Kolesnikova, EA; Makhova, MA | 1 |
| Ai, W; Guo, Y; Rao, L; Wang, B; Wang, X; Wu, X; Xu, Y; Yu, F; Zhao, H; Zhou, Y | 1 |
| Abbo, L; Arias, CA; Bonomo, RA; Chambers, H; Chen, L; Cober, E; Dinh, AQ; Earley, M; Fowler, VG; Fries, BC; Gómez-Villegas, SI; Hanson, BM; Hill, C; Komarow, L; Kreiswirth, BN; Luterbach, CL; Miao, H; Panesso, D; Patel, R; Revolinski, S; Rydell, K; Shelburne, SA; Shropshire, WC; van Duin, D | 1 |
| Chen, S; Chen, Z; Guo, J; Li, S; Li, X; Pan, L; Ren, Z; Rui, Z; Tefsen, B; Xu, Q; Yang, G; Zha, L; Zhang, D; Zou, Y | 1 |
| Liu, X; Liu, Y; Ren, G; Wang, T; Xu, S; Zhang, L; Zhou, S | 1 |
| Jiao, X; Li, GL; Mei, CY; Sun, L; Wang, J; Wang, ZY; Xu, G | 1 |
| Ahmad, M; Annavajhala, MK; Gomez-Simmonds, A; Lopatkin, AJ; Park, H; Rozenberg, FD; Tang, N; Uhlemann, AC | 1 |
| Chen, J; Cheng, J; Dai, Y; Kong, Y; Sun, Q; Wang, Y; Yu, K; Zhang, Y | 1 |
| Al-Bayati, M; Samarasinghe, S | 1 |
| Che, H; Deng, J; Feng, Y; Liao, Q; Liu, Y; Wu, S; Xie, Y; Zhang, W | 1 |
| Bai, J; Ding, M; Hu, R; Li, Q; Liang, Q; Liang, S; Zhang, B; Zhang, F; Zhou, Y | 1 |
| Abdulrazzaq, N; Bharathan, G; Ghazawi, A; Makszin, L; Pál, T; Rizvi, TA; Sonnevend, Á; Thomsen, J | 1 |
| Arslan, F; Aydin, Ö; Çağ, Y; Çaşkurlu, H; Ergen, P; Güneysu, B; İnal, FY; Koçoğlu, ME; Kuşkucu, MA; Midilli, K; Nural, M; Öztürk, H; Üçişik, AC; Vahaboglu, H; Yildirim, B | 1 |
| Cao, J; Li, W; Shi, S; Wang, L; Yao, Z; Zhang, X; Zhang, Y; Zheng, X; Zhou, T | 1 |
| Bhowmick, T; Chen, L; Derti, S; Eilertson, B; Gomez-Simmonds, A; Hoffman, KL; Hong, T; Jenkins, SG; Juretschko, S; Kim, AC; Kreiswirth, BN; Levi, MH; Marino, J; Satlin, MJ; Seo, SK; Sperber, SJ; Tang, YW; Uhlemann, AC; Walsh, TJ; Weinstein, MP; Westblade, LF; Weston, G | 1 |
| Cai, L; Chen, Y; Jiang, B; Ouyang, P; Peng, N; Tan, C; Tan, L; Wang, J; Wu, Y; Xie, L; Ye, J; Yuan, H | 1 |
| Jiang, X; Li, M; Zhao, L; Zhu, J | 1 |
| Chen, Q; Feng, Y; Gong, X; Hu, X; Huang, M; Jia, X; Liu, L | 1 |
| Du, FL; Huang, QS; Liao, W; Liu, Y; Wan, LG; Wei, D; Xiang, TX; Xiong, Z; Zhang, S; Zhang, W | 1 |
| Adhikari, P; Paudel, S; Shah, PK; Singh K C, S; Thapa Shrestha, U | 1 |
| Chan, KB; Chan, WE; Chen, K; Chen, S; Cheng, Q; Ni, H; Wang, H; Xie, M | 1 |
| Chen, J; Huang, XB; Lv, Y; Wang, C; Wei, DQ; Wu, JY; Xiang, Q | 1 |
| Bao, D; Draz, MS; He, F; Jia, H; Ruan, Z; Wu, C; Wu, Y | 1 |
| Dai, J; Jiang, M; Wang, M; Wang, Z; Wen, Z; Xia, F; Zhuge, X | 1 |
| Baykara, B; Cimentepe, M; Kandemir, T; Koksal, F | 1 |
| Chen, H; Li, N; Liang, W; Wang, F; Wang, L | 1 |
| Chen, W; Fu, P; Hu, D; Huang, Y; Jiang, X; Li, G; Li, M; Mu, Q; Ren, P; Tian, D; Wang, W; Wang, Y; Yang, Z; Yu, L; Zhang, Q | 1 |
| Chen, S; He, D; Huang, Y; Li, Y; Lin, J; Liu, C; Sun, Q; Yang, X; Zhang, R | 1 |
| Chen, Y; Fu, Y; Han, X; Hu, H; Jiang, Y; Quan, J; Shi, Q; Wang, Q; Wu, X; Yu, Y; Zhou, J | 1 |
| Amaral, AJ; Caneiras, C; Mendes, G; Menezes, J; Moreira da Silva, J; Poirel, L; Pomba, C; Santos Costa, S | 1 |
| Chan, EW; Chen, K; Chen, S; Xie, M; Zhang, R | 1 |
| Kirikae, T; Lu, YJ; Miida, T; Misawa, S; Mya, S; Tabe, Y; Tada, T; Takei, S; Tin, HH; Tohya, M; Watanabe, S | 1 |
| Guo, H; He, F; Wang, M; Xu, J | 1 |
| Chen, G; Chen, W; Huo, W; Li, M; Liu, Z; Wang, Y; Xu, E | 1 |
| Albarracin, L; Andrade, BGN; Cortez Zamar, J; Dentice Maidana, S; Fukuyama, K; Jure, MÁ; Kitazawa, H; Kurata, S; Ortiz Moyano, R; Vargas, JM; Villena, J | 1 |
| Chen, X; Jiang, J; Li, P; Su, J; Sun, Z; Xu, X | 1 |
| Chen, Y; Cui, Y; Deng, J; Guo, P; Huang, B; Kong, Y; Liao, K; Liu, P; Peng, Y; Wu, Z | 1 |
| Chen, W; Hu, D; Jiang, X; Liu, X; Mu, Q; Tian, D; Wang, W; Wu, J; Zhou, Y | 1 |
| Fu, S; Gao, Z; He, Y; Ma, X; Ni, W; Wang, Y; Yu, W; Zhao, L | 1 |
| Aguirre, C; Conza, JAD; Lösch, LS; Lovera, LMR; Merino, LA; Pellegrini, JL; Soto, SM | 1 |
| Ardizzone, A; Banerjee, K; Bhattacharya, S; Boniche-Alfaro, C; Fries, BC; Motley, MP; Shah, R | 1 |
| Guo, G; Li, M; Li, P; Li, Q; Tan, Z; Wang, Z; Zhang, W; Zhou, L | 1 |
| Correa, NP; de Menezes, FG; de Sales, RO; Koga, PCM; Leaden, L; Marins, MM; Martino, MDV; Migliorini, LB; Mingorance, J; Severino, P; Toniolo, ADR | 1 |
| Chukamnerd, A; Chusri, S; Jeenkeawpiam, K; Pomwised, R; Sakunrang, C; Surachat, K | 1 |
| Alyafawi, DA; Elnasser, ZA; Gharaibeh, MH; Lafi, SQ; Obeidat, HM | 1 |
| Chang, H; Lee, CM; Lee, MC; Lu, CH; Sun, FJ; Wu, AY | 1 |
| Abe, S; Amarasiri, M; Aryukarn, A; Badavath, VN; Chantaravisoot, N; Chatsuwan, T; Hao, LY; Higgins, PG; Hongsing, P; Hurst, C; Kicic, A; Kueakulpattana, N; Kupwiwat, R; Laowansiri, M; Leelahavanichkul, A; Liao, T; Luk-In, S; Ngamwongsatit, N; Nilgate, S; Ounjai, P; Phattharapornjaroen, P; Ragupathi, NKD; Rirerm, U; Saethang, T; Shein, AMS; Srisakul, S; Techawiwattanaboon, T; Wannigama, DL; Yonpiam, M | 1 |
| Li, J; Liu, Y; Wang, H; Wu, G; Xu, X | 1 |
| Chen, C; Li, X; Liu, L; Luo, C; Tian, J; Wang, M; Wang, X; Yang, M; Zhang, K | 1 |
| Chen, H; Chen, W; Fang, L; Hu, D; Li, D; Yang, Q; Zhang, J | 1 |
| Barata, RR; Brasiliense, DM; Camargo, DS; Carneiro, ICRS; Costa, CJS; Dutra, LMG; Lobato, A; Martins, WMBS; Souza, CO | 1 |
| Antelo, V; Dávila, C; Galiana, A; Grill, F; Iraola, G; Salazar, C; Vieytes, M | 1 |
| Bai, F; Chen, S; Cheng, Z; Jin, Y; Pan, X; Wei, X; Wu, W; Xu, C | 1 |
| Bercot, B; Birgy, A; Bonacorsi, S; Hobson, CA; Jacquier, H; Jaouen, E; Pierrat, G; Tenaillon, O | 1 |
| Jia, P; Jia, X; Kang, M; Li, R; Li, X; Liu, X; Xu, Y; Yang, Q; Yu, W; Zhu, Y | 1 |
| Jiang, Y; Lan, W; Qi, Y; Wang, Y; Yang, W | 1 |
| Du, Y; Han, R; Liu, S; Mao, J; Niu, M; Yu, Y | 1 |
| He, P; Liu, Y; Lun, H; Ma, R; Pan, F; Pan, Y; Shi, Y; Wang, J; Wu, Y; Yu, F; Yu, J; Zhang, H | 1 |
| Aanensen, DM; Beis, K; Brett, SJ; Clements, A; David, S; Frankel, G; Giani, T; Low, WW; Morecchiato, F; Rossolini, GM; Rouskin, S; Sanchez-Garrido, J; Wong, JLC; Woo, JZ | 1 |
| Al-Abri, S; Al-Ghabshi, L; Al-Jabri, A; Al-Jardani, A; Al-Rashdi, A; Al-Shekaili, N; Balushi, MA; Kumar, R; Rani, R; Ratna, A; Sumri, SA | 1 |
| Chen, T; Chi, X; Ji, J; Meng, X; Xiao, Y; Xiong, L; Zheng, B; Zhou, Y | 1 |
| Chen, J; Chen, Y; Guo, J; Jin, M; Liu, F; Liu, X; Qin, S; Tang, Y; Wang, C; Yang, X; Zhang, N | 1 |
| Findlay, J; Nordmann, P; Poirel, L; Rens, C | 1 |
| Abdel-Halim, MS; Askoura, M; El-Ganiny, AM; Mansour, B; Yahya, G | 1 |
| Arias, CA; Bonomo, RA; Chen, L; Desai, S; Eilertson, B; Farrell, JJ; Fowler, VG; Gallagher, JC; Hanson, B; Hill, C; Kalayjian, RC; Kaye, KS; Komarow, L; Kreiswirth, BN; Lautenbach, E; Luterbach, CL; McCarty, T; Novick, E; Ostrowsky, B; Pagkalinawan, S; van Duin, D; Wortmann, G | 1 |
| Chen, J; Chen, Y; Guo, J; Jia, R; Jin, M; Jin, Y; Liu, F; Liu, J; Liu, X; Qi, L; Qin, S; Tang, Y; Wang, C; Wang, Y; Yang, X; Zhang, N; Zhang, X | 1 |
| Giske, CG; Hoang, NTB; K K, S; Larsson, M; Nengmongvang, K; Nguyen, HH; Olson, L; Sewunet, T; Sithivong, N; Sychareun, V; Westerlund, F | 1 |
| Dang, Z; Huang, J; Liao, J; Luo, S; Xia, P; Xia, Y; Yang, B; Yi, M; Yuan, Y | 2 |
| Liu, C; Lu, M; Shen, N; Yang, P; Yi, J; Zheng, J | 1 |
| Chang, SK; Cheng, WH; Lai, KS; Lim, SE; Yap, PS | 1 |
| Bao, Y; Guan, X; He, Y; Jin, L; Wan, H; Yu, D; Zhou, H | 1 |
| Bai, Y; Fan, X; Fu, L; Tian, C; Wang, S; Xing, M; Zhao, Y | 1 |
| Cai, H; Fang, L; Hua, X; Lei, T; Li, Y; Yang, Q; Yu, Y; Zheng, M | 1 |
| Beigverdi, R; Emaneini, M; Ghamari, M; Jabalameli, F | 1 |
| Chen, D; Chen, M; Dai, F; Dang, Y; Ding, X; Li, G; Li, W; Liu, N; Liu, X; Lou, J; Yang, G; Yu, Y | 1 |
| He, Z; Li, Y; Sun, B; Zhao, H | 1 |
| Arı, O; Durmaz, R; Sancak, B | 1 |
| Cao, H; Ge, Y; Li, L; Li, M; Lin, Y; Qiu, X; Tan, Y; Wu, Q; Xu, M; Xu, X; Zhang, Z; Zhao, S | 1 |
| Dai, P; Hu, D | 1 |
| Kumkar, SN; Mulani, MS; Pardesi, KR | 1 |
| Aysert-Yildiz, P; Dizbay, M; Habibi, H; Özgen-Top, Ö | 1 |
| Aiezza, N; Andriani, L; Coppi, M; Di Pilato, V; Giani, T; Luzzaro, F; Principe, L; Ricci, S; Rossolini, GM | 1 |
| Chen, Q; Chen, Z; Fan, J; He, J; Hu, H; Hua, X; Jiang, Y; Lan, P; Leptihn, S; Loh, B; Shi, Q; Xu, Q; Yu, Y; Zhang, J; Zhang, W; Zou, Q | 1 |
| Chen, L; Cheng, S; Chu, TY; Clancy, CJ; Driscoll, E; Fleres, G; Hao, B; Kreiswirth, BN; Liu, G; Newbrough, A; Nguyen, MH; Shields, RK; Squires, KM | 1 |
| Feng, Y; Hu, Y; Li, J; McNally, A; Moran, RA; Wei, L; Wen, H; Yang, Y; Zhang, H; Zhang, Z; Zong, Z | 1 |
| Ablordey, A; Akeda, Y; Hayashi, T; Hoshino, Y; Ishino, T; Mahazu, S; Nukui, Y; Ota, Y; Prah, I; Saito, R; Suzuki, M; Suzuki, T | 1 |
| Chen, J; Chen, Q; Gu, B; Li, J; Li, P; Lin, Y; Liu, X; Lyu, J; Song, H; Tian, B; Wang, K | 1 |
| Ghorbanian, F; Jung, IY; Kim, S; Lee, S; Lee, Y; Rahim, MA; Seo, H; Song, HY; Tajdozian, H | 1 |
| Cui, W; Guo, Z; Han, L; Jiang, Y; Lu, J; Meng, H; Zhang, A | 1 |
| A Katouah, H; Acker, M; Al Hadi, R; Ali, M; Alserihi, R; Alyami, J; Alzahrani, E; Amirazodi, M; Amrillah, T; Andreassen, OA; Ardiccioni, C; Ask, H; Atzori, C; Ayorech, Z; Azambuja, JH; Azmi, R; Badem, S; Balci, AB; Bali, H; Baranova, NS; Barantsevich, ER; Barocci, S; Bauer, RJ; Bauermeister, JA; Bazhenova, TA; Biagetti, G; Bigdeli, F; Bonar, EE; Bouloumis, T; Bu, Y; Cai, Z; Cakiroglu, B; Canetto, SS; Cao, J; Caucci, S; Cerbo, I; Chen, C; Chen, J; Chen, Q; Chen, Y; Cheng, B; Cheng, X; Chinappi, M; Choya, A; Cicconardi, F; Cipolletta, S; Colasurdo, G; Costabile, BK; Coughlin, LN; Crippa, P; D'Agostino, M; D'Annessa, I; Daryanoosh, F; Das, R; Davey Smith, G; Davidson, BR; Davies, NM; Davis, TME; Davis, WA; de Rivas, B; Demir, D; Deng, Z; Dhanya, TM; Di Marino, D; Divya, KM; Dong, N; Drinkwater, JJ; Ekholuenetale, M; El-Bindary, AA; El-Bindary, MA; El-Desouky, MG; Elsayed, H; Ema, K; Endraswari, PD; Entilli, L; Ettl, T; Eyado, A; Fan, X; Fang, W; Farina, M; Florimbio, AR; Fowobaje, KR; Gaeini, A; Gao, XM; Gao, Y; Ghaemi, R; Ghelardi, E; Gilmutdinov, IF; Gochicoa-Rangel, L; Goncu, MT; Gözüküçük, R; Grammatikopoulos, P; Gu, Y; Guan, ZJ; Gucu, A; Guldberg, R; Gungor, O; Guo, W; Gutiérrez-Ortiz, JI; Guzmán-Boulloud, N; Guzmán-Valderrábano, C; Głuszko, A; Hama, A; Hamada, M; Han, J; Hashimoto, T; Havdahl, A; Hayashita, T; He, X; Helgeland, Ø; Hinck, AP; Hinck, CS; Holtzapple, M; Hou, Y; Howe, LD; Hu, B; Hu, H; Huang, L; Huang, Z; Hughes, AM; Hussain, G; Ibidoja, OJ; Ichikawa, D; Imber, C; Islam, MR; Iype, S; Jaber, J; Jacobs, R; Jafry, AT; Ji, L; Ji, X; Jiang, L; Jiang, Y; Jie, HFM; Jie, HM; Johansen, MP; Johansson, S; Juan, LX; Juan, W; Kahraman, N; Kallinger, I; Kang, H; Karakulova, YV; Kärmer, T; Kataoka, S; Kato, K; Kawashima, N; Kazim, AH; Khalil, MR; Kitazawa, H; Klimesova, YM; Kojima, S; Kose, M; Kostakis, ID; Koushkie Jahromi, M; Krishna, GA; Krizova, D; La Teana, A; Lan, K; Li, J; Li, JZ; Li, M; Li, R; Li, S; Li, Y; Li, Z; Liu, H; Liu, J; Liu, KG; Liu, L; Liu, Q; Liu, T; Liu, X; Lomachenko, KA; López-Fonseca, R; Ludwig, N; Luo, A; Luo, L; Luo, Y; Lupetti, A; M El-Metwaly, N; Ma, K; Maemura, R; Magnus, P; Manakin, YV; Mancia, F; Mashood, LO; Matsumoto, K; Mehrabi, A; Meier, JK; Mekonnen, Y; Mencarelli, D; Menzo, S; Mikagi, A; Mironov, VS; Misawa-Suzuki, T; Miwata, S; Mizuta, Y; Mohanan, PV; Mondal, J; Morici, P; Morita, K; Morozzo Della Rocca, B; Morris, T; Morsali, A; Morzhukhina, MV; Motta, S; Muramatsu, H; Naidu, R; Narita, A; Narita, K; Nasralla, D; Nemcokova, M; Netukova, M; Nishikawa, E; Nishio, N; Niu, X; Niu, Y; Njølstad, P; Notarstefano, V; Nugroho, MA; Nørgård, BM; Okuno, Y; Olokede, O; Ong, SP; Osailan, A; Ouyang, Z; Ozyazicioglu, AF; Pan, F; Parui, A; Paul, R; Pavoni, E; Payne, TE; Peng, X; Pérez-Padilla, R; Perta, N; Peter, SC; Pierantoni, L; Pietrowska, M; Pissanou, T; Pollok, JM; Prasetio, A; Putra, FS; Qiang, C; Qiao, L; Qutob, HMH; Raptis, DA; Razzo, BM; Reichborn-Kjennerud, T; Reichert, TE; Remigio-Luna, A; Rexha, J; Rivani, E; Rizzato, C; Romagnoli, A; Rossolini, GM; Sa, LY; Saad, RA; Sakaguchi, H; Salesi, M; Salsabilla, Z; Sanderson, E; Sanderson, P; Savitha, DP; Schulz, D; Seker, IB; Selvaganapathy, PR; Sha, D; Shah, SF; Shaikhomar, OA; Sharma, D; Shi, C; Shi, P; Shrotri, A; Sidiq, DH; Simonov, SV; Singh, AK; Song, C; Song, T; Spanier, G; Spoerl, S; Staropoli, A; Statsenko, ME; Steinhauer, S; Stosic, A; Studeny, P; Sugaya, T; Sun, S; Sun, X; Sunbul, SA; Supandi, AR; Suzuki, K; Suzuki, Y; Szczepański, MJ; Takahashi, Y; Taniguchi, R; Tao, Y; Tesli, M; Thirión-Romero, I; Tong, D; Trucchi, E; Tsuchido, Y; Turchetti, C; Turkina, SV; Turner, AW; Uldbjerg, N; Vinale, F; Wakamatsu, M; Walton, MA; Wang, C; Wang, Q; Wang, W; Wang, Y; Wang, Z; Wehberg, S; Wei, ZL; Wen, B; Whiteside, TL; Whittingham, MS; Widodo, ADW; Widłak, P; Wright, AI; Wu, H; Wu, Y; Wu, YL; Xiang, LG; Xiao, G; Xie, B; Xie, L; Xin, H; Xiong, J; Xiong, X; Xu, C; Xu, S; Yagubskii, EB; Yakushev, IA; Yang, H; Yang, J; Yao, J; Yao, ZX; Ye, J; Yerneni, SS; Yirgu, A; Yoshida, N; Yoshida, T; Young, SD; Yu, DN; Yuksel, A; Zac, J; Zac, S; Zarifkar, AH; Zhai, Y; Zhang, F; Zhang, H; Zhang, JW; Zhang, L; Zhang, Q; Zhang, X; Zhang, Y; Zhao, D; Zhao, J; Zhao, M; Zheng, D; Zheng, J; Zhou, G; Zhou, H; Zhu, P; Zhu, T; Zhu, Y; Zimmerman, MA; Zou, X | 1 |
| Barchiesi, F; Brenciani, A; Carelli, M; Giovanetti, E; Leoni, F; Lleò, MM; Malerba, G; Morroni, G; Rocchegiani, E; Simoni, S; Veschetti, L; Vignaroli, C | 1 |
| Crudele, V; De Filippis, A; Della Rocca, MT; Finamore, E; Foglia, F; Franci, G; Galdiero, M; Greco, G | 1 |
| Hu, L; Hu, P; Weng, Y | 1 |
| Fu, AS; Ge, YL; Jiang, J; Ren, HQ; Yang, W; Zhao, Q | 1 |
| Chen, LJ; Jing, XP; Liu, R; Meng, DL; Min, XC; Sun, RL; Wu, TT; Zeng, J; Zhou, H | 1 |
| Bai, J; Duan, J; Guo, Q; Kang, J; Liu, Y; Song, Y; Wang, J; Wang, S; Yin, D | 1 |
| Chen, T; Chi, X; Shen, P; Wang, Y; Xiao, Y; Zheng, B; Zhou, W; Zhou, Y | 1 |
| Cheng, M; Ding, X; Feng, M; Liang, H; Qi, X; Sun, G; Sun, T | 1 |
| Gharanizadeh, D; Hossainpanahi, A; Mohajer, HB; Ramazanzadeh, R; Salimizand, H | 1 |
| Cui, J; Liao, W; Peng, X; Yan, F; Zhang, Z; Zhao, T; Zuo, W | 1 |
| Campino, S; Clark, TG; Perdigão, J; Spadar, A | 1 |
| Vithiya, G | 1 |
| Beamud, B; Coque, TM; Domínguez, MV; Fuster, B; García-González, N; Gimeno, C; Giner, S; González-Candelas, F; Sánchez, A; Sevilla, J | 1 |
| Cao, B; Li, Z; Lu, B; Pu, D; Wu, Y; Zhang, Y; Zhao, J; Zhuo, X | 1 |
| Fang, SB; Fujisawa, M; Kado, M; Maeda, K; Onishi, R; Osawa, K; Shigemura, K; Tanimoto, H; Yang, YM | 1 |
| Eidi, M; Hejazi, SH; Mohammadi, M; Motallebi, M; Saffari, M; Shayestehpour, M; Siadat, SD | 1 |
| Chu, W; Huang, L; Jia, J; Sheng, Y; Xu, A; Xu, H; Zhang, L | 1 |
| Deng, Y; Huang, W; Li, J; Qiao, F; Zhang, W; Zhu, S; Zong, Z | 1 |
| Bouvier, M; Findlay, J; Gaia, V; Nordmann, P; Poirel, L | 1 |
| Bukhari, H; Choudhry, N; Jahan, S; Jamal Gondal, A; Jawad Ahmad, F; Saleem, S; Yasmin, N | 1 |
| Hu, F; Li, S; Qin, X; Wang, C; Wang, J; Wang, M; Zhang, Y; Zhao, X | 1 |
| Bai, T; He, Q; Hui, J; Li, X; Liang, L; Lu, J; Tian, N; Yang, R; Zhu, L | 1 |
| Adnan, NA; Alagely, HS; Baqer, AA; Musa, M; Nor, NSM | 1 |
| Ain Zahra, NU; Jamil, F; Uddin, R | 1 |
| Bonnin, RA; Campino, S; Clark, TG; da Silva, GJ; Dortet, L; Duarte, A; Elias, R; Hendrickx, APA; Perdigão, J; Phelan, JE; Pinto, M; Portugal, I; Spadar, A | 1 |
| Arend, LNVS; Bail, L; Balsanelli, E; Baura, VA; Bergamo, R; Ito, C; Pilonetto, M; Pothier, JF; Rezzonico, F; Rocha, FB; Smits, THM; Tuon, FF | 1 |
| Shamsuzzaman, SM; Sonia, SJ; Uddin, KH | 1 |
| Gao, Z; He, Y; Ma, X; Ni, W; Xi, W; Yang, D; Yu, W; Zhao, L | 1 |
| Chen, WC; Cho, CF; Cho, DY; Ho, LC; Ho, MW; Hsieh, YW; Hsu, KC; Hsueh, PR; Huang, JY; Liang, SJ; Lin, HH; Lin, YT; Tien, N; Tseng, KH; Yu, J | 1 |
| Karampatakis, T; Lowrie, K; Tsergouli, K | 1 |
| Chen, X; Jian, Z; Liang, X; Liu, P; Liu, W; Tang, B; Wang, Z; Yan, Q; Yang, A | 1 |
| Cevahir, N; Yürek, M | 1 |
| Albano, RM; Catanho, M; da Silva, PP; de Lima, EM; de Miranda, AB; de Souza, CMR; Eller, CM; Gomes, MZR; Machado, E; Martins Aires, CA; Oliveira, TRTE; Pereira, PS; Rodrigues, CAS; Rybak, MJ; Silva, FH; Yim, J | 1 |
| Chang, CY; Keller, JJ; Lin, HC; Lin, KT; Tsao, MF; Zhang, YM | 1 |
| Huang, J; Li, B; Xie, Z; Xu, B; Zhang, Q; Zhang, S | 1 |
| Gao, W; Guo, Y; Li, Y; Liu, F; Song, N; Wang, X; Xu, B; Zhang, Y | 1 |
| Ding, L; Guo, Y; Han, R; Hu, F; Jiang, B; Shen, S; Wang, C; Wu, S; Yin, D; Zhang, H | 1 |
| Chen, Y; Gong, YL; Lei, J; Li, QM; Liang, Z; Luo, XQ; Peng, Y; Peng, YZ; Shi, YL; Song, BQ; Xu, C; Yuan, ZQ; Zhang, C; Zhao, CL | 1 |
| Chen, Y; Holt, KE; Lam, MMC; Lin, H; Liu, J; Shen, P; Wei, S; Wyres, KL; Xiao, Y; Xu, T; Xue, CX; Zhou, K | 1 |
| Adaleti, R; Aksaray, S; Arıcı, N; Çalık, Ş; Kansak, N; Nakipoğlu, Y; Şenbayrak, S | 1 |
| Gopakumar, KG; Jithin, TK; Nair, C; Nirmal, G; Parthiban, R | 1 |
| Chen, X; Ren, Y; Xu, J; Zhao, L; Zhu, Q | 1 |
| Ciszek, M; Hryniewiecka, E; Jasińska, K; Pączek, L; Wilkowski, P | 1 |
| Aguilera, F; Araya-Vega, P; Bello-Toledo, H; González-Rocha, G; Ibarra, C; Matus-Köhler, M; Morales-León, F; Opazo-Capurro, A; Torres, I; Venegas, S; Vera, R | 1 |
| Guan, J; Guo, H; Guo, X; Ji, X; Jiang, B; Jing, J; Liu, J; Liu, M; Lu, G; Sun, S; Sun, Y; Wang, Y; Wang, Z; Zhang, W; Zheng, L; Zhu, L | 1 |
| Elken, EM; Haqmal, MA; Kong, LC; Li, SS; Li, XS; Ma, HX; Qi, Y; Xu, GY; Xue, JZ | 1 |
| Cheng, J; Jin, J; Li, G; Li, L; Shao, H; Song, Y; Sun, Y; Wang, L; Wang, S; Zhang, Y | 1 |
| Fuster, B; Garcia-Gonzalez, N; Gimeno, C; Gonzalez-Candelas, F; Salvador, C; Tormo, N | 2 |
| Han, X; Hu, H; Jiang, Y; Quan, J; Shi, Q; Wang, Q; Yu, Y; Zhang, H; Zhang, P; Zhao, D | 1 |
| Almeida, ACS; Calsa Júnior, T; Morais, MMC; Pena, EPN; Ribeiro, ACOA; Silva, FAC; Souza, PMS | 1 |
| Fang, Q; Feng, Y; Hu, Y; McNally, A; Wang, C; Yang, Y; Zhao, F; Zong, Z | 1 |
| Bai, Y; Fan, X; Fu, L; Huang, D; Ren, L; Shi, Y; Tian, C; Wang, S; Xia, D; Zhao, Y | 1 |
| Li, J; Li, W; Liu, X; Shi, L; Xia, H; Yang, L; Yang, S; Yang, X; Zeng, Y; Zhao, M | 1 |
| Abebe, T; Belachew, EB; Beshah, D; Derese, SG; Desalegn, Z; Desta, AF; Gebreselasie, S; Tessema, TS; Woldemichael, GB; Zelelie, TZ | 1 |
| da Silva, KE; de Almeida de Souza, GH; de Oliveira, GG; Dos Santos Radai, JA; Fraga, TL; Simionatto, S; Vaz, MSM; Wender, H | 1 |
| Chen, T; Chi, X; Fu, H; Lu, P; Luo, Q; Shen, P; Wang, Y; Xiao, T; Xiao, Y; Xiong, L; Zheng, B; Zhou, Y | 1 |
| Arcari, G; Bruno, F; Capitani, V; Carattoli, A; Garcia-Fernandez, A; Gentile, G; Polani, R; Raponi, G; Sacco, F; Santilli, S; Villa, L | 1 |
| Chen, L; Du, H; Huang, B; Jia, W; Qu, F; Shan, B; Tang, Y; Wang, T; Weng, Y; Yu, H | 1 |
| Lin, H; Liu, J; Song, Y; Wei, S; Wen, W; Wu, B; Wu, W; Xue, CX; Yan, X; Yang, L; Zhang, W; Zhou, K | 1 |
| Gao, K; Hao, H; Li, W; Lin, H; Lu, Y; Tong, Z; Wang, P | 1 |
| Anacker, M; Bulens, SN; Chan, A; Crawford, R; Duffy, N; Gontjes, KJ; Hayden, MK; Hoffman, S; Kainer, M; Lapp, Z; Lynfield, R; Maloney, M; Meek, J; Moore, C; Nguyen, TN; Noel, D; O'Malley, SM; Octaria, R; Pattee, B; Pearson, C; Pirani, A; See, I; Slayton, RB; Snippes Vagnone, P; Snitkin, E; Thomas, LS; Wolford, H | 1 |
| Borghi, M; Pereira, MF; Schuenck, RP | 1 |
| Okalın, ŞŞ; Öktem, MA; Sarı Kaygısız, AN | 1 |
| Lu, J; Meng, H; Niu, M; Yang, J; Zhou, Y; Zhu, H | 1 |
| Lukovic, B; Petrovic, I; Zornic, S | 1 |
| Ageevets, VA; Alieva, KN; Avdeeva, AA; Dovzhenko, SA; Golikova, MV; Kobrin, MB; Sidorenko, SV; Strukova, EN; Sulian, OS; Zinner, SH | 1 |
| Chen, S; Liu, L; Xu, Y; Ye, L; Zheng, Z | 1 |
| Gačanović, D; Granov, Ð; Halković, J; Husić, E; Kotorić Keser, Š; Lab Ing, AČ; Ljubović, AD; Loga Zec, S | 1 |
| Aldieri, C; Badalucco Ciotta, F; Bassetti, M; Calabresi, A; Cattardico, G; Cattelan, AM; Corcione, S; Cortegiani, A; D'Amico, F; De Rosa, FG; Del Bono, V; Del Puente, F; Di Meco, G; Di Pilato, V; Fanelli, C; Francisci, D; Giacobbe, DR; Giacomini, M; Gori, A; Graziani, L; Lombardi, A; Losito, AR; Marchese, A; Marelli, C; Mazzitelli, M; Merli, M; Mikulska, M; Milazzo, M; Momesso, E; Mularoni, A; Oltolini, C; Pallotto, C; Pontali, E; Raffaelli, F; Russelli, G; Serino, FS; Signori, A; Spinicci, M; Torti, C; Trecarichi, EM; Vena, A | 1 |
| Dai, P; Dong, F; Feng, J; Hu, D; Jing, Y; Luo, X; Xu, M; Yu, L; Zhang, J | 1 |
| Awasthi, A; Dwivedi, A; Kumar, A; Kumar, CB; Rathore, G; Sahu, V; Soni, M | 1 |
| Marimuthu Ragavan, R; Narasingam, A; Raja, S; Sarva, K; Tadi, LJ | 1 |
| Dong, S; Fan, F; Tian, X; Wang, X; Zhang, Y | 1 |
| Akalın, H; Girgin, NK; İşçimen, R; Kahveci, FŞ; Kaya, PK; Önal, U; Özakın, C; Tüzemen, NÜ | 1 |
| Aydemir, Ö; Ayhancı, T; Köroğlu, M; Ormanoğlu, G; Zengin, M | 1 |
| Bao, Y; Chen, J; Guan, X; Jin, L; Wan, H; Yang, J; Yu, D; Zhou, H | 1 |
| Chen, L; Chen, S; Du, H; Qu, F; Wang, T; Wang, X; Zhu, J; Zhu, Z | 1 |
| Ashcraft, D; Feehan, A; Fogel, GB; Garcia-Diaz, J; Huston, C; LaFleur, T; Lain, BN; Lamers, SL; Miele, L; Nolan, DJ; Pankey, G; Rose, R; Rosenthal, S; Velez-Climent, L | 1 |
| Draz, MS; He, F; He, X; Jia, H; Jiang, T; Kong, Y; Mao, W; Ruan, Z; Shao, J; Sun, L; Sun, Q; Wu, C; Wu, J; Wu, Y; Xie, X; Zhang, J | 1 |
| Copur Cicek, A; Ejder, N; Ibik, YE; Rakici, E; Sevim, E; Tanriverdi, ES | 1 |
| He, Y; Li, L; Li, Q; Li, S; Li, T; Wei, X | 1 |
| Kelsom, C; Lou, M; Nieberg, P; Sophonsri, A; Wong-Beringer, A | 1 |
| Chen, F; Chen, X; Wang, Y; Wei, B; Xu, B; Yang, M; Yao, L | 1 |
| Akrami, S; Al-Dahmoshi, HOM; Al-Khafaji, NSK; Bannazadeh Baghi, H; Jafari-Sales, A; Judi, HK; Nasiri, R; Sadeghi Deylamdeh, Z; Saki, M; Shariat, A | 1 |
| Abujamel, TS; Al-Zahrani, IA; Alattas, EM; Alghamdi, AK; Brek, T; Hazazi, MS; Yasir, M | 1 |
| Ak, K; Arabacı, Ç; Arı, O; Büyüktuna, SA; Çetin, ES; Çetinkaya, RA; Dal, T; Durmaz, R; Hasbek, M; Kaynar, T; Köse, Ş; Külahlıoğlu, N; Müderris, T; Şahin, M; Sarı, T; Temel, EN; Yalçın, AN; Yenilmez, E; Yıldırım, BT | 1 |
| Aghamohammad, S; Badmasti, F; Khazani Asforooshani, M; Malek Mohammadi, Y; Sholeh, M | 1 |
| Cai, D; Li, R; Mai, D; Tan, J; Tong, H; Wang, N; Wu, A | 1 |
| Cai, Y; Jiang, Z; Lei, S; Wu, L; Xu, Y; Ying, J; Zhang, L; Zhou, C | 1 |
| Alsharapy, SA; Bertrand, X; Brasme, L; Cholley, P; De Champs, C; Gharout-Sait, A; Guillard, T; Moghram, GS; Muggeo, A; Touati, A | 1 |
| Çağ, Y; Can, F; Ergonul, O; Hacıseyitoğlu, D; Işık, ME; Menekşe, Ş; Şahin, S | 1 |
| Chen, X; Qian, Y; Xia, Q; Zhang, H; Zhang, J | 1 |
| Bilker, W; Bushman, F; Garrigan, C; Goldstein, EJC; Han, JH; Hofstaedter, CE; Jain, T; Kim, D; Lapp, Z; Lautenbach, E; Mattei, L; Nachamkin, I; Slayton, RB; Snitkin, ES; Tolomeo, P; Wise, J; Wolford, HM | 1 |
| Al-Agamy, MH; El-Mahdy, TS; Poirel, L; Radwan, HH | 1 |
| Beis, K; Brett, SJ; Clements, A; Frankel, G; Kerry, LE; Kwong, HS; Low, WW; Romano, M; Wong, JLC | 1 |
| Al Dahouk, S; Kipp, F; Makarewicz, O; Pletz, MW; Stein, C; Vincze, S | 1 |
| Bonelli, RR; de Sousa, VS; Justo-da-Silva, LH; Kraychete, GB; Longo, LGA; Martins, IS; Moreira, BM; Rocha, JA; Superti, SV | 1 |
| Chen, Y; Li, J; Li, Y; Song, N | 1 |
| Ahmad Kamar, A; Chong, CW; Ngoi, ST; Teh, CSJ; Yap, PSX | 1 |
| Chen, S; Wai-Chi Chan, E; Yang, X; Zhang, R | 1 |
| Li, X; Li, Y; Liu, M; Qian, W; Sun, Z; Wang, T; Wang, W; Yang, M; Zhang, J | 1 |
| Anselmo, A; Aquilina, M; Ciammaruconi, A; Fasciana, T; Fillo, S; Fortunato, A; Gentile, B; Giammanco, A; Lista, F; Mascarella, C; Petralito, G | 1 |
| Gao, H; Jin, L; Ouyang, P; Wang, H; Wang, J; Wang, Q; Wang, R; Wang, X; Zhang, Y | 1 |
| Ding, Y; Heath, PT; Hsia, Y; Sharland, M; Wang, Y | 1 |
| Agyeman, AA; Bergen, PJ; Landersdorfer, CB; Nation, RL; Rao, GG | 1 |
| Dadashi, AR; Karami-Zarandi, M; Kazemian, H; Keikha, M; Malekabad, ES; Rahdar, HA; Takei, E | 1 |
| Borjan, J; Meyer, KA; Shields, RK; Wenzler, E | 1 |
| Nishida, S; Ono, Y | 1 |
| Cao, X; Chang, H; Chen, S; Chen, Y; Huang, R; Wei, J; Wu, C; Yan, X; Yao, K; Zhou, W; Zuo, L | 1 |
| Aliyev, B; Kalemci, S; Kizilay, F; Köse, T; Pullukçu, H; Şimşir, A; Taşbakan, M | 1 |
| Gao, GF; Hu, Y; Liu, F; Wang, Y; Zhang, G; Zhu, B | 1 |
| Ainsworth, J; Crook, DW; Eyre, DW; German-Mesner, I; Mathers, AJ; Pannone, A; Peto, T; Sheppard, A; Sifri, CD; Stoesser, N; Vegesana, K; Walker, AS | 1 |
| Guo, Y; Lu, N; Lv, Q; Qiu, J; Sun, X; Wang, J; Zhang, P; Zhou, Y | 1 |
| Chen, Y; Cheng, X; He, W; Jiang, X; Li, Y; Liu, D; Ryffel, B; Shi, T; Zheng, SG; Zheng, Y | 1 |
| Bhandari, S; Hishinuma, T; Kirikae, T; Morioka, S; Shahi, RK; Sherchan, JB; Sherchand, JB; Shrestha, S; Tada, T; Twi, RT; Uchida, H | 1 |
| Yuan, Z; Zhou, HY; Zhu, WM | 1 |
| Jiang, Y; Mao, Y; Shi, Q; Yu, Y; Zhang, P | 1 |
| Chang, FC; Huang, TS; Lee, CC; Lee, SS | 1 |
| Dou, Q; Hu, Y; Huang, Z; Li, J; Liu, J; Tao, X; Wang, H; Zou, M | 1 |
| Alessia, L; Andreoni, M; Angeletti, S; Cella, E; Ciccozzi, M; Favaro, M; Florio, L; Fontana, C; Gherardi, G; Leoni, D; Mirandola, W; Rose, DD; Salemi, M; Sarmati, L; Zehender, G | 1 |
| Chen, PL; Ko, WC; Lee, NY; Li, CW; Li, MC; Syue, LS; Tsai, CS | 1 |
| Bernabeu, S; Bonnin, RA; Dortet, L; Jaureguy, F; Naas, T | 1 |
| Pan, F; Shi, Y; Sun, Y; Wang, B; Wang, C; Zhang, H; Zhang, T; Zhao, W | 1 |
| Baggiani, A; Bellandi, T; Falcone, M; Forni, S; Gemignani, G; Gemmi, F; Iannazzo, S; Lopalco, P; Luchini, G; Mechi, MT; Menichetti, F; Pantosti, A; Petrillo, M; Pezzotti, P; Pieralli, F; Porretta, A; Privitera, G; Righi, L; Rossolini, GM; Roti, L; Sani, S; Tacconi, D; Tavoschi, L; Toccafondi, G; Turini, L; Vivani, P | 1 |
| Cicioglu Arıdogan, B; Ciftci, E; Haydar Kutlu, H; Sesli Cetin, E; Us, E | 1 |
| Chen, C; Idris, A; Ma, C; Qu, X; Tao, Z; Wang, H; Yin, A; Yin, C | 1 |
| Baron Sophie, A; Bournia, M; Charalampaki, N; Chatzipanagiotou, S; Christofidou, M; Fountoulis, K; Hadjadj, L; Hamel, M; Ioannidis, A; Kraniotaki, H; Legakis, N; Papagianni, S; Papaioannou, V; Papamichalopoulos, N; Perivolioti, E; Petinaki, E; Rolain, JM; Skalidis, T; Skarmoutsou, N; Spiliopoulou, I; Tsiplakou, S | 1 |
| Azzam, A; Bariz, K; De Mendonça, R; Denis, O; Houali, K; Nonhoff, C | 1 |
| Bao, M; Fu, Y; Li, C; Su, S; Wang, Y; Yu, L; Zhang, J; Zhang, X; Zhao, Y | 2 |
| Ding, B; Hao, M; Hu, F; Qin, X; Wang, M; Wu, S; Xu, X; Yang, F; Yang, Y; Zhu, J | 1 |
| Shen, P; Wang, Y; Xiao, T; Xiao, Y; Yu, X; Zhang, S; Zhou, Y; Zhu, Y | 1 |
| Dedeić-Ljubović, A; Granov, D; Salimović-Bešić, I | 1 |
| Iwanaga, N; Kolls, JK; McCombs, J; Sandquist, I; Song, K; Wanek, A | 1 |
| Cai, L; Liu, Y; Zhang, X; Zong, Z | 1 |
| Bai, H; Li, X; Qian, Y; Wang, Z; Yang, J | 1 |
| Arab, M; Bameri, Z; Darabi, N; Ebrahimi, A; Ghorbani, R; Hojabri, Z; Pajand, O | 1 |
| Ábrahám, H; Horváth, M; Koderivalappil, S; Kovács, T; Rákhely, G; Schneider, G | 1 |
| Fu, Y; Guo, Y; Li, C; Wang, Y; Zeng, L; Zhang, J; Zhang, X; Zhao, J; Zhao, Y | 1 |
| Benulič, K; Cerar, T; Chlebowicz, M; Couto, N; Lejko Zupanc, T; Pirš, M; Poljak, M; Rossen, JWA; Ružić-Sabljić, E; Seme, K; Zorec, TM | 1 |
| Chen, CM; Guo, MK; Ke, SC; Lin, YP; Nguyen, HV; Pang, YC; Wu, LT | 1 |
| Benson, M; Braxton, JR; Clatworthy, AE; Cosimi, LA; Cummins, K; Earl, AM; Ernst, CM; Hung, DT; Li, L; Manson, AL; Nair, AV; Pironti, A; Rodriguez-Osorio, CA; Zagieboylo, AP | 1 |
| Cappugi, C; Faraone, A; Fortini, A; Giani, T; Poggi, A; Riccobono, E; Tofani, L | 1 |
| Azevedo, A; Correia, S; Figueiredo Dias, P; Lima Alves, C; Neves, J; Paiva, JA; Rocha-Pereira, N; Shahriari, S; Teixeira, J | 1 |
| Aditianingsih, D; Goessens, WHF; Karuniawati, A; Klaassen, CHW; Saharman, YR; Sedono, R; Severin, JA; Verbrugh, HA | 1 |
| Butera, O; Capone, A; Di Caro, A; Mariani, B; Messina, F; Nisii, C; Parisi, G; Proia, A; Rigacci, L; Venditti, C | 1 |
| Chan, EW; Chen, S; Dong, N; Yang, X; Zhang, R | 1 |
| Albiger, B; Alm, E; Brennan, W; Cerar, T; Cormican, M; Del Grosso, M; Denis, O; Dortet, L; Edquist, P; Gatermann, S; Haller, S; Hammerum, AM; Hasman, H; Hopkins, KL; Huang, TD; Jalava, J; Johansson, K; Jousset, AB; Kohlenberg, A; Kumar, N; Lötsch, F; Ludden, C; Monaco, M; Monnet, DL; Oteo-Iglesias, J; Palm, D; Pérez-Vázquez, M; Pirš, M; Räisänen, K; Samuelsen, Ø; Schouls, L; Sjöström, K; Struelens, MJ | 1 |
| Das, A; Dey, S; Gaur, M; Jain, B; Pati, S; Sahoo, RK; Subudhi, E | 1 |
| Almaeen, AH; Bandy, A | 1 |
| Cen, H; Zhang, L | 1 |
| Beyrouthy, R; Birer, A; Bonnet, R; Dalmasso, G; Robin, F | 1 |
| Carone, G; Dalfino, L; De Robertis, A; Del Prete, R; Mosca, A; Romanelli, F; Stufano, M | 1 |
| Abd-Alhalim, S; Al-Hassan, L; Albasha, AM; Alshaib, EF; Altayb, HN; Osman, EH | 1 |
| Cao, T; Li, Y; Liu, Y; Shao, B; Shen, J; Shen, Z; Walsh, TR; Wang, S; Wang, Y | 1 |
| Daikos, GL; Hadjihannas, L; Karapanou, A; Miriagou, V; Psichogiou, M; Spyridopoulou, K; Sypsa, V; Tzouvelekis, L | 1 |
| Álvarez-Fraga, L; Beceiro, A; Bou, G; Gato, E; Martínez-Guitián, M; Oteo Iglesias, J; Pérez, A; Pérez-Vázquez, M; Poza, M; Ramos Vivas, J; Rodiño-Janeiro, BK; Romero, A; Rumbo-Feal, S; Sola Campoy, PJ; Vallejo, JA; Vázquez-Ucha, JC | 1 |
| Leão, M; Lira, A; Lopes, P; Mota, M; Novais, Â; Peixe, L; Rodrigues, C; Silva, L | 1 |
| Dai, Y; Jiao, Z; Lin, G; Pan, J; Wen, X; Yu, X; Zhang, C; Zhou, Z | 1 |
| Cao, J; Chen, S; Hu, F; Hu, Y; Liu, C; Lv, H; Shen, Z; Sun, L; Sun, Q; Wang, Q; Wang, Y; Zhang, R; Zhou, H; Zhou, M | 1 |
| Cao, J; Dhanasekaran, V; Fang, R; Li, J; Lithgow, T; Liu, H; Perlaza-Jiménez, L; Tian, X; Wang, C; Wang, Q; Zhao, Y; Zheng, X; Zhou, T | 1 |
| Avcı, O; Baltacı, S; Büyüktuna, SA; Çelik, C; Elaldı, N; Fırtına Topcu, K; Hasbek, M; Ünlüsavuran, M | 1 |
| Bor, M; Ilhan, O | 1 |
| Chen, C; Liu, T; Wan, Q; Wu, D | 1 |
| Bonomo, RA; Chavda, KD; Chen, L; Dhawan, P; Kreiswirth, BN; Marshall, SH; Niu, S; Wang, D; Wei, J; Zou, C | 1 |
| Chen, G; Chen, Z; Guo, H; Guo, Z; Ma, K; Wang, Z; Zhao, G; Zhu, L | 1 |
| Jin, L; Jing, C; Liu, Y; Wang, H; Wang, Q; Wang, R | 1 |
| Gikas, A; Karakonstantis, S; Kritsotakis, EI | 1 |
| Aitta, AA; Causse, M; Diab, M; Egea, P; El-Defrawy, I; Elías, C; Fam, N; Fernández-Martínez, M; Gamal, D; Martínez-Martínez, L; Pérez-Nadales, E; Salem, D | 1 |
| Liao, W; Liu, Y; Zhang, W | 1 |
| Croda, J; Silva, KE; Simionatto, S; Vasconcelos, NG | 1 |
| Chai, W; Chang, Q; Chen, Q; Chen, Z; Liu, H; Pan, H; Sun, F; Wang, Y; Zhang, G; Zhang, M; Zhou, J; Zhu, D | 1 |
| Bishop, BM; Hitt, SJ; van Hoek, ML | 1 |
| Feng, XH; Hou, SY; Wu, D | 1 |
| He, G; Huang, J; Huang, S; Li, Z; Liu, J; Shen, H; Sun, J; Tan, H; Zhou, Y | 1 |
| Bonnin, RA; Cabanel, N; Chiarelli, A; Glaser, P; Naas, T; Rosinski-Chupin, I; Zongo, PD | 1 |
| Liang, W; Qin, J; Shen, Z; Wang, X; Zhu, W | 1 |
| Hazırolan, G; Karagöz, A | 1 |
| Alkufeidy, RM; Chowdhury, G; Farraj, DAA; Gopal, S; Indrajith, S; Meghanathan, V; Mukhopadhyay, AK; Muthupandian, S; Natesan, S | 1 |
| Alves, EG; Faria-Junior, C; Lima, GRCEC; Nery, DR; Oliveira, PM; Pereira, AL; Silva, DMD; Silva, LOR | 1 |
| Chen, PL; Ko, WC; Lee, NY; Li, CW; Li, MC; Lo, CL; Syue, LS | 1 |
| Ahn, D; Bueno, SM; González, LA; Peñaloza, HF; Piña-Iturbe, A; Schultz, BM | 1 |
| Hirabayashi, A; Kajihara, T; Shibayama, K; Sugai, M; Yahara, K | 1 |
| Chan, EW; Chen, S; Li, Y; Yang, X; Ye, L; Zhang, R | 1 |
| Ascenzioni, F; Cavallo, I; Celesti, I; De Luca, A; Di Domenico, EG; Di Salvo, F; Ensoli, F; Koudriavtseva, T; Marchesi, F; Mengarelli, A; Paluzzi, S; Pelagalli, L; Pimpinelli, F; Prignano, G; Pronesti, C; Sivori, F; Sperduti, I; Toma, L | 1 |
| Duan, X; Feng, Y; Guo, H; Huang, W; Li, Q; Liu, Y; Qiao, F; Ran, S; Wei, L; Wen, H; Wu, X; Xiang, Q; Zhang, W; Zhang, Y; Zheng, L; Zhu, S; Zong, Z | 1 |
| Caeiro, JP; Hernández, D; Lipari, FG; Saka, HA; Vilaró, M | 1 |
| Chen, F; Guo, Y; Hu, F; Li, M; Liu, Y; Ni, Y; Sun, J; Tang, J; Wu, W; Yin, D; Zhang, H; Zhao, H | 1 |
| Katip, W; Oberdorfer, P; Uitrakul, S; Yoodee, J | 1 |
| Bartzavali, C; Christofidou, M; Fligou, F; Georgakopoulou, A; Kolonitsiou, F; Marangos, M; Mplani, V; Papadimitriou-Olivgeris, M; Spiliopoulou, I | 1 |
| Bian, W; Chen, W; Gu, X; Liu, Y; Qin, Y; Wang, S; Zhao, G | 1 |
| Chan, EW; Chen, S; Yang, X; Ye, L; Zhang, R | 1 |
| D'Souza, R; Nguyen, LP; Pinto, NA; Vu, TN; Yong, D | 1 |
| Cao, J; Dong, G; Fang, R; Li, J; Liu, H; Tian, X; Wu, Z; Zhang, X; Zhou, J; Zhou, T | 1 |
| Chatzidimitriou, D; Chatzidimitriou, M; Chatzivasileiou, P; Chatzopoulou, F; Katsifa, E; Kavvada, A; Kyriazidi, M; Mavridou, M; Meletis, G; Mitka, S; Rousis, D; Sakellariou, G; Theodoros, L; Vagdatli, E | 1 |
| Jung, HJ; Pamer, EG; Sorbara, MT | 1 |
| Bernards, AT; Bianco, G; Boattini, M; Cavallo, R; Costa, C; Iannaccone, M; Kraakman, MEM; van Asten, SAV | 1 |
| Andini, R; Boccia, F; Corcione, A; De Rosa, R; Durante-Mangoni, E; Gagliardi, M; Karruli, A; Murino, P; Patauner, F; Ruocco, G; Sommese, P; Ursi, MP; Zampino, R | 1 |
| Bikkarolla, SK; Brito, M; Ferreira, C; Frykholm, K; Lameiras, C; Manaia, CM; Nunes, OC; Pohjanen, S; Westerlund, F | 1 |
| Jiang, Y; Lan, P; Yu, Y; Zhou, J | 1 |
| Giske, CG; Jalasvuori, M; Ketola, T; Koskinen, K; Örmälä-Odegrip, AM; Penttinen, R | 1 |
| Goussetis, E; Ioannidou, ED; Kaisari, K; Kitra, V; Komitopoulou, A; Oikonomopoulou, C; Paisiou, A; Peristeri, I; Sipsas, NV; Tzannou, I; Vessalas, G | 1 |
| Chen, DQ; Chen, G; Chen, Y; Dai, M; Deng, W; Ding, X; El-Gawad El-Sayed Ahmed, MA; Galvão, KN; He, R; Huang, S; Li, HY; Liang, X; Liao, K; Lin, M; Qin, M; Roberts, AP; Tian, GB; Wu, Y; Xia, Y; Yang, Y; Zhang, L; Zhong, LL | 1 |
| Du, FL; Huang, QS; Liao, WJ; Liu, Y; Long, D; Mei, YF; Wan, LG; Wei, DD; Zhang, W | 1 |
| Casal, MC; Martínez, CT; Martínez-Lamas, L; Pérez-Landeiro, A; Pérez-Rodríguez, MT; Pino, CP; Rodríguez, OL; Sousa, A; Suárez, RL; Vidal, FV | 1 |
| Borghi, M; Devereux, M; Ferreira Ventura, R; FerreiraNunes, AP; McCann, M; Pinto Schuenck, R; Souza Dos Santos, AL; Vianez Peregrino, I | 1 |
| Chen, DK; Cui, ZG; Du, XL; Hu, JR; Li, XG; Xu, H; Zhou, HJ | 1 |
| Cui, J; Gao, Z; Guan, J; Liu, Y; Ni, W; Xi, W; Xu, Y; Yang, D; Zhao, L; Zhou, D | 1 |
| Chen, WY; Cheng, YH; Chou, SH; Chuang, C; Huang, PH; Juan, CH; Lin, YT; Wang, FD; Wang, JT | 1 |
| Arato, V; Berlanda Scorza, F; Gasperini, G; Micoli, F; Raso, MM | 1 |
| Dhungana, G; Gyawali, I; Malla, R; Nepal, R; Parajuli, A; Paudel, P; Pradhan, P; Regmi, M; Upadhyay, E; Upreti, H | 1 |
| Chen, L; Du, H; Fouts, DE; Hao, M; Kreiswirth, BN; Satlin, M; Schuyler, J; Shashkina, E; Zhang, H | 1 |
| Chen, IR; Huang, PH; Lin, YT; Wang, FD; Wu, PF | 1 |
| de Haan, A; Hendrickx, APA; Landman, F; Schouls, LM; van Santen-Verheuvel, MG; Witteveen, S | 1 |
| Chen, YC; Chuang, YC; Hsieh, SM; Hsu, JY; Wang, JT | 1 |
| Alkan, M; Ankaralı, H; Arsu, HY; Aygün, G; Balkan, II; Biçer, M; Karaali, R; Karagöz, A; Kaya, SY; Kuşkucu, M; Mete, B; Saltoğlu, N; Şen, S; Tabak, F | 1 |
| Ahmed, MAEE; Chen, G; Chen, Y; Dai, M; Hassan, RM; He, R; Li, H; Liang, X; Qin, M; Roberts, AP; Tian, GB; Wu, Y; Xu, L; Yan, B; Yang, F; Yang, Y; Zhang, L; Zhong, LL | 1 |
| Chen, Q; Fu, Y; Hua, X; Jiang, Y; Jin, X; Shen, F; Wu, X; Yu, Y | 1 |
| Chan, EW; Chen, K; Chen, S; Dong, N; Gu, D; Shu, L; Sun, Q; Xie, M; Xu, Q; Yang, X; Ye, L; Zhang, R; Zheng, Z | 1 |
| Ahn, D; Annavajhala, MK; Bhushan, G; Castano, VG; Chong, AM; Ernst, RK; Hofstaedter, CE; McConville, TH; Prince, A; Shah, SS; Soni, RK; Uhlemann, AC; Wong Fok Lung, T | 1 |
| Cao, X; Guo, Y; Liu, L; Shen, X; Wang, B; Xu, Y; Yu, F; Yu, J; Zhan, Q | 1 |
| Jiang, M; Liu, S; Shao, C; Wang, W; Zhang, F; Zhang, Z | 1 |
| Angulmaduwa, S; De Silva, K; Ekanayake, A; Ip, M; Kalupahana, R; Kuthubdeen, S; Liyanapathirana, V; Munasinghe, T; Subhasinghe, S; Vidanapathirana, G | 1 |
| Gong, Y; Hu, D; Jiang, X; Li, D; Li, Y; Ma, X; Tian, D | 1 |
| Jiang, S; Jiang, Y; Lan, P; Lu, J; Lu, Y; Shen, P; Yan, R; Yu, Y; Zhou, J; Zhu, Y | 1 |
| Hu, K; Huang, W; Li, J; Wang, J; Yang, C; Yin, L; Zeng, L; Zhang, J; Zhang, X; Zou, J | 1 |
| Albarracin, L; Jure, MA; Kitazawa, H; Maidana, SD; Vargas, JM; Villena, J; Zamar, JC | 1 |
| Baldissera, GS; Mathos, D; Rigatto, MH; Rodrigues, D; Sartori, A; Zavascki, AP | 1 |
| Cai, J; Cui, W; Huang, J; Qian, Z; Song, F; Zhang, G; Zhang, K; Zheng, C; Zhou, F; Zhou, H | 1 |
| Doughty, E; Feng, Y; Liu, Y; McNally, A; Tang, L; van Schaik, W; Wei, L; Wen, H; Wu, L; Zhu, S; Zong, Z | 1 |
| Bi, Y; Dong, S; Ju, M; Li, X; Liu, S; Qian, Y | 1 |
| Deng, Z; Liu, G; Liu, J; Liu, M; Ou, HY; Qu, H; Qu, J; Sun, J; Wang, M; Xu, Y; Zhang, J | 1 |
| Chen, Z; Jiang, L; Qin, Z; Tang, Z | 1 |
| Bhagwat, S; Joshi, P; Patel, M; Shrivastava, R | 1 |
| Dao, TD; Hasebe, F; Hirabayashi, A; Kasuga, I; Shibayama, K; Suzuki, M; Takemura, T; Thanh, NH; Tran, HH; Trang, LT | 1 |
| Huws, JC; Morrison, V; Okeah, BO | 1 |
| Chen, C; Chen, YB; Wang, HB; Zhang, BL; Zhu, XY; Zhu, YH | 1 |
| Cai, JC; Chen, JW; Lu, JY; Zhang, R | 1 |
| Chen, G; Feng, H; Fu, C; Guo, ZL; Ma, K; Wang, ZQ; Zhao, GY; Zhu, L | 1 |
| Baraniak, A; Bojarska, K; Fiett, J; Gniadkowski, M; Górska, S; Hryniewicz, W; Izdebski, R; Literacka, E; Zabicka, D | 1 |
| Bonnin, RA; Khelifa, ABH; Lahlaoui, H; Moussa, MB; Naas, T | 1 |
| Ma, X; Sun, X; Xu, L | 1 |
| Amudhan, M; Mythreyee, M; Sekar, R; Srivani, S | 1 |
| Adisetiyo, H; Aldrovandi, G; Didelot, X; Hemarajata, P; Hindler, J; Humphries, R; Kasarskis, A; Li, F; MacCannell, D; Rubin, Z; Russell, D; Sebra, R; Yang, S | 1 |
| Bruno, B; Busca, A; Corcione, S; De Rosa, FG; Raviolo, S | 1 |
| Cancelli, F; Castaldi, D; Ciardi, MR; Cipolla, A; D'Abramo, A; D'Agostino, C; Mascellino, MT; Mastroianni, CM; Oliva, A; Russo, G; Scorzolini, L; Vullo, V | 1 |
| Gomez-Simmonds, A; Uhlemann, AC | 1 |
| Chan, MC; Chang, FY; Chiu, SK; Huang, LY; Lin, JC; Lin, YT; Lu, PL; Siu, LK; Yeh, KM | 1 |
| Blom, D; Fogg, L; Haverkate, M; Hayden, MK; Hines, DW; Kemble, S; Lin, MY; Lolans, K; Lyles, RD; Moore, NM; Okamoto, K; Rhee, Y; Weiner, S; Weinstein, RA | 1 |
| Liu, PP; Liu, Y; Wan, LG; Wang, LH; Wei, DD; Zhang, W | 1 |
| De Gasperi, A; Limuti, R; Mazza, E; Nichelatti, M; Panzeri, MF; Prosperi, M | 1 |
| Abdul Momin, MHF; Liakopoulos, A; Phee, LM; Wareham, DW | 1 |
| Adams, MD; Bonomo, RA; Cober, E; Domitrovic, TN; Hujer, AM; Hujer, KM; Marshall, SH; Perez, F; Richter, SS; Rojas, LJ; Rudin, SD; van Duin, D; Wright, MS | 1 |
| Cherng, BPZ; Choon, RFK; De, PP; Deepak, RN; Fisher, D; Hsu, LY; Khong, WX; Koh, TH; Krishnan, PU; Kurup, A; Lam, CW; Lee, JJ; Lin, RTP; Ling, ML; Marimuthu, K; Ng, OT; Ong, RT; Ooi, ST; Pada, SK; Peng, BAS; Sim, NTW; Smitasin, N; Tan, EL; Tan, TY; Teo, J; Teo, YY; Thoon, KC; Van La, M; Venkatachalam, I; Young, B | 1 |
| Jiang, X; Li, G; Liang, W; Lu, Y; Tang, Y; Xie, Y; Xiong, W | 1 |
| Fortunato, S; Lambelet, P; Leonildi, A; Menichetti, F; Simonetti, F; Stefanelli, A; Tascini, C; Vettori, C | 1 |
| Chang, FY; Chen, H; Chiu, SK; Huang, LY; Lin, JC; Liou, CH; Siu, LK; Tsai, YK; Yeh, KM | 1 |
| Dos Santos, T; Forde, C; Ramon-Pardo, P; Singh, N; Stierman, B | 1 |
| Chen, L; Clancy, CJ; Doi, Y; Kreiswirth, BN; Marini, RV; Nguyen, MH; Potoski, BA; Press, EG; Shields, RK | 1 |
| Chen, Y; Dekker, JP; Drake, SK; Gucek, M; Rosenberg, AZ; Suffredini, AF; Wang, H; Youn, JH | 1 |
| Bassetti, M; Carnelutti, A; Peghin, M; Righi, E | 1 |
| Dong, F; Guo, L; Liu, G; Lu, J; Lyu, S; Song, W; Wang, Y; Yang, Y; Yao, K; Zhang, Y; Zheng, H | 1 |
| An, J; Guo, L; Lai, K; Ma, Y; Yang, J; Ye, L | 1 |
| Adamis, G; Christodoulou, S; Chrysanthakopoulou, M; Giamarellos-Bourboulis, EJ; Gkizeli, K; Karampela, I; Karlis, G; Kyriazopoulou, E; Safarika, A; Veliki, N | 1 |
| Abdalhamid, B; Albunayan, S; Aljindan, R; Alsamman, K; Elhadi, N | 1 |
| Choi, JK; Joo, EJ; Ko, JH; Lee, NR; Moon, SY; Park, DA; Peck, KR | 1 |
| Jia, X; Pu, S; Shi, J; Sun, S; Xu, X; Yan, J; Yang, S; Zhang, L | 1 |
| Antonelli, M; Arcadipane, A; Capitanio, G; Cutuli, SL; De Pascale, G; Di Carlo, D; Di Gravio, V; Di Stefano, R; Martucci, G; Montini, L; Panarello, G; Polidori, P; Spanu, T; Vallecoccia, MS | 1 |
| Cantara, M; Carroll, KC; Curless, MS; Maragakis, LL; Marrone, KA; Mehta, S; Rock, C; Simner, P | 1 |
| Cao, W; Chen, F; Hu, F; Li, P; Li, X; Tang, A; Tian, J; Wang, M; Xia, X; Xie, Y; Yang, M; Zhang, K; Zheng, R | 1 |
| Arlet, G; Ben Hassine, I; Chachaty, E; Decré, D; Forget, S; Jardak, T; Woerther, PL | 1 |
| Bias, TE; Doyle, AM; Lee, DH; Malat, GE; Sharma, A | 1 |
| Ben Jomàa-Jemili, M; Brasme, L; Chouchani, C; de Champs, C; Gharsa, H; Guillard, T; Limelette, A; Ouertani, R | 1 |
| Aksu, HSZ; Candevir Ulu, A; Güven Gökmen, T; İnal, AS; Kibar, F; Kömür, S; Kurtaran, B; Kuşçu, F; Önlen, C; Taşova, Y; Yaman, A | 1 |
| Chen, S; Li, X; Li, Y; Liu, P; Luo, M; Qing, Y; Qiu, J; Su, K; Xu, X | 1 |
| Bialek-Davenet, S; Brisse, S; Duprilot, M; Mayer, N; Nicolas-Chanoine, MH; Pagès, JM; Vergalli, J | 1 |
| Li, M; Xi, W; Yin, X; Zhao, R; Zhu, J | 1 |
| Boinett, CJ; Ellington, MJ; Henson, SP; Kagia, N; Kariuki, S; Morpeth, SC; Mturi, N; Mwarumba, S; Nyongesa, S; Scott, JAG; Thomson, NR | 1 |
| Andrasevic, AT; Brkic, DV; Butic, I; Cipris, I; Jelic, M; Pristas, I | 1 |
| Bertocchi, M; Dodi, F; Fontana, I; Marchese, A; Mariottini, G; Santori, G; Terulla, A; Varotti, G | 1 |
| Araujo, BF; Bueno, MFC; Cerdeira, LT; Cunha, MPV; de Oliveira Garcia, D; Francisco, GR; Gontijo-Filho, PP; Knöbl, T; Lincopan, N; Ribas, RM | 1 |
| Gandra, S; Gupta, P; Kaur, A; Laxminarayan, R; Mehta, Y; Sengupta, S | 1 |
| Diago-Navarro, E; Fries, BC; Khan, N; Opitz, B; Pereira, CL; Reppe, K; Seeberger, PH; Witzenrath, M; Xiao, G | 1 |
| Ambretti, S; Bartoletti, M; Bartoloni, A; Bassetti, M; Cauda, R; Corcione, S; De Rosa, FG; Del Bono, V; Giacobbe, DR; Giannella, M; Lewis, RE; Losito, AR; Marchese, A; Raffaelli, F; Rossolini, GM; Saffioti, C; Spanu, T; Tedeschi, S; Trecarichi, EM; Tumbarello, M; Viale, P; Viscoli, C | 1 |
| Hussein, NH | 1 |
| Chen, L; Kreiswirth, BN | 1 |
| Kioseva, E; Politi, L; Savov, E; Spanakis, N; Trifonova, A; Tsakris, A | 1 |
| D'Arezzo, S; Di Caro, A; Nisii, C; Venditti, C; Vulcano, A | 1 |
| Kousouli, E; Polimeri, K; Politi, L; Pournaras, S; Themeli-Digalaki, K; Tsakris, A; Vrioni, G; Zarkotou, O | 1 |
| Arzate-Barbosa, P; Castro-Escarpulli, G; Ibarra, JA; Juárez-de la Rosa, KC; Lara-Hernández, A; Ostria-Hernandez, ML; Sakai, F; Vidal, JE | 1 |
| Bercker, S; Eckmanns, T; Faucheux, S; Finstermeier, K; Häntzsch, M; Kaase, M; Kaiser, T; Kaisers, UX; Lippmann, N; Lübbert, C; Rodloff, AC; Thiery, J | 1 |
| Ansari, M; Azad, M; Davoodian, P; Farahani, A; Faridi, F; Javadpour, S; Karmostaji, A; Mobarrez, BD; Shoja, S | 1 |
| Abbo, LM; Aragon, L; Bonomo, RA; Camargo, JF; Hujer, AM; Martinez, O; Nicolau, DP; Perez, F; Perez-Cardona, A; Rojas, LJ; Rosa, R; Rudin, SD; Tekin, A | 1 |
| Macesic, N; Nelson, B; Uhlemann, AC | 1 |
| Anselmo, A; Di Gregorio, A; Fortunato, A; Gentile, B; Gismondo, MR; Lista, F; Pagani, C; Palozzi, AM; Pittiglio, V; Ridolfo, AL; Rimoldi, SG; Rizzardini, G | 1 |
| Bonten, MJM; Bootsma, MCJ; Dautzenberg, MJD; Derde, LPG; Gniadkowski, M; Gurieva, T | 1 |
| Chen, DK; Zhou, HJ | 1 |
| Hauser, AR; Krapp, F; Morris, AR; Ozer, EA | 1 |
| Barrera, S; Cevallos, N; Escobar, LE; Quezada, V; Reyes, J; Romero-Alvarez, D; Satán, C; Trueba, G; Villacís, JE | 1 |
| Chan, EW; Chen, JHK; Chen, S; Man, MY; Shum, HP; Wong, MHY; Wu, A; Yuen, KY | 1 |
| Chen, S; Du, XD; Qin, S; Shen, J; Yao, H | 1 |
| Huang, YL; Yang, ZQ; Zhang, R; Zhou, HW; Zhu, K | 1 |
| Chen, C; Du, P; Zhang, Y | 1 |
| Jang, HJ; Jo, KM; Kiem, S; Kim, HJ; Kim, HK; Kim, YK; Lee, JH; Lee, JN; Oh, M; Park, J; Song, SA | 1 |
| Babosan, A; Bajolet, O; Bertrand, X; de Champs, C; François, C; Guillard, T; Klein, F; Muggeo, A; Reffuveille, F | 1 |
| Barth, AL; Dalmolin, TV; de Lima-Morales, D; Martins, AF; Zavascki, AP | 1 |
| Becker, L; Borgmann, S; Pfeifer, Y; Rieß, B; Sagel, U; Siegmund, R | 1 |
| Huang, D; Jacobs, DM; Minhaj, F; Parker, A; Rao, GG; Safir, MC | 1 |
| Berglund, B; Hanberger, H; Hoang, NTB; Khu, DTK; Larsson, M; Le, HT; Le, NK; Nilsson, LE; Nilsson, M; Olson, L; Svartström, O; Tärnberg, M; Welander, J | 1 |
| Bassi, C; Lienhard, R; Mancini, S; Nordmann, P; Poirel, L; Tritten, ML | 1 |
| Cai, J; Cao, B; Chen, H; Gu, B; Guo, Z; Hu, T; Huang, J; Huang, W; Jia, X; Jin, L; Li, B; Li, H; Li, W; Liao, K; Liu, L; Ma, X; Man, S; Pei, F; Tian, J; Wang, H; Wang, Q; Wang, S; Wen, H; Xie, L; Yang, C; Yang, H; Yin, Y; Zhang, L; Zhang, X; Zhang, Y; Zou, C | 1 |
| Cha, CJ; Jeon, JH; Jeong, BC; Kim, YB; Lee, CR; Lee, JH; Lee, SH; Park, KS | 1 |
| Chan, YJ; Chuang, C; Chuang, YC; Fung, CP; Huang, CT; Lin, JC; Lin, YT; Lu, PL; Siu, LK; Su, CF; Wang, JT | 1 |
| Berglund, B; Hanberger, H; Hoang, NTB; Khu, DTK; Larsson, M; Le, HT; Le, NK; Nilsson, LE; Nilsson, M; Olson, L; Tärnberg, M; Welander, J | 1 |
| Guducuoglu, H; Gursoy, NC; Karasin, G; Otlu, B; Parlak, M; Sunnetcioglu, M; Yakupogullari, Y | 1 |
| Miki, M | 1 |
| Huang, L; Qin, RR; Sun, LY; Wang, Z | 1 |
| Chen, F; Liu, J; Liu, Y; Shen, L; Simner, P; Tamma, P; Yu, J | 1 |
| Cao, SJ; Feng, D; Wan, LP; Wang, GJ; Xiao, XG; Xu, H; Zheng, SH | 1 |
| Khedkar, S; Khedkar, U; Lind, F; Nerkar, SS; Odsbu, I; Orsini, N; Stålsby Lundborg, C; Tamhankar, AJ | 1 |
| Arlet, G; Boutiba-Ben Boubaker, I; Ferjani, S; Fernandez Martinez, M; Genel, N; Hammami, S; Hamzaoui, Z; Harbaoui, S; Maamar, E; Martinez-Martinez, L; Ocampo-Sosa, A; Saidani, M; Slim, A | 1 |
| Bonura, C; Carattoli, A; Geraci, DM; Giuffrè, M; Graziano, G; Maida, CM; Rizzo, A; Torregrossa, MV; Vecchio, D | 1 |
| Bonomo, RA; Cober, E; Domitrovic, TN; Hujer, AM; Hujer, KM; Karichu, J; Kaye, KS; Keller, G; Marshall, S; Otiso, J; Perez, F; Richter, SS; Rojas, LJ; Rudin, SD; Salata, R; van Duin, D; Van Heule, H | 1 |
| Horvath, E; Kazmierczak, KM; Sahm, DF; Wise, MG; Young, K | 1 |
| Band, VI; Burd, EM; Farley, MM; Jacob, JT; Satola, SW; Weiss, DS | 1 |
| Fanelli, I; Flocco, R; Guerrizio, G; Ripabelli, G; Sammarco, ML; Scutellà, M; Tamburro, M | 1 |
| Chen, D; Huang, W; Wang, X; Xu, G; Zhang, X | 1 |
| Cohen, B; Furuya, EY; Jia, H; Larson, EL | 1 |
| Chen, CH; Chen, JY; Kuo, HY; Lai, YC; Lin, YY; Liou, ML; Lu, CW | 1 |
| Aldrovandi, G; Cheng, QJ; Hemarajata, P; Humphries, RM; Kim, S; Muthusamy, VR; Rubin, ZA; Russell, D; Trout, AM; Uslan, DZ; Yang, S; Zaroda, T | 1 |
| Feng, Y; Liu, L; Long, H; McNally, A; Zong, Z | 1 |
| Dai, E; Duan, X; Fang, H; Feng, J; Gao, B; Luo, Y; Tong, Y; Wang, J; Xu, Y; Yin, Z; Zhan, Z; Zhang, Y; Zhou, D | 1 |
| Basso, MS; Bernaschi, P; Candusso, M; Cardile, S; Del Chierico, F; Grimaldi, C; Liccardo, D; Pansani, L; Pietrobattista, A; Putignani, L; Russo, A; Torre, G | 1 |
| Albladi, M; Aldrees, M; Aljohani, S; Alrodayyan, M; Balkhy, HH; Siddique, MI; Zaman, TU | 1 |
| Cao, Y; He, L; Hu, F; Wang, A; Wang, C; Yin, D; Zhang, L | 1 |
| Adamo, R; Margarit, I | 1 |
| Chou, SH; Huang, YH; Huang, YW; Liang, SW; Lin, YT; Ni, CE; Yang, TC | 1 |
| Dong, F; Guo, LY; Liu, G; Song, WQ; Wang, Y; Zhang, Y | 1 |
| Chen, C; Du, P; Hou, J; Huang, Y; Lu, X; Qin, T; Ren, H; Sui, W; Wang, L; Wang, M; Zhou, H | 1 |
| Allard, MW; Anderson, K; Crawford, MA; Fisher, DJ; Hodge, DR; Hughes, MA; Khan, E; Lascols, C; Lomonaco, S; Morse, SA; Pillai, SP; Sharma, SK; Timme, RE | 1 |
| Chen, Q; Fan, JZ; Qiu, CN; Ruan, Z; Wang, MM; Wang, XJ; Zhou, JW | 1 |
| Gu, D; Lv, H; Shu, L; Sun, Q; Zhang, R | 1 |
| Cai, J; Chan, EW; Chen, S; Dong, N; Hu, Y; Huang, Y; Xie, M; Zhang, R; Zhou, H | 1 |
| Abu Sin, M; Claus, H; Eckmanns, T; Feig, M; Koppe, U; Kroll, LE; Noll, I; Schneider, M; von Laer, A | 1 |
| Le, J; Mashni, O; Nazer, L | 1 |
| Faghri, J; Moghadampour, M; Rezaei, A | 1 |
| Adamou, P; Galani, I; Giamarellou, H; Karaiskos, I; Souli, M | 1 |
| Alexandrova, I; Danilov, G; Ershova, K; Ershova, O; Fursova, N; Kurdyumova, N; Savin, I; Shifrin, M; Sokolova, E; Wong, D; Zelman, V | 1 |
| Guo, Q; Guo, Y; Li, D; Su, J; Xu, X; Zheng, Y | 1 |
| Ernst, CM; Hung, DT; Laibinis, HH; Ma, P | 1 |
| Florou, Z; Malli, E; Papagiannitsis, CC; Petinaki, E; Stefos, A; Tsilipounidaki, K; Voulgaridi, I; Xitsas, S | 1 |
| Ehricht, R; Hellmark, B; Jass, J; Khan, FA; Söderquist, B | 1 |
| Hayden, MK; Won, SY | 1 |
| Bassis, C; Cisneros, EC; Dangana, T; Fogg, L; Hayden, MK; Lin, MY; Lolans, K; Moore, NM; Okamoto, K; Rhee, Y; Schoeny, M; Seekatz, A; Shimasaki, T; Weinstein, RA; Yelin, RD; Young, VB | 1 |
| Bertolini, G; Carrara, G; Crespi, D; Langer, M; Malacarne, P; Mondini, M; Nattino, G; Poole, D; Rossi, C; Rossolini, GM; Tascini, C; Viaggi, B | 1 |
| Amoura, K; Baron, S; Dahi, A; Dandachi, I; Dekhil, M; Diene, SM; Hadjadj, L; Lalaoui, R; Merah, A; Messalhi, N; Rolain, JM; Yousfi, H | 1 |
| Chen, H; Li, W; Peng, J; Wu, S | 1 |
| Akeda, Y; Hamada, S; Laolerd, W; Motooka, D; Sakamoto, N; Santanirand, P; Sugawara, Y; Takeuchi, D; Yamamoto, N | 1 |
| Abdollahi, A; Feizabadi, MM; Haeili, M; Harati, AA; Jabalameli, F; Jafari, S; Jafari, Z; Kardan-Yamchi, J; Meysamie, A | 1 |
| Bergman, Y; Carroll, KC; Fan, Y; Kazmi, AQ; Lewis, S; Pertea, G; Schatz, MC; Simner, PJ; Tamma, PD; Timp, W | 1 |
| Deng, Y; Huang, J; Huang, W; Li, J; Qiao, F; Zhang, Y; Zong, Z | 1 |
| Feng, Y; Huang, W; Lin, J; Liu, L; Qiao, F; Tang, G; Zong, Z | 1 |
| Biscaro, V; Caltagirone, M; Carattoli, A; Espinal, P; Fernandes, MR; Mattioni Marchetti, V; Migliavacca, R; Nucleo, E; Rigoli, R; Villa, L | 1 |
| Bleasdale, SC | 1 |
| Huan, JN; Xiang, J | 1 |
| Feng, Y; Liu, L; McNally, A; Zong, Z | 1 |
| Earl, AM; Fodor, AA; Manson, AL; Mulder, HP; Passaretti, C; Sautter, RL; Spencer, MD; Winglee, K | 1 |
| Barcelos, DDP; Bueno, MFC; Casella, T; da Silva, NS; Darini, ALDC; de Andrade, LN; de Oliveira Garcia, D; Franscisco, GR; Lobo, SM; Nogueira, MCL; Polotto, M; Tolentino, FM; Tomaz, FMMB | 1 |
| Kato, A; Kirikae, T; Miyairi, I; Sugahara, Y; Tada, T; Tohya, M; Uchida, H | 1 |
| Bardhan, T; Basu, M; Bhattacharjee, B; Chakraborty, M | 1 |
| Clardy, J; Liao, J; Mevers, EE; Watnick, PI; Xu, G | 1 |
| Antachopoulos, C; Diamantopoulou, G; Iosifidis, E; Karampatakis, T; Karyoti, A; Mouloudi, E; Politi, L; Roilides, E; Tsakris, A; Tsergouli, K | 1 |
| Antona, C; Bandi, C; Brilli, M; Comandatore, F; Dichirico, B; Gismondo, MR; Piazza, A; Ridolfo, A; Rimoldi, SG; Romeri, F | 1 |
| Guirong, T; Guixia, L; Liming, S; Wenxin, S | 1 |
| Akamatsu, N; Hasegawa, H; Izumikawa, K; Kaku, N; Kaneko, Y; Kosai, K; Matsuda, J; Miyazaki, T; Morinaga, Y; Mukae, H; Tsubouchi, T; Uno, N; Yamakawa, H; Yanagihara, K | 1 |
| Mobasseri, G; Ooi, PT; Teh, CSJ; Thong, KL | 1 |
| Akkoyunlu, Y; Aslan, T; Daskaya, H; Durdu, B; Hakyemez, IN; Meric Koc, M; Sumbul Gultepe, B | 1 |
| Abdelaziz, A; El-Ekhnawy, E; Elbanna, T; Sonbol, F | 1 |
| Growcott, EJ; Nguyen, P; Pulse, ME; Weiss, WJ | 1 |
| Gu, Q; Huang, J; Li, L; Li, M; Liu, J; Qu, H; Sun, J; Tan, R; Wang, J; Wang, X; Wu, J; Zhao, Y | 1 |
| Alousi, S; Arabaghian, H; Araj, GF; Panossian, B; Salloum, T; Tokajian, S | 1 |
| Antoniadou, E; Iosifidis, E; Kontopoulou, K; Malisiovas, N; Malli, E; Metallidis, S; Petinaki, E; Tasioudis, P; Vatopoulos, A | 1 |
| Barth, AL; de Lima-Morales, D; Gomes Dias, CA; Mott, MP; Paim, TG; Raro, OHF; Riche, CVW; Teixeira, UF; Waechter, FL | 1 |
| Chen, L; Dou, Q; Duan, J; Fu, C; Huang, X; Li, C; Li, J; Liu, S; Liu, W; Liu, Y; Meng, X; Peng, Z; Wang, J; Wen, X; Wu, A; Yan, Q; Yang, J; Zou, M | 1 |
| Castellanos, Á; Frasquet, J; Gordon, M; Martín, M; Ramirez, P; Ruiz, J; Sánchez, MÁ; Villarreal, E | 1 |
| Akram, N; Ali, A; Bokhari, H; Humayun, A; Iqbal, T; Kamran, R; Kumar, A; Saleem, S; Siddiqui, FM | 1 |
| Almirante, B; Escolà-Vergé, L; González-López, JJ; Larrosa, N; Len, O; Los-Arcos, I; Pigrau, C; Viñado, B | 1 |
| Chen, L; Goodman, AL; Jung, HJ; Kreiswirth, BN; Leiner, IM; Ling, L; Littmann, ER; Pamer, EG; Peled, J; Seok, R; Taur, Y; van den Brink, M | 1 |
| Dillon, N; Nizet, V; Pogliano, J; Sakoulas, G; Tsunemoto, H; Ulloa, ER | 1 |
| Abushelaibi, A; Ajat, M; Akseer, R; Lai, KS; Lim, SE; Thomas, W; Yang, SK; Yusoff, K | 1 |
| Jin, X; Jin, Y; Wang, K; Wang, Y; Yu, J; Zhang, Q | 1 |
| Brindle, R; Heinz, E; Morgan-McCalla, A; Peters, K; Thomson, NR | 1 |
| Chen, Y; Ding, H; Fang, X; Hang, Y; Hu, L; Hu, X; Liu, Y; Xu, X; Yu, F; Zhong, Q | 1 |
| Alcoba Florez, J; García Martínez de Artola, D; Pérez Roth, E; Sampere, Á | 1 |
| Campos, CC; Carvalho-Assef, APD; Chang, MR; Chaves, CEV; Ferreira, YM; Rezende, IN; Rocha-de-Souza, CM; Rodrigues, ACS; Santos, ICO | 1 |
| Al-Bustan, SA; Alkhudhairy, MK; Alshadeedi, SMJ; Ghasemian, A; Mahmood, SS | 1 |
| Aprile, A; Bongiorno, D; Chiacchiaretta, M; Cirillo, DM; Corazza, E; Gona, F; Mezzatesta, ML; Pasqua, B; Scuderi, MG; Stefani, S | 1 |
| Huang, J; Huang, X; Huang, Y; Liu, E; Liu, JH; Lu, J; Lv, L; Song, Q; Wan, M; Xun, H; Zhang, Q; Zhang, Z; Zhuang, Z; Zhuo, C | 1 |
| Alfonso, C; Berger, MA; Cejas, D; De Paulis, A; Elena, A; Fernández-Canigia, L; Guevara Nuñez, D; Gutkind, G; Magariños, F; Radice, M; Sevillano Platero, P | 1 |
| Bonomo, RA; Cober, E; Doi, Y; Evans, S; Fowler, VG; Harris, A; Henderson, H; Kalayjian, RC; Kaye, KS; Luterbach, CL; Napravnik, S; Richter, SS; Salata, RA; Van Duin, D; Watkins, RR | 1 |
| Płusa, T | 1 |
| Chen, S; Dong, N; Huang, Y; Shu, L; Sun, Q; Ye, L; Zhang, R | 1 |
| Anandan, S; Babu, P; Jeyaseelan, V; Munusamy, E; Nabarro, LE; Ravi, R; Rupali, P; Shankar, C; Veeraraghavan, B; Verghese, VP | 1 |
| Parikh, F | 1 |
| Hsueh, PR; Lai, YC; Lu, MC | 1 |
| Goodman, JL; Hartley, DM; Koch, M; Malchione, MD; Torres, LM | 1 |
| Fang, C; Hou, Z; Hu, Y; Li, M; Lu, L; Luo, X; Ma, B; Wang, M; Xue, X; Zhou, Y | 1 |
| Bettiol, M; Corso, A; De Belder, D; Faccone, D; Gatti, B; Gomez, S; Pasteran, F; Petroni, A; Rapoport, M; Veliz, O | 1 |
| Giannella, M; Lewis, R; Petrosillo, N; Viale, P | 1 |
| Baziaka, F; Galani, L; Giamarellou, H; Karaiskos, I | 1 |
| Fanti, KS; Garcia, DO; Levin, AS; Mostardeiro, M; Pereira, GH | 1 |
| Hu, L; Hu, X; Pan, J; Parsons, C; Qin, Z; Tu, J; Wang, L; Xu, Y; Yu, F; Zhang, B; Zhong, Q | 1 |
| Chen, L; Cheng, S; Clancy, CJ; Doi, Y; Hong, JH; Kreiswirth, BN; Nguyen, MH; Perlin, DS; Shields, RK; Zhao, Y | 1 |
| Crandon, JL; Hagihara, M; Nicolau, DP; Urban, C | 1 |
| Fujimoto, N; Hamasuna, R; Matsumoto, T; Muratani, T; Sho, T; Yakushiji, H | 1 |
| Al-Agamy, MH; Elkhizzi, NA; Livermore, DM; Meunier, D; Shibl, AM; Turton, JF | 1 |
| Castanheira, M; Farrell, SE; Jones, RN; Mendes, RE; Rolston, KV; Wanger, A | 1 |
| Citerio, G; Fiori, L; Patruno, A | 1 |
| Cooper, MA; Espedido, BA; Gosbell, IB; Grimmond, SM; Jensen, SO; Steen, JA; van Hal, SJ; Ziochos, H | 1 |
| Caio, C; Ceccarelli, G; Falcone, M; Giordano, A; Mezzatesta, ML; Stefani, S; Venditti, M | 1 |
| Arend, LN; Pilonetto, M; Rocha, JL; Tuon, FF; Wallbach, K; Zanin, HA | 1 |
| Kuehn, BM | 2 |
| Alba, L; Clock, SA; Kubin, CJ; Saiman, L; Tabibi, S; Whittier, S | 1 |
| Crandon, JL; Nicolau, DP; Wiskirchen, DE | 1 |
| Alp, E; Colakoğlu, S; Durmaz, S; Ekincioğlu, P; Güneş, T; Kürkcü, CA; Perçin, D | 1 |
| Chang, CM; Chang, YH; Chen, CP; Chen, TL; Chen, YT; Fung, CP; Huang, TW; Kirby, R; Lai, JF; Lauderdale, TL; Lee, YT; Liao, TL; Lin, AC; Liu, YM; Siu, LK; Tan, MC; Tsai, SF; Wu, KM | 1 |
| Cornaglia, G; Kocsis, E; Mazzariol, A; Piccoli, M; Savio, C | 1 |
| Castanheira, M; Jones, RN; Kaiser, RM; Lynfield, R; Tenover, F | 1 |
| Orsi, GB; Venditti, M | 1 |
| Kim, SY; Ko, KS; Shin, J; Shin, SY | 1 |
| Crandon, JL; Nicolau, DP; Nordmann, P; Wiskirchen, DE | 1 |
| Chung, GT; Kim, HM; Kim, HS; Lee, YS; Yang, JW; Yoo, JI; Yoo, JS | 1 |
| Cao, X; Chen, R; Guan, H; Huang, XL; Pei, XF; Xu, X; Zhou, T | 1 |
| Huprikar, S; Patel, G; Rana, MM; Sturdevant, M | 1 |
| Arena, F; Bracco, S; Conte, V; Giani, T; Luzzaro, F; Migliavacca, R; Pagani, L; Pantosti, A; Pini, B; Rossolini, GM | 1 |
| Capone, A; Carattoli, A; De Paolis, P; Dolejska, M; Fortini, D; Petrosillo, N; Rodríguez, I; Taglietti, F; Villa, L | 1 |
| Arlet, G; Bidet, P; Bingen, E; Decré, D; Lafeuille, E; Mahjoub-Messai, F | 1 |
| Damjanova, I; Gám, T; Kovács, K; Melegh, S; Mestyán, G; Nyul, A; Patkó, B; Tóth, A | 1 |
| Bethe, A; Ewers, C; Guenther, S; Hassdenteufel, E; Pfeifer, Y; Prenger-Berninghoff, E; Scheufen, S; Stamm, I; Stolle, I | 1 |
| Anderson, KF; Banach, DB; Calfee, DP; Kitchel, B; LaBombardi, V; Patel, G; Phillips, M; Poliansky Blash, S; Sharma, S; Srinivasan, A; Swaminathan, M | 1 |
| McKenna, M | 1 |
| Giakkoupi, P; Kotsakis, SD; Miriagou, V; Papagiannitsis, CC; Tzelepi, E; Tzouvelekis, LS; Vatopoulos, AC | 1 |
| Asticcioli, S; Caltagirone, MS; Daturi, R; Debiaggi, M; Labonia, M; Matti, C; Migliavacca, R; Navarra, A; Nucleo, E; Piazza, A; Spalla, M | 1 |
| Chen, L; Cheng, S; Clancy, CJ; Doi, Y; Farrell, AN; Hao, B; Hong, JH; Kreiswirth, BN; Nguyen, MH; Perlin, DS; Shields, RK; Zhao, Y | 1 |
| Chen, TY; Dubrovskaya, Y; Esaian, D; Mehta, SA; Papadopoulos, J; Phillips, MS; Scipione, MR | 1 |
| Slaughter, LM | 1 |
| Giamarellou, H; Katerelos, P; Kioumis, I; Kontopidou, F; Maltezou, HC; Maragos, A; Trikka-Graphakos, E; Valakis, C | 1 |
| Andrade, LN; Barin, J; Barth, AL; Darini, ALDC; Linhares, AR; Ribeiro, VB; Zavascki, AP | 1 |
| Abdel-Massih, R; Bogdanovich, T; Chavda, KD; Chen, L; Cheng, S; Clancy, CJ; Doi, Y; Hao, B; Hong Nguyen, M; Hong, JH; Humar, A; Kreiswirth, BN; Kwak, EJ; Perlin, DS; Shields, RK; Silveira, FP; Zhao, Y | 1 |
| Aitha, M; Crowder, MW; Feng, L; LaCuran, AE; Oelschlaeger, P; Yang, KW; Yang, SK | 1 |
| Giannella, M; Lewis, R; Petrosillo, N; Trecarichi, EM; Tumbarello, M; Viale, P | 1 |
| Alvarez-Tejado, M; Codoñer, FM; De la Cruz, F; Galván, B; Garcillán-Barcia, MP; Gómez-Gil, R; López-Camacho, E; Lorenzo, M; Manrique, M; Mingorance, J; Moatassim, Y; Pareja, E; Salanueva, IJ; Salvarelli, E; Tobes, R | 1 |
| Bartels, M; Becker-Rux, D; Busch, T; Kaisers, UX; Laudi, S; Lübbert, C; Rodloff, AC | 1 |
| Fridrichová, M; Hrabák, J; Jakubu, V; Papagiannitsis, CC; Študentová, V; Zemlickova, H | 1 |
| Ji, Y; Jiang, Q; Li, K; Mi, Z; Shi, M; Shi, W; Wang, Y | 1 |
| Banach, DB; Blash, S; Calfee, DP; Francois, J; Jenkins, SG; Kreiswirth, BN; LaBombardi, V; Patel, G; Srinivasan, A | 1 |
| Basu, S; Datta, S; Mitra, S; Saha, A; Viswanathan, R | 1 |
| Aktas, F; Dizbay, M; Guzel Tunccan, O; Karasahin, O | 1 |
| Nobari, S; Rahmati Ghezelgeh, F; Shahcheraghi, F; Valizadeh, B | 1 |
| Anyfantis, I; Argyropoulou, A; Daikos, GL; Georgiadou, S; Goukos, D; Markogiannakis, A; Miriagou, V; Nepka, M; Psichogiou, M; Skoutelis, A; Stefanou, I; Sypsa, V; Tsaousi, S; Tzouvelekis, LS | 1 |
| Cotter, M; Crowley, B; Fanning, S; Haughton, P; Karczmarczyk, M; Lynch, M; Power, K; Schaffer, K; Wang, J | 1 |
| D'Abramo, A; D'Agostino, C; Gallinelli, C; Iannetta, M; Mascellino, MT; Mastroianni, CM; Oliva, A; Vullo, V | 1 |
| Ambretti, S; Arghittu, M; Bua, G; Cariani, L; Colombo, R; Gaibani, P; Landini, MP; Lombardo, D; Sambri, V; Torresani, E | 1 |
| Fan, H; Lu, Y; Pan, L; Shi, Y; Sun, K; Yan, Y; Yang, H | 1 |
| Bamberg, WM; Barron, MA; Epson, EE; Gould, CV; Janelle, SJ; Kallen, AJ; Kitchel, B; Limbago, BM; MacCannell, DR; Pisney, LM; Rasheed, JK; Wendt, JM | 1 |
| Barron, MA; Havens, D; Kassner, E; Madinger, NE; Pisney, LM | 1 |
| Brisse, S; Burack, S; Chen, L; Diago-Navarro, E; Fries, BC; Kodiyanplakkal, RP; Kreiswirth, BN; Levi, MH; Passet, V; Ulacia-Hernando, A | 1 |
| Anh, ND; Chan, WM; Garcia, J; Harijanto, E; Lee, C; Loo, CM; Mustafa, M; Van Kinh, N | 1 |
| Al Johani, SM; Al Salman, J; Al-Abri, S; Al-Jardani, A; Alfaresi, M; AlJindan, RY; Balkhy, HH; Dashti, AA; Ibrahim, E; Kutbi, AH; Paterson, DL; Sartor, AL; Schlebusch, S; Sidjabat, HE; Walsh, TR; Zowawi, HM | 1 |
| Clarke, LG; Doi, Y; Qureshi, ZA; Shields, RK; Syed, A | 1 |
| Bartoletti, M; Cescon, M; Cristini, F; Ercolani, G; Giannella, M; Lewis, RE; Morelli, MC; Pasqualini, E; Pinna, AD; Tedeschi, S; Viale, P | 1 |
| Chen, H; Liu, DW; Long, Y; Wang, XT; Zhang, HM | 1 |
| Christidou, A; Dimopoulou, D; Kofteridis, DP; Mantadakis, E; Maraki, S; Samonis, G; Valachis, A | 1 |
| Bartoletti, M; Bassetti, M; Cauda, R; Corcione, S; De Rosa, FG; Del Bono, V; Giannella, M; Losito, AR; Marchese, A; Pagani, N; Raffaelli, F; Saffioti, C; Spanu, T; Tedeschi, S; Trecarichi, EM; Tumbarello, M; Tumietto, F; Viale, P; Viscoli, C | 1 |
| Gartzonika, C; Levidiotou-Stefanou, S; Politi, L; Priavali, E; Tsakris, A; Voulgari, E; Vrioni, G | 1 |
| Bonomo, RA; Cline, M; Cober, E; Conlan, S; Evans, S; Fowler, VG; Fox, J; Hall, GS; Hanrahan, J; Jacobs, MR; Kalayjian, RC; Kaye, KS; Mason, P; Perez, F; Richter, SS; Rudin, SD; Salata, RA; Segre, JA; van Duin, D; Webber, R; Ziegler, J | 1 |
| Caccuri, F; Caruso, A; Corbellini, S; De Francesco, MA; Fiorentini, S; Gelmi, M; Giagulli, C | 1 |
| Adams, MD; Bonomo, RA; Brinkac, L; Cober, E; Hujer, AM; Hujer, KM; Jacobs, MR; Kaye, K; Marshall, SH; Perez, F; Rudin, SD; van Duin, D; Wright, MS | 1 |
| Bonomo, RA; Cline, M; Cober, ED; Evans, SR; Fowler, VG; Kalayjian, RC; Kaye, KS; Perez, F; Richter, SS; Salata, RA; van Duin, D | 1 |
| Gastmeier, P; Hummel, M; Klefisch, FR; Kola, A; Schweizer, C; Zweigner, J | 1 |
| Broucqsault-Dedrie, C; Laurans, C; Ledez, R; Meybeck, A; Nottebaert, S; Nyunga, M; Vachée, A; Vanbaelinghem, C; Verheyde, I; Waes, S | 1 |
| Falagas, ME; Karageorgopoulos, DE; Tansarli, GS; Vardakas, KZ | 1 |
| Acar, A; Aktas, Z; Budak, S; Erdem, H; Gorenek, L; Oncul, O; Ozyurt, M; Turhan, V | 1 |
| Albayrak, R; Aydin, S; Bilgi, EA; Kelesoglu, FM; Kuvat, N; Nazik, H; Ongen, B; Pakaştiçali, N; Yildiz, I; Yilmaz, F | 1 |
| Bartoletti, M; Bassetti, M; Cardellino, CS; Cauda, R; Corcione, S; De Rosa, FG; Del Bono, V; Giannella, M; Lewis, RE; Losito, AR; Maiuro, G; Saffioti, C; Tedeschi, S; Trecarichi, EM; Tumbarello, M; Viale, P; Viscoli, C | 1 |
| Axelrod, P; Gallagher, JC; Haynes, K; Kuriakose, S | 1 |
| Bigot, S; Bouldouyre, MA; Bukreyeva, I; Ceci, JM; Daroukh, A; Delaunay, C; Maisonneuve, L; Porcheret, H; Raisin, J; Siddhoun, N | 1 |
| Chang, YY; Chuang, YC; Fung, CP; Huang, LJ; Lin, JC; Lin, YT; Lu, PL; Siu, LK; Wang, JT; Wang, LS; Wu, TL | 1 |
| Cohen, HW; Minamoto, GY; Muggia, V; Simkins, J | 1 |
| Barozzi, A; Ciccarese, V; Gagliotti, C; Giordani, S; Giovinazzi, A; Moro, ML; Pietrantonio, AM; Pinelli, G; Sarti, M | 1 |
| Gu, B; Mei, Y; Wen, Y; Xia, W; Zhang, X | 1 |
| Crandon, JL; MacVane, SH; Nichols, WW; Nicolau, DP | 1 |
| Al Johani, SM; Aldrees, M; Aldughashem, FA; Alrodayyan, M; Balkhy, HH; Uz Zaman, T | 1 |
| Danishuddin, M; Faheem, M; Khan, A; Khan, AU | 1 |
| Cao, YP; Li, B; Wang, MH; Xu, XH; Zhao, ZC | 1 |
| Hampton, T | 1 |
| Dal Forno, NL; Hörner, R; Meneghetti, BH; Righi, RA; Salla, A; Seibert, G | 1 |
| Bonomo, RA; Chavda, KD; Chen, L; DeLeo, FR; Kreiswirth, BN; Mathema, B | 1 |
| Bertaina, A; Ciceri, F; Cudillo, L; Girmenia, C; Lombardini, L; Pastore, D; Piciocchi, A; Pisapia, G; Rambaldi, A; Rossolini, GM; Scimè, R; Severino, A; Sica, S; Viscoli, C | 1 |
| Alp, E; Altay-Kürkçü, C; Cevahir, F; Ozturk, A; Percin, D; Ulu-Kilic, A | 1 |
| Gefen-Halevi, S; Hindiyeh, MY; Keller, N; Mendelson, E; Smollan, G | 1 |
| Borghi, L; Guida, L; Lauretani, F; Lippi, G; Maggio, M; Meschi, T; Morelli, I; Nouvenne, A; Ridolo, E; Ticinesi, A | 1 |
| Gonzalez-Padilla, M; López-Cerero, L; Natera, C; Pascual, A; Pontes-Moreno, A; Rivera-Espinar, F; Rivero, A; Rodríguez, M; Rodríguez-Baño, J; Rodríguez-López, F; Salcedo, I; Torre-Cisneros, J | 1 |
| Arena, F; Garcia-Fernandez, A; Giani, T; Grundmann, H; Monaco, M; Pantosti, A; Pollini, S; Raffone, M; Rossolini, GM | 1 |
| Bandi, C; Carretto, E; Comandatore, F; Corbella, M; Dalla Valle, C; Epis, S; Farina, C; Gaiarsa, S; Gaibani, P; Labonia, M; Landini, MP; Marone, P; Pongolini, S; Sambri, V; Sassera, D; Scaltriti, E | 1 |
| Brizendine, KD; Cober, ED; Richter, SS; van Duin, D | 1 |
| Chen, Z; Li, L; Sun, Z; Tian, L; Wang, Y; Yan, S; Zhang, B; Zhu, X | 1 |
| Li, J; Mukhopadhyay, A; Tambyah, PA; Vasudevan, A; Yuen, EG | 1 |
| Fouzas, I; Gritsi-Gerogianni, N; Imvrios, G; Iosifidis, E; Kydona, C; Massa, E; Mouloudi, E; Papadopoulos, S; Papanikolaou, V; Piperidou, M; Roilides, I; Theodoridou, T | 1 |
| Egea, P; González-Padilla, M; Gracia-Ahufinger, I; López-Cerero, L; Pascual, A; Rodríguez-Baño, J; Rodríguez-López, F | 1 |
| Antoniadou, E; Antypa, E; Falagas, ME; Koteli, A; Matthaiou, DK; Vardakas, KZ | 2 |
| Achkar, M; Charrouf, FO; Dabboussia, F; Hamze, M; Mallat, H | 1 |
| Fujimoto, Y; Ichiyama, S; Ito, Y; Machida, K; Matsumura, Y; Nagao, M; Ogawa, K; Okamoto, S; Takakura, S; Tanaka, M; Uemoto, S; Yamamoto, M; Yoshizawa, A | 1 |
| Ahn, S; Han, WD; Kim, ES; Kim, HB; Kim, NH; Kim, TS; Park, KU; Seo, HK; Shin, MJ; Song, KH; Yoo, JS | 1 |
| Bonomo, RA; Cober, E; Evans, S; Fowler, VG; Kalayjian, RC; Kaye, KS; Perez, F; Richter, SS; Salata, RA; van Duin, D | 2 |
| Mataraci-Kara, E; Ozbek Celik, B; Yilmaz, M | 1 |
| Chen, L; Clancy, CJ; Clarke, LG; Eschenauer, GA; Kreiswirth, BN; Nguyen, MH; Potoski, BA; Press, EG; Shields, RK | 1 |
| Giske, CG; Tängdén, T | 1 |
| Aksu, HS; Bozkurt, S; Candevir Ulu, A; Gürel, D; Inal, AS; Kibar, F; Kılıç, F; Kömür, S; Kurtaran, B; Taşova, Y; Yaman, A; Yapıcı Çiçekdemir, H | 1 |
| Ciardi, MR; Cipolla, A; D'Abramo, A; De Rosa, A; Mascellino, MT; Mastroianni, CM; Oliva, A; Savinelli, S; Vullo, V | 1 |
| Lü, J; Wang, X; Zhang, R | 1 |
| Edwards, JR; Fridkin, SK; Magill, SS; Ricks, PM; Sievert, DM; Soe, MM | 1 |
| Amit, S; Carmeli, Y; Kotlovsky, T; Mishali, H; Schwaber, MJ | 1 |
| Aleo, A; Bonura, C; Di Bernardo, F; Fasciana, T; Geraci, DM; Giuffrè, M; Graziano, G; Mammina, C; Palma, DM; Saporito, L; Stampone, T | 1 |
| Ghebremedhin, B; Rasche, K; Yayan, J | 1 |
| Abu-Hanna, J; Adler, A; Carmeli, Y; Cohen Percia, S; Kazma Matalon, M; Lerner, A | 1 |
| Bassetti, M; Cavallo, R; Corcione, S; De Rosa, FG; Di Perri, G | 1 |
| Alonso, P; Hidalgo, M; Jugo, MB; Maccallini, G; Perren, P; Santana, G; Villar, HE | 1 |
| Dong, Y; Huang, Y; Jiao, Y; Li, Q; Liu, J; Liu, R; Qin, Y; Shang, Y | 1 |
| Deresinski, S; Watkins, RR | 1 |
| Bartoletti, M; Campoli, C; Cristini, F; Danese, I; Ercolani, G; Faenza, S; Giannella, M; Lauria, ND; Lewis, R; Morelli, MC; Pasqualini, E; Pinna, AD; Tedeschi, S; Tumietto, F; Viale, P | 1 |
| Hamzan, NI; Hasan, H; Rahman, RA; Rahman, ZA; Yean, CY | 1 |
| Bai, Y; Fan, H; Jin, Y; Li, J; Shao, C; Wang, Y | 1 |
| Aydemir, S; Mermer, S; Ozgiray, E; Sipahi, OR | 1 |
| Bassetti, M; Botti, S; Ciceri, F; Cudillo, L; Errico, A; Farina, C; Giannella, M; Girmenia, C; Locatelli, F; Lombardini, L; Luzzaro, F; Majolino, I; Piciocchi, A; Rambaldi, A; Rossolini, GM; Sarmati, L; Tascini, C; Viscoli, C | 1 |
| Chen, JC; Chen, JY; Chen, TL; Hui, CF; Pan, CY; Wu, JL | 1 |
| Huan, J | 1 |
| Chow, DC; Fryszczyn, B; Hu, L; Nordmann, P; Palzkill, T; Poirel, L; Prasad, BV; Sankaran, B; Stojanoski, V | 1 |
| Adler, A; Ben-Dalak, M; Carmeli, Y; Chmelnitsky, I | 1 |
| Bonten, MJ; Derde, LP; Dobiasova, H; Dolejska, M; Esteves, FJ; Gniadkowski, M; Hrabák, J; Izdebski, R; Papagiannitsis, CC; Studentova, V | 1 |
| Chuang, YC; Ku, YH; Lee, MF; Tang, HJ; Yu, WL | 1 |
| Colombo, A; Cornetta, M; Costa, E; Di Girolamo, L; Gaia, P; Lombardi, F; Moroni, A; Ramundo, F; Tejada, MR; Valaperta, R; Valisi, M | 1 |
| Adámková, V; Balejova, M; Bergerová, T; Chmelařová, E; Dvořáková, L; Hrabák, J; Jakubů, V; Ježek, P; Kabelíková, P; Kolář, M; Papagiannitsis, C; Paterová, P; Študentová, V; Tejkalová, R; Žemličková, H | 1 |
| Carbonnelle, E; Compain, F; Geri, G; Kernéis, S; Lavollay, M; Mainardi, JL; Rostane, H; Valade, S | 1 |
| Emond, JE; Goudie, S; Pereira, MR; Pouch, SM; Scully, BF; Uhlemann, AC; Verna, EC | 1 |
| Wang, F; Xiao, X; Yao, B; Zhang, J; Zhang, X; Zhou, L | 1 |
| Botziori, C; Kakasi, E; Koteli, A; Meletis, G; Oustas, E | 1 |
| Nordmann, P; Pitout, JD; Poirel, L | 1 |
| Aleo, A; Bonura, C; Di Bernardo, F; Fasciana, T; Giammanco, A; Giuffrè, M; Mammina, C; Palma, DM; Stampone, T | 1 |
| Blood, A; Buising, KL; Chang, LW; Cocks, J; Cronin, K; Greenough, J; Howden, BP; Jeremiah, CJ; Kwong, J; Poy Lorenzo, YS; Waters, MJ | 1 |
| Guo, W; Li, J; Shan, K; Xu, B | 1 |
| Bonomo, RA; Garber, K; Harris, PN; Hecker, M; Hurless, K; Jacobs, MR; Kalayjian, RC; Khatri, A; Naeger Murphy, N; Osborn, M; Paterson, DL; Perez, F; Rudin, SD; Salata, RA; van Duin, D; Wiest, P | 1 |
| Nieberg, P; Ny, P; Wong-Beringer, A | 1 |
| Batbaatar, G; Bolormaa, E; Huang, AH; Huang, YT; Kao, CY; Khosbayar, T; Udval, U; Urangoo, Z; Wu, HM; Wu, JJ; Yan, JJ | 1 |
| Biberg, CA; Chang, MR; Chaves, CE; do Carmo, SF; Gales, AC; Rodrigues, AC | 1 |
| Bauernfeind, A; Boyanova, L; Dacheva, D; Kaneva, R; Markovska, R; Mitev, V; Mitov, I; Popova, V; Schneider, I; Stoeva, T | 1 |
| Cao, B; Chen, H; Hu, Z; Li, H; Li, S; Liu, W; Wang, H; Wang, Q; Wang, X; Zeng, J; Zhang, F; Zhang, Y; Zhao, C; Zhao, F | 1 |
| Bella, A; D'Ancona, F; Giambi, C; Hoxha, A; Kärki, T; Montano, C; Sisto, A | 1 |
| Caballero, S; Carter, R; Ke, X; Kim, GJ; Leiner, IM; Ling, L; Manova, K; Miller, L; Pamer, EG; Sušac, B | 1 |
| Ardanuy, C; Ayats, J; Cubero, M; Cuervo, G; Dominguez, MÁ; Gallego, L; Liñares, J; Martí, S; Peña, C; Pujol, M; Sevillano, E; Tubau, F | 1 |
| Coskun, K | 1 |
| Dube, G; Kubin, CJ; Lee, JR; Pereira, MR; Pouch, SM; Satlin, MJ; Tsapepas, DS | 1 |
| Akkoyunlu, Y; Beriş, FŞ; Çopur Çiçek, A; Doymaz, MZ; Iraz, M; Karaoğlu, H; Özad Düzgün, A; Özgümüş, OB; Peleg, AY; Sandallı, C; Saral, A | 1 |
| Hsieh, CL; Liu, YM; Lu, HL; Mu, JJ; Tseng, IL; Tseng, YC; Wang, SJ; Yeh, HY | 1 |
| Abbo, LM; Aragon, L; Beduschi, T; Camargo, JF; Cantón, R; Morris, MI; Pérez-Cardona, A; Prado, CE; Simkins, J; Tekin, A | 1 |
| Chen, FJ; Chien, CC; Lee, CH; Li, CC; Liu, JW; Su, LH; Tang, YF | 1 |
| Kiratisin, P; Netikul, T | 1 |
| Kieffer, N; Nordmann, P; Poirel, L | 1 |
| Hsueh, PR; Ko, WC; Lee, CC; Lee, NY; Li, CW; Li, MC; Lo, CL | 1 |
| Aouni, M; Ben Haj Khalifa, A; Chatre, P; Dahmen, S; Grami, R; Haenni, M; Madec, JY; Mansour, W | 1 |
| Bentchouala, C; Cuzon, G; Dortet, L; Héry, M; Lezzar, A; Naas, T; Smati, F; Vogel, A | 1 |
| Alby, K; Han, JH; Mills, JP; Talati, NJ | 1 |
| Alicino, C; Copello, F; Del Bono, V; Giacobbe, DR; Icardi, G; Orsi, A; Sarteschi, G; Tassinari, F; Trucchi, C; Viscoli, C | 1 |
| Han, SB; Jeong, DC; Kang, JH; Lee, SC; Lee, SY | 1 |
| Angeletti, S; Avola, A; Cella, E; Crea, F; De Florio, L; Dicuonzo, G; Fagioni, M; Lo Presti, A; Vitali, MA | 1 |
| Chavda, KD; Chen, L; Cienfuegos, AV; Jiménez, JN; Kreiswirth, BN; Ocampo, AM; Roncancio, G | 1 |
| Bonura, C; Carattoli, A; Endimiani, A; Feudi, C; Fortini, D; Mammina, C; Pires, J; Villa, L | 1 |
| Cprek, JB; Gallagher, JC | 1 |
| Hagiya, H; Ogawa, H; Otsuka, F; Takahashi, Y; Yamamoto, A | 1 |
| Díaz, A; Garcés, C; Jaimes, F; Ortiz, DC; Restrepo, AV; Trujillo, M | 1 |
| Chan, EW; Chen, GX; Chen, S; Gu, D; Lin, D; Zhang, R | 1 |
| Barbadora, K; Ferrelli, JG; Green, M; Nowalk, A; Roberts, TL; Stillwell, T; Weissman, SJ | 1 |
| Biehle, LR; Cottreau, JM; Filipek, RL; Hirsch, EB; Lasco, TM; Mahoney, MV; O'Donnell, JN; Thompson, DJ | 1 |
| Chan, R; Chapin, KC; Cunha, CB; Kassakian, SZ; Mermel, LA; Tenover, FC; Ziakas, P | 1 |
| El-Defrawy, I; Fernández-Martínez, M; Gamal, D; Martínez-Martínez, L; Montes, LÁ; Ocampo-Sosa, AA; Salem, D | 1 |
| Guo, Q; Sheng, ZK; Wang, M; Wang, W; Xu, X; Yang, Y | 1 |
| Andrasevic, AT; Bejuk, D; Butic, I; Cipris, I; Jajic, I; Jelic, M; Koscak, I; Marinkovic, S; Pal, MP; Plecko, V | 1 |
| Castanheira, M; Deshpande, LM; Jenkins, SG; Jones, RN; Mills, JC; Schuetz, AN; Soave, R | 1 |
| Cui, T; Su, M; Wang, J; Yan, H; Yang, H; Yang, Z; Yao, Q; Zhan, Y; Zhao, P | 1 |
| Brinkworth, AJ; Chen, L; DeLeo, FR; Dorward, DW; Kobayashi, SD; Kreiswirth, BN; Porter, AR | 1 |
| Bamford, CM; Jacobson, RK; Manesen, MR; Moodley, C; Nicol, MP; Smith, M; Williams, SG | 1 |
| Cacioni, M; Mencacci, A; Merlini, L; Monari, C; Nardelli, E; Repetto, A; Vecchiarelli, A | 1 |
| Alós, JI; Asenjo, A; Bautista, V; Fuentes, E; González-Torralba, A; Oteo, J | 1 |
| Carrion, AF | 1 |
| Jitwasinkul, T; Preechachuawong, P; Samret, W; Santimaleeworagun, W | 1 |
| Glupczynski, Y; Huang, TD; Jans, B; Mertens, R; Piérard, D; Schallier, A; Trémérie, JM; Yusuf, E | 1 |
| Song, T; Yu, H | 1 |
| Hemarajata, P; Humphries, R; Kim, S; Makker, J; Mohamadnejad, M; Muthusamy, VR; Rubin, Z; Russell, D; Sedarat, A; Watson, RR; Yang, S | 1 |
| Ahlstedt, E; Caceres, M; Hasan, B; Hernandez, J; Järhult, JD; Laurell, K; Rakib, MM | 1 |
| Dias, C; Perez, LR; Rodrigues, D | 1 |
| Dai, H; Hu, Y; Li, L; Ping, Y; Xu, H; Yan, X | 1 |
| Calgin, MK; Cetinkol, Y; Telli, M; Yildirim, AA | 1 |
| Chou, A; Daroy, ML; Evangelista, MA; Klinzing, DC; Lagamayo, E; Navoa-Ng, J; Roa, M; Sucgang, R; Sulit, AK; Torres, BC; Zechiedrich, L | 1 |
| Angkititrakul, S; Chaimanee, P; Chanawong, A; Charoensri, N; Chetchotisakd, P; Lulitanond, A; Lunha, K; Saenjamla, P; Wilailuckana, C; Wonglakorn, L | 1 |
| Buising, KL; Cronin, K; Jeremiah, CJ; Mandrawa, CL; Poy Lorenzo, YS; Waters, MJ | 1 |
| Bernardeschi, G; Malcarne, P; Ripoli, A; Sbrana, F; Tascini, C | 1 |
| Antachopoulos, C; Iosifidis, E; Karampatakis, T; Roilides, E; Tsakris, A | 1 |
| Fransén, J; Hanberger, H; Huss, FR; Nilsson, LE; Rydell, U; Sjöberg, F | 1 |
| Grigoras, C; Kalbasi, A; Karanika, S; Mylonakis, E; Paudel, S | 1 |
| Bonomo, RA; Chain, PS; Davenport, KW; Jacobs, MR; Johnson, SL; Perez, F; Ramazani, A; Ramirez, MS; Sherratt, DJ; Tolmasky, ME; Traglia, GM; van Duin, D; Xie, G | 1 |
| Akova, M; Al-Zahrani, IA; Aladag, E; Atmaca, O; Boral, B; Cakir, B; Day, KM; Eser, OK; Perry, JD; Zarakolu, P | 1 |
| Domínguez Jiménez, MC; Vergara-López, S | 1 |
| Di Pilato, V; Giakkoupi, P; Giani, T; Landini, G; Miriagou, V; Papagiannitsis, CC; Riccobono, E; Rossolini, GM; Vatopoulos, AC | 1 |
| Abdallah, M; Bratu, S; Collins, B; Cortes, C; Ghitan, M; Landman, D; Olafisoye, O; Quale, J; Urban, C | 1 |
| Brega, C; Coppo, E; Del Bono, V; Di Biase, C; Giacobbe, DR; Marchese, A; Olivieri, GM; Salsano, A; Santini, F; Sportelli, E; Viscoli, C | 1 |
| Arena, F; Cannatelli, A; Di Pilato, V; Fortunato, S; Giani, T; Henrici De Angelis, L; Menichetti, F; Rossolini, GM; Tascini, C | 1 |
| Aversa, F; Busca, A; Candoni, A; Cattaneo, C; Del Principe, MI; Delia, M; Di Blasi, R; Fanci, R; Fianchi, L; Lessi, F; Martino, B; Melillo, L; Nadali, G; Pagano, L; Perriello, V; Sica, S; Trecarichi, EM; Tumbarello, M | 1 |
| Li, F; Li, P; Yin, Y; Zhang, Q; Zhang, Y | 1 |
| Anandan, S; Nabarro, LEB; Shankar, C; Veeraraghavan, B | 1 |
| El-Mowafy, M; Elgaml, A; Khalil, MAF | 1 |
| Lewis, RE | 1 |
| Gupta, M; Singh, SK | 1 |
| Alves, Tda S; Bartolleti, F; Capuzzo Dos Santos, C; Felipe, CB; Lemo, ME; Mimica, MJ; Passadore, LF; Sampaio, JL; Sampaio, SC; Seco, BM; Zavascki, AP | 1 |
| Ejaz, H; Javed, H; Rathore, AW; Zafar, A | 1 |
| Bel Haj Khalifa, A; Bouallègue, O; Boujâafar, N; Chaouch, C; Haenni, M; Madec, JY; Mansour, W; Messaoudi, A; Naija, W; Saras, E | 1 |
| Chung, PY | 1 |
| Barchiesi, F; Castelli, P; Fiorentini, A; Manso, E; Mocchegiani, F; Montalti, R; Nicolini, D; Staffolani, S; Vivarelli, M | 1 |
| Falco, A; Franco, E; Guzmán, A; Ramos, Y; Takiff, H | 1 |
| Capoccia, L; Mansour, W; Menna, D; Montelione, N; Sirignano, P; Speziale, F | 1 |
| Aloj, F; Castaldi, D; D'Abramo, A; De Angelis, M; Gizzi, F; Mascellino, MT; Mastroianni, CM; Oliva, A; Scorzolini, L; Storto, M; Vullo, V | 1 |
| Chikala, R; Ratnakar, KS; Sritharan, V; Swathi, CH | 1 |
| Bellù, R; Bonfanti, P; Caramma, I; Condò, M; Giani, T; Luzzaro, F; Principe, L; Rossolini, GM | 1 |
| Bedenic, B; Mestrovic, T | 1 |
| Giacobbe, DR; Marchese, A; Salsano, A; Santini, F | 1 |
| Ambretti, S; Bruzzi, P; Cardellino, CS; Coppo, E; Corcione, S; De Rosa, FG; Del Bono, V; Giacobbe, DR; Giannella, M; Magnasco, L; Maraolo, AE; Marchese, A; Pagani, N; Saffioti, C; Viale, P; Viscoli, C | 1 |
| Bonomo, RA; Cober, E; Doi, Y; Domitrovic, TN; Evans, S; Fowler, VG; Hujer, AM; Hujer, KM; Kalayjian, RC; Kaye, KS; Marshall, S; Perez, F; Richter, SS; Rojas, LJ; Rudin, SD; Salata, RA; Salim, M; van Duin, D; Watkins, RR | 1 |
| Cenderello, N; Crisalli, MP; Cristina, ML; Fabbri, P; Lo Pinto, G; Ottria, G; Sartini, M; Schinca, E; Spagnolo, AM; Usiglio, D | 1 |
| Florou, Z; Hrabak, J; Malli, E; Mantzarlis, K; Papagiannitsis, CC; Petinaki, E; Sarrou, S; Zakynthinos, E | 1 |
| Creighton, J; Heffernan, H; Howard, JC; Werno, A | 1 |
| Harris, PN; Lane, SW; Liborio, M; Paterson, DL; Peri, AM; Righi, E; Wailan, AM | 1 |
| Bilker, WB; Goldstein, EJ; Han, JH; Lautenbach, E; Tolomeo, P; Wise, J | 1 |
| Arthur, F; Bonnin, RA; Cotellon, G; Creton, E; Dortet, L; Gauthier, L; Jousset, AB; Naas, T; Tlili, L; Urvoy, N | 1 |
| Dobashi, H; Imataki, O; Kadowaki, N; Kuwahara, T; Matsuka, H; Mori, H; Nakayama-Imaohji, H; Ohue, Y; Uchida, S; Uemura, M | 1 |
| Biswal, S; Ghosh, AS; Issa, B; Kar, D; Kumar, G | 1 |
| Alonso-Isa, M; Benítez-Sala, R; García-Rojo, E; Gil-Moradillo, J; González-Padilla, DA; Justo-Quintas, J; Lara-Isla, A; Medina-Polo, J; Passas-Martínez, JB; Sopeña-Sutil, R; Tejido-Sánchez, Á | 1 |
| Araque, Y; Caña, L; De Donato, M; García, J; Gonzáiez, D; Martínez, D; Rodríguez, L; Roduifo, H | 1 |
| Falgenhauer, L; Fuchs, K; Gerlach, RG; Gessner, A; Hiergeist, A; Jantsch, J; Melzl, H; Pfeifer, Y; Reischl, U; Richert, K; Simon, M | 1 |
| Akeda, Y; Aoki, K; Hagiya, H; Ishii, Y; Nishi, I; Sakamoto, N; Tomono, K; Yamamoto, N; Yoshida, H | 1 |
| Bajolet, O; Barbe, C; Brasme, L; De Champs, C; Guillard, T; Limelette, A; Muggeo, A; Thierry, A; Vernet-Garnier, V | 1 |
| Ajao, AO; Albrecht, JS; Furuno, JP; Harris, AD; Johnson, JK; Pineles, LL; Robinson, GL; Thom, KA; Zhao, L | 1 |
| Fernando, MM; Gunathilake, MP; Luke, WA; Miththinda, JK; Premaratna, R; Sebastiampillai, BS; Silva, FH; Wickramasinghe, RD | 1 |
| Cheong, EYL; Crook, DW; Gottlieb, T; Kizny Gordon, AE; Kotay, S; Mathers, AJ; Peto, TEA; Stoesser, N; Walker, AS | 1 |
| Barmpouti, E; Galani, L; Giamarellou, H; Karaiskos, I; Masgala, A; Souli, M | 1 |
| Perez, LRR | 1 |
| Arena, F; Cannatelli, A; Cavallo, R; D'Andrea, MM; Di Pilato, V; Fossati, L; Giani, T; Henrici De Angelis, L; Rossolini, GM | 1 |
| Ballarò, D; Bucaneve, G; Capria, S; Cartoni, C; Foà, R; Gentile, G; Grammatico, S; Micozzi, A; Minotti, C; Pacetti, E; Santilli, S | 1 |
| Badur, S; Cagatay, AA; Carrër, A; Eraksoy, H; Nordmann, P; Poirel, L | 1 |
| Apisarnthanarak, A; Kiratisin, P; Mundy, LM | 1 |
| Aziz, N; Bahar, J; Bishara, J; Israel, S; Madar-Shapiro, L; Samra, Z | 1 |
| Bogaerts, P; Cuzon, G; Glupczynski, Y; Huang, TD; Naas, T; Nordmann, P | 1 |
| Calfee, D; Jenkins, SG | 1 |
| Araj, GF; Corkill, J; Cuzon, G; Kattar, MM; Matar, GM; Naas, T; Nordmann, P | 1 |
| Calfee, DP; Factor, SH; Huprikar, S; Jenkins, SG; Patel, G | 1 |
| Carmeli, Y; Leavitt, A; Navon-Venezia, S; Patel, JB; Rasheed, JK; Schwaber, MJ; Srinivasan, A | 1 |
| Knabbe, C; Ohler, S; Schönthal, S; Weile, J | 1 |
| Giske, CG; Hjetland, R; Naseer, U; Onken, A; Samuelsen, Ø; Skutlaberg, DH; Sundsfjord, A; Tofteland, S | 1 |
| Bamia, C; Daikos, GL; Georgousi, K; Kosmidis, C; Petrikkos, G; Petrikkos, P; Psichogiou, M; Skoutelis, A; Tassios, PT; Tzouvelekis, LS; Vryonis, E | 1 |
| Khan, L; Nadkarni, AS; Schliep, T; Zeana, CB | 1 |
| Bonatti, H; Brassinga, AK; Cox, HL; Hazen, KC; Kitchel, B; Mathers, AJ; Patel, JB; Pruett, TL; Sawyer, RG; Sifri, CD; Wispelwey, B | 1 |
| Della-Latta, P; Dib-Hajj, F; Dougherty, BA; Gootz, TD; He, W; Huard, RC; Lescoe, MK | 1 |
| Calfee, DP; Huprikar, S; Jenkins, SG; Lee, J; Patel, G | 1 |
| Allen, G; Augenbraun, M; Bratu, S; Hui, A; Kochar, S; Landman, D; Quale, J; Sharma, R; Sheard, T; Tolentino, E | 1 |
| Cuzon, G; Naas, T; Nordmann, P | 1 |
| Adler, A; Benenson, S; Block, C; Carmeli, Y; Moses, AE; Navon-Venezia, S; Strahilevitz, J | 1 |
| Pitlik, SD | 1 |
| Farrell, DJ; Fuksa, M; Krajden, S; Lo, S; Melano, R; Pillai, DR; Rawte, P; Roda, N; Tijet, N | 1 |
| Giakoupi, P; Maltezou, H; Pappa, O; Polemis, M; Saroglou, G; Vatopoulos, A | 1 |
| Abid, J; Adams-Haduch, JM; Doi, Y; Dossenback, DA; Halstead, DC; Paterson, DL; Sellen, TJ | 1 |
| Finkelstein, R; Hussein, K; Kassis, I; Mashiach, T; Oren, I; Sprecher, H | 1 |
| Shah, PM | 1 |
| Autenrieth, IB; Fladerer, C; Gröbner, S; Linke, D; Madlung, J; Pfeifer, Y; Schütz, W; Witte, W | 1 |
| Fuksa, M; Krajden, S; Low, DE; Pillai, DR; Toye, B | 1 |
| Bratu, S; Landman, D; Quale, J | 1 |
| Badal, RE; Bouchillon, SK; Hackel, M; Hawser, SP; Hoban, DJ; Johnson, JL | 1 |
| Ishii, Y; Katho, M; Kouyama, Y; Odashiro, R; Suwabe, A; Tateda, K; Yamada, Y; Yamaguchi, K; Yamahata, K | 1 |
| Chalevelakis, G; Damala, M; Falagas, ME; Michalopoulos, A; Rafailidis, P; Virtzili, S | 1 |
| Borer, A; Eskira, S; Nativ, R; Peled, N; Riesenberg, K; Saidel-Odes, L; Schlaeffer, F; Sherf, M | 1 |
| Cai, JC; Chen, GX; Chen, LR; Zhang, R; Zhou, HW | 1 |
| Broide, E; Kopuit, P; Lachish, T; Raveh, D; Rudensky, B; Schlesinger, Y; Wiener-Well, Y; Yinnon, AM | 1 |
| Munoz-Price, LS; Quinn, JP | 1 |
| Abu-Elmagd, KM; Adams-Haduch, JM; Doi, Y; Paterson, DL; Potoski, BA; Sidjabat, HE; Silveira, FP | 1 |
| Carmeli, Y; Chmelnitsky, I; Leavitt, A; Navon-Venezia, S; Ofek, I | 1 |
| Andremont, A; Barbier, F; Giakkoupi, P; Lucet, J; Ruppé, E; Vatopoulos, A; Wildenberg, L; Wolff, M | 1 |
| Calvert, K; Hayden, MK; Lin, M; Lolans, K; Munoz-Price, LS; Stemer, A; Weinstein, RA; Won, S | 1 |
| Kiratisin, P; Leelaporn, A; Leelarasmee, A; Netikul, T | 1 |
| Goering, RV; Gould, C; Gregory, CJ; Llata, E; Robledo, IE; Santiago, LM; Srinivasan, A; Stine, N; Tomashek, KM; Vazquez, GJ | 1 |
| Carmeli, Y; Chmelnitsky, I; Goren, MG; Leavitt, A; Navon-Venezia, S; Ofek, I | 1 |
| Bryan, M; Della-Latta, P; Eschenauer, GA; Furuya, EY; Kubin, CJ; Nguyen, M; O'Neil, K | 1 |
| Benhamou, M; Cuzon, G; Lesenne, A; Naas, T; Nordmann, P | 1 |
| Mariano, N; Rahal, JJ; Urban, C | 1 |
| Ben-David, D; Keller, N; Maor, Y; Rahav, G; Regev-Yochay, G; Shachar, D; Smollan, G; Tal, I; Zlotkin, A | 1 |
| Babics, A; Boytchev, I; Cuzon, G; Fortineau, N; Gayral, F; Naas, T; Nordmann, P | 1 |
| Böröcz, K; Damjanova, I; Dobák, A; Farkas, M; Jánvári, L; Pászti, J; Puskás, E; Tóth, A | 1 |
| Badal, RE; Baquero, F; Bouchillon, SK; Cantón, R; Hawser, SP; Hoban, DJ | 1 |
| Arikan Akan, O; Dolapci, I; Karahan, ZC; Sahin, F; Tekeli, A; Us, E | 1 |
| Baquero, F; Cantón, R; Coque, TM; Curiao, T; Morosini, MI; Robustillo, A; Ruiz-Garbajosa, P | 1 |
| Adams, MD; Bajaksouzian, S; Bonomo, RA; Decker, BK; Dul, MJ; Ecker, DJ; Endimiani, A; Hujer, KM; Jacobs, MR; Perez, F; Ray, AJ; Salata, RA; Toltzis, P; Wallace, CJ; Windau, A | 1 |
| Chia, JH; Kuo, AJ; Lee, MH; Shih, NY; Siu, LK; Su, LH; Wu, TL | 1 |
| Bergerová, T; Cervená, D; Chudácková, E; Empel, J; Fajfrlík, K; Gniadkowski, M; Hrabák, J; Urbásková, P | 1 |
| Araj, GF; Benouda, A; Khairallah, MT; Matar, GM; Touzani, O | 1 |
| Bulik, CC; Nicolau, DP | 2 |
| Antoniadou, E; Kontopoulou, K; Koteli, A; Kriti, M; Protonotariou, E; Sofianou, D; Vasilakos, K | 1 |
| Carrer, A; Nordmann, P | 1 |
| Albertí, S; Cantón, R; Coque, MT; García, L; Morosini, M; Tato, M | 1 |
| Fluit, AC; Leverstein-van Hall, MA; Roelofsen, E; Stuart, JC; Versteeg, D; Voets, GM | 1 |
| Bowler, IC; Gaulton, T; Perry, C; Pike, R; Turton, J; Webster, DP; Woodford, N | 1 |
| Aleo, A; Bonura, C; Calà, C; Conti, A; Degl'Innocenti, R; Mammina, C; Nastasi, A; Pecile, P; Pesavento, G | 1 |
| Markou, F; Pitiriga, V; Poulou, A; Pournaras, S; Ranellou, K; Spanakis, N; Tsakris, A | 1 |
| Webster, PC | 1 |
| Ambretti, S; Caroli, F; Gaibani, P; Miragliotta, L; Sambri, V | 1 |
| Finkelstein, R; Geffen, Y; Oren, I; Shalaginov, R; Sprecher, H; Tavleva, I | 1 |
| Giasnetsova, T; Gritsi-Gerogianni, N; Iosifidis, E; Karapanagiotou, A; Mouloudi, E; Protonotariou, E; Roilides, E; Sofianou, D; Tsioka, A; Zagorianou, A | 1 |
| Bonten, MJ; Kluytmans, J; Kulberg, BJ | 1 |
| Feizabadi, MM; Mahamadi-Yeganeh, S; Mahboobi, M; Mirafshar, SM; Mirsalehian, A; Nili, F; Yadegarinia, D | 1 |
| Benyamini, N; Fineman, R; Finkelstein, R; Oren, I; Rowe, JM; Sprecher, H; Zuckerman, T | 1 |
| Baritaki, S; Georgiladakis, A; Maraki, S; Messaritakis, H; Neonakis, IK; Samonis, G; Spandidos, DA | 1 |
| Bernabeu, S; Nordmann, P; Poirel, L; Revathi, G | 1 |
| Bheemreddy, S; Blunden, C; Bonomo, RA; Chen, TY; Chopra, T; Dhar, S; Endimiani, A; Hafeez, W; Hothi, J; Hujer, AM; Kaye, KS; Lephart, PR; Marchaim, D; Moshos, J; Navon-Venezia, S; Perez, F; Pogue, JM; Reid, D; Rudin, S; Salimnia, H; Shango, M; Slim, J | 1 |
| alNaiemi, N; Bernards, A; Kalpoe, J; Lettinga, K; Paltansing, S; van Apeldoorn, M | 1 |
| Abbanat, D; Barron, A; Bunting, RA; Fernandez, J; Flamm, RK; Hall, L; Hilliard, JJ; Lynch, AS; Melton, JL; Ward, CK | 1 |
| Crowley, B; Kelly, S; Lynch, M; O'Rourke, K; Prior, AR; Roche, C | 1 |
| Lienhard, R; Malinverni, R; Nordmann, P; Poirel, L; Potron, A; Siegrist, HH | 1 |
| Al Naiemi, N; Kalpoe, JS; Nordmann, P; Poirel, L | 1 |
| Bonomo, RA | 1 |
| Binotto, E; George, N; Hayashi, Y; Htin, A; Li, J; Nation, RL; Nimmo, GR; Paterson, DL; Sidjabat, H; Walsh, TR | 1 |
| Cai, J; Liu, J; Wu, D | 1 |
| Alexander, DC; Lastovetska, O; Low, DE; Melano, RG; Patel, SN; Richardson, D; Tijet, N | 1 |
| Carmeli, Y; Israeli, A; Lev, B; Rubinovitch, B; Schwaber, MJ; Shalit, I; Smollan, G; Solter, E | 1 |
| Chiang, T; Colon-Urban, R; Eng, RH; Gomez, E; Huang, DB; Mariano, N; Urban, C | 1 |
| Ersoy, Y; Görgeç, S; Kuzucu, C; Yetkin, F | 1 |
| Cuzon, G; Gondret, R; Naas, T; Nordmann, P; Ouanich, J | 1 |
| Ambretti, S; Berlingeri, A; Bielli, A; Gaibani, P; Gelsomino, F; Landini, MP; Sambri, V | 1 |
| Goff, DA; Parbhoo, RK; Schafer, JJ; Winters, HA | 1 |
| Carrër, A; Decroisette, E; Deiber, M; Lecomte, C; Levast, M; Mallaval, FO; Nordmann, P; Poirel, L | 1 |
| Cai, JC; Chen, GX; Hu, QF; Lv, HX; Wang, XD; Zhang, R; Zhou, HW | 1 |
| Bonomo, RA; Endimiani, A; Fraser, TG; Hall, GS; Neuner, EA; Sekeres, J; Shrestha, NK; van Duin, D; Yeh, JY | 1 |
| Hsueh, PR; Huang, WH; Ko, WC; Lee, NY; Tsui, KC | 1 |
| Boyd, DA; Gelosia, A; Jenkins, SG; Katz, K; Kreiswirth, N; Low, DE; Mataseje, LF; Mulvey, MR; Poutanen, SM; Prayitno, N; Willey, BM | 1 |
| Sekar, U; Shanthi, M | 1 |
| Barbeito, G; Crespo, C; García-Riestra, C; Navarro, D; Regueiro, BJ; Treviño, M | 1 |
| Daikos, GL; Markogiannakis, A | 1 |
| Benenson, S; Block, C; Cohen, MJ; Gross, I; Levin, PD; Moses, AE; Schwartz, C; Weiss, Y | 1 |
| Miriagou, V; Tassios, PT | 1 |
| Akpaka, PE; Legall, B; Padman, J | 1 |
| Ben-David, D; Gal-Mor, O; Keller, N; Kordevani, R; Maor, Y; Marzel, A; Rahav, G; Tal, I | 1 |
| Merino, P; Picazo, JJ; Rodríguez-Avial, C; Rodríguez-Avial, I | 1 |
| Bosi, A; Casalone, E; Donnarumma, F; Fanci, R; Goti, E; Indorato, C; Mastromei, G; Nicoletti, P; Pecile, P | 1 |
| Garcia, DO; Levin, AS; Mostardeiro, M; Ogassavara, CT; Pereira, GH | 1 |
| Crowley, B; Fenelon, C; Fenelon, LE; FitzGerald, SF; Flynn, A; Murphy, V; O'Brien, DJ; Roche, C; Rose, L; Schaffer, K; Wrenn, C | 1 |
| Albertí, S; Barbier, M; Doménech-Sánchez, A; García-Sureda, L; Gascó, J; Juan, C | 1 |
| Ben-David, D; Carmeli, Y; Fridental, I; Masarwa, S; Mishali, H; Navon-Venezia, S; Rubinovitch, B; Schwaber, MJ; Smollan, G | 1 |
| Bardenstein, R; Ciobotaro, P; Nadir, E; Oved, M; Zimhony, O | 1 |
| Agodi, A; Barchitta, M; Giaquinta, L; Koumaki, V; Politi, L; Romeo, MA; Spanakis, N; Tsakris, A; Valenti, G; Voulgari, E | 1 |
| Borer, A; Eskira, S; Livshiz-Riven, I; Nativ, R; Peled, N; Riesenberg, K; Saidel-Odes, L; Schlaeffer, F; Sherf, M | 2 |
| Barguellil, F; Lahlaoui, H; Moussa, MB; Nordmann, P; Poirel, L | 1 |
| Benouda, A; Hays, C; Nordmann, P; Poirel, L | 1 |
| Jiang, RJ; Kong, HS; Mi, ZH; Zhang, F; Zhu, JM | 1 |
| Bae, IK; Jeong, SH; Kim, J; Kim, JM; Lee, K; Shin, SY; Yong, D | 1 |
| Chen, G; Hu, ZQ; Ito, R; Kimura, S; Zhao, WH | 1 |
| Moolman, J; Peirano, G; Pitondo-Silva, A; Pitout, JD | 1 |
| Blumenthal, JS; Calfee, DP; Cohen, AB; Furuya, EY; Jenkins, SG; Kubin, CJ; Satlin, MJ; Wilson, SJ | 1 |
| Anderson, KF; Banaei, N; Gans, H; Kallen, AJ; Kitchel, B; Limbago, BM; Munro, S; Rasheed, JK; Watz, N; Zhu, W | 1 |
| Alvarez-Avello, J; Asensio, A; Azañedo, L; Balandín-Moreno, B; Campos, J; Cuevas, O; Fernández-Romero, S; Isidoro, B; Muñoz-Algarra, M; Oteo, J; Sáez, D; Sánchez-Romero, I; Vindel, A | 1 |
| Bonnin, RA; Nordmann, P; Poirel, L | 1 |
| Watson, R | 1 |
| Aydin, S; Ergul, Y; Keleşoğlu, FM; Mete, B; Nazik, H; Öngen, B; Tabak, F; Yemişen, M | 1 |
| Hall, MH | 1 |
| Borer, A; Codish, S; Eskira, S; Peled, N; Polachek, H; Riesenberg, K; Saidel-Odes, L; Schlaeffer, F; Smolykov, R; Trabelsi, Y; Yousef, B | 1 |
| Bishara, J; Cohen, J; Goldberg, E; Lev, S; Singer, P | 1 |
| Acosta, F; Cottagnoud, M; Cottagnoud, P; Egerman, U; Laeuffer, JM; Stucki, A | 1 |
| Bonomo, RA; Chavda, KD; Chen, L; Jacobs, MR; Kreiswirth, BN; Levi, MH; Mediavilla, JR | 1 |
| Fujimoto, N; Hamasuna, R; Matsumoto, T; Mizokami, Y; Muratani, T; Sho, T | 1 |
| Al Johani, SM; Al-Ahdal, MN; Al-Qahtani, AA; Alothman, A; Altayeb, HT; Arabi, Y; Balkhy, HH; El-Saed, A; Francis, C; Sallah, M | 1 |
| Dalit, S; David, L; Debby, BD; Galia, R; Ganor, O; Ilana, T; Nathan, K; Smollan, G; Yasmin, M | 1 |
| Ko, WC; Lee, NY; Lin, SH; Tsai, LH; Wu, JJ; Yan, JJ | 1 |
| Martínez-Martínez, L; Ocampo-Sosa, AA; Revillo, MJ; Rezusta, A; Román, E; Ruiz, E; Torres, C | 1 |
| Block, C; Hidalgo-Grass, C; Moses, AE; Partridge, SR; Strahilevitz, J; Temper, V; Tolmasky, ME; Warburg, G | 1 |
| Cormican, M; Cunney, R; Kelly, S; McArdle, E; McDermott, H; Morris, D; O'Mahony, G | 1 |
| Díaz-Agero Pérez, C; Monge, V; Pita López, MJ; Robustillo Rodela, A; Ruiz-Garbajosa, P; Sanchez Sagrado, T | 1 |
| del Rio Martin, J; Factor, SH; Huprikar, S; Kalpoe, JS; Patel, G; Schiano, T; Sonnenberg, E | 1 |
| Rapp, RP; Urban, C | 1 |
| Bonomo, RA; Briceño, DF; Dul, M; Grossberg, R; Hujer, AM; Hujer, KM; Jacobs, MR; Marshall, SH; Perez, F; Toltzis, P; Viau, RA | 1 |
| Benenson, S; Block, C; Hidalgo-Grass, C; Moses, AE; Strahilevitz, J; Temper, V; Warburg, G | 2 |
| Ikeda, Y; Koseki, T; Mamiya, T; Mouri, A; Nabeshima, T; Narusawa, S; Nishiyama, H | 1 |
| Abdelaziz, MO; Aleo, A; Bonura, C; El-Domany, RA; Fasciana, T; Mammina, C | 1 |
| Aleo, A; Bonura, C; Brunelli, T; Degl'Innocenti, R; Fasciana, T; Mammina, C; Nastasi, A; Pesavento, G | 1 |
| Gu, H; Lu, X; Wang, L | 1 |
| Aramă, V; Breuil, J; Hristea, A; Olaru, ID; Popoiu, M | 1 |
| Araj, GF; Baroud, M; El-Herte, RI; Kanafani, ZA; Kanj, SS; Matar, GM | 1 |
| Horowitz, A; Muchtar, E; Paul, M; Raanani, P; Shpilberg, O | 1 |
| Cifuentes, M; Delpiano, L; García, P; Ponce, R; Quintanilla, R; Reyes, S; Rojas, R; San Martín, P; Silva, F; Wolff, M; Zúñiga, J | 1 |
| Alaghehbandan, R; Azimi, L; Fallah, F; Rahbar, M; Rastegar Lari, A | 1 |
| Angeli, P; Gatta, A; Piano, S; Romano, A; Rosi, S | 1 |
| Ben-Dov, IZ; Benenson, S; Bleumin, D; Bloch, A; Cohen, MJ; Esnault, VL; Haviv, YS; Levi, R; Mor-Yosef Levi, I; Moranne, O; Paltiel, O; Tzukert, K | 1 |
| Chan, KS; Choudhury, S; Koh, TH | 1 |
| Balm, MN; Fisher, DA; Jureen, R; Lin, RT; Teo, J; Venkatachalam, I | 1 |
| Aiello, E; D'Ancona, F; Dematte, L; Goglio, A; Meledandri, M; Pantosti, A; Raglio, A; Rossolini, GM; Serra, R; Sisto, A | 1 |
| Aleo, A; Bonura, C; Di Bernardo, F; Fasciana, T; Mammina, C; Palma, DM; Saporito, MA; Sodano, C; Tetamo, R; Verde, MS | 1 |
| Henderson, DK; Palmore, TN; Segre, JA; Snitkin, ES; Stock, F; Thomas, PJ; Zelazny, AM | 1 |
| Jayanthi, V; Rela, M; Varghese, J | 1 |
| Chen, CH; Chen, JB; Chuang, FR; Lee, CH; Lee, CT; Li, SH; Wu, CH; Yang, CC | 1 |
| Beau De Rochars, V; Cancio, M; Caruthers, PS; Chitnis, AS; Gould, CV; Guh, AY; Kitchel, B; Lamb, J; Lurvey, R; Rao, AK; Török, TJ; Wise, ME | 1 |
| Jiang, WY; Li, FQ; Li, XY; Liu, Y; Wan, LG; Yang, JH | 1 |
| Traynor, K | 1 |
| Baqi, M; Borgia, S; Chung, C; Eshaghi, A; Lastovetska, O; Low, DE; McGeer, A; Melano, RG; Pantelidis, R; Patel, SN; Ricci, G; Richardson, D; Sawicki, R; Xiong, J | 1 |
| Barl, P; Bedenić, B; Bošnjak, Z; Cornaglia, G; Mazzariol, A; Plečko, V; Vraneš, J | 1 |
| Garcés, C; Hurtado, IC; Mesa, JG; Restrepo, A; Tamayo, C; Trujillo, M | 1 |
| Anh, DD; Duong, TN; Hien, NT; Hoang, TH; Izumiya, H; Minh, NB; Ohnishi, M; Phuong, TT; Shibayama, K; Son, TH; Wertheim, H | 1 |
| Ahmed, S; Cherabuddi, K; Chundi, V; Hayden, MK; Lin, MY; Lolans, K; McNally, M; Norris, A; Odeh, R; Prabaker, K; Weinstein, RA | 1 |
| Cabral, AB; Lopes, AC; Maciel, MA; Melo, Rde C | 1 |
| Amicosante, G; Bellio, P; Bottoni, C; Celenza, G; Frascaria, P; Grimaldi, A; Mariani, M; Perilli, M; Segatore, B | 1 |
| Casini, B; Costanzo, S; Leonetti, P; Leonildi, A; Malacarne, P; Menichetti, F; Sbrana, F; Tascini, C; Viaggi, B | 1 |
| Alrabaa, SF; Baluch, A; Greene, JN; Karlapalem, C; Kelker, D; Martin, S; Montero, J; Nguyen, P; Sams, K; Sanderson, R; Sandin, RL; Thompson, P | 1 |
| Colakoğlu, S; Durmaz, S; Ekincioğlu, P; Perçin, D | 1 |
| de la Peña, S; Fernández-Soria, VM; Gómez-Gil, R; Gomez-Puertas, P; López-Camacho, E; Lusa-Bernal, S; Mingorance, J; Ramos-Ruiz, R; Ruiz-Carrascoso, G; Wesselink, JJ | 1 |
| Burgess, DS; Lee, GC | 1 |
| Daikos, G; Katerelos, P; Kontopidou, F; Maltezou, HC; Roilides, E; Theodoridou, M | 1 |
| Boyd, DA; Hoang, L; Imperial, M; Lefebvre, B; Mataseje, LF; Miller, M; Mulvey, MR; Poutanen, SM; Roscoe, D; Willey, BM | 1 |
| Assous, MV; Bdolah-Abram, T; Kopuit, P; Lachish, T; Shilo, S; Wiener-Well, Y; Yinnon, AM | 1 |
| Dassey, D; Marquez, P; Mascola, L; Terashita, D | 1 |
| Bonomo, RA; Chavda, KD; Chen, L; Jacobs, MR; Kreiswirth, BN; Levi, MH; Melano, RG | 1 |
| Carmeli, Y; Chmelnitsky, I; Edgar, R; Lerner, A; Navon-Venezia, S; Romano, J | 1 |
| Emaneini, M; Jabalameli, F; Kalantar, D | 1 |
| Alaghehbandan, R; Lari, AR | 1 |
| Chan, WW; Peirano, G; Pitout, JD; Smyth, DJ | 1 |
| Finkelstein, R; Hussein, K; Kassis, I; Neuberger, A; Oren, I; Raz-Pasteur, A; Shachor-Meyouhas, Y | 1 |
| Camargo, TZ; Correa, L; Gales, AC; Marra, AR; Martino, MD; Pasternak, J; Scherer, PF; Silva, CV; Siqueira, I | 1 |
| Nakahama, C | 1 |
| Chlebicki, MP; Oh, HM | 1 |
| Inglima, K; Kornblum, J; Livermore, DM; Painter, RE; Palepou, MF; Shungu, D; Silver, LL; Suber, DF; Tierno, PM; Tysall, L; Ward, E; Woodford, N; Young, K | 1 |
| Bernabéu-Wittel, M; de Cueto, M; del Carmen Conejo, M; García, I; Jiménez-Mejías, ME; Martínez-Martínez, L; Pachón, J; Pachón-Ibáñez, ME; Pascual, A; Pichardo, C | 1 |
| Chang, LY; Hsueh, PR; Huang, LM; Lee, CY; Lee, PI; Lu, CY; Shao, PL; Wang, CY; Wu, TZ; Yang, CY | 1 |
| Bratu, S; Gullans, C; Karumudi, U; Landman, D; Mooty, M; Nichani, S; Pettinato, B; Quale, J; Tolaney, P | 1 |
| Alam, M; Bratu, S; Eramo, A; Haag, R; Landman, D; Quale, J; Recco, R | 1 |
| Ikonomidis, A; Kristo, I; Maniatis, AN; Mantzana, P; Pournaras, S; Sofianou, D; Tokatlidou, D; Tsakris, A | 1 |
| Bratu, S; Landman, D; Quale, J; Salvani, JK | 1 |
| Chiu, S; Chou, YH; Huang, YC; Lien, RI; Lin, TY | 1 |
| Díaz-Antolín, P; Gutiérrez-Urbón, O; Oliver-Palomo, A; Requena-Rodríguez, MJ | 1 |
| Cal, RG; Castelo, A; do Carmo Filho, JR; Marra, AR; Pereira, CA; Sader, HS; Wey, SB | 1 |
| Paterson, DL | 1 |
| Correa, A; Lolans, K; Lopez, JA; Quinn, JP; Suarez, CJ; Vallejo, M; Villegas, MV | 1 |
| Aguilar, J; Almela, M; Balasso, V; López, F; Marco, F; Martínez, JA; Mensa, J; Pozo, L; Soriano, A | 1 |
| Lee, CH; Liu, JW; Su, LH; Tang, YF | 1 |
| Dib-Hajj, F; Gootz, TD; Kaczmarek, FM; Shang, W | 1 |
| Agapova, ED; Aleksandrova, IA; Beloborodova, NV; Il'ina, VN; Ivanova, SF; Marusina, NE; Multykh, IG; Polikarpova, SV; Reshed'ko, GK; Riabkova, EL; Skal'skiĭ, SV; Suborova, TN; Toropova, IA; Turkutiukov, VB; Vostrikova, TIu; Zdzitovetskiĭ, DE | 1 |
| Daikos, GL; Loli, A; Miriagou, V; Panagiotakopoulou, A; Tzelepi, E; Tzouvelekis, LS | 1 |
| Carmeli, Y; Chmelnitsky, I; Leavitt, A; Navon-Venezia, S; Schwaber, MJ | 1 |
| Chelvatzoglou, FC; Falagas, ME; Kofteridis, D; Maraki, S; Michalopoulos, A; Papaioannou, V; Rafailidis, PI; Samonis, G; Virtzili, S | 1 |
| Bishara, J; Lishtzinsky, Y; Madar-Shapiro, L; Ofir, O; Samra, Z | 1 |
| Avlamis, A; Daikos, GL; Kosmidis, C; Paniara, O; Platsouka, E; Psichogiou, M; Stefanou, I; Tassios, PT; Toutouza, M; Tzouvelekis, LS; Xanthaki, A | 1 |
| Cuzon, G; Demachy, MC; Naas, T; Nordmann, P | 1 |
| Borgianni, L; Cagnacci, S; Centanaro, M; Debbia, E; Docquier, JD; Dodi, F; Gualco, L; Mannelli, S; Marchese, A; Rossolini, GM; Roveta, S | 1 |
| Yoshida, A | 1 |
| Carmeli, Y; Klarfeld-Lidji, S; Leavitt, A; Navon-Venezia, S; Schwaber, MJ; Schwartz, D | 1 |
| Bell, JM; Jones, RN; Mendes, RE; Sun, Z; Turnidge, JD; Yang, Q; Yu, Y | 1 |
| Altindis, M; Caylan, R; Demirdağ, K; Günaydin, M; Gündes, S; Hoşoğlu, S; Karadenizli, A; Kolayli, F; Ucmak, H | 1 |
| Aktaş, Z; Bauernfeind, A; Can, B; Kayacan, CB; Midilli, K; Schneider, I | 1 |
| Ivanov, DV | 1 |
| Gülmez, D; Hascelik, G; Kocagoz, S; Livermore, DM; Metan, G; Mushtaq, S; Palepou, MF; Uzun, O; Woodford, N; Yakupogullari, Y | 1 |
| Anderson, KF; Biddle, JW; Chenoweth, C; Newton, DW; Patel, JB; Perrin, J; Rasheed, JK; Washer, L | 1 |
| Vatopoulos, A | 1 |
| Livermore, DM; Yuan, M | 1 |
| Bradford, PA; Bush, K; Mariano, N; Projan, SJ; Rahal, JJ; Urban, C | 1 |
| Ardanuy, C; Benedí, VJ; Domínguez, MA; Hernández-Allés, S; Liñares, J; Martínez-Martínez, L | 1 |
| Iwatsubo, E; Kawakami, Y; Manabe, N; Matsumoto, T; Takahashi, K | 1 |
55 review(s) available for carbapenems and Infections, Klebsiella
| Article | Year |
|---|---|
A meta-analysis for the role of aminoglycosides and tigecyclines in combined regimens against colistin- and carbapenem-resistant Klebsiella pneumoniae bloodstream infections.
Topics: Aminoglycosides; Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Colistin; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Sepsis; Tigecycline | 2022 |
Challenge of evolving
Topics: Carbapenems; Humans; Klebsiella Infections; Klebsiella pneumoniae; Renal Dialysis; Virulence | 2022 |
Klebsiella pneumoniae Carbapenemase Variants Resistant to Ceftazidime-Avibactam: an Evolutionary Overview.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Ceftazidime; Drug Combinations; Drug Resistance, Multiple, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2022 |
MgrB Mutations and Altered Cell Permeability in Colistin Resistance in
Topics: Anti-Bacterial Agents; Bacterial Proteins; Carbapenems; Colistin; Drug Resistance, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Mutation; Permeability | 2022 |
The making of hypervirulent Klebsiella pneumoniae.
Topics: Animals; Anti-Bacterial Agents; Carbapenems; Klebsiella Infections; Klebsiella pneumoniae; Virulence; Virulence Factors | 2022 |
Impact of dexamethasone and tocilizumab on hematological parameters in COVID-19 patients with chronic disease.
Topics: Acetaminophen; Acetylcarnitine; Acetylcholinesterase; Acids; Acinetobacter baumannii; Acinetobacter Infections; Adaptation, Psychological; Adolescent; Adsorption; Adult; Aged; Alcohol Drinking; Alzheimer Disease; Amikacin; Ammonia; Anaerobiosis; Animals; Anorexia; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Anxiety; Aptamers, Nucleotide; Asthenia; Attention Deficit Disorder with Hyperactivity; Bacterial Proteins; Beryllium; beta-Lactamases; Biofuels; Biomass; Biosensing Techniques; Bismuth; Blister; Body Mass Index; Body Surface Area; Boronic Acids; Brain; Breast Neoplasms; Butyrylcholinesterase; Cannabis; Carbapenems; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Carboxylic Acids; Carcinoma, Hepatocellular; Cardiovascular Diseases; Carnitine; Case-Control Studies; Catalysis; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Child; China; Cholinesterase Inhibitors; Clarithromycin; Clostridioides; Clostridioides difficile; Clostridium Infections; Cohort Studies; Colistin; Colitis; Colon; Coloring Agents; Coronary Artery Bypass; Creatinine; Crystalloid Solutions; Cytokines; Depression; Dextran Sulfate; Dextrans; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Diarrhea; Dietary Supplements; Diphenhydramine; Disease Models, Animal; Disease Outbreaks; Double-Blind Method; Doxorubicin; Drosophila; Drug Tapering; Dysbiosis; Electrons; Escherichia coli; Extracellular Vesicles; Fatigue; Female; Fermentation; gamma-Cyclodextrins; Gastrointestinal Microbiome; Glucose; Graft Survival; Graft vs Host Disease; Head and Neck Neoplasms; Heart Arrest, Induced; Hematopoietic Stem Cell Transplantation; High-Intensity Interval Training; Hippocampus; Humans; Hydrogen-Ion Concentration; Hypertension; Incidence; Interferon-gamma; Italy; Kinetics; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Lactoferrin; Larva; Length of Stay; Lignin; Liver; Liver Neoplasms; Liver Transplantation; Living Donors; Low Back Pain; Lung; Lung Volume Measurements; Macrophages; Male; Melphalan; Men; Mendelian Randomization Analysis; Meropenem; Methane; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Mitochondrial Proteins; Molecular Docking Simulation; Molecular Structure; Mothers; Motivation; Mycoplasma; Mycoplasma hominis; Mycoplasma Infections; NAD; Nanocomposites; Nanoparticles; Nanotubes, Carbon; Naproxen; Neovascularization, Pathologic; Neurons; Nitrates; Nucleolin; Opuntia; Paratyphoid Fever; Phenotype; Phosphatidylinositol 3-Kinases; Phytochemicals; Plant Extracts; Pregnancy; Prevalence; Prospective Studies; Proto-Oncogene Proteins c-akt; Pulmonary Disease, Chronic Obstructive; Rats; Rats, Wistar; Resveratrol; Retrospective Studies; Rifampin; Risk Factors; RNA, Messenger; Selenium; Sleep; Social Behavior; Soil; Soil Pollutants; Squamous Cell Carcinoma of Head and Neck; Staphylococcus aureus; Structure-Activity Relationship; Suicidal Ideation; Suicide; Superoxide Dismutase-1; Surveys and Questionnaires; Swimming; Syndrome; Tannins; Temperature; Transforming Growth Factor beta; Transplantation Conditioning; Treatment Outcome; Triple Negative Breast Neoplasms; Troponin T; Tumor Microenvironment; United Kingdom; Ureaplasma; Ureaplasma urealyticum; Urinary Tract Infections; Viscum; Waste Disposal Facilities; Wastewater; Water; Water Pollutants, Chemical; Wolfiporia; Young Adult | 2022 |
Relationship between antibiotic exposure and carbapenem-resistant Klebsiella pneumoniae infection within four types of control patients: A systematic review and meta-analysis.
Topics: Aminoglycosides; Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Drug Resistance, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Quinolones; Tigecycline | 2023 |
Efficacy and safety of ceftazidime-avibactam compared to other antimicrobials for the treatment of infections caused by carbapenem-resistant Klebsiella pneumoniae strains, a systematic review and meta-analysis.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Ceftazidime; Drug Combinations; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2023 |
Prevalence and clonal diversity of carbapenem-resistant Klebsiella pneumoniae causing neonatal infections: A systematic review of 128 articles across 30 countries.
Topics: Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Communicable Diseases; Humans; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Prevalence | 2023 |
Risk factors for carbapenem-resistant Klebsiella pneumoniae infection: A meta-analysis.
Topics: Carbapenems; Case-Control Studies; Drug Resistance, Bacterial; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Retrospective Studies; Risk Factors | 2020 |
Systematic review of carbapenem-resistant Enterobacteriaceae causing neonatal sepsis in China.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; China; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Genes, Bacterial; Humans; Infant; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Neonatal Sepsis | 2019 |
A systematic review and meta-analysis of treatment outcomes following antibiotic therapy among patients with carbapenem-resistant Klebsiella pneumoniae infections.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Drug Resistance, Bacterial; Drug Therapy, Combination; Humans; Klebsiella Infections; Klebsiella pneumoniae; Polymyxins; Tigecycline; Treatment Outcome | 2020 |
Risk factors for carbapenem-resistant Klebsiella pneumoniae infection relative to two types of control patients: a systematic review and meta-analysis.
Topics: Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Drug Resistance, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Risk Factors | 2020 |
Carbapenem Resistance-Encoding and Virulence-Encoding Conjugative Plasmids in Klebsiella pneumoniae.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Carbapenems; Drug Resistance, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Plasmids; Virulence | 2021 |
Treatment options for K. pneumoniae, P. aeruginosa and A. baumannii co-resistant to carbapenems, aminoglycosides, polymyxins and tigecycline: an approach based on the mechanisms of resistance to carbapenems.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Klebsiella Infections; Klebsiella pneumoniae; Polymyxins; Pseudomonas aeruginosa; Pseudomonas Infections; Tigecycline | 2020 |
Virulence evolution, molecular mechanisms of resistance and prevalence of ST11 carbapenem-resistant Klebsiella pneumoniae in China: A review over the last 10 years.
Topics: Carbapenems; China; Evolution, Molecular; Humans; Klebsiella Infections; Klebsiella pneumoniae; Prevalence; Virulence | 2020 |
Polymyxin monotherapy versus polymyxin-based combination therapy against carbapenem-resistant Klebsiella pneumoniae: A systematic review and meta-analysis.
Topics: Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Humans; Klebsiella Infections; Klebsiella pneumoniae; Polymyxins | 2020 |
A global perspective on the convergence of hypervirulence and carbapenem resistance in Klebsiella pneumoniae.
Topics: Asia; Carbapenems; China; Humans; Klebsiella Infections; Klebsiella pneumoniae; Virulence | 2021 |
Prophylaxis and Treatment against
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae | 2021 |
Predictors of mortality in patients with carbapenem-resistant Klebsiella pneumoniae infection: a meta-analysis and a systematic review.
Topics: Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Humans; Klebsiella Infections; Klebsiella pneumoniae; Risk Factors | 2021 |
[Research progress on the mechanism of two-component systems in regulating carbapenem resistance of Klebsiella pneumoniae].
Topics: Anti-Bacterial Agents; Carbapenems; Drug Resistance, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae | 2021 |
Antimicrobial stewardship and infection prevention interventions targeting healthcare-associated
Topics: Anti-Bacterial Agents; Antimicrobial Stewardship; Carbapenems; Clostridioides; Clostridioides difficile; Delivery of Health Care; Humans; Klebsiella Infections; Klebsiella pneumoniae | 2021 |
Systematic review and meta-analysis of mortality of patients infected with carbapenem-resistant Klebsiella pneumoniae.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Global Health; Humans; Klebsiella Infections; Klebsiella pneumoniae | 2017 |
Clinical Implications of Genomic Adaptation and Evolution of Carbapenem-Resistant Klebsiella pneumoniae.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Evolution, Molecular; Genomics; Host-Pathogen Interactions; Humans; Klebsiella Infections; Klebsiella pneumoniae; Molecular Epidemiology; Plasmids; Serogroup; Virulence Factors | 2017 |
How Should We Treat HAP/VAP Caused by Carbapenemase-Producing Enterobacteriaceae?
Topics: Anti-Bacterial Agents; Bacteriological Techniques; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cross Infection; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Enterobacteriaceae Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Nebulizers and Vaporizers; Pneumonia; Pneumonia, Ventilator-Associated; Renal Insufficiency; Risk Factors | 2017 |
Risk Factors for Carbapenem-Resistant Klebsiella pneumoniae Infection: A Meta-Analysis.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Catheterization, Central Venous; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Length of Stay; Parenteral Nutrition; Respiration, Artificial; Risk Factors; Steroids; Tracheostomy; Transplant Recipients | 2018 |
Triple combination antibiotic therapy for carbapenemase-producing Klebsiella pneumoniae: a systematic review.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; Carbapenems; Colistin; Drug Combinations; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Minocycline; Pneumonia; Polymyxin B; Polymyxins; Tigecycline; Treatment Outcome; Urinary Tract Infections | 2017 |
Antimicrobial Resistance of Hypervirulent
Topics: Bacteremia; Bacterial Capsules; Bacterial Proteins; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Humans; Hydroxamic Acids; Klebsiella Infections; Klebsiella pneumoniae; Liver Abscess; Molecular Epidemiology; Phylogeography; Serogroup; Urinary Tract Infections; Virulence; Virulence Factors | 2017 |
Critical Review of Double-Carbapenem Therapy for the Treatment of Carbapenemase-Producing Klebsiella pneumoniae.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged | 2019 |
[Pathogenetic conditions of treatment of infections caused by antibiotic-resistant strains Klebsiella pneumoniae].
Topics: Anti-Bacterial Agents; Carbapenems; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2019 |
Hypervirulence and carbapenem resistance: two distinct evolutionary directions that led high-risk
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Community-Acquired Infections; Drug Resistance, Multiple, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Molecular Epidemiology; Plasmids; Virulence | 2019 |
Carbapenem and colistin resistance in Enterobacteriaceae in Southeast Asia: Review and mapping of emerging and overlapping challenges.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Asia, Southeastern; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Child; Child, Preschool; Colistin; Drug Resistance, Bacterial; Escherichia coli Infections; Female; Genotype; Humans; Infant; Infant, Newborn; Klebsiella Infections; Male; Middle Aged; Young Adult | 2019 |
Treatment of carbapenem-resistant Klebsiella pneumoniae: the state of the art.
Topics: Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Colistin; Drug Therapy, Combination; Fosfomycin; Humans; Klebsiella Infections; Klebsiella pneumoniae; Minocycline; Rifampin; Risk Factors; Tigecycline | 2013 |
Predictors of mortality in multidrug-resistant Klebsiella pneumoniae bloodstream infections.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Models, Statistical; Risk Factors; Survival Analysis; Treatment Outcome | 2013 |
Carbapenemase-producing Klebsiella pneumoniae: molecular and genetic decoding.
Topics: Bacterial Proteins; beta-Lactamases; Carbapenems; DNA Transposable Elements; Drug Resistance, Bacterial; Genomics; Humans; Klebsiella Infections; Klebsiella pneumoniae; Multilocus Sequence Typing; Plasmids | 2014 |
Global dissemination of extensively drug-resistant carbapenemase-producing Enterobacteriaceae: clinical perspectives on detection, treatment and infection control.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Communicable Disease Control; Enterobacteriaceae Infections; Global Health; Humans; Klebsiella Infections; Klebsiella pneumoniae | 2015 |
Critical issues for Klebsiella pneumoniae KPC-carbapenemase producing K. pneumoniae infections: a critical agenda.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Colistin; Cross Infection; Drug Therapy, Computer-Assisted; Humans; Infection Control; Klebsiella Infections; Klebsiella pneumoniae; Minocycline; Risk Factors; Tigecycline | 2015 |
Carbapenemase-Producing Klebsiella pneumoniae, a Key Pathogen Set for Global Nosocomial Dominance.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Clone Cells; Conjugation, Genetic; Cross Infection; DNA Transposable Elements; Gene Expression Regulation, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Plasmids; Porins; Recombination, Genetic | 2015 |
Molecular epidemiology of carbapenem-resistant Klebsiella pneumoniae in Greece.
Topics: Anti-Bacterial Agents; Carbapenems; Greece; Humans; Klebsiella Infections; Klebsiella pneumoniae; Molecular Epidemiology | 2016 |
Systematic Review and Meta-analysis of Clinical and Economic Outcomes from the Implementation of Hospital-Based Antimicrobial Stewardship Programs.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cross Infection; Hospitals; Humans; Intensive Care Units; Klebsiella; Klebsiella Infections; Length of Stay; Methicillin-Resistant Staphylococcus aureus; Pseudomonas aeruginosa; Pseudomonas Infections; Staphylococcal Infections | 2016 |
Minocycline and Tigecycline: What Is Their Role in the Treatment of Carbapenem-Resistant Gram-Negative Organisms?
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Case-Control Studies; Drug Resistance, Multiple, Bacterial; Genes, MDR; Humans; India; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Minocycline; Tigecycline | 2017 |
The emerging problems of Klebsiella pneumoniae infections: carbapenem resistance and biofilm formation.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Biofilms; Carbapenems; Humans; Klebsiella Infections; Klebsiella pneumoniae; Opportunistic Infections; Urinary Catheters | 2016 |
A structural, epidemiological & genetic overview of
Topics: Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Lactams; Microbial Sensitivity Tests; Phylogeny | 2016 |
Global prevalence of carbapenem resistance in neutropenic patients and association with mortality and carbapenem use: systematic review and meta-analysis.
Topics: Acinetobacter; Adult; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; Carbapenems; Drug Resistance, Bacterial; Female; Global Health; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Greece; Humans; Israel; Italy; Klebsiella; Klebsiella Infections; Male; Middle Aged; Neutropenia; Prevalence; Pseudomonas | 2017 |
The Hospital Water Environment as a Reservoir for Carbapenem-Resistant Organisms Causing Hospital-Acquired Infections-A Systematic Review of the Literature.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cross Infection; Disease Outbreaks; Disease Reservoirs; Disinfection; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Equipment and Supplies, Hospital; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Typing; Pseudomonas aeruginosa; Pseudomonas Infections; Water Microbiology; Water Supply | 2017 |
Infections caused by carbapenem-resistant Klebsiella pneumoniae with hypermucoviscous phenotype: A case report and literature review.
Topics: Anti-Bacterial Agents; Carbapenems; Drug Resistance, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Phenotype | 2017 |
The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria.
Topics: Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Humans; Klebsiella Infections; Klebsiella pneumoniae | 2009 |
Extended-spectrum beta-lactamase-producing bacterial infections in adult solid organ transplant recipients.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; beta-Lactamases; Carbapenems; Escherichia coli Infections; Female; Gram-Negative Bacteria; Humans; Kidney Transplantation; Klebsiella Infections; Liver Transplantation; Male; Microbial Sensitivity Tests; Middle Aged; Pancreas Transplantation; Recurrence; Retrospective Studies; Time Factors; Treatment Outcome | 2011 |
Carbapenemase-producing Klebsiella pneumoniae: (when) might we still consider treating with carbapenems?
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Therapy, Combination; Humans; Klebsiella Infections; Klebsiella pneumoniae; Mice; Microbial Sensitivity Tests; Treatment Outcome | 2011 |
Klebsiella pneumoniae carbapenemases in Enterobacteriaceae: history, evolution, and microbiology concerns.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Clinical Trials as Topic; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Evolution, Molecular; Humans; Hydrolysis; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2012 |
Treatment of Klebsiella pneumoniae carbapenemase (KPC) infections: a review of published case series and case reports.
Topics: Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Combinations; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Minocycline; Polymyxins; Tigecycline; Treatment Outcome | 2012 |
[Klebsiella infection].
Topics: 4-Quinolones; Anti-Infective Agents; beta-Lactamases; Carbapenems; Cephalosporins; Drug Resistance, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Penicillinase; Respiratory Tract Infections; Sepsis; Urinary Tract Infections | 2003 |
Resistance in gram-negative bacteria: enterobacteriaceae.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Carbapenems; Cephalosporins; Ciprofloxacin; Community-Acquired Infections; Drug Resistance, Bacterial; Drug Resistance, Multiple; Enterobacteriaceae; Enterobacteriaceae Infections; Gram-Negative Bacterial Infections; Humans; Klebsiella Infections; Quinolones; Urinary Tract Infections | 2006 |
[Attention-getting cross infections: Extended-spectrum beta-lactamase-producing bacterial infections].
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Proteus; Proteus Infections | 2007 |
High rates of metallo-beta-lactamase-producing Klebsiella pneumoniae in Greece--a review of the current evidence.
Topics: beta-Lactamases; Carbapenems; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Europe; Greece; Humans; Incidence; Klebsiella Infections; Klebsiella pneumoniae | 2008 |
7 trial(s) available for carbapenems and Infections, Klebsiella
| Article | Year |
|---|---|
Impact of dexamethasone and tocilizumab on hematological parameters in COVID-19 patients with chronic disease.
Topics: Acetaminophen; Acetylcarnitine; Acetylcholinesterase; Acids; Acinetobacter baumannii; Acinetobacter Infections; Adaptation, Psychological; Adolescent; Adsorption; Adult; Aged; Alcohol Drinking; Alzheimer Disease; Amikacin; Ammonia; Anaerobiosis; Animals; Anorexia; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Anxiety; Aptamers, Nucleotide; Asthenia; Attention Deficit Disorder with Hyperactivity; Bacterial Proteins; Beryllium; beta-Lactamases; Biofuels; Biomass; Biosensing Techniques; Bismuth; Blister; Body Mass Index; Body Surface Area; Boronic Acids; Brain; Breast Neoplasms; Butyrylcholinesterase; Cannabis; Carbapenems; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Carboxylic Acids; Carcinoma, Hepatocellular; Cardiovascular Diseases; Carnitine; Case-Control Studies; Catalysis; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Child; China; Cholinesterase Inhibitors; Clarithromycin; Clostridioides; Clostridioides difficile; Clostridium Infections; Cohort Studies; Colistin; Colitis; Colon; Coloring Agents; Coronary Artery Bypass; Creatinine; Crystalloid Solutions; Cytokines; Depression; Dextran Sulfate; Dextrans; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Diarrhea; Dietary Supplements; Diphenhydramine; Disease Models, Animal; Disease Outbreaks; Double-Blind Method; Doxorubicin; Drosophila; Drug Tapering; Dysbiosis; Electrons; Escherichia coli; Extracellular Vesicles; Fatigue; Female; Fermentation; gamma-Cyclodextrins; Gastrointestinal Microbiome; Glucose; Graft Survival; Graft vs Host Disease; Head and Neck Neoplasms; Heart Arrest, Induced; Hematopoietic Stem Cell Transplantation; High-Intensity Interval Training; Hippocampus; Humans; Hydrogen-Ion Concentration; Hypertension; Incidence; Interferon-gamma; Italy; Kinetics; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Lactoferrin; Larva; Length of Stay; Lignin; Liver; Liver Neoplasms; Liver Transplantation; Living Donors; Low Back Pain; Lung; Lung Volume Measurements; Macrophages; Male; Melphalan; Men; Mendelian Randomization Analysis; Meropenem; Methane; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Mitochondrial Proteins; Molecular Docking Simulation; Molecular Structure; Mothers; Motivation; Mycoplasma; Mycoplasma hominis; Mycoplasma Infections; NAD; Nanocomposites; Nanoparticles; Nanotubes, Carbon; Naproxen; Neovascularization, Pathologic; Neurons; Nitrates; Nucleolin; Opuntia; Paratyphoid Fever; Phenotype; Phosphatidylinositol 3-Kinases; Phytochemicals; Plant Extracts; Pregnancy; Prevalence; Prospective Studies; Proto-Oncogene Proteins c-akt; Pulmonary Disease, Chronic Obstructive; Rats; Rats, Wistar; Resveratrol; Retrospective Studies; Rifampin; Risk Factors; RNA, Messenger; Selenium; Sleep; Social Behavior; Soil; Soil Pollutants; Squamous Cell Carcinoma of Head and Neck; Staphylococcus aureus; Structure-Activity Relationship; Suicidal Ideation; Suicide; Superoxide Dismutase-1; Surveys and Questionnaires; Swimming; Syndrome; Tannins; Temperature; Transforming Growth Factor beta; Transplantation Conditioning; Treatment Outcome; Triple Negative Breast Neoplasms; Troponin T; Tumor Microenvironment; United Kingdom; Ureaplasma; Ureaplasma urealyticum; Urinary Tract Infections; Viscum; Waste Disposal Facilities; Wastewater; Water; Water Pollutants, Chemical; Wolfiporia; Young Adult | 2022 |
Clinical impact of endemic NDM-producing Klebsiella pneumoniae in intensive care units of the national referral hospital in Jakarta, Indonesia.
Topics: Adult; Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Female; Humans; Indonesia; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Length of Stay; Male; Microbial Sensitivity Tests; Middle Aged; Pharynx; Prospective Studies; Rectum | 2020 |
Double carbapenem as a rescue strategy for the treatment of severe carbapenemase-producing Klebsiella pneumoniae infections: a two-center, matched case-control study.
Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Case-Control Studies; Drug Resistance, Multiple; Ertapenem; Female; Humans; Italy; Klebsiella Infections; Klebsiella pneumoniae; Length of Stay; Logistic Models; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Statistics, Nonparametric | 2017 |
Epidemiology and molecular characterization of bacteremia due to carbapenem-resistant Klebsiella pneumoniae in transplant recipients.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; Carbapenems; DNA, Bacterial; Female; Follow-Up Studies; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Organ Transplantation; Polymerase Chain Reaction; Prognosis; Retrospective Studies; Risk Factors; Survival Rate | 2013 |
A PROspective study on the Usage patterns of Doripenem in the Asia-Pacific region (PROUD study).
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Asia; Carbapenems; Doripenem; Escherichia coli; Escherichia coli Infections; Female; Humans; Intensive Care Units; Intraabdominal Infections; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Pneumonia, Ventilator-Associated; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Treatment Outcome; Urinary Tract Infections; Young Adult | 2014 |
Intravenous fosfomycin for the treatment of nosocomial infections caused by carbapenem-resistant Klebsiella pneumoniae in critically ill patients: a prospective evaluation.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Critical Illness; Cross Infection; Female; Fosfomycin; Humans; Infusions, Intravenous; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Prospective Studies; Treatment Outcome | 2010 |
A randomized, double-blind, placebo-controlled trial of selective digestive decontamination using oral gentamicin and oral polymyxin E for eradication of carbapenem-resistant Klebsiella pneumoniae carriage.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Carrier State; Colistin; Digestive System; Double-Blind Method; Drug Therapy, Combination; Female; Gentamicins; Groin; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Pharynx; Rectum; Urine | 2012 |
977 other study(ies) available for carbapenems and Infections, Klebsiella
| Article | Year |
|---|---|
Characterisation of bla
Topics: Carbapenems; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Multilocus Sequence Typing | 2021 |
Blocking of Birc3/TLR4/Myd88 signaling protects carbapenem-resistant klebsiella pneumoniae in a mouse model of infection.
Topics: Animals; Anti-Bacterial Agents; Baculoviral IAP Repeat-Containing 3 Protein; Carbapenems; Klebsiella Infections; Klebsiella pneumoniae; Mice; Myeloid Differentiation Factor 88; Pneumonia, Bacterial; Signal Transduction; Toll-Like Receptor 4 | 2021 |
Detection of NDM-1 and VIM Genes in Carbapenem-Resistant Klebsiella pneumoniae Isolates from a Tertiary Health-Care Center in Kathmandu, Nepal.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Nepal | 2021 |
Carbapenem and Colistin Resistant Klebsiella Pneumoniae ST14 and ST2096 Dominated in Two Hospitals in Turkey.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Colistin; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Multilocus Sequence Typing; RNA, Ribosomal, 16S; Turkey | 2021 |
Inappropriate use of antibiotics exacerbates inflammation through OMV-induced pyroptosis in MDR Klebsiella pneumoniae infection.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Carbapenems; Chaperonin 60; Cytokines; Drug Resistance, Multiple, Bacterial; Extracellular Vesicles; Inflammation; Klebsiella Infections; Klebsiella pneumoniae; Macrophages; Mice; Mice, Inbred C57BL; Phagocytosis; Pyroptosis; RNA Interference; RNA, Small Interfering; Scavenger Receptors, Class E; Survival Rate | 2021 |
Amikacin in combination with zinc pyrithione prevents growth of a multidrug-resistant carbapenem-resistant Klebsiella pneumoniae isolate.
Topics: Amikacin; Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Organometallic Compounds; Pyridines | 2021 |
Aerobactin Seems To Be a Promising Marker Compared With Unstable RmpA2 for the Identification of Hypervirulent Carbapenem-Resistant
Topics: Carbapenems; Computer Simulation; Humans; Hydroxamic Acids; Klebsiella Infections; Klebsiella pneumoniae | 2021 |
Acquisition of the Conjugative Virulence Plasmid From a CG23 Hypervirulent
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Escherichia coli; Klebsiella Infections; Klebsiella pneumoniae; Mice; Plasmids; Virulence | 2021 |
Antimicrobial treatment of monomicrobial phenotypic carbapenem-resistant Klebsiella pneumoniae bacteremia: Two are better than one.
Topics: Anti-Bacterial Agents; Bacteremia; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Humans; Klebsiella Infections; Klebsiella pneumoniae; Retrospective Studies | 2022 |
Droplets generated from toilets during urination as a possible vehicle of carbapenem-resistant Klebsiella pneumoniae.
Topics: Aerosol Propellants; Anions; Bathroom Equipment; Betaine; Carbapenems; Carbonates; Deodorants; Drug Resistance, Bacterial; Drug Resistance, Multiple; Esters; Fatty Acids; Fatty Alcohols; Humans; Hydrogen-Ion Concentration; Klebsiella Infections; Klebsiella pneumoniae; Lipotropic Agents; Surface-Active Agents; Urination; Urine | 2021 |
Comparative genome analysis of colistin-resistant OXA-48-producing Klebsiella pneumoniae clinical strains isolated from two Iranian hospitals.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Colistin; Drug Resistance, Bacterial; Genome, Bacterial; Hospitals; Humans; Iran; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Whole Genome Sequencing | 2021 |
Molecular characterisation of carbapenem- and tigecycline-resistant Klebsiella pneumoniae strains isolated from blood and bile samples.
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Bile; Carbapenems; Drug Resistance, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Tigecycline | 2022 |
Analysis of Risk Factors for Carbapenem-Resistant Klebsiella pneumoniae Infection and Its Effect on the Outcome of Early Infection After Kidney Transplantation.
Topics: Anti-Bacterial Agents; Carbapenems; Drug Resistance, Bacterial; Humans; Kidney Transplantation; Klebsiella Infections; Klebsiella pneumoniae; Retrospective Studies; Risk Factors | 2021 |
The Metabolome of Carbapenem-Resistant Klebsiella pneumoniae Infection in Plasma.
Topics: Adult; Aged; Biomarkers; Carbapenems; Case-Control Studies; China; Drug Resistance, Bacterial; Female; Follow-Up Studies; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Metabolome; Middle Aged; Prognosis | 2021 |
Within patient genetic diversity of bla
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Proteins; beta-Lactamases; Carbapenems; Colombia; Drug Resistance, Bacterial; Female; Genetic Variation; Genome, Bacterial; Genomics; Hospitalization; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Retrospective Studies; Whole Genome Sequencing; Young Adult | 2021 |
In vivo evolution of carbapenem resistance in hypervirulent Klebsiella pneumoniae in a patient undergoing long-term treatment.
Topics: Carbapenems; Humans; Klebsiella Infections; Klebsiella pneumoniae | 2022 |
Using Whole Genome Sequencing to Investigate a Mock-Outbreak of Carbapenem-Resistant Klebsiella pneumoniae in Real-Time.
Topics: Anti-Bacterial Agents; Carbapenems; Disease Outbreaks; Humans; Klebsiella Infections; Klebsiella pneumoniae; Laboratories, Clinical; Microbial Sensitivity Tests; Multilocus Sequence Typing; Whole Genome Sequencing | 2022 |
Risk factors for bloodstream infection by multidrug-resistant organisms in critically ill patients in a reference trauma hospital.
Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Critical Illness; Drug Resistance, Multiple, Bacterial; Enterococcus; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Methicillin-Resistant Staphylococcus aureus; Prospective Studies; Risk Factors; Sepsis | 2022 |
Regional differences in carbapenem-resistant Klebsiella pneumoniae.
Topics: Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Humans; Klebsiella Infections; Klebsiella pneumoniae | 2022 |
Clinical outcomes and bacterial characteristics of carbapenem-resistant Klebsiella pneumoniae complex among patients from different global regions (CRACKLE-2): a prospective, multicentre, cohort study.
Topics: Anti-Bacterial Agents; Bacteremia; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cohort Studies; Humans; Klebsiella Infections; Klebsiella pneumoniae; Prospective Studies; Respiratory Sounds | 2022 |
Co-existence of NDM-1 and OXA-48 genes in Carbapenem Resistant
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Egypt; Humans; Incidence; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2021 |
Clonal spread of carbapenem-resistant Klebsiella pneumoniae among patients at admission and discharge at a Vietnamese neonatal intensive care unit.
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cross Infection; Feces; Female; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Multilocus Sequence Typing; Patient Admission; Patient Discharge; Phylogeny; Prospective Studies; Vietnam; Whole Genome Sequencing | 2021 |
Epidemiology and infection control of carbapenem resistant Acinetobacter baumannii and Klebsiella pneumoniae at a German university hospital: a retrospective study of 5 years (2015-2019).
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Carbapenems; Hospitals, University; Humans; Infection Control; Klebsiella Infections; Klebsiella pneumoniae; Retrospective Studies | 2021 |
Replicative transposition contributes to the evolution and dissemination of KPC-2-producing plasmid in
Topics: beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Disease Outbreaks; DNA Replication; DNA Transposable Elements; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae Infections; Evolution, Molecular; Gene Transfer, Horizontal; Humans; Klebsiella Infections; Klebsiella pneumoniae; Molecular Epidemiology; Multilocus Sequence Typing; Plasmids | 2022 |
High-Resolution Genomic Profiling of Carbapenem-Resistant Klebsiella pneumoniae Isolates: A Multicentric Retrospective Indian Study.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Genomics; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Multilocus Sequence Typing; Phylogeny; Retrospective Studies | 2021 |
Complexity of Genomic Epidemiology of Carbapenem-Resistant Klebsiella pneumoniae Isolates in Colombia Urges the Reinforcement of Whole Genome Sequencing-Based Surveillance Programs.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Colombia; Genomics; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Whole Genome Sequencing | 2021 |
Klebsiella oxytoca Complex: Update on Taxonomy, Antimicrobial Resistance, and Virulence.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Enterocolitis, Pseudomembranous; Humans; Klebsiella Infections; Klebsiella oxytoca; Klebsiella pneumoniae; Microbial Sensitivity Tests; Virulence | 2022 |
Isolation and Characterization of Novel Phages Targeting Pathogenic
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacteriophages; beta-Lactamases; Carbapenems; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Multilocus Sequence Typing; Phage Therapy | 2021 |
Comparison of Carbapenem-Resistant
Topics: Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Humans; Intestines; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Multilocus Sequence Typing; Retrospective Studies; Virulence | 2021 |
Molecular Mechanisms Driving the
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Bacterial Proteins; beta-Lactamases; Carbapenems; Ceftazidime; China; Drug Combinations; Drug Resistance, Multiple, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Plasmids; Whole Genome Sequencing; Young Adult | 2021 |
Emergence of ST39 carbapenem-resistant Klebsiella pneumoniae producing VIM-1 and KPC-2.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Phylogeny | 2022 |
NDM-5-producing carbapenem-resistant Klebsiella pneumoniae of sequence type 789 emerged as a threat for neonates: a multicentre, genome-based study.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Humans; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2022 |
Using Whole Genome Sequencing to Trace, Control and Characterize a Hospital Infection of IMP-4-Producing
Topics: Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cross Infection; Humans; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Multilocus Sequence Typing; Tertiary Care Centers; Whole Genome Sequencing | 2021 |
Molecular Epidemiology and Risk Factors of Carbapenem-Resistant Klebsiella Pneumoniae Bloodstream Infections in Wuhan, China.
Topics: Adult; Bacterial Proteins; beta-Lactamases; Carbapenems; China; Drug Resistance, Bacterial; Female; Genes, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Molecular Epidemiology; Retrospective Studies; Risk Factors; Sepsis | 2022 |
Carriage of distinct bla
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Egypt; Humans; Klebsiella Infections; Klebsiella pneumoniae; Plasmids | 2022 |
Genetic Characteristics and Microbiological Profile of Hypermucoviscous Multidrug-Resistant Klebsiella variicola Coproducing IMP-4 and NDM-1 Carbapenemases.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Child, Preschool; China; Drug Resistance, Multiple, Bacterial; Female; Genetic Variation; Humans; Klebsiella; Klebsiella Infections; Microbial Sensitivity Tests; Phylogeny; Plasmids; Virulence | 2022 |
Characterization of phage resistance and phages capable of intestinal decolonization of carbapenem-resistant Klebsiella pneumoniae in mice.
Topics: Animals; Anti-Bacterial Agents; Bacteriophages; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Intestines; Klebsiella Infections; Klebsiella pneumoniae; Mice; Virome | 2022 |
Molecular characterisation of carbapenem-resistant Klebsiella pneumoniae clinical isolates: preliminary experience from a tertiary care teaching hospital in the Himalayas.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cross-Sectional Studies; Hospitals, Teaching; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Tertiary Healthcare | 2022 |
regentrans: a framework and R package for using genomics to study regional pathogen transmission.
Topics: Carbapenems; Cross Infection; Databases, Genetic; Drug Resistance, Multiple, Bacterial; Genomics; Humans; Klebsiella Infections; Klebsiella pneumoniae; Phylogeny; Software; Whole Genome Sequencing | 2022 |
Surveillance of carbapenem-resistant
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Child; China; Drug Resistance, Bacterial; Hospitals, Pediatric; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Multilocus Sequence Typing; Prevalence | 2022 |
Carbapenemase Production and Epidemiological Characteristics of Carbapenem-Resistant
Topics: Adult; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Child; China; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Plasmids | 2021 |
Prediction of Prognosis in Adult Patients With Carbapenem-Resistant
Topics: Adult; Aged; Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; China; Humans; Klebsiella Infections; Klebsiella pneumoniae | 2021 |
Molecular epidemiology of carbapenem-resistant Klebsiella pneumoniae in China, 2016-20.
Topics: Carbapenem-Resistant Enterobacteriaceae; Carbapenems; China; Humans; Klebsiella Infections; Klebsiella pneumoniae; Molecular Epidemiology | 2022 |
Discrimination between Carbapenem-Resistant and Carbapenem-Sensitive Klebsiella pneumoniae Strains through Computational Analysis of Surface-Enhanced Raman Spectra: a Pilot Study.
Topics: Anti-Bacterial Agents; Carbapenems; Discriminant Analysis; Drug Resistance, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Machine Learning; Microbial Sensitivity Tests; Neural Networks, Computer; Pilot Projects; Spectrum Analysis, Raman | 2022 |
IS
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; DNA Transposable Elements; Genomics; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Plasmids | 2021 |
Microbial Characteristics and Genomic Analysis of an ST11 Carbapenem-Resistant
Topics: beta-Lactamases; Carbapenems; Genomics; Humans; Klebsiella Infections; Klebsiella pneumoniae; Plasmids | 2021 |
Pathway Driven Target Selection in
Topics: Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Humans; Klebsiella Infections; Klebsiella pneumoniae | 2022 |
A retrospective observational cohort study of the clinical epidemiology of bloodstream infections due to carbapenem-resistant Klebsiella pneumoniae in an OXA-48 endemic setting.
Topics: Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cohort Studies; Humans; Klebsiella Infections; Klebsiella pneumoniae; Retrospective Studies; Risk Factors; Sepsis | 2022 |
Risk factors for and clinical outcomes of ceftazidime-avibactam-resistant carbapenem-resistant Klebsiella pneumoniae nosocomial infections: a single-center retrospective study.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Carbapenems; Ceftazidime; Cross Infection; Drug Combinations; Humans; Klebsiella Infections; Klebsiella pneumoniae; Retrospective Studies; Risk Factors | 2022 |
Adipose tissue is a predictor of 30-days mortality in patients with bloodstream infection caused by carbapenem-resistant Klebsiella pneumoniae.
Topics: Adipose Tissue; Anti-Bacterial Agents; Bacteremia; Carbapenems; COVID-19; Humans; Klebsiella Infections; Klebsiella pneumoniae; Retrospective Studies; Risk Factors; SARS-CoV-2; Sepsis | 2022 |
Reduced Virulence and Enhanced Host Adaption during Antibiotics Therapy: a Story of a Within-Host Carbapenem-Resistant Klebsiella pneumoniae Sequence Type 11 Evolution in a Patient with a Serious Scrotal Abscess.
Topics: Anti-Bacterial Agents; Carbapenems; Host Adaptation; Humans; Klebsiella Infections; Klebsiella pneumoniae; Liver Abscess; Tigecycline; Virulence | 2022 |
Correlation between antibiotic consumption and the occurrence of multidrug-resistant organisms in a Malaysian tertiary hospital: a 3-year observational study.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Cephalosporins; Cross Infection; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Humans; Inappropriate Prescribing; Klebsiella; Klebsiella Infections; Malaysia; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Tertiary Care Centers | 2022 |
Phenotypic and Genotypic Characterization of a Hypervirulent Carbapenem-Resistant Klebsiella pneumoniae ST17-KL38 Clinical Isolate Harboring the Carbapenemase IMP-4.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Disease Models, Animal; Klebsiella Infections; Klebsiella pneumoniae; Mice; Plasmids; Protein Synthesis Inhibitors; Serogroup | 2022 |
Multicenter Genomic Analysis of Carbapenem-Resistant Klebsiella pneumoniae from Bacteremia in China.
Topics: Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Genomics; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2022 |
Modelling of the transmission dynamics of carbapenem-resistant Klebsiella pneumoniae in hospitals and design of control strategies.
Topics: Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Drug Resistance, Bacterial; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae | 2022 |
Effect of sigma E on carbapenem resistance in OXA-48-producing Klebsiella pneumoniae.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cephalosporins; Humans; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Porins | 2022 |
Phenotypic Changes Associated With
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Colistin; Drug Resistance, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Mice; Microbial Sensitivity Tests | 2022 |
The evaluation of vancomycin-resistant enterococci and carbapenamase producing Klebsiella colonization among ICU-Hospitalized Patients.
Topics: beta-Lactam Resistance; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Carrier State; Hospitalization; Humans; Intensive Care Units; Klebsiella; Klebsiella Infections; Klebsiella pneumoniae; Rectum; Vancomycin Resistance; Vancomycin-Resistant Enterococci | 2021 |
Effects of preservative fluid associated possible donor-derived carbapenem-resistant Klebsiella Pneumoniae infection on kidney transplantation recipients.
Topics: Anti-Bacterial Agents; Carbapenems; Humans; Kidney Transplantation; Klebsiella Infections; Klebsiella pneumoniae; Retrospective Studies | 2022 |
Risk factors for infection and mortality caused by carbapenem-resistant Klebsiella pneumoniae: A large multicentre case-control and cohort study.
Topics: Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Case-Control Studies; Cohort Studies; Drug Resistance, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Risk Factors | 2022 |
Characteristics and outcomes of carbapenemase harbouring carbapenem-resistant Klebsiella spp. bloodstream infections: a multicentre prospective cohort study in an OXA-48 endemic setting.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Prospective Studies; Sepsis | 2022 |
Molecular genetic characteristics of resistome and virulome of carbapenem-resistant Klebsiella pneumoniae clinical strains.
Topics: Anti-Bacterial Agents; Carbapenems; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Biology | 2022 |
Co-Occurrence of Rare ArmA-, RmtB-, and KPC-2-Encoding Multidrug-Resistant Plasmids and Hypervirulence
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Escherichia coli; Escherichia coli Proteins; Humans; Klebsiella Infections; Klebsiella pneumoniae; Methyltransferases; Microbial Sensitivity Tests; Operon; Plasmids | 2022 |
Accessory Genomes Drive Independent Spread of Carbapenem-Resistant Klebsiella pneumoniae Clonal Groups 258 and 307 in Houston, TX.
Topics: Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Humans; Klebsiella Infections; Klebsiella pneumoniae; Prospective Studies | 2022 |
Clinical management of infections caused by carbapenem-resistant Klebsiella pneumoniae in critically ill patients: A nationwide survey of tertiary hospitals in mainland China.
Topics: Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; China; Critical Illness; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Tertiary Care Centers | 2022 |
Emergence of carbapenem- and tigecycline-resistant Klebsiella pneumoniae ST617.
Topics: beta-Lactamases; Carbapenems; Humans; Klebsiella Infections; Klebsiella pneumoniae; Tigecycline | 2022 |
Population structure of blaKPC-harbouring IncN plasmids at a New York City medical centre and evidence for multi-species horizontal transmission.
Topics: Bacterial Proteins; beta-Lactamases; Carbapenems; Gene Transfer, Horizontal; Humans; Klebsiella Infections; Klebsiella pneumoniae; Multilocus Sequence Typing; New York City; Phylogeny; Plasmids | 2022 |
Coexistence of two bla
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Multilocus Sequence Typing; Phylogeny | 2022 |
Biofilm and Gene Expression Characteristics of the Carbapenem-Resistant Enterobacterales,
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Biofilms; Carbapenems; Drug Resistance, Bacterial; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Gene Expression; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2022 |
Emergence of ceftazidime-avibactam resistance due to a novel blaKPC-2 mutation during treatment of carbapenem-resistant Klebsiella pneumoniae infections.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Ceftazidime; Drug Combinations; Humans; Klebsiella; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Mutation | 2022 |
Comparison of Two Distinct Subpopulations of Klebsiella pneumoniae ST16 Co-Occurring in a Single Patient.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Escherichia coli; Humans; Interleukins; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Plasmids | 2022 |
The first nationwide surveillance of carbapenem-resistant Enterobacterales in the United Arab Emirates - increased association of Klebsiella pneumoniae CC14 clone with Emirati patients.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Clone Cells; Gammaproteobacteria; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Multilocus Sequence Typing; United Arab Emirates | 2022 |
Carbapenem-resistant
Topics: Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Case-Control Studies; COVID-19; Disease Outbreaks; Drug Resistance, Bacterial; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Retrospective Studies | 2022 |
Antimicrobial peptide WAM-1: a promising antibacterial and anti-inflammatory drug against carbapenem-resistant Klebsiella pneumoniae.
Topics: Alkaline Phosphatase; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antimicrobial Peptides; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Drug Resistance, Bacterial; Hemolysis; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Moths; Tumor Necrosis Factor-alpha | 2022 |
Impact of a Rapid Molecular Test for Klebsiella pneumoniae Carbapenemase and Ceftazidime-Avibactam Use on Outcomes After Bacteremia Caused by Carbapenem-Resistant Enterobacterales.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Bacteremia; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Ceftazidime; Drug Combinations; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2022 |
Characteristics of ST11 KPC-2-producing carbapenem-resistant hypervirulent Klebsiella pneumoniae causing nosocomial infection in a Chinese hospital.
Topics: Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cross Infection; Humans; Klebsiella Infections; Klebsiella pneumoniae; Retrospective Studies; Tertiary Care Centers | 2022 |
An Outbreak of ST859-K19 Carbapenem-Resistant Hypervirulent Klebsiella pneumoniae in a Chinese Teaching Hospital.
Topics: Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Disease Outbreaks; East Asian People; Hospitals, Teaching; Humans; Klebsiella Infections; Klebsiella pneumoniae | 2022 |
A Small KPC-2-Producing Plasmid in
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Plasmids | 2022 |
Nosocomial transmission and rearrangement of large resistance-virulence hybrid plasmids between two bacteremic ST11 carbapenem-resistant hypervirulent Klebsiella pneumoniae strains with low fitness cost.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cross Infection; Humans; Klebsiella Infections; Klebsiella pneumoniae; Plasmids; Virulence | 2022 |
Higher Rate of Extreme Drug-resistant Klebsiella pneumoniae Infections among Cardiac Patients.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Colistin; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Nepal | 2022 |
A novel clinical therapy to combat infections caused by Hypervirulent Carbapenem-Resistant Klebsiella pneumoniae.
Topics: Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Humans; Klebsiella Infections; Klebsiella pneumoniae | 2022 |
Different Effects of Antibiotics on
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; China; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Quinolones; Retrospective Studies | 2022 |
Global evolution and geographic diversity of hypervirulent carbapenem-resistant Klebsiella pneumoniae.
Topics: Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Humans; Klebsiella Infections; Klebsiella pneumoniae | 2022 |
Dissemination of virulence and resistance genes among Klebsiella pneumoniae via outer membrane vesicle: An important plasmid transfer mechanism to promote the emergence of carbapenem-resistant hypervirulent Klebsiella pneumoniae.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Escherichia coli; Humans; Klebsiella Infections; Klebsiella pneumoniae; Plasmids; Virulence | 2022 |
Investigation of the Relationship between Colistin Resistance and Capsule Serotypes in Carbapenem Resistant Klebsiella pneumoniae Strains.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Colistin; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Serogroup | 2022 |
Carbapenem antibiotic stress increases bla
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; DNA Copy Number Variations; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2022 |
Prevalence of Carbapenem-Resistant Hypervirulent
Topics: Animals; Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; China; Klebsiella Infections; Klebsiella pneumoniae; Mice; Prevalence | 2022 |
Risk factors and clinical impact associated with infections caused by different types of carbapenem-resistant Klebsiella pneumoniae in China: A clinical study from 2014 to 2017.
Topics: Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; China; Humans; Klebsiella Infections; Klebsiella pneumoniae; Risk Factors | 2022 |
Epidemiological Characteristics of OXA-232-Producing Carbapenem-Resistant Klebsiella pneumoniae Strains Isolated during Nosocomial Clonal Spread Associated with Environmental Colonization.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cross Infection; Disinfectants; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2022 |
KPC-3-Producing Klebsiella pneumoniae Sequence Type 392 from a Dog's Clinical Isolate in Portugal.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Dogs; Drug Resistance, Multiple, Bacterial; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Portugal | 2022 |
Characterisation of clinical carbapenem-resistant K1 Klebsiella quasipneumoniae subsp. similipneumoniae strains harbouring a virulence plasmid.
Topics: Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Humans; Klebsiella; Klebsiella Infections; Klebsiella pneumoniae; Plasmids; Virulence | 2022 |
Spread of Carbapenem-Resistant Klebsiella pneumoniae Clinical Isolates Producing NDM-Type Metallo-β-Lactamase in Myanmar.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Myanmar; Plasmids; RNA, Ribosomal, 16S | 2022 |
Genomic and phylogenetic analysis of a multidrug-resistant Klebsiella pneumoniae ST15 strain co-carrying bla
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Gallbladder; Genomics; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Multilocus Sequence Typing; Phylogeny | 2022 |
Genomic characterization of hypervirulent carbapenem-resistant clinical Klebsiella pneumoniae ST11 isolate from China.
Topics: Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Genomics; Humans; Klebsiella Infections; Klebsiella pneumoniae | 2022 |
Genomic and Immunological Characterization of Hypermucoviscous Carbapenem-Resistant
Topics: Animals; Anti-Bacterial Agents; Argentina; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Genomics; Klebsiella Infections; Klebsiella pneumoniae; Mice; Virulence Factors | 2022 |
Insertion sequence mediating mrgB disruption is the major mechanism of polymyxin resistance in carbapenem-resistant Klebsiella pneumoniae isolates from China.
Topics: Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Colistin; DNA Transposable Elements; Humans; Klebsiella Infections; Klebsiella pneumoniae; Polymyxin B; Polymyxins | 2022 |
Risk factors and mortality for elderly patients with bloodstream infection of carbapenem resistance Klebsiella pneumoniae: a 10-year longitudinal study.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Carbapenems; Drug Resistance, Bacterial; Humans; Hypertension; Klebsiella Infections; Klebsiella pneumoniae; Longitudinal Studies; Retrospective Studies; Risk Factors; Sepsis | 2022 |
Prevalence of hypervirulent and carbapenem-resistant
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Humans; Klebsiella Infections; Klebsiella pneumoniae; Plasmids; Prevalence; Serogroup | 2022 |
Proteomics Study of the Synergistic Killing of Tigecycline in Combination With Aminoglycosides Against Carbapenem-Resistant
Topics: Aminoglycosides; Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Drug Resistance, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Proteomics; Tigecycline | 2022 |
[Colistin resistance in carbapenem-resistant Klebsiella pneumoniae isolates from a pediatric hospital from Corrientes, Argentina].
Topics: Anti-Bacterial Agents; Argentina; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Ceftazidime; Child; Colistin; Hospitals, Pediatric; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Tigecycline | 2022 |
Patient-Derived Antibody Data Yields Development of Broadly Cross-Protective Monoclonal Antibody against ST258 Carbapenem-Resistant
Topics: Animals; Anti-Bacterial Agents; Antibodies, Monoclonal; Carbapenems; Klebsiella Infections; Klebsiella pneumoniae; Macrophages; Mice | 2022 |
Combing Immunoinformatics with Pangenome Analysis To Design a Multiepitope Subunit Vaccine against Klebsiella pneumoniae K1, K2, K47, and K64.
Topics: Anti-Bacterial Agents; Carbapenems; Cross Infection; Humans; Klebsiella Infections; Klebsiella pneumoniae; Molecular Docking Simulation; Vaccines, Subunit | 2022 |
The Gastrointestinal Load of Carbapenem-Resistant Enterobacteriacea Is Associated With the Transition From Colonization to Infection by
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cross Infection; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Multilocus Sequence Typing | 2022 |
Genomic insights into bla
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Genomics; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Multilocus Sequence Typing; Plasmids; Thailand; Virulence Factors | 2022 |
Emergence of mcr-1 gene and carbapenemase-encoding genes among colistin-resistant Klebsiella pneumoniae clinical isolates in Jordan.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Colistin; Drug Resistance, Bacterial; Humans; Jordan; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2022 |
Association between Antimicrobial Consumption and the Prevalence of Nosocomial Carbapenem-Resistant Escherichia coli and Klebsiella pneumoniae in a Tertiary Hospital in Northern Taiwan.
Topics: Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cross Infection; Doripenem; Escherichia coli; Fluoroquinolones; Humans; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Piperacillin, Tazobactam Drug Combination; Prevalence; Retrospective Studies; Taiwan; Tertiary Care Centers | 2022 |
High prevalence of mgrB-mediated colistin resistance among carbapenem-resistant Klebsiella pneumoniae is associated with biofilm formation, and can be overcome by colistin-EDTA combination therapy.
Topics: Animals; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Colistin; Drug Resistance, Bacterial; Edetic Acid; Klebsiella Infections; Klebsiella pneumoniae; Mice; Microbial Sensitivity Tests; Prevalence | 2022 |
Intravenous plus intraventricular tigecycline-amikacin therapy for the treatment of carbapenem-resistant Klebsiella pneumoniae ventriculitis: A case report.
Topics: Amikacin; Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Central Nervous System Infections; Cerebral Ventriculitis; Encephalitis; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Tigecycline | 2022 |
Reduced porin expression with EnvZ-OmpR, PhoPQ, BaeSR two-component system down-regulation in carbapenem resistance of Klebsiella Pneumoniae based on proteomic analysis.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Chromatography, Liquid; Down-Regulation; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Porins; Proteomics; Tandem Mass Spectrometry | 2022 |
Pyogenic liver abscess-caused Klebsiella pneumoniae in a tertiary hospital in China in 2017: implication of hypervirulent carbapenem-resistant strains.
Topics: Anti-Bacterial Agents; Carbapenems; China; Humans; Klebsiella Infections; Klebsiella pneumoniae; Liver Abscess, Pyogenic; Microbial Sensitivity Tests; Multilocus Sequence Typing; Tertiary Care Centers; Virulence | 2022 |
Genomic characterization of BKC-1-producing Klebsiella pneumoniae strain belonging to high-risk clone sequence type 11 isolated from a river in Brazil.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Brazil; Carbapenems; Clone Cells; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Genomics; Humans; Klebsiella; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Plasmids; Polymyxins; Rivers; Siderophores; Type VI Secretion Systems | 2022 |
First detection and origin of multi-drug resistant Klebsiella pneumoniae ST15 harboring OXA-48 in South America.
Topics: beta-Lactamases; Carbapenems; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Neurodegenerative Diseases | 2022 |
Development of Resistance to Eravacycline by Klebsiella pneumoniae and Collateral Sensitivity-Guided Design of Combination Therapies.
Topics: Animals; Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Drug Collateral Sensitivity; Klebsiella Infections; Klebsiella pneumoniae; Mice; Microbial Sensitivity Tests; Porins; Protease La; Proteomics; Tetracyclines | 2022 |
Emergence of a Novel NDM-5-Producing Sequence Type 4523 Klebsiella pneumoniae Strain Causing Bloodstream Infection in China.
Topics: Aged; Amikacin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Cephalosporins; Colistin; Female; Formaldehyde; Humans; Klebsiella Infections; Klebsiella pneumoniae; Levofloxacin; Microbial Sensitivity Tests; Multilocus Sequence Typing; Phylogeny; Plasmids; Sepsis | 2022 |
Molecular characterization of a hypermucoviscous, hypervirulent, and carbapenem-resistant ST15/K19 Klebsiella pneumoniae clone from human infection.
Topics: Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Clone Cells; Humans; Klebsiella Infections; Klebsiella pneumoniae | 2022 |
The effect of siderophore virulence genes entB and ybtS on the virulence of Carbapenem-resistant Klebsiella pneumoniae.
Topics: Animals; Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Klebsiella Infections; Klebsiella pneumoniae; Mice; Microbial Sensitivity Tests; Siderophores; Tumor Necrosis Factor-alpha; Virulence | 2022 |
The Molecular Epidemiology of Prevalent Klebsiella pneumoniae Strains and Humoral Antibody Responses against Carbapenem-Resistant K. pneumoniae Infections among Pediatric Patients in Shanghai.
Topics: Anti-Bacterial Agents; Antibody Formation; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Child; China; Humans; Immunoglobulin G; Klebsiella Infections; Klebsiella pneumoniae; Molecular Epidemiology; Polysaccharides; Uronic Acids | 2022 |
Recurrent emergence of
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; Carbapenems; Disease Models, Animal; Klebsiella Infections; Klebsiella pneumoniae; Mice; Microbial Sensitivity Tests; Mutation; Phylogeny; Pneumonia, Bacterial; Porins; RNA, Messenger | 2022 |
Genomic analysis of the emerging carbapenem-resistant Klebsiella pneumoniae sequence type 11 harbouring Klebsiella pneumoniae carbapenemase (KPC) in Oman.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Genomics; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Multilocus Sequence Typing; Oman | 2022 |
Small wards in the ICU: a favorable measure for controlling the transmission of carbapenem-resistant Klebsiella pneumoniae.
Topics: Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cross Infection; Hospitals; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Phylogeny; Retrospective Studies | 2022 |
Genomic Evolution of ST11 Carbapenem-Resistant
Topics: Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Evolution, Molecular; Humans; Klebsiella Infections; Klebsiella pneumoniae; Multilocus Sequence Typing | 2022 |
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Ceftazidime; Cephalosporins; Drug Combinations; Escherichia coli; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests | 2022 |
In vitro activity of celastrol in combination with thymol against carbapenem-resistant Klebsiella pneumoniae isolates.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Humans; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Molecular Docking Simulation; Thymol | 2022 |
Transmission of Carbapenem-Resistant Klebsiella pneumoniae in US Hospitals.
Topics: Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cohort Studies; Drug Resistance, Bacterial; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Prospective Studies | 2023 |
Clinical and Molecular Characterizations of Carbapenem-Resistant Klebsiella pneumoniae Causing Bloodstream Infection in a Chinese Hospital.
Topics: Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Sepsis | 2022 |
Fecal carriage and clonal dissemination of blaNDM-1 carrying Klebsiella pneumoniae sequence type 147 at an intensive care unit in Lao PDR.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Escherichia coli; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Laos; Microbial Sensitivity Tests; Plasmids | 2022 |
Emergence of a Fatal ST11-KL64 Tigecycline-Resistant Hypervirulent Klebsiella pneumoniae Clone Cocarrying
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Phylogeny; Plasmids; Tigecycline | 2022 |
Convergence of two serotypes within the epidemic ST11 KPC-producing Klebsiella pneumoniae creates the "Perfect Storm" in a teaching hospital.
Topics: Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Female; Hospitals, Teaching; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Retrospective Studies; Serogroup; Virulence | 2022 |
Glycyrrhetinic acid prevents carbapenem-resistant Klebsiella pneumoniae-induced cell injury by inhibiting mitochondrial dysfunction via Nrf-2 pathway.
Topics: Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Drug Resistance, Bacterial; Glycyrrhetinic Acid; Humans; Klebsiella Infections; Klebsiella pneumoniae; Mitochondria | 2023 |
Whole genome sequencing of OXA-232-producing
Topics: Amikacin; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Chromosomes; Ciprofloxacin; DNA Transposable Elements; Ertapenem; Humans; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Multilocus Sequence Typing; Phylogeny; Plasmids; Sepsis; Virulence; Virulence Factors; Whole Genome Sequencing | 2022 |
A novel KPC-113 variant conferring carbapenem and ceftazidime-avibactam resistance in a multidrug-resistant Pseudomonas aeruginosa isolate.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Ceftazidime; Drug Combinations; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Docking Simulation; Pseudomonas aeruginosa | 2023 |
Antimicrobial resistance pattern, virulence determinants and molecular analysis of carbapenem-resistant Klebsiella pneumoniae isolated from clinical samples in Iran.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Humans; Iran; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Random Amplified Polymorphic DNA Technique; Virulence; Virulence Factors | 2022 |
Epidemic, risk factors of carbapenem-resistant
Topics: Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Carcinoma, Hepatocellular; Drug Resistance, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Liver Neoplasms; Liver Transplantation; Retrospective Studies; Risk Factors | 2022 |
Epidemiology of carbapenem-resistant Klebsiella pneumoniae ST15 of producing KPC-2, SHV-106 and CTX-M-15 in Anhui, China.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; China; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Multilocus Sequence Typing; Phylogeny; Tertiary Care Centers | 2022 |
Whole-Genome Sequence Analysis of Carbapenem-Heteroresistant Klebsiella pneumoniae and Escherichia coli Isolates.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Multilocus Sequence Typing | 2022 |
Genomic Analysis and Molecular Characteristics in Carbapenem-Resistant Klebsiella pneumoniae Strains.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Drug Resistance, Multiple, Bacterial; Genomics; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Multilocus Sequence Typing; Plasmids | 2022 |
Characterization of Novel
Topics: Anti-Bacterial Agents; Bacteriophages; Biofilms; Carbapenems; Humans; Klebsiella; Klebsiella Infections; Klebsiella pneumoniae | 2022 |
Efficacy and safety of intravenous fosfomycin for the treatment of carbapenem-resistant
Topics: Adult; Anti-Bacterial Agents; Bacteremia; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Fosfomycin; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Pneumonia; Urinary Tract Infections | 2023 |
Deciphering variable resistance to novel carbapenem-based β-lactamase inhibitor combinations in a multi-clonal outbreak caused by Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae resistant to ceftazidime/avibactam.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Ceftazidime; Disease Outbreaks; Drug Combinations; Humans; Klebsiella; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2023 |
Opposite evolution of pathogenicity driven by in vivo wzc and wcaJ mutations in ST11-KL64 carbapenem-resistant Klebsiella pneumoniae.
Topics: Anti-Bacterial Agents; Carbapenems; Klebsiella Infections; Klebsiella pneumoniae; Multilocus Sequence Typing; Mutation; Virulence | 2023 |
Within-Host Genotypic and Phenotypic Diversity of Contemporaneous Carbapenem-Resistant Klebsiella pneumoniae from Blood Cultures of Patients with Bacteremia.
Topics: Animals; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Blood Culture; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Klebsiella Infections; Klebsiella pneumoniae; Mice; Microbial Sensitivity Tests; Sepsis | 2022 |
Competitive Transmission of Carbapenem-Resistant Klebsiella pneumoniae in a Newly Opened Intensive Care Unit.
Topics: Aftercare; Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Patient Discharge; Prospective Studies | 2022 |
Klebsiella Species and Enterobacter cloacae Isolates Harboring
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Enterobacter cloacae; Ghana; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Plasmids | 2022 |
Clonal Spread of Carbapenem-Resistant Klebsiella pneumoniae Sequence Type 11 in Chinese Pediatric Patients.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Child; Cross Infection; East Asian People; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Plasmids | 2022 |
Coexistence of Multidrug Resistance and Virulence in a Single Conjugative Plasmid from a Hypervirulent Klebsiella pneumoniae Isolate of Sequence Type 25.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Drug Resistance, Multiple; Humans; Klebsiella Infections; Klebsiella pneumoniae; Plasmids; Virulence | 2022 |
Topics: Acetic Acid; Animals; Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Guinea Pigs; Klebsiella Infections; Klebsiella pneumoniae; Mice; Republic of Korea | 2022 |
Clinical Outcomes and Risk Factors for Death following Carbapenem-Resistant Klebsiella pneumoniae Infection in Solid Organ Transplant Recipients.
Topics: Anti-Bacterial Agents; Carbapenems; Drug Resistance, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Middle Aged; Organ Transplantation; Retrospective Studies; Risk Factors; Shock, Septic | 2023 |
The Emerging Nosocomial Pathogen Klebsiella michiganensis
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Phylogeny; Plasmids | 2023 |
Antimicrobial resistance changing trends of Klebsiella pneumoniae isolated over the last 5 years.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Fosfomycin; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2022 |
Baicalein Inhibits Plasmid-Mediated Horizontal Transmission of the blaKPC Multidrug Resistance Gene from Klebsiella pneumoniae to Escherichia coli.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Escherichia coli; Genes, MDR; Humans; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Paraoxon; Plasmids | 2023 |
Invasive Liver Abscess Syndrome Caused by Carbapenem-Resistant Hypervirulent Klebsiella Pneumoniae: a Case Report.
Topics: Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Humans; Klebsiella Infections; Klebsiella pneumoniae; Liver Abscess; Virulence | 2022 |
Newly Detected Transmission of bla
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Humans; Klebsiella Infections; Klebsiella pneumoniae | 2023 |
Antibiotic resistance and virulence characteristics of four carbapenem-resistant Klebsiella pneumoniae strains coharbouring bla
Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; China; Drug Resistance, Microbial; Escherichia coli; Escherichia coli Proteins; Hospitals, Teaching; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Virulence | 2023 |
Recombination Drives Evolution of Carbapenem-Resistant Klebsiella pneumoniae Sequence Type 11 KL47 to KL64 in China.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; China; Humans; Klebsiella Infections; Klebsiella pneumoniae; Lipopolysaccharides; Phylogeny; Recombination, Genetic | 2023 |
Changes of Klebsiella pneumoniae infection and carbapenem resistance in ICU elderly infected patients before and after the COVID-19 pandemic in Zhengzhou, China.
Topics: Aged; Anti-Bacterial Agents; Carbapenems; China; COVID-19; Drug Resistance, Bacterial; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Pandemics | 2023 |
Investigation of NDM-1 and OXA-48 producing carbapenem resistant Klebsiella pneumoniae ST15 in Iran.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Humans; Iran; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Multilocus Sequence Typing | 2023 |
Fatal Stent-Associated Respiratory Tract Infection Caused by K64-ST11 KPC-2-Producing Carbapenem-Resistant Hypervirulent
Topics: Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Middle Aged; Respiratory Tract Infections; Stents | 2023 |
Large-scale genomic analysis of global Klebsiella pneumoniae plasmids reveals multiple simultaneous clusters of carbapenem-resistant hypervirulent strains.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Genomics; Humans; Klebsiella Infections; Klebsiella pneumoniae; Plasmids; Virulence | 2023 |
Outbreak of Carbapenem-Resistant Klebsiella pneumoniae in a Neonatal Intensive Care Unit.
Topics: Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cross Infection; Disease Outbreaks; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2023 |
Tracking the Emergence and Dissemination of a
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Phylogeny; Plasmids | 2023 |
Within-host resistance evolution of a fatal ST11 hypervirulent carbapenem-resistant Klebsiella pneumoniae.
Topics: Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Colistin; Humans; Klebsiella Infections; Klebsiella pneumoniae | 2023 |
Molecular characteristics and genetic analysis of the genes related to carbapenemase, efflux pump, and outer membrane proteins in carbapenem-resistant Klebsiella pneumoniae.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Multilocus Sequence Typing; Porins | 2023 |
Isolation, characterization, therapeutic potency, and genomic analysis of a novel bacteriophage vB_KshKPC-M against carbapenemase-producing Klebsiella pneumoniae strains (CRKP) isolated from Ventilator-associated pneumoniae (VAP) infection of COVID-19 pat
Topics: Anti-Bacterial Agents; Bacteriophages; Carbapenems; Colistin; COVID-19; Genomics; Humans; Klebsiella Infections; Klebsiella pneumoniae; Phylogeny; Ventilators, Mechanical | 2023 |
Genomic characterization of two carbapenem-resistant
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; Carbapenems; China; Drug Resistance, Bacterial; Genome, Bacterial; Genomics; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Plasmids; Serratia Infections; Serratia marcescens | 2023 |
Analysis of risk factors associated with healthcare-associated carbapenem-resistant Klebsiella pneumoniae infection in a large general hospital: a case-case-control study.
Topics: Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Case-Control Studies; Cross Infection; Delivery of Health Care; Drug Resistance, Bacterial; Hospitals, General; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Risk Factors | 2023 |
Resistance to ceftazidime-avibactam in a KPC-2-producing Klebsiella pneumoniae caused by the extended-spectrum beta-lactamase VEB-25.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Ceftazidime; Drug Combinations; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2023 |
Emergence of multidrug-resistant ST11 blaKPC-2 producing Klebsiella pneumoniae coharboring blaCTX-M and blaSHV in Pakistan.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Multilocus Sequence Typing; Pakistan; Plasmids | 2023 |
Ceftazidime-avibactam-based combination therapy for hospital-acquired central nervous system infections caused by carbapenem-resistant Klebsiella pneumoniae.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Ceftazidime; Central Nervous System Infections; Drug Combinations; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Retrospective Studies | 2023 |
ISOLATION AND CHARACTERIZATION OF BACTERIOPHAGE WITH LYTIC ACTIVITY AGAINST CARBAPENEM RESISTANCE STRAIN OF KLEBSIELLA PNEUMONIA.
Topics: Bacteriophages; Carbapenems; Humans; Klebsiella Infections; Klebsiella pneumoniae; Myoviridae; Pneumonia | 2023 |
Construction of a comprehensive protein-protein interaction map for multi drug resistant klebsiella pneumoniae to identify drug targets: A computational approach.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Protein Interaction Maps | 2023 |
Emergence of KPC-3- and OXA-181-producing ST13 and ST17 Klebsiella pneumoniae in Portugal: genomic insights on national and international dissemination.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Genomics; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Chaperones; Phylogeny; Portugal; Tumor Suppressor Proteins | 2023 |
Dissemination of NDM-producing bacteria in Southern Brazil.
Topics: Anti-Bacterial Agents; beta-Lactamases; Brazil; Carbapenems; Drug Resistance, Multiple, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Plasmids | 2023 |
Carbapenem Resistance among Klebsiella pneumoniae in a Tertiary Care Hospital in Bangladesh.
Topics: Agar; Anti-Bacterial Agents; Bangladesh; beta-Lactamases; Carbapenems; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Tertiary Care Centers | 2023 |
Collateral sensitivity between tetracyclines and aminoglycosides constrains resistance evolution in carbapenem-resistant Klebsiella pneumoniae.
Topics: Aminoglycosides; Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Drug Collateral Sensitivity; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Tetracyclines | 2023 |
Direct prediction of carbapenem-resistant, carbapenemase-producing, and colistin-resistant Klebsiella pneumoniae isolates from routine MALDI-TOF mass spectra using machine learning and outcome evaluation.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Colistin; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2023 |
Outer Membrane Vesicles Transmitting
Topics: Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Humans; Klebsiella Infections; Klebsiella pneumoniae; Meropenem | 2023 |
[Investigation of Virulence Genes and Carbapenem Resistance Genes in Hypervirulent and Classical Isolates of Klebsiella pneumoniae Isolated from Various Clinical Specimens].
Topics: Anti-Bacterial Agents; Carbapenems; Community-Acquired Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Virulence; Virulence Factors; Young Adult | 2023 |
Outbreak report of polymyxin-carbapenem-resistant Klebsiella pneumoniae causing untreatable infections evidenced by synergy tests and bacterial genomes.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Brazil; Carbapenems; Disease Outbreaks; Genome, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Polymyxins | 2023 |
Rapid identification of carbapenem-resistant Klebsiella pneumoniae based on matrix-assisted laser desorption ionization time-of-flight mass spectrometry and an artificial neural network model.
Topics: Anti-Bacterial Agents; Carbapenems; Humans; Klebsiella Infections; Klebsiella pneumoniae; Lasers; Neural Networks, Computer; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2023 |
Genomic and functional characterization of carbapenem-resistant Klebsiella pneumoniae from hospital wastewater.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Genomics; Hospitals, Teaching; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Phylogeny; Wastewater | 2023 |
Virulence, antimicrobial resistance, and molecular characteristics of carbapenem-resistant Klebsiella pneumoniae in a hospital in Shijiazhuang City from China.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; China; Drug Resistance, Bacterial; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Multilocus Sequence Typing; Virulence | 2023 |
A Nationwide Genomic Study of Clinical Klebsiella pneumoniae Carrying
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Genomics; Humans; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Plasmids | 2023 |
BL02, a phage against carbapenem- and polymyxin-B resistant Klebsiella pneumoniae, isolated from sewage: A preclinical study.
Topics: Animals; Anti-Bacterial Agents; Bacteriophages; Carbapenems; Klebsiella Infections; Klebsiella pneumoniae; Male; Mice; Microbial Sensitivity Tests; Phylogeny; Polymyxin B; Sewage | 2023 |
A point mutation in recC associated with subclonal replacement of carbapenem-resistant Klebsiella pneumoniae ST11 in China.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; China; Humans; Klebsiella Infections; Klebsiella pneumoniae; Point Mutation | 2023 |
Investigation of in vitro efficacy of meropenem/polymyxin B and meropenem/fosfomycin combinations against carbapenem resistant Klebsiella pneumoniae strains.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Fosfomycin; Humans; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Polymyxin B | 2023 |
Prevalence and Outcomes of Carbapenem-resistant Bloodstream Infection in Children With Cancer.
Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Child; Female; Hematologic Neoplasms; Humans; Klebsiella Infections; Male; Neutropenia; Prevalence; Retrospective Studies; Shock, Septic | 2023 |
Risk factors and molecular epidemiology of bloodstream infections due to carbapenem-resistant Klebsiella pneumoniae.
Topics: Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Humans; Klebsiella Infections; Klebsiella pneumoniae; Molecular Epidemiology; Multilocus Sequence Typing; Observational Studies as Topic; Phylogeny; Risk Factors; Sepsis | 2023 |
Breaking Antimicrobial Resistance: High-Dose Amoxicillin with Clavulanic Acid for Urinary Tract Infections Due to Extended-Spectrum Beta-Lactamase (ESBL)-Producing Klebsiella pneumoniae.
Topics: Amoxicillin; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Clavulanic Acid; Drug Resistance, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Urinary Tract Infections | 2023 |
Molecular Characterization of the Convergent Carbapenem-Resistant and Hypervirulent Klebsiella pneumoniae Strain K1-ST23, Collected in Chile during the COVID-19 Pandemic.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Chile; COVID-19; Humans; Klebsiella Infections; Klebsiella pneumoniae; Pandemics; Plasmids | 2023 |
Characteristics of Carbapenem-resistant Klebsiella pneumoniae in sewage from a tertiary hospital in Jilin Province, China.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; China; Chlorine; Disinfectants; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Multilocus Sequence Typing; Sewage; Tertiary Care Centers; Wastewater | 2023 |
Analysis of an IncR plasmid carried by carbapenem-resistant Klebsiella pneumoniae: A survey of swine Klebsiella pneumoniae in Jilin Province.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Klebsiella Infections; Klebsiella pneumoniae; Mice; Plasmids; Swine | 2023 |
Genomic Epidemiology and Characterization of Carbapenem-Resistant Klebsiella pneumoniae in ICU Inpatients in Henan Province, China: a Multicenter Cross-Sectional Study.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Colistin; Cross-Sectional Studies; Genomics; Humans; Inpatients; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2023 |
Genomic analysis of the initial dissemination of carbapenem-resistant
Topics: beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Clone Cells; Genomics; Humans; Klebsiella Infections; Klebsiella pneumoniae; Tertiary Care Centers | 2023 |
Prevalence and molecular characteristics of colistin-resistant isolates among clinically isolated carbapenem-resistant Klebsiella pneumoniae in China.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Carbapenems; Colistin; Drug Resistance, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Lipid A; Microbial Sensitivity Tests; Prevalence | 2023 |
Distinct carbapenems susceptibility profiles in isogenic isolates of Klebsiella pneumoniae presenting Ompk36 disruption and expression of down-regulated blaKPC-2.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Carbapenems; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Porins | 2023 |
Emergence of IS26-mediated pLVPK-like virulence and NDM-1 conjugative fusion plasmid in hypervirulent carbapenem-resistant Klebsiella pneumoniae.
Topics: Anti-Bacterial Agents; beta-Lactamases; Biological Evolution; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Humans; Klebsiella Infections; Klebsiella pneumoniae; Virulence | 2023 |
The association between ambient temperature and antimicrobial resistance of
Topics: Anti-Bacterial Agents; Carbapenems; Case-Control Studies; China; Drug Resistance, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Retrospective Studies; Risk Factors; Temperature | 2023 |
High burden of ESBL and carbapenemase-producing gram-negative bacteria in bloodstream infection patients at a tertiary care hospital in Addis Ababa, Ethiopia.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Bacterial Proteins; beta-Lactamases; Carbapenems; Cesarean Section; Cross-Sectional Studies; Ethiopia; Female; Gram-Negative Bacteria; Humans; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Pregnancy; Sepsis; Tertiary Care Centers | 2023 |
Antimicrobial activity of cinnamaldehyde against multidrug-resistant Klebsiella pneumoniae: an in vitro and in vivo study.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Carbapenems; Drug Resistance, Multiple, Bacterial; Klebsiella Infections; Klebsiella pneumoniae; Mice; Microbial Sensitivity Tests; Polymyxins | 2023 |
Clinical, biological and genome-wide comparison of carbapenem-resistant Klebsiella pneumoniae with susceptibility transformation to polymyxin B during therapy.
Topics: Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Polymyxin B; Retrospective Studies | 2023 |
Multiplicity of
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Bacterial Proteins; beta-Lactamases; Carbapenems; Ceftazidime; Humans; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Plasmids | 2023 |
Multicenter Study of Colistin Heteroresistance in Carbapenem-Resistant Klebsiella pneumoniae Strains in China.
Topics: Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Colistin; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2023 |
An IncN-ST7 epidemic plasmid mediates the dissemination of carbapenem-resistant Klebsiella pneumoniae in a neonatal intensive care unit in China over 10 years.
Topics: Adult; Anti-Bacterial Agents; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Child; China; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Plasmids | 2023 |
Clinical and Genomic Characteristics of Carbapenem-Resistant Klebsiella pneumoniae Isolates from Acute Pancreatitis with Infection in China.
Topics: Anti-Bacterial Agents; Carbapenems; China; Drug Resistance, Bacterial; Genomics; Humans; Klebsiella Infections; Klebsiella pneumoniae; Pancreatitis; Retrospective Studies | 2023 |
Distinct Origins and Transmission Pathways of
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Plasmids | 2023 |
The Presence of Virulent and Multidrug-Resistant Clones of Carbapenem-Resistant Klebsiella pneumoniae in Southeastern Brazil.
Topics: Anti-Bacterial Agents; Brazil; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Colistin; Humans; Klebsiella Infections; Klebsiella pneumoniae; Multilocus Sequence Typing | 2023 |
[Determination of Whole Genome Sequence and Resistance Genes in Hypermucoviscous Klebsiella pneumoniae with Long-Read Sequencing Technology].
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Plasmids | 2023 |
Risk factors and clinical outcomes of carbapenem-resistant Klebsiella pneumoniae bacteraemia in children: a retrospective study.
Topics: Adolescent; Anti-Bacterial Agents; Bacteremia; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Child; Humans; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Retrospective Studies; Risk Factors; Sepsis; Shock, Septic | 2023 |
In vitro activity of imipenem/relebactam and ceftazidime/avibactam against carbapenem-resistant Klebsiella pneumoniae from blood cultures in a University hospital in Serbia.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Blood Culture; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Ceftazidime; Colistin; Drug Combinations; Hospitals, University; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Serbia | 2023 |
Testing the mutant selection window hypothesis with meropenem: In vitro model study with OXA-48-producing Klebsiella pneumoniae.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Humans; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests | 2023 |
Genomic insight into the distribution and genetic environment of bla
Topics: Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; China; Escherichia coli; Genomics; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Phylogeny; Plasmids | 2023 |
Prevalence of extended-spectrum β-lactamase and carbapenem-resistant
Topics: Adult; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Prevalence; Retrospective Studies | 2023 |
Mortality in KPC-producing Klebsiella pneumoniae bloodstream infections: a changing landscape.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Bacteremia; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Ceftazidime; Disease Susceptibility; Drug Combinations; Humans; Klebsiella Infections; Klebsiella pneumoniae; Retrospective Studies; Sepsis | 2023 |
Coexistence of blaKPC-2 and blaNDM-1 in one IncHI5 plasmid confers transferable carbapenem resistance from a clinical isolate of Klebsiella michiganensis in China.
Topics: Carbapenems; Humans; Klebsiella; Klebsiella Infections; Plasmids | 2023 |
Detection of clinically relevant carbapenemase encoding genes in carbapenem-resistant Enterobacter cloacae complex and Klebsiella pneumoniae isolated from farmed freshwater fish.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Enterobacter cloacae; Escherichia coli; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Multilocus Sequence Typing; RNA, Ribosomal, 16S | 2023 |
Performance of Carbapenemase Nordmann-Poirel, Modified Carbapenem Inactivation, and EDTA Carbapenem Inactivation Methods for Detecting Carbapenem-Resistant
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Edetic Acid; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2023 |
The dynamic evolution and IS26-mediated interspecies transfer of a bla
Topics: Bacterial Outer Membrane Proteins; Carbapenems; Escherichia coli; Escherichia coli Proteins; Humans; Klebsiella Infections; Klebsiella pneumoniae; Multilocus Sequence Typing; Plasmids; Virulence Factors | 2023 |
Evaluation of the combination treatments with intravenous fosfomycin for carbapenem-resistant Klebsiella pneumoniae.
Topics: Adult; Anti-Bacterial Agents; Carbapenems; Fosfomycin; Humans; Klebsiella Infections; Klebsiella pneumoniae; Pneumonia, Ventilator-Associated; Retrospective Studies; Sepsis | 2023 |
Investigation of in vitro efficacy of quercetin-meropenem combination in carbapenemase-producing Klebsiella pneumoniae isolates.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Humans; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Quercetin | 2023 |
Polydatin prevent lung epithelial cell from Carbapenem-resistant Klebsiella pneumoniae injury by inhibiting biofilm formation and oxidative stress.
Topics: Anti-Bacterial Agents; Antioxidants; Biofilms; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Epithelial Cells; Humans; Klebsiella Infections; Klebsiella pneumoniae; Lung; Oxidative Stress; Reactive Oxygen Species | 2023 |
Emergence of colistin-heteroresistant and carbapenem-resistant hypervirulent Klebsiella pneumoniae.
Topics: Animals; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Colistin; Humans; Klebsiella Infections; Klebsiella pneumoniae; Larva | 2023 |
Whole-genome sequencing of carbapenem-resistant Enterobacterales isolates in southeast Louisiana reveals persistent genetic clusters spanning multiple locations.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Escherichia coli; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Multilocus Sequence Typing; Plasmids | 2023 |
Global Phylogeography and Genomic Epidemiology of Carbapenem-Resistant bla
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Genomics; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Phylogeny; Phylogeography; Plasmids | 2023 |
Evaluating molecular epidemiology of carbapenem non-susceptible Klebsiella pneumoniae isolates with MLST, MALDI-TOF MS, PFGE.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Colistin; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Epidemiology; Multilocus Sequence Typing; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2023 |
Molecular characteristics and antimicrobial resistance profiles of Carbapenem-Resistant Klebsiella pneumoniae isolates at a tertiary hospital in Nanning, China.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; China; Drug Resistance, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Multilocus Sequence Typing; Tertiary Care Centers | 2023 |
Risk factors and outcome associated with coinfection with carbapenem-resistant
Topics: Acinetobacter; Adult; Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Coinfection; Humans; Klebsiella Infections; Klebsiella pneumoniae; Pneumonia; Pseudomonas aeruginosa; Risk Factors | 2023 |
A critical role of outer membrane vesicles in antibiotic resistance in carbapenem-resistant Klebsiella pneumoniae.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Chromatography, Liquid; Drug Resistance, Microbial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Multilocus Sequence Typing; Tandem Mass Spectrometry; Tertiary Care Centers | 2023 |
Occurrence of some common carbapenemase genes in carbapenem-resistant Klebsiella pneumoniae isolates collected from clinical samples in Tabriz, northwestern Iran.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cross-Sectional Studies; Humans; Imipenem; Iran; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests | 2023 |
Prevalence and molecular determinants of carbapenemase-producing Klebsiella pneumoniae isolated from Jazan, Saudi Arabia.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Gammaproteobacteria; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Pandemics; Prevalence; Saudi Arabia; Tertiary Care Centers | 2023 |
Molecular epidemiological investigation of carbapenem resistant Klebsiella pneumoniae isolated from intensive care unit patients of six geographical regions of Turkey.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Multilocus Sequence Typing; Turkey | 2023 |
Decoding the genetic structure of conjugative plasmids in international clones of Klebsiella pneumoniae: A deep dive into blaKPC, blaNDM, blaOXA-48, and blaGES genes.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Health Facilities; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Plasmids | 2023 |
Identification of hypervirulent Klebsiella pneumoniae based on biomarkers and Galleria mellonella infection model.
Topics: Animals; Anti-Bacterial Agents; Biomarkers; Carbapenems; Humans; Klebsiella Infections; Klebsiella pneumoniae; Moths; Reproducibility of Results; Siderophores; Virulence | 2023 |
Risk factors in ICU patients with initial acquisition of carbapenemase-resistant
Topics: Aged; Anti-Bacterial Agents; Carbapenems; Drug Resistance, Bacterial; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Male; Risk Factors | 2023 |
Characterization of Carbapenem-Resistant Enterobacteriaceae Clinical Isolates in Al Thawra University Hospital, Sana'a, Yemen.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactam Resistance; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Child; Child, Preschool; Clone Cells; Enterobacter cloacae; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Female; Gene Expression; Hospitals, University; Humans; Infant; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Plasmids; Quinolones; Yemen | 2020 |
The effect of colistin resistance and other predictors on fatality among patients with bloodstream infections due to Klebsiella pneumoniae in an OXA-48 dominant region.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Colistin; Drug Resistance, Bacterial; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Risk Factors; Tertiary Care Centers; Tigecycline; Young Adult | 2019 |
Graft Hepatic Artery Rupture Due to Carbapenem-Resistant Klebsiella pneumoniae Infection After Liver Transplant.
Topics: Carbapenems; Drug Resistance, Bacterial; Fatal Outcome; Hepatic Artery; Hepatitis B; Humans; Klebsiella Infections; Klebsiella pneumoniae; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Risk Factors; Rupture, Spontaneous; Treatment Outcome | 2020 |
Whole-Genome Sequencing To Identify Drivers of Carbapenem-Resistant Klebsiella pneumoniae Transmission within and between Regional Long-Term Acute-Care Hospitals.
Topics: Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Prospective Studies; Whole Genome Sequencing | 2019 |
Cooccurrence of NDM-1, ESBL, RmtC, AAC(6')-Ib, and QnrB in Clonally Related
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; RNA, Ribosomal, 16S; Saudi Arabia | 2019 |
OmpK36-mediated Carbapenem resistance attenuates ST258 Klebsiella pneumoniae in vivo.
Topics: Amino Acid Sequence; Animals; Anti-Bacterial Agents; Bacterial Proteins; Carbapenems; Crystallography, X-Ray; Drug Resistance, Bacterial; Female; Klebsiella Infections; Klebsiella pneumoniae; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mutation; Porins; Sequence Homology, Amino Acid; Virulence | 2019 |
Carbapenem-resistant Klebsiella pneumoniae with low chlorhexidine susceptibility.
Topics: Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Chlorhexidine; Colistin; Humans; Klebsiella Infections; Klebsiella pneumoniae | 2019 |
Colistin resistance emerges in pandrug-resistant Klebsiella pneumoniae epidemic clones in Rio de Janeiro, Brazil.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Brazil; Carbapenems; Colistin; Cross Infection; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Klebsiella Infections; Klebsiella pneumoniae; Membrane Proteins; Microbial Sensitivity Tests; Transcription Factors; Whole Genome Sequencing | 2019 |
Genomic Insights into Two Colistin-Resistant
Topics: Anti-Bacterial Agents; Base Sequence; Carbapenems; Cephalosporins; Colistin; Drug Resistance, Multiple, Bacterial; Feces; Fluoroquinolones; Genes, Bacterial; Genomics; Humans; Infant, Newborn; Infant, Premature; Intensive Care Units, Neonatal; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Mutagenesis, Insertional; Plasmids; Virulence; Whole Genome Sequencing | 2020 |
A conjugative plasmid that augments virulence in Klebsiella pneumoniae.
Topics: Animals; Anti-Bacterial Agents; Carbapenems; Drug Resistance, Multiple, Bacterial; Genome, Bacterial; Klebsiella Infections; Klebsiella pneumoniae; Larva; Male; Mice; Moths; Plasmids; Virulence | 2019 |
Antimicrobial and antibiofilm activities of paeoniflorin against carbapenem-resistant Klebsiella pneumoniae.
Topics: Anti-Bacterial Agents; Biofilms; Carbapenems; Drug Resistance, Bacterial; Glucosides; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Monoterpenes | 2020 |
Co-existence of virulence factors and antibiotic resistance in new Klebsiella pneumoniae clones emerging in south of Italy.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Genotype; Humans; Klebsiella Infections; Klebsiella pneumoniae; Middle Aged; Multilocus Sequence Typing; Phylogeny; Polymorphism, Single Nucleotide; Sicily; Virulence Factors | 2019 |
Evolution of hypervirulence in carbapenem-resistant Klebsiella pneumoniae in China: a multicentre, molecular epidemiological analysis.
Topics: beta-Lactam Resistance; Carbapenems; China; Evolution, Molecular; Humans; Klebsiella Infections; Klebsiella pneumoniae; Molecular Epidemiology; Retrospective Studies; Virulence | 2020 |
Correlation between biofilm formation and carbapenem resistance among clinical isolates of
Topics: Anti-Bacterial Agents; Biofilms; Carbapenems; Drug Resistance, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2019 |
Activity of ceftazidime-avibactam alone and in combination with polymyxin B against carbapenem-resistant Klebsiella pneumoniae in a tandem in vitro time-kill/in vivo Galleria mellonella survival model analysis.
Topics: Animals; Anti-Bacterial Agents; Azabicyclo Compounds; Carbapenems; Ceftazidime; Drug Combinations; Drug Resistance, Bacterial; Drug Synergism; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Moths; Polymyxin B | 2020 |
Genomic analysis of a pan-resistant Klebsiella pneumoniae sequence type 11 identified in Japan in 2016.
Topics: Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Humans; Japan; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Multilocus Sequence Typing; Plasmids; Whole Genome Sequencing | 2020 |
Risk factors and mortality for patients with Bloodstream infections of Klebsiella pneumoniae during 2014-2018: Clinical impact of carbapenem resistance in a large tertiary hospital of China.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; China; Drug Resistance, Bacterial; Female; Humans; Intensive Care Units; Kaplan-Meier Estimate; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Retrospective Studies; Risk Factors; Tertiary Care Centers | 2020 |
Carbapenem-resistant Klebsiella pneumonia infection outbreak in a tertiary urology clinic: analysis of influencing factors with a controlled trial
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Disease Outbreaks; Humans; Klebsiella Infections; Klebsiella pneumoniae; Middle Aged; Urinary Tract Infections | 2020 |
Detection of mobile colistin resistance gene mcr-9 in carbapenem-resistant Klebsiella pneumoniae strains of human origin in Europe.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Colistin; Drug Resistance, Bacterial; Europe; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2020 |
Risk factors for Klebsiella pneumoniae carbapenemase (KPC) gene acquisition and clinical outcomes across multiple bacterial species.
Topics: Academic Medical Centers; Adult; Aged; Aged, 80 and over; Bacterial Proteins; beta-Lactamases; Carbapenems; Case-Control Studies; Cross Infection; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Risk Factors; Ubiquitin-Protein Ligases; Virginia | 2020 |
Isoalantolactone restores the sensitivity of gram-negative Enterobacteriaceae carrying MCR-1 to carbapenems.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Carbapenems; Enterobacteriaceae; Escherichia coli; Escherichia coli Infections; Female; Klebsiella Infections; Klebsiella pneumoniae; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Polymyxin B; Sesquiterpenes | 2020 |
Secoeudesma sesquiterpenes lactone A alleviates inflammation and offers adjuvant protection in severe infection of carbapenem-resistant Klebsiella pneumoniae.
Topics: Adjuvants, Immunologic; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Carbapenems; Cytokines; Drug Resistance, Bacterial; Female; Inula; Klebsiella Infections; Klebsiella pneumoniae; Lactones; Lipopolysaccharides; Mice; Mice, Inbred C57BL; RAW 264.7 Cells; Sepsis; Sesquiterpenes | 2020 |
Emergence of clinical isolates of highly carbapenem-resistant Klebsiella pneumoniae co-harboring bla
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Genome, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Nepal; Plasmids; Whole Genome Sequencing | 2020 |
Effect of ramR loss-of-function insertion on tigecycline resistance in clinical isolates of carbapenem-resistant Klebsiella pneumoniae.
Topics: Carbapenems; Drug Resistance, Bacterial; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Middle Aged; Minocycline; Tigecycline | 2020 |
Detection of carbapenem-resistant Klebsiella pneumoniae on the basis of matrix-assisted laser desorption ionization time-of-flight mass spectrometry by using supervised machine learning approach.
Topics: Algorithms; Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cross Infection; DNA, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Predictive Value of Tests; Random Amplified Polymorphic DNA Technique; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Supervised Machine Learning | 2020 |
Risk factors and outcomes for carbapenem-resistant Klebsiella pneumoniae bacteremia in onco-hematological patients.
Topics: Adolescent; Adult; Aged; Bacteremia; Carbapenems; Child; Child, Preschool; China; Female; Hematologic Diseases; Humans; Infant; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Neoplasms; Retrospective Studies; Risk Factors; Young Adult | 2019 |
Whole genome sequencing of carbapenem-resistant
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Disease Outbreaks; Evolution, Molecular; Female; Genome, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Molecular Epidemiology; Multilocus Sequence Typing; Phylogeny; Whole Genome Sequencing; Young Adult | 2020 |
Treatment Outcome of Bacteremia Due to Non-Carbapenemase-producing Carbapenem-Resistant Klebsiella pneumoniae Bacteremia: Role of Carbapenem Combination Therapy.
Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Drug Therapy, Combination; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2020 |
MCR-8 mediated colistin resistance in a carbapenem-resistant Klebsiella pneumoniae isolated from a repatriated patient from Morocco.
Topics: Aged; Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Drug Resistance, Bacterial; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Morocco; Transferases (Other Substituted Phosphate Groups) | 2020 |
Molecular epidemiology of Carbapenem-resistant Klebsiella pneumoniae in a paediatric hospital in China.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; China; Drug Resistance, Bacterial; Female; Hospitals, Pediatric; Humans; Infant; Klebsiella Infections; Klebsiella pneumoniae; Male; Molecular Epidemiology; Multilocus Sequence Typing; Plasmids; Virulence | 2020 |
Prolonged outbreak of New Delhi metallo-beta-lactamase-producing carbapenem-resistant Enterobacterales (NDM-CRE), Tuscany, Italy, 2018 to 2019.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Child; Child, Preschool; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Female; Humans; Infant; Infant, Newborn; Italy; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Young Adult | 2020 |
Investigation of Carbapenem resistance mechanisms in Klebsiella pneumoniae by using phenotypic tests and a molecular assay.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Phenotype | 2019 |
Surveillance of carbapenem-resistant Klebsiella pneumoniae in Chinese hospitals - A five-year retrospective study.
Topics: beta-Lactam Resistance; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; China; Cross Infection; Epidemiological Monitoring; Humans; Klebsiella Infections; Klebsiella pneumoniae; Retrospective Studies; Tertiary Care Centers | 2019 |
Inactivation of mgrB gene regulator and resistance to colistin is becoming endemic in carbapenem-resistant Klebsiella pneumoniae in Greece: A nationwide study from 2014 to 2017.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Greece; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Polymerase Chain Reaction | 2020 |
Multidrug resistance of the extended-spectrum beta-lactamase-producing Klebsiella pneumoniae isolated in Tizi-Ouzou (Algeria).
Topics: Algeria; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Phylogeny | 2019 |
Outbreak of KPC-2-Producing
Topics: Adhesins, Bacterial; Aminoglycosides; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; China; Conjugation, Genetic; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gene Expression; Genome, Bacterial; Hospital Units; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Multilocus Sequence Typing; Neurosurgery; Plasmids; Sulfonamides; Trimethoprim; Whole Genome Sequencing | 2020 |
The Colonization of Carbapenem-Resistant Klebsiella pneumoniae: Epidemiology, Resistance Mechanisms, and Risk Factors in Patients Admitted to Intensive Care Units in China.
Topics: Adult; Aged; Anti-Bacterial Agents; Carbapenems; Case-Control Studies; China; Critical Illness; Drug Resistance, Bacterial; Female; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Multilocus Sequence Typing; Nasopharynx; Prospective Studies; Rectum; Risk Factors; Whole Genome Sequencing | 2020 |
A Retrospective Analysis of Risk Factors and Outcomes of Carbapenem-Resistant Klebsiella pneumoniae Bacteremia in Nontransplant Patients.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Carbapenems; China; Drug Resistance, Multiple, Bacterial; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Retrospective Studies; Risk Factors; Survival Analysis; Time Factors | 2020 |
Characterization of Carbapenemase-Producing
Topics: Academic Medical Centers; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Bosnia and Herzegovina; Carbapenems; Cross Infection; Disease Outbreaks; Gene Expression; Genotype; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Epidemiology; Multilocus Sequence Typing; Phylogeny; Plasmids | 2020 |
Host immunology and rational immunotherapy for carbapenem-resistant Klebsiella pneumoniae infection.
Topics: Animals; Carbapenems; Drug Resistance, Microbial; Immunity, Innate; Interleukin-22; Interleukins; Klebsiella Infections; Klebsiella pneumoniae; Lymphocyte Subsets; Mice, Inbred C57BL; Mice, Knockout | 2020 |
Enhanced survival of ST-11 carbapenem-resistant
Topics: Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Microbial Viability | 2020 |
Allograft hemorrhage as a manifestation of carbapenem-resistant Klebsiella pneumonia infection in kidney transplant recipients: Case series.
Topics: Adult; Allografts; Carbapenems; China; Female; Hemorrhage; Humans; Kidney Transplantation; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Retrospective Studies | 2020 |
The emergence of the hypervirulent Klebsiella pneumoniae (hvKp) strains among circulating clonal complex 147 (CC147) harbouring bla
Topics: Bacterial Capsules; Bacterial Proteins; beta-Lactamases; Carbapenems; DNA Fingerprinting; Drug Resistance, Multiple, Bacterial; Epidemiological Monitoring; Humans; Iran; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Phylogeny; Polymerase Chain Reaction; Tertiary Care Centers; Virulence | 2020 |
Identification of a newly isolated lytic bacteriophage against K24 capsular type, carbapenem resistant Klebsiella pneumoniae isolates.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Biofilms; Biological Therapy; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Disease Models, Animal; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Mice; Phylogeny; Siphoviridae | 2020 |
The determination of gyrA and parC mutations and the prevalence of plasmid-mediated quinolone resistance genes in carbapenem resistant Klebsiella pneumonia ST11 and ST76 strains isolated from patients in Heilongjiang Province, China.
Topics: Aged; Anti-Bacterial Agents; Bacterial Proteins; Carbapenems; China; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bacterial; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Plasmids; Prevalence; Quinolones | 2020 |
Whole genome sequencing characterization of Slovenian carbapenem-resistant Klebsiella pneumoniae, including OXA-48 and NDM-1 producing outbreak isolates.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Disease Outbreaks; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Multilocus Sequence Typing; Plasmids; Slovenia; Whole Genome Sequencing | 2020 |
Characterization of the Genetic Background of KPC-2-Producing
Topics: Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Electrophoresis, Gel, Pulsed-Field; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Multilocus Sequence Typing; Mutagenesis, Insertional; Phylogeny; Porins | 2020 |
Adaptive evolution of virulence and persistence in carbapenem-resistant Klebsiella pneumoniae.
Topics: Adaptation, Biological; Adult; Animals; Bacterial Capsules; beta-Lactam Resistance; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cells, Cultured; Evolution, Molecular; Female; Genome, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Transgenic; Phylogeny; Polymorphism, Single Nucleotide; Urinary Tract Infections; Virulence; Zebrafish | 2020 |
Inappropriate use of carbapenems in an internal medicine ward: Impact of a carbapenem-focused antimicrobial stewardship program.
Topics: Anti-Bacterial Agents; Antimicrobial Stewardship; Carbapenems; Drug Resistance, Bacterial; Hospitals; Humans; Internal Medicine; Klebsiella Infections; Klebsiella pneumoniae | 2020 |
Persuasive antimicrobial stewardship intervention in the context of a KPC outbreak: a controlled interrupted time series analysis.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antimicrobial Stewardship; Carbapenems; Cross Infection; Disease Outbreaks; Female; Humans; Interrupted Time Series Analysis; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Patient Readmission; Tertiary Care Centers; Young Adult | 2020 |
Reduced Susceptibility to Carbapenems in a Klebsiella pneumoniae Clinical Isolate Producing SCO-1 and CTX-M-15 β-Lactamases Together with OmpK35 and OmpK36 Porin Deficiency.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Porins | 2020 |
Molecular epidemiology and drug-resistance mechanisms in carbapenem-resistant Klebsiella pneumoniae isolated in patients from a tertiary hospital in Valencia, Spain.
Topics: Carbapenems; Humans; Klebsiella Infections; Klebsiella pneumoniae; Molecular Epidemiology; Pharmaceutical Preparations; Spain; Tertiary Care Centers | 2020 |
Cross-border spread of
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Disease Outbreaks; Emigration and Immigration; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Whole Genome Sequencing | 2020 |
Genomic characterization of XDR Klebsiella pneumoniae ST147 co-resistant to carbapenem and colistin - The first report in India.
Topics: Carbapenems; Colistin; Genomics; Humans; India; Klebsiella Infections; Klebsiella pneumoniae | 2020 |
Pathogenic spectrum of blood stream infections and resistance pattern in Gram-negative bacteria from Aljouf region of Saudi Arabia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Anti-Bacterial Agents; Bacteremia; Carbapenems; Cross-Sectional Studies; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Saudi Arabia; Young Adult | 2020 |
Management of carbapenem-resistant Klebsiella pneumoniae infection in a patient with diabetic foot ulcer and necrotizing soft tissue infection, bacteremia and lung infection: A case report.
Topics: Aged; Amputation, Surgical; Bacteremia; Carbapenems; Debridement; Diabetic Foot; Drug Resistance, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Leg; Male; Necrosis; Negative-Pressure Wound Therapy; Pneumonia, Bacterial; Soft Tissue Infections | 2020 |
Carbapenem Resistance Conferred by OXA-48 in K2-ST86 Hypervirulent Klebsiella pneumoniae, France.
Topics: Animals; Anti-Bacterial Agents; Carbapenems; France; Humans; Klebsiella Infections; Klebsiella pneumoniae; Mice; Virulence | 2020 |
In Vitro Activity of Ceftazidime/Avibactam Alone and in Combination With Fosfomycin and Carbapenems Against KPC-producing Klebsiella Pneumoniae.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamases; Carbapenems; Ceftazidime; Drug Combinations; Fosfomycin; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2020 |
Detection of several carbapenems resistant and virulence genes in classical and hyper-virulent strains of Klebsiella pneumoniae isolated from hospitalized neonates and adults in Khartoum.
Topics: Adult; beta-Lactam Resistance; Carbapenems; Cross Infection; Female; Genes, Bacterial; Humans; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Sudan; Virulence Factors | 2020 |
Outbreak of KPC-2 Carbapenem-resistant Klebsiella pneumoniae ST76 and Carbapenem-resistant K2 Hypervirulent Klebsiella pneumoniae ST375 strains in Northeast China: molecular and virulent characteristics.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; China; Disease Outbreaks; Electrophoresis, Gel, Pulsed-Field; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Plasmids; Serogroup; Serotyping; Virulence; Whole Genome Sequencing; Young Adult | 2020 |
A public health concern: emergence of carbapenem-resistant Klebsiella pneumoniae in a public transportation environment.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Multilocus Sequence Typing; Public Health; Transportation | 2020 |
Containing Carbapenemase-producing Klebsiella pneumoniae in an endemic setting.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Endemic Diseases; Greece; Humans; Infection Control; Klebsiella Infections; Klebsiella pneumoniae; Prevalence; Tertiary Care Centers | 2020 |
Kpi, a chaperone-usher pili system associated with the worldwide-disseminated high-risk clone
Topics: A549 Cells; Animals; Anti-Bacterial Agents; Bacterial Adhesion; Biofilms; Carbapenems; Cell Line; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Epithelial Cells; Europe; Female; Fimbriae, Bacterial; Gene Deletion; Genes, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Mice; Mice, Inbred BALB C; Molecular Chaperones; Multilocus Sequence Typing; Operon; Phylogeny | 2020 |
Fourier transform infrared (FT-IR) spectroscopy typing: a real-time analysis of an outbreak by carbapenem-resistant Klebsiella pneumoniae.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; beta-Lactamases; Carbapenems; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Multilocus Sequence Typing; Portugal; Spectroscopy, Fourier Transform Infrared | 2020 |
TDM-guided medication of polymyxin B in a patient with CRKP-induced bloodstream infection: a case report.
Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Diagnosis, Differential; Drug Administration Schedule; Drug Resistance, Bacterial; Fever; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Polymyxin B | 2021 |
Prevalence, risk factors and molecular epidemiology of carbapenem-resistant
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; China; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Epidemiology; Prevalence | 2020 |
First description of antimicrobial resistance in carbapenem-susceptible Klebsiella pneumoniae after imipenem treatment, driven by outer membrane remodeling.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Carbapenems; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Fosfomycin; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Phylogeny; Plasmids; Virulence Factors; Whole Genome Sequencing | 2020 |
[Klebsiella pneumoniae Infections in the Intensive Care Unit: Risk Factors Related to Carbapenem Resistance and Patient Mortality].
Topics: Adult; Aged; Aged, 80 and over; Animals; Anti-Bacterial Agents; Carbapenems; Drug Resistance, Bacterial; Female; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Pneumonia; Reproducibility of Results; Retrospective Studies; Risk Factors; Sheep | 2020 |
Carbapenem-Resistant Klebsiella pneumoniae Outbreak in a Neonatal Intensive Care Unit: Risk Factors for Mortality.
Topics: Anti-Bacterial Agents; Carbapenems; Disease Outbreaks; Drug Resistance, Bacterial; Humans; Infant, Newborn; Intensive Care Units; Intensive Care Units, Neonatal; Klebsiella Infections; Klebsiella pneumoniae; Retrospective Studies; Risk Factors | 2021 |
Risk Factors for Acquisition of Carbapenem-Resistant Klebsiella pneumoniae and Mortality Among Abdominal Solid Organ Transplant Recipients with K. pneumoniae Infections.
Topics: Abdomen; Adult; Anti-Bacterial Agents; Carbapenems; Drug Resistance, Bacterial; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Retrospective Studies; Risk Factors; Transplant Recipients | 2020 |
A Ceftazidime-Avibactam-Resistant and Carbapenem-Susceptible Klebsiella pneumoniae Strain Harboring
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Bacterial Proteins; beta-Lactamases; Carbapenems; Ceftazidime; Drug Combinations; Drug Resistance, Multiple, Bacterial; Genome, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; New York City; Plasmids | 2020 |
Successful Treatment of Early Post-Transplant Bloodstream and Pulmonary Infection Caused by Carbapenem-Resistant Klebsiella pneumoniae With a Combination of Ceftazidime-Avibactam and Carbapenem: A Case Report.
Topics: Adult; Anti-Bacterial Agents; Azabicyclo Compounds; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Ceftazidime; Drug Combinations; Drug Therapy, Combination; Female; Humans; Kidney Transplantation; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Respiratory Tract Infections; Sepsis; Transplant Recipients | 2020 |
Neutrophil extracellular traps (NETs)-mediated killing of carbapenem-resistant hypervirulent
Topics: Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cells, Cultured; Diabetes Mellitus, Type 2; Disease Susceptibility; Extracellular Traps; Humans; Immunity, Innate; Klebsiella Infections; Klebsiella pneumoniae; Neutrophils; Phagocytosis | 2020 |
High-risk clones and novel sequence type ST4497 of Klebsiella pneumoniae clinical isolates producing different alleles of NDM-type and other carbapenemases from a single tertiary-care centre in Egypt.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Drug Resistance, Bacterial; Egypt; Humans; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Tertiary Care Centers | 2020 |
Antibacterial activity of Cinnamomum cassia L. essential oil in a carbapenem- and polymyxin-resistant Klebsiella aerogenes strain.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cinnamomum aromaticum; Enterobacter aerogenes; Humans; Klebsiella Infections; Klebsiella pneumoniae; Oils, Volatile; Polymyxins | 2020 |
Epidemiology, mortality and risk factors for patients with K. pneumoniae bloodstream infections: Clinical impact of carbapenem resistance in a tertiary university teaching hospital of Beijing.
Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Drug Resistance, Bacterial; Hospitals, Teaching; Humans; Klebsiella Infections; Klebsiella pneumoniae; Retrospective Studies; Risk Factors; Universities | 2020 |
Komodo-dragon cathelicidin-inspired peptides are antibacterial against carbapenem-resistant
Topics: Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cathelicidins; Colistin; Klebsiella Infections; Klebsiella pneumoniae; Lizards; Microbial Sensitivity Tests; Moths | 2020 |
Risk Factors Affecting Clinical Outcome in Patients with Carbapenem-Resistant K. pneumoniae: A Retrospective Study.
Topics: Aged; Aged, 80 and over; Carbapenems; Drug Resistance, Bacterial; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Retrospective Studies; Risk Factors; Treatment Outcome | 2020 |
Diversity of mucoid to non-mucoid switch among carbapenemase-producing Klebsiella pneumoniae.
Topics: Animals; Anti-Bacterial Agents; Bacterial Capsules; Bacterial Proteins; beta-Lactamases; Biofilms; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Gene Expression Regulation, Bacterial; Genes, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Phenotype; Virulence; Virulence Factors | 2020 |
Dissemination and Stability of the
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Child; Conjugation, Genetic; Drug Resistance, Bacterial; Gene Transfer, Horizontal; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Plasmids | 2020 |
Emergence of carbapenemase-producing and colistin resistant Klebsiella pneumoniae ST101 high-risk clone in Turkey.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Genes, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Epidemiology; Multilocus Sequence Typing; Turkey | 2020 |
Molecular insights of Carbapenem resistance Klebsiella pneumoniae isolates with focus on multidrug resistance from clinical samples.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Multiple; Humans; India; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2021 |
Insertion sequences disrupting mgrB in carbapenem-resistant Klebsiella pneumoniae strains in Brazil.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Brazil; Carbapenems; Colistin; DNA Transposable Elements; Drug Resistance, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2021 |
Clinical impact of cefepime breakpoint in patients with carbapenem-resistant Klebsiella pneumoniae bacteraemia.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cefepime; Drug Therapy, Combination; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged | 2021 |
L-Arginine Enhances Intracellular Killing of Carbapenem-Resistant
Topics: Animals; Arginine; Carbapenems; Klebsiella Infections; Klebsiella pneumoniae; Mice; Neutrophils | 2020 |
Geographical distribution of Enterobacterales with a carbapenemase IMP-6 phenotype and its association with antimicrobial use: An analysis using comprehensive national surveillance data on antimicrobial resistance.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Humans; Imipenem; Japan; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Phenotype | 2020 |
Identification of a Chromosomal Integrated DNA Fragment Containing the
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; DNA Transposable Elements; DNA, Bacterial; Genome, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Multilocus Sequence Typing; Plasmids; Virulence; Virulence Factors | 2020 |
Biofilm Production by Carbapenem-Resistant
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Biofilms; Carbapenems; Drug Resistance, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Middle Aged | 2020 |
Handwashing Sink Contamination and Carbapenem-resistant Klebsiella Infection in the Intensive Care Unit: A Prospective Multicenter Study.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Hand Disinfection; Humans; Intensive Care Units; Klebsiella; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Prospective Studies | 2020 |
[Clinical, epidemiological and microbiological characterization of bacteremia produced by carbapenem-resistant enterobacteria in a university hospital in Córdoba, Argentina].
Topics: Anti-Bacterial Agents; Argentina; Bacteremia; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Enterobacteriaceae; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Retrospective Studies | 2020 |
Performance of VITEK 2, E-test, Kirby-Bauer disk diffusion, and modified Kirby-Bauer disk diffusion compared to reference broth microdilution for testing tigecycline susceptibility of carbapenem-resistant K. pneumoniae and A. baumannii in a multicenter st
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; China; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Tigecycline | 2021 |
Efficacy of loading dose colistin versus carbapenems for treatment of extended spectrum beta lactamase producing Enterobacteriaceae.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cohort Studies; Colistin; Escherichia coli; Escherichia coli Infections; Female; Humans; Kaplan-Meier Estimate; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Retrospective Studies; Treatment Outcome | 2021 |
External validation of INCREMENT-CPE score in a retrospective cohort of carbapenemase-producing Klebsiella pneumoniae bloodstream infections in critically ill patients.
Topics: Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; Carbapenems; Cohort Studies; Critical Illness; Drug Resistance, Multiple, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Reproducibility of Results; Retrospective Studies; Sepsis | 2021 |
[Analysis of related factors of carbapenem resistant Klebsiella pneumoniae infection in patients with artificial airway].
Topics: Anti-Bacterial Agents; Carbapenems; Drug Resistance, Bacterial; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Risk Factors | 2020 |
Characterization of an IncFIB/IncHI1B Plasmid Encoding Efflux Pump TMexCD1-TOprJ1 in a Clinical Tigecycline- and Carbapenem-Resistant Klebsiella pneumoniae Strain.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Carbapenems; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Plasmids; Tigecycline | 2021 |
Proof of the triple prerequisite conditions which are essential for carbapenem resistance development in Klebsiella pneumoniae by using radiation-mediated mutagenesis.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Mutagenesis; Porins; Radiation | 2021 |
Difference in biofilm formation between carbapenem-resistant and carbapenem-sensitive Klebsiella pneumoniae based on analysis of mrkH distribution.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Biofilms; Carbapenems; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2021 |
Ceftazidime/avibactam and eravacycline susceptibility of carbapenem-resistant Klebsiella pneumoniae in two Greek tertiary teaching hospitals.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Bacterial Proteins; beta-Lactamases; Carbapenems; Ceftazidime; Greece; Hospitals, Teaching; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Tetracyclines | 2021 |
TAM mediates adaptation of carbapenem-resistant Klebsiella pneumoniae to antimicrobial stress during host colonization and infection.
Topics: Adaptation, Physiological; Animals; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cell Membrane Permeability; Female; Klebsiella Infections; Klebsiella pneumoniae; Mice; Mice, Inbred C57BL; Proteome; Stress, Physiological | 2021 |
Ceftazidime-avibactam resistance and restoration of carbapenem susceptibility in KPC-producing Klebsiella pneumoniae infections: A case series.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Bacterial Proteins; beta-Lactamases; Carbapenems; Ceftazidime; Drug Combinations; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Retrospective Studies | 2021 |
Multidrug-Resistant Infections and Outcome of Critically Ill Patients with Coronavirus Disease 2019: A Single Center Experience.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Aspirin; Carbapenems; COVID-19; COVID-19 Drug Treatment; Critical Illness; Drug Resistance, Multiple, Bacterial; Female; Hospital Mortality; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Length of Stay; Male; Middle Aged; Opportunistic Infections; Piperacillin, Tazobactam Drug Combination; Pneumonia; Retrospective Studies; SARS-CoV-2; Steroids; Survival Analysis; Treatment Outcome | 2021 |
Polyphasic characterization of carbapenem-resistant Klebsiella pneumoniae clinical isolates suggests vertical transmission of the blaKPC-3 gene.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Conjugation, Genetic; Evolution, Molecular; Humans; Klebsiella Infections; Klebsiella pneumoniae | 2021 |
Systematic Comparison of Epidemic and Non-Epidemic Carbapenem Resistant
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Epidemics; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2021 |
Is Carbapenem-resistant Klebsiella pneumoniae Infection in Pediatric Bone Marrow Transplantation Recipients Inevitably Fatal?
Topics: Adolescent; Anti-Bacterial Agents; Bone Marrow Transplantation; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Child; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2022 |
Molecular characterization of carbapenem-resistant and virulent plasmids in
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; China; Drug Resistance, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Epidemiology; Moths; Phylogeny; Sepsis; Virulence | 2021 |
Prevalence of Carbapenem-Resistant
Topics: beta-Lactamases; Carbapenems; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Multilocus Sequence Typing; Plasmids; Prevalence; Sepsis; Virulence | 2020 |
Mortality-related factors in patients with OXA-48 carbapenemase-producing Klebsiella pneumoniae bacteremia.
Topics: Adult; Anti-Bacterial Agents; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Case-Control Studies; Drug Resistance, Microbial; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Retrospective Studies | 2021 |
Antibacterial activity and carbapenem re-sensitizing ability of 1,10-phenanthroline-5,6-dione and its metal complexes against KPC-producing Klebsiella pneumoniae clinical strains.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Coordination Complexes; Drug Resistance, Multiple, Bacterial; Drug Synergism; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Phenanthrolines | 2021 |
[Genomic subtyping of nosocomial transmission of carbapenem resistant
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cross Infection; Genomics; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Multilocus Sequence Typing; Phylogeny | 2021 |
In vitro and in vivo synergistic effects of tigecycline combined with aminoglycosides on carbapenem-resistant Klebsiella pneumoniae.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Carbapenems; Drug Synergism; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Multilocus Sequence Typing; Rats; Tigecycline | 2021 |
Risk factors and mechanisms of in vivo emergence of colistin resistance in carbapenem-resistant Klebsiella pneumoniae.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; Carbapenems; Colistin; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Membrane Proteins; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Risk Factors; Taiwan; Tertiary Care Centers | 2021 |
Therapeutic Efficacy of Bacteriophage Therapy to Treat Carbapenem Resistant Klebsiella Pneumoniae in Mouse Model.
Topics: Animals; Carbapenems; Klebsiella Infections; Klebsiella pneumoniae; Mice; Nepal; Phage Therapy | 2021 |
Apramycin resistance in epidemic carbapenem-resistant Klebsiella pneumoniae ST258 strains.
Topics: Anti-Bacterial Agents; Carbapenems; Epidemics; Humans; Klebsiella Infections; Klebsiella pneumoniae; Multilocus Sequence Typing; Nebramycin | 2021 |
Clinical characteristics and outcomes of 56 patients with pneumonia caused by carbapenem-resistant Klebsiella pneumoniae.
Topics: Adult; Anti-Bacterial Agents; Carbapenems; Humans; Klebsiella Infections; Klebsiella pneumoniae; Pneumonia; Retrospective Studies; Taiwan | 2021 |
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Klebsiella Infections; Klebsiella pneumoniae; Multilocus Sequence Typing; Netherlands; Plasmids | 2021 |
Healthcare-associated carbapenem-resistant Klebsiella pneumoniae bloodstream infections: Risk factors, mortality, and antimicrobial susceptibility, 2017-2019.
Topics: Anti-Bacterial Agents; Carbapenems; Case-Control Studies; Delivery of Health Care; Humans; Klebsiella Infections; Klebsiella pneumoniae; Risk Factors; Sepsis | 2021 |
Colistin resistance increases 28-day mortality in bloodstream infections due to carbapenem-resistant Klebsiella pneumoniae.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Colistin; Drug Resistance, Bacterial; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Proportional Hazards Models; Retrospective Studies; Sepsis | 2021 |
Emergence of Hypervirulent Carbapenem-Resistant Klebsiella pneumoniae Coharboring a
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Child; Child, Preschool; Egypt; Female; Humans; Infant; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Plasmids; Tertiary Care Centers; Virulence Factors; Young Adult | 2021 |
Resistance evolution of hypervirulent carbapenem-resistant
Topics: Aged; Carbapenems; Drug Resistance, Bacterial; Evolution, Molecular; Frameshift Mutation; High-Throughput Nucleotide Sequencing; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Polymyxins; Tigecycline; Whole Genome Sequencing | 2021 |
Clinical evolution of ST11 carbapenem resistant and hypervirulent Klebsiella pneumoniae.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Genome, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Plasmids; Virulence | 2021 |
An acquired acyltransferase promotes Klebsiella pneumoniae ST258 respiratory infection.
Topics: Acetylation; Acyltransferases; Animals; Bacterial Proteins; Carbapenems; Citric Acid Cycle; Gene Deletion; Glucose; Glycolysis; Klebsiella Infections; Klebsiella pneumoniae; Lipid A; Lung; Lysine; Male; Metabolome; Metabolomics; Mice, Inbred C57BL; Phylogeny; Protein Processing, Post-Translational; Respiratory Tract Infections | 2021 |
Distribution of fluoroquinolone resistance determinants in Carbapenem-resistant Klebsiella pneumoniae clinical isolates associated with bloodstream infections in China.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Carbapenems; China; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Klebsiella Infections; Klebsiella pneumoniae; Multilocus Sequence Typing; Plasmids; Sepsis | 2021 |
Molecular Epidemiology and Drug Resistant Mechanism of Carbapenem-Resistant
Topics: Aged; Bacterial Proteins; beta-Lactamases; Carbapenems; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Epidemiology; Multilocus Sequence Typing; Pharmaceutical Preparations; Respiratory Tract Infections | 2021 |
Colonization with selected antibiotic resistant bacteria among a cohort of Sri Lankan university students.
Topics: Adult; Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cohort Studies; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Klebsiella; Klebsiella Infections; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Sri Lanka; Staphylococcal Infections; Students; Universities; Young Adult | 2021 |
Convergence of carbapenem resistance and hypervirulence leads to high mortality in patients with postoperative Klebsiella pneumoniae meningitis.
Topics: Anti-Bacterial Agents; Carbapenems; Humans; Klebsiella Infections; Klebsiella pneumoniae; Meningitis; Multilocus Sequence Typing | 2021 |
A Sequence Type 23 Hypervirulent
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; China; Humans; Klebsiella Infections; Klebsiella pneumoniae; Mice; Microbial Sensitivity Tests; Plasmids | 2021 |
An Outbreak of Carbapenem-Resistant
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; China; Disease Outbreaks; Hospitals, Teaching; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Multilocus Sequence Typing | 2021 |
Draft genome sequences of two hypermucoviscous carbapenem-resistant ST25 Klebsiella pneumoniae strains causing respiratory and systemic infections.
Topics: Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Humans; Klebsiella Infections; Klebsiella pneumoniae | 2021 |
Amikacin for the treatment of carbapenem-resistant Klebsiella pneumoniae infections: clinical efficacy and toxicity.
Topics: Acute Kidney Injury; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Colistin; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Treatment Outcome; Young Adult | 2021 |
Clinical Characteristics, Risk Factors, and Outcomes of Patients with Polymicrobial
Topics: Adult; Aged; Bacteremia; Carbapenems; Ertapenem; Female; Hospitalization; Humans; Imipenem; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Odds Ratio; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome | 2021 |
Spread of Carbapenem-Resistant Klebsiella pneumoniae in an Intensive Care Unit: A Whole-Genome Sequence-Based Prospective Observational Study.
Topics: Anti-Bacterial Agents; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Prospective Studies; Whole Genome Sequencing | 2021 |
Mobilization of the nonconjugative virulence plasmid from hypervirulent Klebsiella pneumoniae.
Topics: beta-Lactam Resistance; Carbapenems; Computational Biology; Conjugation, Genetic; Escherichia coli; Genome, Bacterial; Klebsiella Infections; Klebsiella pneumoniae; Molecular Sequence Annotation; Plasmids; Polysaccharides, Bacterial; Sequence Analysis, DNA; Virulence; Whole Genome Sequencing | 2021 |
Activity of β-lactam plus β-lactam-enhancer combination cefepime/zidebactam against Klebsiella pneumoniae harbouring defective OmpK35/36 porins and carbapenemases.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Cyclooctanes; Drug Resistance, Multiple, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Mutation; Porins | 2021 |
A Transferable IncC-IncX3 Hybrid Plasmid Cocarrying
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; China; Drug Resistance, Multiple, Bacterial; Enterobacter aerogenes; Escherichia coli Infections; Humans; Klebsiella Infections; Microbial Sensitivity Tests; Plasmids; Tigecycline | 2021 |
Clinical characteristics and risk factors associated with secondary bloodstream infection in patients with intensive care unit-acquired pneumonia due to carbapenem-resistant Klebsiella pneumoniae.
Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Pneumonia; Risk Factors | 2021 |
[Antibiotic resistance and virulence characteristics analysis of a carbapenem-resistant hypervirulent
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Microbial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Multilocus Sequence Typing; Plasmids; Virulence | 2021 |
Treatment of Donor-derived Carbapenem-resistant Klebsiella pneumoniae Infection after Renal Transplantation with Tigecycline and Extended-infusion Meropenem.
Topics: Adolescent; Adult; Bacterial Proteins; beta-Lactamases; Carbapenems; Child; Drug Resistance, Bacterial; Female; Humans; Infant; Kidney Transplantation; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Tigecycline; Tissue Donors; Young Adult | 2021 |
Multiregional dissemination of KPC-producing Klebsiella pneumoniae ST258/ST512 genotypes in Poland, 2010-14.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Disease Outbreaks; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Genotype; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Multilocus Sequence Typing; Plasmids; Poland; Polymerase Chain Reaction | 2017 |
First report of OXA-232-producing Klebsiella pneumoniae strains in Tunisia.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Disk Diffusion Antimicrobial Tests; Humans; Klebsiella Infections; Klebsiella pneumoniae; Multilocus Sequence Typing; Tunisia | 2017 |
Carbapenem resistance in a rural part of southern India:
Topics: beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; India; Klebsiella; Klebsiella Infections; Microbial Sensitivity Tests | 2016 |
Evolution and Transmission of Carbapenem-Resistant Klebsiella pneumoniae Expressing the blaOXA-232 Gene During an Institutional Outbreak Associated With Endoscopic Retrograde Cholangiopancreatography.
Topics: beta-Lactamases; Carbapenems; Cholangiopancreatography, Endoscopic Retrograde; Cross Infection; Disease Outbreaks; Enzyme Activation; Genetic Variation; Genome, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Phylogeny; Plasmids; Whole Genome Sequencing | 2017 |
Management of carbapenem-resistant K. pneumoniae in allogenic stem cell transplant recipients: the Turin bundle.
Topics: Adult; Anti-Bacterial Agents; Carbapenems; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Humans; Italy; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Stem Cell Transplantation | 2017 |
In vitro evaluation of different antimicrobial combinations against carbapenemase-producing Klebsiella pneumoniae: the activity of the double-carbapenem regimen is related to meropenem MIC value.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Colistin; Doripenem; Drug Resistance, Multiple, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Thienamycins | 2017 |
Tigecycline resistance among carbapenem-resistant Klebsiella Pneumoniae: Clinical characteristics and expression levels of efflux pump genes.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Biological Transport; Carbapenems; Drug Resistance, Bacterial; Female; Genes, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Minocycline; Real-Time Polymerase Chain Reaction; Tigecycline; Urinary Tract Infections | 2017 |
Modifiable Risk Factors for the Spread of Klebsiella pneumoniae Carbapenemase-Producing Enterobacteriaceae Among Long-Term Acute-Care Hospital Patients.
Topics: Aged; Bacterial Proteins; beta-Lactamases; Carbapenems; Case-Control Studies; Comorbidity; Cross Infection; Female; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Long-Term Care; Male; Middle Aged; Population Surveillance; Rectum; Risk Factors | 2017 |
Capsular Polysaccharide Types and Virulence-Related Traits of Epidemic KPC-Producing Klebsiella pneumoniae Isolates in a Chinese University Hospital.
Topics: Adult; Aged; Aged, 80 and over; Animals; Anti-Bacterial Agents; Bacterial Capsules; Biofilms; Carbapenems; China; Drug Resistance, Multiple, Bacterial; Female; Hospitals, University; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Middle Aged; Moths; Multilocus Sequence Typing; Phylogeny; Polysaccharides, Bacterial; Serogroup; Virulence | 2017 |
Carbapenem-Resistant Klebsiella Pneumoniae Infections Early After Liver Transplantation: A Single-Center Experience.
Topics: Adult; Anti-Bacterial Agents; Carbapenems; Drug Resistance, Bacterial; Female; Humans; Incidence; Intensive Care Units; Klebsiella Infections; Liver Transplantation; Male; Middle Aged; Odds Ratio; Retrospective Studies; Risk Factors | 2017 |
Emergence and nosocomial spread of carbapenem-resistant OXA-232-producing Klebsiella pneumoniae in Brunei Darussalam.
Topics: beta-Lactam Resistance; beta-Lactamases; Brunei; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Conjugation, Genetic; Disease Outbreaks; Gene Order; Gene Transfer, Horizontal; Genotype; Humans; Klebsiella Infections; Klebsiella pneumoniae; Molecular Epidemiology; Multilocus Sequence Typing; Plasmids; Random Amplified Polymorphic DNA Technique; Sequence Analysis, DNA | 2017 |
NDM-5 and OXA-181 Beta-Lactamases, a Significant Threat Continues To Spread in the Americas.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Humans; India; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Plasmids | 2017 |
Clinical and Molecular Epidemiology of Carbapenem-Resistant Enterobacteriaceae Among Adult Inpatients in Singapore.
Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cross Infection; DNA, Bacterial; Electronic Health Records; Enterobacter cloacae; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Female; Genome, Bacterial; High-Throughput Nucleotide Sequencing; Humans; Incidence; Inpatients; Klebsiella Infections; Klebsiella pneumoniae; Male; Surveys and Questionnaires; Young Adult | 2017 |
Anti-Restriction Protein, KlcA
Topics: Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; China; Escherichia coli; Gene Transfer, Horizontal; Genes, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Epidemiology; Multilocus Sequence Typing; Plasmids; Recombinant Proteins; Retrospective Studies; Sequence Alignment; Sequence Analysis, DNA; Transformation, Genetic; Viral Proteins | 2017 |
Oral gentamicin therapy for Carbapenem-resistant Klebsiella pneumoniae gut colonization in hematologic patients: a single center experience.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Drug Resistance, Bacterial; Female; Gentamicins; Hematologic Diseases; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Rectum | 2017 |
Roles of
Topics: Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Drug Resistance, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Membrane Transport Proteins; Microbial Sensitivity Tests; Minocycline; Multidrug Resistance-Associated Proteins; Mutation; Plasmids; Tetracycline Resistance; Tigecycline; Trans-Activators | 2017 |
Carbapenem-resistant Klebsiella pneumoniae in Barbados: Driving change in practice at the national level.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Barbados; Carbapenems; Caribbean Region; Case-Control Studies; Child; Child, Preschool; Cross-Sectional Studies; Female; Humans; Infant; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Longitudinal Studies; Male; Middle Aged; Prevalence; Risk Factors; Young Adult | 2017 |
Ceftazidime-Avibactam Is Superior to Other Treatment Regimens against Carbapenem-Resistant Klebsiella pneumoniae Bacteremia.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Azabicyclo Compounds; Bacteremia; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Ceftazidime; Drug Combinations; Drug Resistance, Multiple, Bacterial; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Treatment Outcome | 2017 |
Peptide Markers for Rapid Detection of KPC Carbapenemase by LC-MS/MS.
Topics: Bacterial Proteins; beta-Lactamases; Carbapenems; Chromatography, Liquid; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Peptides; Tandem Mass Spectrometry | 2017 |
Epidemiology of Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infections in a Chinese Children's Hospital: Predominance of New Delhi Metallo-β-Lactamase-1.
Topics: Adolescent; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Blood Culture; Carbapenems; Child; Child, Preschool; China; Drug Resistance, Multiple, Bacterial; Female; Gene Expression Regulation, Bacterial; Hospitals, Pediatric; Humans; Isoenzymes; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Multilocus Sequence Typing; Plasmids; Survival Analysis | 2018 |
Molecular characterization of clinical IMP-producing Klebsiella pneumoniae isolates from a Chinese Tertiary Hospital.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Humans; Inosine Monophosphate; Klebsiella Infections; Klebsiella pneumoniae; Plasmids; Tertiary Care Centers | 2017 |
Lipid peroxidation in Gram-negative bacteremia modulates the risk for septic shock and infections by resistant Klebsiella pneumoniae.
Topics: Aged; Anti-Bacterial Agents; Antioxidants; Bacteremia; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Lipid Peroxidation; Male; Malondialdehyde; Neutrophils; Prospective Studies; Risk Factors; Shock, Septic | 2017 |
First description of methyltransferases in extensively drug-resistant Klebsiella pneumoniae isolates from Saudi Arabia.
Topics: Aminoglycosides; Anti-Bacterial Agents; Carbapenems; DNA, Bacterial; Drug Resistance, Bacterial; Fluoroquinolones; Genotype; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Methyltransferases; Molecular Typing; Polymerase Chain Reaction; Saudi Arabia; Sequence Analysis, DNA | 2017 |
Impact of appropriateness of empiric therapy on outcomes in community-onset bacteremia by extended-spectrum-β-lactamase producing Escherichia coli and Klebisella pneumoniae definitively treated with carbapenems.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; Carbapenems; Community-Acquired Infections; Escherichia coli; Escherichia coli Infections; Female; Humans; Inappropriate Prescribing; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Retrospective Studies | 2017 |
Multidrug Resistance Mechanisms of Carbapenem Resistant Klebsiella pneumoniae Strains Isolated in Chongqing, China.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; China; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Multilocus Sequence Typing; Plasmids | 2017 |
Resolution of Carbapenemase-Producing Klebsiella pneumoniae Outbreak in a Tertiary Cancer Center; the Role of Active Surveillance.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Disease Outbreaks; Drug Resistance, Bacterial; Epidemiological Monitoring; Humans; Klebsiella Infections; Klebsiella pneumoniae; Maryland; Tertiary Care Centers | 2017 |
ST37 Klebsiella pneumoniae: development of carbapenem resistance in vivo during antimicrobial therapy in neonates.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Chi-Square Distribution; DNA, Bacterial; Humans; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Multilocus Sequence Typing; Treatment Outcome | 2017 |
A Long-Term Study of the Diversity of OXA-48-Like Carbapenemase-Producing Bacterial Strains in Infected Patients and Carriers.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Carrier State; DNA Fingerprinting; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; France; Gene Expression; Genetic Variation; Hospitals; Humans; Isoenzymes; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Phylogeny; Plasmids | 2018 |
Clinical outcomes associated with carbapenem resistant Klebsiella pneumoniae (CRKP) in abdominal solid organ transplant (SOT) recipients.
Topics: Carbapenems; Enterobacteriaceae; Humans; Incidence; Kidney Transplantation; Klebsiella Infections; Klebsiella pneumoniae; Risk Factors; Urinary Tract Infections | 2018 |
Prevalence of a New Variant OXA-204 and OXA-48 Carbapenemases Plasmids Encoded in Klebsiella pneumoniae Clinical Isolates in Tunisia.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cross Infection; Electrophoresis, Gel, Pulsed-Field; Gene Expression Regulation, Bacterial; Hospitals, Military; Humans; Isoenzymes; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Phylogeny; Plasmids; Prevalence; Tunisia | 2018 |
Molecular epidemiology of carbapenem-resistant Klebsiella pneumoniae at a Turkish centre: Is the increase of resistance a threat for Europe?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Child; Child, Preschool; Cross Infection; Europe; Female; Hospitalization; Hospitals; Humans; Infant; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Epidemiology; Turkey; Young Adult | 2017 |
In-vivo loss of carbapenem resistance by extensively drug-resistant Klebsiella pneumoniae during treatment via porin expression modification.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cephalosporins; Drug Resistance, Multiple, Bacterial; Female; Gene Expression Regulation, Bacterial; Genome, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Middle Aged; Mutation; Nitrobenzenes; Penicillins; Porins; Tetracyclines; Urinary Tract Infections | 2017 |
Emergence of low virulent carbapenem-resistant hypermucoviscous Klebsiella pneumoniae in China.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; China; Humans; Klebsiella Infections; Klebsiella pneumoniae | 2017 |
Molecular epidemiology of Klebsiella pneumoniae invasive infections over a decade at Kilifi County Hospital in Kenya.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Community-Acquired Infections; Cross Infection; Disease Outbreaks; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Hospitals, County; Kenya; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Epidemiology; Multilocus Sequence Typing; Phylogeny; R Factors; Rural Population | 2017 |
Successful containment of the first KPC-producing Klebsiella pneumoniae outbreak in Croatia.
Topics: Bacterial Proteins; Bacterial Typing Techniques; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Croatia; Disease Outbreaks; DNA, Bacterial; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Genes, Bacterial; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Epidemiology; Multilocus Sequence Typing; Polymerase Chain Reaction | 2017 |
Impact of carbapenem-resistant Klebsiella pneumoniae (CR-KP) infections in kidney transplantation.
Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Delayed Graft Function; Disease Outbreaks; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Survival; Humans; Incidence; Italy; Kaplan-Meier Estimate; Kidney Transplantation; Klebsiella Infections; Klebsiella pneumoniae; Length of Stay; Male; Matched-Pair Analysis; Middle Aged; Retrospective Studies; Sepsis | 2017 |
IncX3 plasmid harboring a non-Tn4401 genetic element (NTE
Topics: Anti-Bacterial Agents; Base Sequence; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Humans; Interspersed Repetitive Sequences; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Plasmids; Polymyxins; Sequence Analysis, DNA | 2017 |
Clinical outcome of dual colistin- and carbapenem-resistant Klebsiella pneumoniae bloodstream infections: A single-center retrospective study of 75 cases in India.
Topics: Anti-Bacterial Agents; Bacteremia; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Female; Humans; India; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Treatment Outcome | 2017 |
A Semi-Synthetic Glycoconjugate Vaccine Candidate for Carbapenem-Resistant Klebsiella pneumoniae.
Topics: Animals; Anti-Bacterial Agents; Antibodies, Bacterial; Bacterial Vaccines; Carbapenems; Drug Resistance, Bacterial; Enzyme-Linked Immunosorbent Assay; Glycoconjugates; Klebsiella Infections; Klebsiella pneumoniae; Mice; Oligosaccharides; Phagocytosis; Rabbits; Vaccines, Synthetic | 2017 |
Effect of combination therapy containing a high-dose carbapenem on mortality in patients with carbapenem-resistant Klebsiella pneumoniae bloodstream infection.
Topics: Aged; Bacteremia; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Colistin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Gentamicins; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Minocycline; Propensity Score; Tertiary Care Centers; Tigecycline; Treatment Outcome | 2018 |
Emergence of NDM-1 among carbapenem-resistant Klebsiella pneumoniae in Iraqi hospitals.
Topics: beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Humans; Iraq; Klebsiella Infections; Klebsiella pneumoniae; Phylogeny | 2018 |
Convergence of carbapenem-resistance and hypervirulence in Klebsiella pneumoniae.
Topics: Carbapenems; Disease Outbreaks; Epidemiologic Studies; Humans; Klebsiella Infections; Klebsiella pneumoniae | 2018 |
NDM-1 Hazard in the Balkan States: Evidence of the First Outbreak of NDM-1-Producing Klebsiella pneumoniae in Bulgaria.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Bulgaria; Carbapenems; Clone Cells; Disease Outbreaks; Electrophoresis, Gel, Pulsed-Field; Gene Expression; Genotype; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Multilocus Sequence Typing; Plasmids | 2018 |
Letter to the Editor: Surveillance of mcr-1 and mcr-2 genes in Carbapenem-resistant Klebsiella pneumoniae strains from an Italian Hospital.
Topics: Anti-Bacterial Agents; Carbapenems; Colistin; Humans; Italy; Klebsiella Infections; Klebsiella pneumoniae | 2017 |
Infection control interventions affected by resource shortages: impact on the incidence of bacteremias caused by carbapenem-resistant pathogens.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Female; Germany; Humans; Infection Control; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Tertiary Care Centers | 2018 |
Nosocomial, Multidrug-Resistant Klebsiella pneumoniae Strains Isolated from Mexico City Produce Robust Biofilms on Abiotic Surfaces but Not on Human Lung Cells.
Topics: Adhesins, Bacterial; Anti-Bacterial Agents; Bacterial Proteins; Biofilms; Carbapenems; Cells, Cultured; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Fimbriae, Bacterial; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Mexico; Virulence | 2018 |
Stalking a lethal superbug by whole-genome sequencing and phylogenetics: Influence on unraveling a major hospital outbreak of carbapenem-resistant Klebsiella pneumoniae.
Topics: Carbapenems; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Genome, Bacterial; Germany; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Molecular Epidemiology; Phylogeny; Retrospective Studies | 2018 |
Identification of Carbapenem-Resistant Klebsiella pneumoniae with Emphasis on New Delhi Metallo-Beta-Lactamase-1 (bla
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Humans; Iran; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Multilocus Sequence Typing | 2018 |
Application of "Precision Medicine" Through the Molecular Characterization of Extensively Drug-Resistant Klebsiella pneumoniae in a Multivisceral Transplant Patient.
Topics: Adult; Anti-Bacterial Agents; Antibiotic Prophylaxis; Carbapenems; Drug Resistance, Multiple, Bacterial; Ertapenem; Female; Fosfomycin; Humans; Intestines; Kidney Transplantation; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Postoperative Complications; Precision Medicine | 2017 |
Colistin Resistance in Carbapenem-Resistant Klebsiella pneumoniae: De Novo or Drug Exposure?
Topics: Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Colistin; Humans; Klebsiella Infections; Klebsiella pneumoniae | 2017 |
Whole genome sequencing for the molecular characterization of carbapenem-resistant Klebsiella pneumoniae strains isolated at the Italian ASST Fatebenefratelli Sacco Hospital, 2012-2014.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Colistin; Drug Resistance, Bacterial; Fluoroquinolones; Genome, Bacterial; Genotype; Hospitals; Humans; Italy; Klebsiella Infections; Klebsiella pneumoniae; Multilocus Sequence Typing; Polymorphism, Single Nucleotide; Whole Genome Sequencing | 2017 |
The Transmissibility of Antibiotic-Resistant Enterobacteriaceae in Intensive Care Units.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cephalosporins; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Europe; Humans; Intensive Care Units; Klebsiella Infections; Longitudinal Studies; Microbial Sensitivity Tests; Models, Theoretical; Prospective Studies | 2018 |
[Molecular epidemiology of carbapenem resistant
Topics: Anti-Bacterial Agents; Beijing; Carbapenems; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Molecular Epidemiology; Multilocus Sequence Typing | 2017 |
Virulence Characteristics of Carbapenem-Resistant Klebsiella pneumoniae Strains from Patients with Necrotizing Skin and Soft Tissue Infections.
Topics: Adult; Aged; Animals; Carbapenems; Drug Resistance, Bacterial; Female; Genotype; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Mice; Mice, Inbred C57BL; Middle Aged; Phagocytosis; Pneumonia; Retrospective Studies; Skin Diseases; Soft Tissue Infections; Virulence | 2017 |
First case of New Delhi metallo-β-lactamase in Klebsiella pneumoniae from Ecuador: An update for South America.
Topics: Adult; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Ecuador; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; R Factors | 2017 |
Emergence of carbapenem-resistant hypervirulent Klebsiella pneumoniae.
Topics: Carbapenems; Disease Outbreaks; Epidemiologic Studies; Humans; Klebsiella Infections; Klebsiella pneumoniae | 2018 |
Emergence of carbapenem-resistant hypervirulent Klebsiella pneumoniae.
Topics: Carbapenems; Disease Outbreaks; Epidemiologic Studies; Humans; Klebsiella Infections; Klebsiella pneumoniae | 2018 |
Persistent carbapenem-resistant Klebsiella pneumoniae: a Trojan horse.
Topics: Carbapenems; Disease Outbreaks; Epidemiologic Studies; Humans; Klebsiella Infections; Klebsiella pneumoniae | 2018 |
Emergence of carbapenem-resistant hypervirulent Klebsiella pneumoniae.
Topics: Carbapenems; Disease Outbreaks; Epidemiologic Studies; Humans; Klebsiella Infections; Klebsiella pneumoniae | 2018 |
Clinical factors predicting persistent carriage of Klebsiella pneumoniae carbapenemase-producing carbapenem-resistant Enterobacteriaceae among patients with known carriage.
Topics: Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Carrier State; Female; Hospitalization; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Patient Readmission; Retrospective Studies; Risk Factors | 2018 |
Spread of Klebsiella pneumoniae ST395 non-susceptible to carbapenems and resistant to fluoroquinolones in North-Eastern France.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; France; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Multilocus Sequence Typing; Plasmids; R Factors | 2018 |
Acquisition of the mcr-1 gene by a high-risk clone of KPC-2-producing Klebsiella pneumoniae ST437/CC258, Brazil.
Topics: Anti-Bacterial Agents; beta-Lactamases; Brazil; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2018 |
Findings from an outbreak of carbapenem-resistant Klebsiella pneumoniae emphasize the role of antibiotic treatment for cross transmission.
Topics: Adult; Aged; Aged, 80 and over; beta-Lactamases; Carbapenems; Cross Infection; Disease Outbreaks; Drug Resistance, Bacterial; Female; Germany; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Risk Factors | 2018 |
Insertion sequence transpositions and point mutations in mgrB causing colistin resistance in a clinical strain of carbapenem-resistant Klebsiella pneumoniae from Vietnam.
Topics: Bacterial Proteins; Carbapenems; Colistin; DNA Transposable Elements; Drug Resistance, Multiple, Bacterial; Hospitals, Pediatric; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Point Mutation; Vietnam | 2018 |
Emergence of an MDR Klebsiella pneumoniae ST231 producing OXA-232 and RmtF in Switzerland.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Switzerland; Whole Genome Sequencing | 2018 |
Epidemiology of Carbapenem-Resistant Enterobacteriaceae Infections: Report from the China CRE Network.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; China; Citrobacter freundii; Enterobacter cloacae; Enterobacteriaceae Infections; Escherichia coli; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Polymyxin B; Urinary Tract Infections | 2018 |
Treatment outcome of non-carbapenemase-producing carbapenem-resistant Klebsiella pneumoniae infections: a multicenter study in Taiwan.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Female; Hospitalization; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Retrospective Studies; Risk Factors; Taiwan; Treatment Outcome | 2018 |
Colistin- and carbapenem-resistant Klebsiella pneumoniae carrying mcr-1 and blaOXA-48 isolated at a paediatric hospital in Vietnam.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Colistin; Drug Resistance, Bacterial; Hospitals, Pediatric; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Multilocus Sequence Typing; Polymerase Chain Reaction; Polymorphism, Single Nucleotide; Vietnam; Whole Genome Sequencing | 2018 |
Hospital Outbreak of a Colistin-Resistant, NDM-1- and OXA-48-Producing Klebsiella pneumoniae: High Mortality from Pandrug Resistance.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Colistin; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Escherichia coli Proteins; Female; Hospitals; Humans; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Multilocus Sequence Typing; Plasmids; Young Adult | 2018 |
To Use, or Not to Use Carbapenem When Extended-spectrum β-lactamase (ESBL)-producing Bacteria Are Isolated from Sputum Cultures, That Is the Question.
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactamases; Carbapenems; Humans; Klebsiella Infections; Sputum | 2018 |
Risk Factors for Carbapenem-resistant
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Carbapenems; Case-Control Studies; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Logistic Models; Male; Middle Aged; Odds Ratio; Pneumonia, Bacterial; Risk Factors | 2018 |
Emergence and establishment of KPC-2-producing ST11 Klebsiella pneumoniae in a general hospital in Shanghai, China.
Topics: Aged; Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; China; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Genome, Bacterial; Hospitals, General; Humans; Infant; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Multilocus Sequence Typing; Plasmids; Primary Prevention; Sequence Analysis, DNA | 2018 |
Risk factors, outcomes and genotypes of carbapenem-nonsusceptible Klebsiella pneumoniae bloodstream infection: a three-year retrospective study in a large tertiary hospital in Northern China.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; China; Drug Resistance, Bacterial; Female; Genes, Bacterial; Genome, Bacterial; Genotype; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Retrospective Studies; Risk Factors; Tertiary Care Centers | 2018 |
Trends in Resistance to Extended-Spectrum Cephalosporins and Carbapenems among Escherichia coli and Klebsiella spp. Isolates in a District in Western India during 2004-2014.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cephalosporins; Drug Resistance, Microbial; Escherichia coli; Escherichia coli Infections; Female; Humans; India; Klebsiella; Klebsiella Infections; Male; Microbial Sensitivity Tests | 2018 |
An Outbreak of NDM-1-Producing Klebsiella pneumoniae, Associated with OmpK35 and OmpK36 Porin Loss in Tunisia.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Disease Outbreaks; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Plasmids; Porins; Tunisia | 2018 |
Outbreak of ST395 KPC-Producing Klebsiella pneumoniae in a Neonatal Intensive Care Unit in Palermo, Italy.
Topics: Bacteriological Techniques; beta-Lactam Resistance; Carbapenems; Disease Outbreaks; Humans; Infection Control; Intensive Care Units, Neonatal; Italy; Klebsiella Infections; Klebsiella pneumoniae | 2018 |
Evaluation of Sensititre Broth Microdilution Plate for determining the susceptibility of carbapenem-resistant Klebsiella pneumoniae to polymyxins.
Topics: Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Colistin; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Polymyxin B | 2018 |
Global survey of Klebsiella pneumoniae major porins from ertapenem non-susceptible isolates lacking carbapenemases.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenems; DNA, Bacterial; Electrophoresis, Polyacrylamide Gel; Ertapenem; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Mutation; Porins | 2018 |
Carbapenem-Resistant
Topics: Animals; Carbapenems; Colistin; Disease Models, Animal; Drug Resistance, Bacterial; Enterobacteriaceae; Klebsiella Infections; Klebsiella pneumoniae; Mice; Polymyxins | 2018 |
Tracking Multidrug-Resistant Klebsiella pneumoniae from an Italian Hospital: Molecular Epidemiology and Surveillance by PFGE, RAPD and PCR-Based Resistance Genes Prevalence.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Humans; Infant, Newborn; Intensive Care Units; Italy; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Epidemiology; Polymerase Chain Reaction; Random Amplified Polymorphic DNA Technique; Young Adult | 2018 |
Molecular epidemiology and drug resistant mechanism in carbapenem-resistant Klebsiella pneumoniae isolated from pediatric patients in Shanghai, China.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Child; Child, Preschool; China; Drug Resistance, Multiple, Bacterial; Female; Humans; Infant; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Molecular Epidemiology; Multilocus Sequence Typing | 2018 |
Long-Term Impact of Universal Contact Precautions on Rates of Multidrug-Resistant Organisms in ICUs: A Comparative Effectiveness Study.
Topics: Academic Medical Centers; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Gram-Positive Bacterial Infections; Humans; Infection Control; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Methicillin-Resistant Staphylococcus aureus; New York City; Retrospective Studies; Staphylococcal Infections; Universal Precautions; Vancomycin-Resistant Enterococci | 2018 |
Dissemination of carbapenem-resistant Klebsiella pneumoniae harboring KPC-carrying plasmid pKPC_P16, a pKPC_LK30 variant, in northern Taiwan.
Topics: beta-Lactam Resistance; Carbapenems; Cross-Sectional Studies; Genotype; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Molecular Epidemiology; Molecular Typing; Plasmids; Prevalence; Sequence Analysis, DNA; Taiwan | 2018 |
Duodenoscope-Related Outbreak of a Carbapenem-Resistant Klebsiella pneumoniae Identified Using Advanced Molecular Diagnostics.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Case-Control Studies; Cholangiopancreatography, Endoscopic Retrograde; Cross Infection; Disease Outbreaks; Disinfection; Duodenoscopes; Equipment Contamination; Female; Humans; India; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Pathology, Molecular; Young Adult | 2017 |
Sequence Type 273 Carbapenem-Resistant Klebsiella pneumoniae Carrying
Topics: Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; High-Throughput Nucleotide Sequencing; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Pancreatitis; Plasmids; Whole Genome Sequencing | 2018 |
Sequencing of pT5282-CTXM, p13190-KPC and p30860-NR, and comparative genomics analysis of IncX8 plasmids.
Topics: Aminoglycosides; Anti-Bacterial Agents; Base Sequence; beta-Lactamases; Carbapenems; Cephalosporins; DNA Transposable Elements; Drug Resistance, Multiple, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Evolution, Molecular; Fluoroquinolones; Gene Expression; Genetic Variation; Genomics; High-Throughput Nucleotide Sequencing; Humans; Klebsiella Infections; Klebsiella pneumoniae; Multigene Family; Penicillins; Phylogeny; Plasmids; Replicon | 2018 |
Liver Transplantation and Gut Microbiota Profiling in a Child Colonized by a Multi-Drug Resistant
Topics: Anti-Bacterial Agents; Carbapenems; Drug Resistance, Bacterial; Female; Gastrointestinal Microbiome; Humans; Infant; Klebsiella Infections; Klebsiella pneumoniae; Liver Transplantation; Postoperative Complications | 2018 |
Clonal diversity and genetic profiling of antibiotic resistance among multidrug/carbapenem-resistant Klebsiella pneumoniae isolates from a tertiary care hospital in Saudi Arabia.
Topics: Bacterial Proteins; Bacterial Typing Techniques; beta-Lactamases; Carbapenems; Conjugation, Genetic; Drug Resistance, Multiple, Bacterial; Escherichia coli; Genetic Variation; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Multilocus Sequence Typing; Phylogeny; Saudi Arabia; Tertiary Care Centers | 2018 |
Clinical and molecular epidemiologic characteristics of carbapenem-resistant Klebsiella pneumoniae infection/colonization among neonates in China.
Topics: Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Carrier State; China; Drug Therapy, Combination; Female; Fosfomycin; Hospitals, Pediatric; Humans; Infant; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Retrospective Studies; Treatment Outcome | 2018 |
Fighting Antibiotic-Resistant Klebsiella pneumoniae with "Sweet" Immune Targets.
Topics: Animals; Anti-Bacterial Agents; Antibodies, Monoclonal; Candy; Carbapenems; Humans; Klebsiella Infections; Klebsiella pneumoniae; Mice | 2018 |
Emergence of an XDR and carbapenemase-producing hypervirulent Klebsiella pneumoniae strain in Taiwan.
Topics: Aged, 80 and over; Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Female; Genotype; Humans; Klebsiella Infections; Klebsiella pneumoniae; Mice; Mice, Inbred C57BL; Multilocus Sequence Typing; Phylogeny; Plasmids; Polymorphism, Single Nucleotide; Taiwan; Tigecycline; Virulence | 2018 |
Risk factors for carbapenem-resistant K. pneumoniae bloodstream infection and predictors of mortality in Chinese paediatric patients.
Topics: Adolescent; Anti-Bacterial Agents; Bacteremia; Carbapenems; Case-Control Studies; Child; Child Mortality; Child, Preschool; China; Drug Resistance, Multiple, Bacterial; Female; Humans; Infant; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Male; Prognosis; Retrospective Studies; Risk Factors; Survival Analysis | 2018 |
Whole genome sequence revealed the fine transmission map of carbapenem-resistant
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; China; Critical Care; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Genome, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Multilocus Sequence Typing; Retrospective Studies; Whole Genome Sequencing | 2018 |
Resistome of carbapenem- and colistin-resistant Klebsiella pneumoniae clinical isolates.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Carbapenems; Colistin; DNA Restriction Enzymes; DNA, Bacterial; Drug Resistance, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Typing; Plasmids; Whole Genome Sequencing | 2018 |
Antimicrobial susceptibility and microbiological and epidemiological characteristics of hypermucoviscous Klebsiella pneumoniae strains in a tertiary hospital in Hangzhou, China.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; China; Humans; Klebsiella Infections; Klebsiella pneumoniae; Multilocus Sequence Typing; Tertiary Care Centers | 2018 |
Emergence of tet(A) and bla
Topics: Animals; Antiporters; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Feces; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Plasmids; Tigecycline | 2018 |
Evolution of tigecycline- and colistin-resistant CRKP (carbapenem-resistant Klebsiella pneumoniae) in vivo and its persistence in the GI tract.
Topics: Adult; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Carbapenems; Caspofungin; Colistin; Diarrhea; Drug Resistance, Bacterial; Echinocandins; Feces; Gastrointestinal Tract; Humans; Klebsiella Infections; Klebsiella pneumoniae; Leukemia, Monocytic, Acute; Lipopeptides; Male; Microbial Sensitivity Tests; Minocycline; Tigecycline; Treatment Outcome | 2018 |
Carbapenem non-susceptibility of
Topics: Adult; Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Colistin; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Gentamicins; Germany; Hospitals; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Tertiary Care Centers; Tigecycline; Trimethoprim, Sulfamethoxazole Drug Combination; Young Adult | 2018 |
The emergence of bla
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Child; Child, Preschool; Cross Infection; Drug Resistance, Bacterial; Female; Humans; Infant; Iran; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Tertiary Care Centers; Young Adult | 2018 |
Evaluation of ComASP™ Colistin (formerly SensiTest™ Colistin), a commercial broth microdilution-based method to evaluate the colistin minimum inhibitory concentration for carbapenem-resistant Klebsiella pneumoniae isolates.
Topics: Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2018 |
Implementing an infection control and prevention program decreases the incidence of healthcare-associated infections and antibiotic resistance in a Russian neuro-ICU.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Anti-Bacterial Agents; Carbapenems; Child; Cross Infection; Drug Resistance, Bacterial; Female; Humans; Incidence; Infection Control; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Prospective Studies; Russia; Young Adult | 2018 |
In Vitro Bactericidal Activity of Trimethoprim-Sulfamethoxazole/Colistin Combination Against Carbapenem-Resistant Klebsiella pneumoniae Clinical Isolates.
Topics: Anti-Bacterial Agents; Carbapenems; China; Colistin; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Epidemiology; Trimethoprim, Sulfamethoxazole Drug Combination | 2019 |
Carbapenem Resistance Caused by High-Level Expression of OXA-663 β-Lactamase in an OmpK36-Deficient Klebsiella pneumoniae Clinical Isolate.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Porins | 2018 |
Evaluation of rapid polymyxin NP test to detect colistin-resistant Klebsiella pneumoniae isolated in a tertiary Greek hospital.
Topics: Anti-Bacterial Agents; Automation, Laboratory; Bacterial Proteins; beta-Lactamases; Carbapenems; Colistin; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial; False Positive Reactions; Greece; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Polymyxins; Sensitivity and Specificity; Tertiary Care Centers | 2018 |
Related carbapenemase-producing Klebsiella isolates detected in both a hospital and associated aquatic environment in Sweden.
Topics: Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Genotype; Hospitals; Humans; Klebsiella Infections; Klebsiella oxytoca; Klebsiella pneumoniae; Microbial Sensitivity Tests; Phenotype; Phylogeny; Rivers; Sweden; Wastewater; Water Microbiology; Whole Genome Sequencing | 2018 |
Carbapenem-Sparing Therapy for Extended-Spectrum β-Lactamase-Producing E coli and Klebsiella pneumoniae Bloodstream Infection: The Search Continues.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2018 |
Increased Relative Abundance of Klebsiella pneumoniae Carbapenemase-producing Klebsiella pneumoniae Within the Gut Microbiota Is Associated With Risk of Bloodstream Infection in Long-term Acute Care Hospital Patients.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Female; Gastrointestinal Microbiome; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Longitudinal Studies; Male; Middle Aged; Proportional Hazards Models; ROC Curve | 2019 |
Mortality attributable to different Klebsiella susceptibility patterns and to the coverage of empirical antibiotic therapy: a cohort study on patients admitted to the ICU with infection.
Topics: Adult; Aged; Anti-Bacterial Agents; Carbapenems; Cohort Studies; Female; Humans; Intensive Care Units; Italy; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged | 2018 |
Colistin- and Carbapenem-Resistant Klebsiella pneumoniae Clinical_Isolates: Algeria.
Topics: Algeria; Amino Acid Substitution; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Colistin; Drug Resistance, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2019 |
A comparison of pyogenic liver abscess in patients with or without diabetes: a retrospective study of 246 cases.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Alkaline Phosphatase; Anti-Bacterial Agents; Blood Glucose; Carbapenems; Child; Child, Preschool; Diabetes Complications; Female; gamma-Glutamyltransferase; Humans; Hypertension; Klebsiella Infections; Klebsiella pneumoniae; Liver Abscess, Pyogenic; Male; Middle Aged; Retrospective Studies; Weight Loss; Young Adult | 2018 |
Genomic Characterization of Carbapenemase-Producing Klebsiella pneumoniae with Chromosomally Carried
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Chromosome Mapping; Chromosomes, Bacterial; DNA Transposable Elements; Gene Expression; Genome, Bacterial; Homologous Recombination; Humans; Klebsiella Infections; Klebsiella pneumoniae; Mutagenesis, Insertional; Plasmids; Thailand; Transposases | 2018 |
Molecular Epidemiology and Drug Resistance Pattern of Carbapenem-Resistant Klebsiella pneumoniae Isolates from Iran.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Colistin; Drug Resistance; Humans; Iran; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Epidemiology | 2019 |
Applying Rapid Whole-Genome Sequencing To Predict Phenotypic Antimicrobial Susceptibility Testing Results among Carbapenem-Resistant Klebsiella pneumoniae Clinical Isolates.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cohort Studies; Computational Biology; Drug Resistance, Multiple, Bacterial; Gene Expression; Gene Library; Genome, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Phenotype; Polymorphism, Single Nucleotide; Whole Genome Sequencing | 2019 |
In-hospital Medical Costs of Infections Caused by Carbapenem-resistant Klebsiella pneumoniae.
Topics: Adult; Aged; Anti-Bacterial Agents; Carbapenems; Case-Control Studies; China; Drug Resistance, Bacterial; Female; Hospital Costs; Hospital Mortality; Hospitalization; Humans; Klebsiella Infections; Klebsiella pneumoniae; Length of Stay; Male; Middle Aged; Retrospective Studies; Risk Factors | 2018 |
Carbapenem-resistant Isolates of the Klebsiella pneumoniae Complex in Western China: The Common ST11 and the Surprising Hospital-specific Types.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; beta-Lactamases; Carbapenems; China; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Genome, Bacterial; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Multilocus Sequence Typing; Plasmids | 2018 |
Genomics of Klebsiella pneumoniae ST16 producing NDM-1, CTX-M-15, and OXA-232.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Genetic Variation; Genome, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Phylogeny; Plasmids; Polymorphism, Single Nucleotide; Sequence Analysis, DNA | 2019 |
Do We Need Another Study to Control Carbapenem-resistant Organisms, or Do We Just Need to Get Better at the Basics?
Topics: Acinetobacter baumannii; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Humans; Klebsiella Infections; Pseudomonas aeruginosa | 2019 |
[Further understanding of infection of carbapenems-resistant
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Burns; Carbapenems; Drug Resistance, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2018 |
Coexistence of three bla
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Plasmids | 2019 |
Whole Genome Sequencing detects Inter-Facility Transmission of Carbapenem-resistant Klebsiella pneumoniae.
Topics: Anti-Bacterial Agents; Asymptomatic Infections; Carbapenems; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Genome, Bacterial; Health Facilities; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Movement; North Carolina; Prevalence; Whole Genome Sequencing | 2019 |
Endemicity of the High-Risk Clone
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Brazil; Carbapenems; Drug Resistance, Multiple, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Epidemiology; Multilocus Sequence Typing; Quinolones; Tertiary Care Centers | 2019 |
Emergence in Japan of an isolate of Klebsiella pneumoniae co-harbouring bla
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Child, Preschool; Drug Resistance, Multiple, Bacterial; Genome, Bacterial; Humans; Japan; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Plasmids | 2019 |
Resistance profiles and resistome mapping of multidrug resistant carbapenem-hydrolyzing Klebsiella pneumoniae strains isolated from the nares of preterm neonates.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Genes, Bacterial; Humans; Hydrolysis; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Nose; Respiratory Distress Syndrome, Newborn | 2019 |
A high-throughput, whole cell assay to identify compounds active against carbapenem-resistant Klebsiella pneumoniae.
Topics: Anti-Bacterial Agents; Carbapenems; Drug Discovery; Drug Resistance, Multiple, Bacterial; Fungi; High-Throughput Screening Assays; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2018 |
Molecular Epidemiology of Endemic Carbapenem-Resistant Gram-Negative Bacteria in an Intensive Care Unit.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Endemic Diseases; Gene Expression; Greece; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Epidemiology; Phylogeny; Pseudomonas aeruginosa; Pseudomonas Infections | 2019 |
Identification of
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cephalosporins; Cross Infection; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gene Expression; Genes, Bacterial; Hospitals; Humans; Italy; Klebsiella Infections; Klebsiella pneumoniae; Macrolides; Microbial Sensitivity Tests; Penicillins; Tetracyclines; Whole Genome Sequencing | 2019 |
HMGB1 signaling blocking protects against carbapenem-resistant klebsiella pneumoniae in a murine model of infection.
Topics: Animals; Carbapenems; Cytokines; Drug Resistance; HMGB1 Protein; Immunoglobulin G; Inflammation; Klebsiella Infections; Klebsiella pneumoniae; Mice; Signal Transduction | 2018 |
Molecular and epidemiological analysis of IMP-1 metallo-β-lactamase-producing Klebsiella pneumoniae in a tertiary care hospital in Japan.
Topics: Aged; Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactamases; Carbapenems; Case-Control Studies; Child; Child, Preschool; Drug Resistance, Multiple, Bacterial; Female; Humans; Infant; Infection Control; Japan; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Retrospective Studies; Risk Factors; Tertiary Care Centers | 2019 |
The emergence of colistin-resistant Klebsiella pneumoniae strains from swine in Malaysia.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Colistin; Conjugation, Genetic; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Genetic Variation; Genotype; Genotyping Techniques; Klebsiella Infections; Klebsiella pneumoniae; Malaysia; Microbial Sensitivity Tests; Plasmids; Swine; Swine Diseases | 2019 |
Risk Factors Affecting Patterns of Antibiotic Resistance and Treatment Efficacy in Extreme Drug Resistance in Intensive Care Unit-Acquired Klebsiella Pneumoniae Infections: A 5-Year Analysis.
Topics: Adult; Aged; Anti-Bacterial Agents; Carbapenems; Colistin; Cross Infection; Drug Resistance, Bacterial; Drug Resistance, Microbial; Female; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Pneumonia; Retrospective Studies; Risk Factors; Survival Rate; Tigecycline; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination | 2019 |
Exposure to Sublethal Concentrations of Benzalkonium Chloride Induces Antimicrobial Resistance and Cellular Changes in
Topics: Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents, Local; Benzalkonium Compounds; Carbapenems; Cephalosporins; Drug Resistance, Bacterial; Fluoroquinolones; Gene Expression; Genes, MDR; Humans; Klebsiella Infections; Klebsiella pneumoniae; Macrolides; Membrane Transport Proteins; Microbial Sensitivity Tests; Multidrug Resistance-Associated Proteins; Nitrobenzenes; Penicillins; Tetracyclines | 2019 |
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Disease Models, Animal; Female; Klebsiella Infections; Klebsiella pneumoniae; Mice; Monobactams; Pyelonephritis | 2019 |
Infection-prevention and control interventions to reduce colonisation and infection of intensive care unit-acquired carbapenem-resistant
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; China; Cross Infection; Drug Resistance, Bacterial; Female; Humans; Infection Control; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Young Adult | 2019 |
Molecular Characterization of Carbapenem Resistant Klebsiella pneumoniae and Klebsiella quasipneumoniae Isolated from Lebanon.
Topics: beta-Lactam Resistance; Carbapenems; Genome, Bacterial; Humans; Klebsiella; Klebsiella Infections; Klebsiella pneumoniae; Lebanon; Multilocus Sequence Typing | 2019 |
The clinical significance of carbapenem-resistant Klebsiella pneumoniae rectal colonization in critically ill patients: from colonization to bloodstream infection.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Carbapenems; Case-Control Studies; Critical Illness; Drug Resistance, Bacterial; Female; Greece; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Prospective Studies; Rectum; Risk Factors; Young Adult | 2019 |
Putative horizontal transfer of carbapenem resistance between Klebsiella pneumoniae and Kluyvera ascorbata during abdominal infection: A case report.
Topics: Adult; Anti-Bacterial Agents; beta-Lactamases; Bile Ducts; Brazil; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Kluyvera; Male; Microbial Sensitivity Tests | 2019 |
Assessing Molecular Epidemiology of Carbapenem-resistant Klebsiella pneumoniae (CR-KP) with MLST and MALDI-TOF in Central China.
Topics: Carbapenems; China; Disease Outbreaks; Drug Resistance, Bacterial; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Molecular Epidemiology; Retrospective Studies; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2019 |
Influence of antibiotic pressure on multi-drug resistant
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Cephalosporins; Critical Illness; Drug Resistance, Multiple, Bacterial; Female; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Prospective Studies | 2019 |
Incidence of metallo-beta-lactamase-producing Klebsiella pneumoniae isolates from hospital setting in Pakistan.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Hospitalization; Humans; Incidence; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Pakistan; Young Adult | 2018 |
Infections by OXA-48-like-producing Klebsiella pneumoniae non-co-producing extended-spectrum beta-lactamase: Can they be successfully treated with cephalosporins?
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cefepime; Ceftriaxone; Cephalosporins; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Nephritis; Retrospective Studies; Spain | 2019 |
Genome-Wide Screening for Enteric Colonization Factors in Carbapenem-Resistant ST258 Klebsiella pneumoniae.
Topics: Animals; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Disease Models, Animal; DNA Transposable Elements; Genetic Testing; Genome, Bacterial; Klebsiella Infections; Klebsiella pneumoniae; Mice; Mutagenesis, Insertional; Virulence Factors | 2019 |
Avibactam Sensitizes Carbapenem-Resistant NDM-1-Producing Klebsiella pneumoniae to Innate Immune Clearance.
Topics: Animals; Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Drug Resistance, Multiple, Bacterial; Female; Humans; Immunity, Innate; Klebsiella Infections; Klebsiella pneumoniae; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests | 2019 |
Disruption of KPC-producing Klebsiella pneumoniae membrane via induction of oxidative stress by cinnamon bark (Cinnamomum verum J. Presl) essential oil.
Topics: Bacterial Proteins; beta-Lactamases; Carbapenems; Cinnamomum zeylanicum; Drug Resistance, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Oils, Volatile; Oxidative Stress; Plant Bark | 2019 |
Epidemiology and antimicrobial susceptibility profiles of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichiacoli in China.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Child; Child, Preschool; China; Escherichia coli; Escherichia coli Infections; Female; Gentamicins; Humans; Infant; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Young Adult | 2019 |
Caribbean multi-centre study of Klebsiella pneumoniae: whole-genome sequencing, antimicrobial resistance and virulence factors.
Topics: Anti-Bacterial Agents; Carbapenems; Caribbean Region; Community-Acquired Infections; Drug Resistance, Multiple, Bacterial; Genes, Bacterial; Genome, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Phylogeny; Pilot Projects; Virulence Factors; Whole Genome Sequencing | 2019 |
Dissemination of Klebsiella pneumoniae ST11 isolates with carbapenem resistance in integrated and emergency intensive care units in a Chinese tertiary hospital.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Proteins; Bacterial Typing Techniques; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; China; Emergency Medical Services; Female; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Multilocus Sequence Typing; Tertiary Care Centers; Young Adult | 2019 |
Emergence of carbapenem-resistant NDM-1-producing Klebsiella pneumoniae high-risk sequence type 147 in a tertiary care hospital in Tenerife, Spain.
Topics: Adult; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Spain; Tertiary Care Centers | 2019 |
Non-clonal occurrence of pmrB mutations associated with polymyxin resistance in carbapenem-resistant Klebsiella pneumoniae in Brazil.
Topics: Anti-Bacterial Agents; Biodiversity; Carbapenems; Drug Resistance, Multiple, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Mutation; Polymerase Chain Reaction; Polymyxins | 2019 |
Comparison of adhesin genes expression among Klebsiella oxytoca ESBL-non-producers in planktonic and biofilm mode of growth, and imipenem sublethal exposure.
Topics: Adhesins, Bacterial; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Biofilms; Carbapenems; Gene Expression Regulation, Bacterial; Genes, Bacterial; Humans; Imipenem; Klebsiella Infections; Klebsiella oxytoca; Microbial Sensitivity Tests; Phenotype | 2019 |
Emergence of two novel sequence types (3366 and 3367) NDM-1- and OXA-48-co-producing K. pneumoniae in Italy.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; beta-Lactamases; Carbapenems; Disease Outbreaks; Electrophoresis, Gel, Pulsed-Field; Humans; Infant, Newborn; Intensive Care, Neonatal; Italy; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Multilocus Sequence Typing; Whole Genome Sequencing | 2019 |
Rapid Increase in Carbapenemase-Producing Enterobacteriaceae in Retail Meat Driven by the Spread of the
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; China; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Meat; Microbial Sensitivity Tests; Plasmids | 2019 |
Changing epidemiology of KPC-producing Klebsiella pneumoniae in Argentina: Emergence of hypermucoviscous ST25 and high-risk clone ST307.
Topics: Argentina; Bacterial Proteins; Bacterial Typing Techniques; beta-Lactamases; beta-Lactams; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Epidemiology; Molecular Typing; Multilocus Sequence Typing; Plasmids | 2019 |
The Pitt Bacteremia Score Predicts Mortality in Nonbacteremic Infections.
Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Enterobacteriaceae Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Prospective Studies; Retrospective Studies; Risk Factors | 2020 |
Evolution of Carbapenem-Resistant Serotype K1 Hypervirulent Klebsiella pneumoniae by Acquisition of
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Genome, Bacterial; Klebsiella Infections; Klebsiella pneumoniae; Male; Mice; Multilocus Sequence Typing; Plasmids; Serogroup; Virulence; Virulence Factors | 2019 |
Extremely High Mortality Rates in Patients with Carbapenem-resistant, Hypermucoviscous Klebsiella pneumoniae Blood Stream Infections.
Topics: Bacteremia; Carbapenems; Drug Resistance, Bacterial; Humans; India; Klebsiella Infections; Klebsiella pneumoniae | 2018 |
Carbapenem-resistant Hypermucoviscous Klebsiella pneumoniae - Emerging Superbug.
Topics: Anti-Bacterial Agents; Carbapenems; Drug Resistance, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae | 2018 |
The antimicrobial peptide thanatin disrupts the bacterial outer membrane and inactivates the NDM-1 metallo-β-lactamase.
Topics: Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Catalytic Domain; Cell Wall; Disease Models, Animal; Escherichia coli; Escherichia coli Infections; Human Umbilical Vein Endothelial Cells; Humans; Inhibitory Concentration 50; Klebsiella Infections; Klebsiella pneumoniae; Mice; Microbial Sensitivity Tests; Zinc | 2019 |
Intrapatient emergence of OXA-247: a novel carbapenemase found in a patient previously infected with OXA-163-producing Klebsiella pneumoniae.
Topics: Adolescent; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cephalosporins; DNA, Bacterial; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Epidemiology; Molecular Sequence Data; Sequence Analysis, DNA | 2013 |
Notes from the field: hospital outbreak of carbapenem-resistant Klebsiella pneumoniae producing New Delhi metallo-beta-lactamase--Denver, Colorado, 2012.
Topics: Adult; Aged; beta-Lactamases; Carbapenems; Colorado; Cross Infection; Disease Outbreaks; Drug Resistance, Bacterial; Female; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Young Adult | 2013 |
Effectiveness of a double-carbapenem regimen for infections in humans due to carbapenemase-producing pandrug-resistant Klebsiella pneumoniae.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Doripenem; Drug Combinations; Drug Resistance, Bacterial; Ertapenem; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Middle Aged; Thienamycins; Treatment Outcome; Urinary Tract Infections | 2013 |
Outbreak of carbapenem-resistant Klebsiella pneumoniae: two-year epidemiologic follow-up in a tertiary hospital.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Child; Child, Preschool; Cross Infection; Disease Outbreaks; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Genotype; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Polymerase Chain Reaction; Tertiary Care Centers; Young Adult | 2013 |
Emergence of blaNDM-1 among Klebsiella pneumoniae ST15 and novel ST1031 clinical isolates in China.
Topics: Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; China; Conjugation, Genetic; Gene Transfer, Horizontal; Genotype; Hospitals, Teaching; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Molecular Typing; Transformation, Bacterial; Young Adult | 2013 |
Characterization of porin expression in Klebsiella pneumoniae Carbapenemase (KPC)-producing K. pneumoniae identifies isolates most susceptible to the combination of colistin and carbapenems.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Biomarkers, Pharmacological; Carbapenems; Colistin; Drug Resistance, Bacterial; Drug Synergism; Drug Therapy, Combination; Gene Expression Regulation, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Porins | 2013 |
Vital signs: carbapenem-resistant Enterobacteriaceae.
Topics: Adolescent; Adult; Aged; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Hospitals; Humans; Klebsiella Infections; Middle Aged; Population Surveillance; United States; Young Adult | 2013 |
Efficacy of doripenem and ertapenem against KPC-2-producing and non-KPC-producing Klebsiella pneumoniae with similar MICs.
Topics: Animals; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Disease Models, Animal; Doripenem; Ertapenem; Klebsiella Infections; Klebsiella pneumoniae; Mice; Microbial Sensitivity Tests; Treatment Outcome | 2013 |
The mechanism of high-level carbapenem resistance in Klebsiella pneumoniae: underlying Ompk36-deficient strains represent a threat of emerging high-level carbapenem-resistant K. pneumoniae with IMP-1 β-lactamase production in Japan.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Conjugation, Genetic; Electrophoresis, Gel, Pulsed-Field; Humans; Japan; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Mutagenesis, Insertional; Open Reading Frames; Plasmids; Porins; Sequence Analysis, DNA | 2013 |
Persistence of Klebsiella pneumoniae clones with OXA-48 or NDM carbapenemases causing bacteraemias in a Riyadh hospital.
Topics: Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Saudi Arabia | 2013 |
Rapid expansion of KPC-2-producing Klebsiella pneumoniae isolates in two Texas hospitals due to clonal spread of ST258 and ST307 lineages.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Electrophoresis, Gel, Pulsed-Field; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Plasmids; Sequence Analysis, DNA; Texas | 2013 |
Carbapenem-resistant Klebsiella pneumoniae in the CSF: smile, please! We are taking photos.
Topics: Adult; Anti-Bacterial Agents; Carbapenems; Cerebral Ventricles; Cross Infection; Diagnosis, Differential; Drug Resistance, Bacterial; Endoscopy; Female; Humans; Hydrocephalus; Klebsiella Infections; Klebsiella pneumoniae | 2013 |
Whole genome sequence analysis of the first Australian OXA-48-producing outbreak-associated Klebsiella pneumoniae isolates: the resistome and in vivo evolution.
Topics: Anti-Bacterial Agents; Australia; beta-Lactamases; Carbapenems; Cross Infection; Disease Outbreaks; DNA, Bacterial; Drug Resistance, Bacterial; Genome, Bacterial; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Plasmids; Polymorphism, Single Nucleotide; Sequence Analysis, DNA; Transcription, Genetic; Virulence | 2013 |
Successful ertapenem-doripenem combination treatment of bacteremic ventilator-associated pneumonia due to colistin-resistant KPC-producing Klebsiella pneumoniae.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Carbapenems; Colistin; Doripenem; Drug Resistance, Bacterial; Drug Therapy, Combination; Ertapenem; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Pneumonia, Ventilator-Associated; Treatment Outcome | 2013 |
Treatment and outcome of nine cases of KPC-producing Klebsiella pneumoniae meningitis.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Renal Dialysis | 2013 |
"Nightmare" bacteria on the rise in US hospitals, long-term care facilities.
Topics: Carbapenems; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Long-Term Care; United States | 2013 |
In vitro activity of doripenem alone and in multi-agent combinations against extensively drug-resistant Acinetobacter baumannii and Klebsiella pneumoniae.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Amikacin; Anti-Bacterial Agents; Carbapenems; Cross Infection; Doripenem; Drug Resistance, Multiple, Bacterial; Drug Synergism; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Polymyxin B; Rifampin | 2013 |
Impact of various conditions on the efficacy of dual carbapenem therapy against KPC-producing Klebsiella pneumoniae.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Disease Models, Animal; Drug Therapy, Combination; Immunocompromised Host; Klebsiella Infections; Klebsiella pneumoniae; Mice; Mice, Inbred ICR; Neutropenia; Treatment Outcome | 2013 |
Molecular characterization of carbapenem-resistant Klebsiella pneumoniae in a tertiary university hospital in Turkey.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Child; Child, Preschool; Female; Hospitals, University; Humans; Infant; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Tertiary Care Centers; Turkey; Young Adult | 2013 |
Copy Number Change of the NDM-1 sequence in a multidrug-resistant Klebsiella pneumoniae clinical isolate.
Topics: Adult; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Colony Count, Microbial; DNA Copy Number Variations; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Plasmids; Sequence Analysis, DNA; Tandem Repeat Sequences | 2013 |
Klebsiella pneumoniae harbouring OXA-48 carbapenemase in a Libyan refugee in Italy.
Topics: Adult; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Humans; Inpatients; Intensive Care Units; Italy; Klebsiella Infections; Klebsiella pneumoniae; Libya; Male; Microbial Sensitivity Tests; Refugees | 2013 |
Trends in Klebsiella pneumoniae carbapenemase-positive K. pneumoniae in US hospitals: report from the 2007-2009 SENTRY Antimicrobial Surveillance Program.
Topics: Antineoplastic Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Epidemiological Monitoring; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Prevalence; United States | 2013 |
Carbapenem-resistant Klebsiella pneumoniae transmission associated to endoscopy.
Topics: beta-Lactam Resistance; Carbapenems; Case-Control Studies; Endoscopy; Humans; Infection Control; Klebsiella Infections; Klebsiella pneumoniae | 2013 |
Characteristics of carbapenem-resistant Enterobacteriaceae isolates from Korea.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Electrophoresis, Gel, Pulsed-Field; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Minocycline; Multilocus Sequence Typing; Mutation; Polymyxins; Porins; Republic of Korea; Tigecycline | 2013 |
Efficacy of humanized carbapenem exposures against New Delhi metallo-β-lactamase (NDM-1)-producing enterobacteriaceae in a murine infection model.
Topics: Animals; Anti-Bacterial Agents; Bacterial Load; beta-Lactamases; beta-Lactams; Carbapenems; Disease Models, Animal; Doripenem; Drug Evaluation, Preclinical; Drug Resistance, Bacterial; Ertapenem; Humans; Klebsiella Infections; Klebsiella pneumoniae; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Neutropenia; Time Factors | 2013 |
Detection of clonal KPC-2-producing Klebsiella pneumoniae ST258 in Korea during nationwide surveillance in 2011.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Conjugation, Genetic; Drug Resistance, Multiple, Bacterial; Genotype; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Plasmids; Prevalence; Republic of Korea; Tertiary Care Centers | 2013 |
[A study on carbapenem resistance in klebsiella pneumoniae].
Topics: beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Humans; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Pneumonia | 2013 |
Klebsiella necrotizing soft tissue infections in liver transplant recipients: a case series.
Topics: Adult; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Fatal Outcome; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Liver Transplantation; Male; Middle Aged; Risk Factors; Skin Diseases, Bacterial; Soft Tissue Infections | 2013 |
Epidemic diffusion of KPC carbapenemase-producing Klebsiella pneumoniae in Italy: results of the first countrywide survey, 15 May to 30 June 2011.
Topics: Bacterial Proteins; beta-Lactamases; Carbapenems; Colony Count, Microbial; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Humans; Infection Control; Italy; Klebsiella Infections; Klebsiella pneumoniae; Laboratories, Hospital; Microbial Sensitivity Tests; Specimen Handling | 2013 |
Reversion to susceptibility of a carbapenem-resistant clinical isolate of Klebsiella pneumoniae producing KPC-3.
Topics: Abdominal Abscess; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; DNA Transposable Elements; DNA, Bacterial; Genomic Instability; Humans; Kidney Transplantation; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Sequence Analysis, DNA; Surgical Wound Infection; Transplantation | 2013 |
OXA-48 carbapenemase-producing Klebsiella pneumoniae isolated from Libyan patients.
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactam Resistance; beta-Lactamases; Carbapenems; DNA Transposable Elements; Gene Expression; Gene Transfer, Horizontal; Humans; Klebsiella Infections; Klebsiella pneumoniae; Libya; Microbial Sensitivity Tests; Penicillins; Plasmids | 2013 |
Emergence of VIM-4 metallo-β-lactamase-producing Klebsiella pneumoniae ST15 clone in the Clinical Centre University of Pécs, Hungary.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Genes, Bacterial; Hospitals, University; Humans; Hungary; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Typing; Polymerase Chain Reaction | 2014 |
Emergence of OXA-48 carbapenemase-producing Escherichia coli and Klebsiella pneumoniae in dogs.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cluster Analysis; Conjugation, Genetic; DNA, Bacterial; Dogs; Escherichia coli; Escherichia coli Infections; Genotype; Germany; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Typing; Phylogeny; Plasmids; Polymerase Chain Reaction; Sequence Analysis, DNA | 2013 |
Prevalence and risk factors for acquisition of carbapenem-resistant Enterobacteriaceae in the setting of endemicity.
Topics: Adult; Aged; Aged, 80 and over; Anal Canal; beta-Lactam Resistance; Carbapenems; Carrier State; Case-Control Studies; Cross Infection; Electrophoresis, Gel, Pulsed-Field; Endemic Diseases; Female; Hospitals, University; Hospitals, Urban; Humans; Klebsiella Infections; Klebsiella pneumoniae; Lung Diseases; Male; Middle Aged; New York City; Prevalence; Respiration, Artificial; Risk Factors; Young Adult | 2013 |
Antibiotic resistance: the last resort.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Centers for Disease Control and Prevention, U.S.; Drug Resistance, Bacterial; Enterobacteriaceae; Epidemiological Monitoring; Humans; Infection Control; Internationality; Israel; Klebsiella Infections; Klebsiella pneumoniae; Public Health Surveillance; Shock, Septic; United States; Vancomycin | 2013 |
OmpK35 and OmpK36 porin variants associated with specific sequence types of Klebsiella pneumoniae.
Topics: Bacterial Proteins; beta-Lactam Resistance; Carbapenems; DNA Mutational Analysis; Greece; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Multilocus Sequence Typing; Polymorphism, Genetic; Porins; Sequence Analysis, Protein | 2013 |
Emergence of a VIM-1 MBL and CTX-M-15 ESbL-producing Klebsiella pneumoniae clone from acute and rehabilitation hospitals in Italy.
Topics: Anti-Infective Agents; beta-Lactamases; Carbapenems; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Hospitals; Humans; Italy; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Plasmids; Polymerase Chain Reaction; Rehabilitation Centers | 2013 |
Mutations of the ompK36 porin gene and promoter impact responses of sequence type 258, KPC-2-producing Klebsiella pneumoniae strains to doripenem and doripenem-colistin.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; beta-Lactamases; Carbapenems; Colistin; Doripenem; Drug Combinations; Drug Resistance, Multiple, Bacterial; Drug Synergism; Gene Expression; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Sequence Data; Multivariate Analysis; Mutation; Porins; Promoter Regions, Genetic | 2013 |
Risk factors for treatment failure of polymyxin B monotherapy for carbapenem-resistant Klebsiella pneumoniae infections.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Drug Resistance, Multiple, Bacterial; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Logistic Models; Male; Microbial Sensitivity Tests; Middle Aged; Polymyxin B; Renal Insufficiency, Chronic; Retrospective Studies; Risk Factors; Survival Analysis; Treatment Failure | 2013 |
Antibiotics: Support US policy change.
Topics: Animals; Animals, Domestic; Anti-Bacterial Agents; Carbapenems; Drug Resistance, Bacterial; Enterobacteriaceae; Humans; Klebsiella Infections; Meat; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections; Zoonoses | 2013 |
Infections caused by carbapenem-resistant Klebsiella pneumoniae among patients in intensive care units in Greece: a multi-centre study on clinical outcome and therapeutic options.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Female; Greece; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Treatment Outcome; Young Adult | 2014 |
Molecular characterization of Klebsiella pneumoniae carbapenemase-producing isolates in southern Brazil.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Brazil; Carbapenems; Enterobacter cloacae; Genotype; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Molecular Epidemiology; Serratia marcescens | 2013 |
New β-phospholactam as a carbapenem transition state analog: Synthesis of a broad-spectrum inhibitor of metallo-β-lactamases.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Humans; Klebsiella Infections; Klebsiella pneumoniae; Molecular Docking Simulation; Phosphorylation | 2013 |
Genomic analysis of the emergence and evolution of multidrug resistance during a Klebsiella pneumoniae outbreak including carbapenem and colistin resistance.
Topics: Adult; Aged; Anti-Bacterial Agents; Carbapenems; Colistin; Disease Outbreaks; DNA, Bacterial; Drug Resistance, Multiple; Evolution, Molecular; Female; Genome, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Molecular Sequence Data; Mutation Rate; Sequence Analysis, DNA | 2014 |
Colonization of liver transplant recipients with KPC-producing Klebsiella pneumoniae is associated with high infection rates and excess mortality: a case-control analysis.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Case-Control Studies; Drug Resistance, Bacterial; Female; Germany; Hospitals, University; Humans; Klebsiella Infections; Klebsiella pneumoniae; Liver Transplantation; Male; Middle Aged; Retrospective Studies; Risk; Transplant Recipients | 2014 |
Carbapenemase-producing Klebsiella pneumoniae in the Czech Republic in 2011.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Czech Republic; Drug Resistance, Multiple, Bacterial; Female; Greece; Humans; Incidence; Integrons; Italy; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Molecular Typing; Plasmids; Travel | 2013 |
Carbapenem and cefoxitin resistance of Klebsiella pneumoniae strains associated with porin OmpK36 loss and DHA-1 β-lactamase production.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cefoxitin; China; DNA, Bacterial; Drug Resistance, Bacterial; Electrophoresis, Polyacrylamide Gel; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Weight; Polymerase Chain Reaction; Porins | 2013 |
Active surveillance for carbapenem-resistant Enterobacteriaceae using stool specimens submitted for testing for Clostridium difficile.
Topics: Aged; beta-Lactam Resistance; Carbapenems; Carrier State; Case-Control Studies; Clostridioides difficile; DNA, Bacterial; Enterocolitis, Pseudomembranous; Feces; Humans; Klebsiella Infections; Klebsiella oxytoca; Klebsiella pneumoniae; Middle Aged; Public Health Surveillance | 2014 |
Characterization of novel plasmid-mediated β-lactamases (SHV-167 and ACT-16) associated with New Delhi metallo-β-lactamase-1 harbouring isolates from neonates in India.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; beta-Lactamases; Carbapenems; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Humans; India; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Molecular Sequence Data; Plasmids; Sepsis; Sequence Analysis, DNA | 2014 |
Emergence of carbapenem-resistant Klebsiella spp. infections in a Turkish university hospital: epidemiology and risk factors.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Cross Infection; Female; Hospitals, University; Humans; Incidence; Klebsiella; Klebsiella Infections; Male; Middle Aged; Retrospective Studies; Risk Factors; Turkey; Young Adult | 2014 |
Molecular characterization of carbapenem-resistant strains of Klebsiella pneumoniae isolated from Iranian patients: first identification of blaKPC gene in Iran.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cephalosporins; Clone Cells; Drug Resistance, Multiple, Bacterial; Gene Expression; Hospitals; Humans; Integrons; Iran; Isoenzymes; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Plasmids | 2014 |
Carbapenemase-producing Klebsiella pneumoniae bloodstream infections: lowering mortality by antibiotic combination schemes and the role of carbapenems.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Female; Humans; Kaplan-Meier Estimate; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Proportional Hazards Models; Young Adult | 2014 |
Molecular analysis of OXA-48-carrying conjugative IncL/M-like plasmids in clinical isolates of Klebsiella pneumoniae in Ireland.
Topics: Anti-Bacterial Agents; Base Sequence; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Conserved Sequence; DNA Transposable Elements; Gene Expression; Humans; Ireland; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids | 2014 |
Synergistic activity and effectiveness of a double-carbapenem regimen in pandrug-resistant Klebsiella pneumoniae bloodstream infections.
Topics: Adult; Bacteremia; Carbapenems; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Fatal Outcome; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Treatment Outcome | 2014 |
Successful containment and infection control of a Carbapenem-resistant Klebsiella pneumoniae outbreak in an Italian hospital.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Containment of Biohazards; Cross Infection; Disease Outbreaks; Drug Resistance, Bacterial; Hospitals; Humans; Infection Control; Italy; Klebsiella Infections; Klebsiella pneumoniae | 2014 |
Improving the efficiency of the modified Hodge test in KPC-producing Klebsiella pneumoniae isolates by incorporating an EDTA disk.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Edetic Acid; Genotype; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Phenotype; Sensitivity and Specificity | 2014 |
Carbapenem-resistant Klebsiella pneumoniae producing New Delhi metallo-β-lactamase at an acute care hospital, Colorado, 2012.
Topics: Adult; Aged; beta-Lactamases; Carbapenems; Colorado; Cross Infection; Disease Outbreaks; Drug Resistance, Bacterial; Female; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Sequence Analysis, DNA; Young Adult | 2014 |
Carbapenem-resistant Enterobacteriaceae rectal screening during an outbreak of New Delhi metallo-β-lactamase-producing Klebsiella pneumoniae at an acute care hospital.
Topics: Adult; Aged; beta-Lactamases; Carbapenems; Colorado; Confidence Intervals; Disease Outbreaks; Female; Hospitals, Teaching; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Multivariate Analysis; Population Surveillance; Rectum; Young Adult | 2014 |
Carbapenem-resistant Klebsiella pneumoniae exhibit variability in capsular polysaccharide and capsule associated virulence traits.
Topics: Aged; Aged, 80 and over; Animals; Anti-Bacterial Agents; Antibodies, Bacterial; Bacterial Capsules; beta-Lactam Resistance; Biofilms; Blood Bactericidal Activity; Carbapenems; Female; Genotype; Humans; Klebsiella Infections; Klebsiella pneumoniae; Lepidoptera; Macrophages; Male; Mice, Inbred BALB C; Middle Aged; Molecular Typing; Retrospective Studies; Survival Analysis; United States; Virulence | 2014 |
Molecular characterization of carbapenemase-producing Escherichia coli and Klebsiella pneumoniae in the countries of the Gulf cooperation council: dominance of OXA-48 and NDM producers.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Middle East; Oxytocin | 2014 |
Epidemiology and clinical outcomes of patients with carbapenem-resistant Klebsiella pneumoniae bacteriuria.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteriuria; Carbapenems; Cohort Studies; Doxycycline; Female; Hospitalization; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Multivariate Analysis; Pennsylvania; Retrospective Studies; Treatment Outcome; Urinary Tract Infections; Young Adult | 2014 |
Carbapenem-resistant Klebsiella pneumoniae colonization at liver transplantation: a management challenge.
Topics: Carbapenems; Drug Resistance, Bacterial; Female; Humans; Incidence; Klebsiella Infections; Klebsiella pneumoniae; Liver Failure; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Treatment Outcome | 2014 |
Bloodstream infection with carbapenem-resistant Klebsiella pneumoniae and multidrug-resistant Acinetobacter baumannii: a case report.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Bacteremia; Carbapenems; Drug Resistance, Multiple, Bacterial; Fatal Outcome; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Shock, Septic | 2014 |
Risk factors for carbapenem-resistant Klebsiella pneumoniae infection/colonization: a case-case-control study.
Topics: Adult; Aged; Aged, 80 and over; Carbapenems; Case-Control Studies; Drug Resistance, Bacterial; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Retrospective Studies; Risk Factors | 2014 |
Predictive models for identification of hospitalized patients harboring KPC-producing Klebsiella pneumoniae.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Case-Control Studies; Cohort Studies; Female; Fluoroquinolones; Hospitalization; Humans; Intensive Care Units; Italy; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Retrospective Studies; Risk Factors | 2014 |
The Balkan region: NDM-1-producing Klebsiella pneumoniae ST11 clonal strain causing outbreaks in Greece.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; Base Sequence; beta-Lactamases; Carbapenems; Cross Infection; Disease Outbreaks; DNA, Bacterial; Drug Resistance, Bacterial; Female; Genotype; Greece; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Multilocus Sequence Typing; Plasmids; Sequence Analysis, DNA | 2014 |
Surveillance of carbapenem-resistant Klebsiella pneumoniae: tracking molecular epidemiology and outcomes through a regional network.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Drug Resistance, Bacterial; Female; Genome, Bacterial; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Molecular Epidemiology; Polymerase Chain Reaction; Public Health Surveillance; Survival Analysis; Thienamycins; Treatment Outcome | 2014 |
Emergence of carbapenem-resistant Klebsiella Pneumoniae strains producing KPC-3 in Brescia Hospital, Italy.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Female; Hospitals; Humans; Italy; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Phylogeny; Young Adult | 2014 |
Population structure of KPC-producing Klebsiella pneumoniae isolates from midwestern U.S. hospitals.
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Midwestern United States; Phylogeny; Plasmids; Polymorphism, Single Nucleotide; Polysaccharides, Bacterial | 2014 |
Tigecycline therapy for carbapenem-resistant Klebsiella pneumoniae (CRKP) bacteriuria leads to tigecycline resistance.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteriuria; Carbapenems; Cohort Studies; DNA, Bacterial; Drug Resistance, Bacterial; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Minocycline; Molecular Sequence Data; Sequence Analysis, DNA; Tigecycline | 2014 |
A carbapenem-resistant Klebsiella pneumoniae outbreak following bronchoscopy.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Bronchoscopy; Carbapenems; Disease Outbreaks; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Pneumonia, Bacterial | 2014 |
Rapid containment of coincident outbreaks with 2 carbapenem-resistant Klebsiella pneumoniae strains in an intensive care unit.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Cross Infection; Disease Outbreaks; Humans; Infection Control; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae | 2014 |
Deaths attributable to carbapenem-resistant Enterobacteriaceae infections.
Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Case-Control Studies; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Prospective Studies; Retrospective Studies | 2014 |
The determination of carbapenem resistance in Escherichia coli and Pneumoniae isolates related to nosocomial infections and the evaluation of risk factors.
Topics: Adult; Aged; Anti-Bacterial Agents; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Polymerase Chain Reaction; Prospective Studies; Risk Factors | 2014 |
Detection and spread of oxa-48-producing Klebsiella oxytoca isolates in Istanbul, Turkey.
Topics: Anti-Bacterial Agents; Carbapenems; Disease Outbreaks; Electrophoresis, Gel, Pulsed-Field; Female; Humans; Infant; Klebsiella Infections; Klebsiella oxytoca; Male; Microbial Sensitivity Tests; Polymerase Chain Reaction; Treatment Outcome; Turkey | 2014 |
Risk factors for carbapenem-resistant Klebsiella pneumoniae bloodstream infection among rectal carriers: a prospective observational multicentre study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Carrier State; Case-Control Studies; Female; Hospitals, Teaching; Humans; Incidence; Italy; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Prospective Studies; Rectum; Risk Factors; Tertiary Care Centers; Young Adult | 2014 |
Case-case-control study of patients with carbapenem-resistant and third-generation-cephalosporin-resistant Klebsiella pneumoniae bloodstream infections.
Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Case-Control Studies; Cephalosporins; Drug Resistance, Bacterial; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Retrospective Studies; Risk Factors | 2014 |
Characteristics and costs of carbapenemase-producing enterobacteria carriers (2012/2013).
Topics: Aged; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Carrier State; Cross Infection; Disease Outbreaks; Enterobacteriaceae; Enterobacteriaceae Infections; Female; France; Hospital Costs; Hospital Units; Hospitals, General; Humans; Infection Control; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Length of Stay; Male; Middle Aged; Patient Isolation; Personnel, Hospital; Retrospective Studies | 2014 |
Clinical features of patients with carbapenem nonsusceptible Klebsiella pneumoniae and Escherichia coli in intensive care units: a nationwide multicenter study in Taiwan.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Enterobacteriaceae; Escherichia coli Infections; Female; Hospitals; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Risk Factors; Survival Analysis; Taiwan | 2015 |
Carbapenem-resistant Klebsiella pneumoniae infections in kidney transplant recipients: a case-control study.
Topics: Adult; Aged; Anti-Bacterial Agents; Carbapenems; Case-Control Studies; Diabetes Mellitus; Drug Resistance, Bacterial; Female; Hospitalization; Humans; Kidney Transplantation; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Retrospective Studies; Risk Factors; Survival Rate | 2014 |
Risk factors for colonization with carbapenemase-producing Klebsiella pneumoniae in hospital: a matched case-control study.
Topics: Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Case-Control Studies; Cross Infection; Female; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Prospective Studies; Risk Factors | 2014 |
Increasing resistance rate to carbapenem among blood culture isolates of Klebsiella pneumoniae, Acinetobacter baumannii and Pseudomonas aeruginosa in a university-affiliated hospital in China, 2004-2011.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Cephalosporins; China; Drug Resistance, Bacterial; Gram-Negative Bacteria; Hospitals, University; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Thienamycins | 2015 |
Unexpected in vivo activity of ceftazidime alone and in combination with avibactam against New Delhi metallo-β-lactamase-producing Enterobacteriaceae in a murine thigh infection model.
Topics: Animals; Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamases; Carbapenems; Ceftazidime; Disease Models, Animal; Drug Combinations; Escherichia coli; Escherichia coli Infections; Klebsiella Infections; Klebsiella pneumoniae; Mice; Microbial Sensitivity Tests | 2014 |
Multi-drug carbapenem-resistant Klebsiella pneumoniae infection carrying the OXA-48 gene and showing variations in outer membrane protein 36 causing an outbreak in a tertiary care hospital in Riyadh, Saudi Arabia.
Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; beta-Lactamases; Carbapenems; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Genes, Bacterial; Genetic Variation; Humans; Klebsiella Infections; Klebsiella pneumoniae; Saudi Arabia; Tertiary Care Centers | 2014 |
Evaluation of inhibitory action of novel non β-lactam inhibitor against Klebsiella pneumoniae carbapenemase (KPC-2).
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Cell Line; Ertapenem; HeLa Cells; Humans; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Protein Binding; Thienamycins | 2014 |
High prevalence of metallo-β-lactamase among carbapenem-resistant Klebsiella pneumoniae in a teaching hospital in China.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; China; Genotype; Hospitals, Teaching; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Prevalence | 2014 |
Efforts mount to curb carbapenem-resistant infections.
Topics: Carbapenems; Centers for Disease Control and Prevention, U.S.; Cross Infection; Drug Resistance, Bacterial; Escherichia coli Infections; Humans; Infection Control; Klebsiella Infections; Practice Guidelines as Topic; United States | 2014 |
Nosocomial infections by Klebsiella pneumoniae carbapenemase producing enterobacteria in a teaching hospital.
Topics: Adolescent; Adult; Bacterial Proteins; beta-Lactamases; Carbapenems; Child; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Hospitals, Teaching; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Polymerase Chain Reaction; Retrospective Studies; Young Adult | 2014 |
Infections by carbapenem-resistant Klebsiella pneumoniae in SCT recipients: a nationwide retrospective survey from Italy.
Topics: Adolescent; Adult; Aged; Allografts; Autografts; Carbapenems; Drug Resistance, Bacterial; Female; Hematologic Diseases; Humans; Italy; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Retrospective Studies; Stem Cell Transplantation | 2015 |
Risk factors for carbapenem resistant Klebsiella pneumoniae rectal colonization in pediatric units.
Topics: Adolescent; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Case-Control Studies; Child; Child, Preschool; Female; Hospitals, Pediatric; Humans; Infant; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Male; Rectum; Risk Factors; Turkey | 2014 |
Molecular detection of antibiotic resistance genes from positive blood cultures.
Topics: Anti-Bacterial Agents; Automation, Laboratory; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Culture Media; DNA Primers; Gene Expression; Humans; Hydrolysis; Klebsiella Infections; Klebsiella pneumoniae; Real-Time Polymerase Chain Reaction; Reference Standards; Ribonuclease P; Sepsis | 2015 |
Comorbidities and disease severity as risk factors for carbapenem-resistant Klebsiella pneumoniae colonization: report of an experience in an internal medicine unit.
Topics: Aged; Aged, 80 and over; beta-Lactam Resistance; Carbapenems; Case-Control Studies; Comorbidity; Cross-Sectional Studies; Female; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Male; Risk Factors; Severity of Illness Index | 2014 |
Gentamicin therapy for sepsis due to carbapenem-resistant and colistin-resistant Klebsiella pneumoniae.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Cohort Studies; Colistin; Disease Outbreaks; Drug Resistance, Bacterial; Female; Gentamicins; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Retrospective Studies; Risk Factors; Sepsis; Survival Analysis; Treatment Outcome; Young Adult | 2015 |
Colistin resistance superimposed to endemic carbapenem-resistant Klebsiella pneumoniae: a rapidly evolving problem in Italy, November 2013 to April 2014.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Endemic Diseases; Health Surveys; Humans; Italy; Klebsiella Infections; Klebsiella pneumoniae; Laboratories, Hospital; Microbial Sensitivity Tests; Polymerase Chain Reaction; Sentinel Surveillance | 2014 |
Genomic epidemiology of Klebsiella pneumoniae in Italy and novel insights into the origin and global evolution of its resistance to carbapenem antibiotics.
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; Base Sequence; beta-Lactamases; Carbapenems; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Evolution, Molecular; Humans; Italy; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Multilocus Sequence Typing; Polymorphism, Single Nucleotide; Sequence Analysis, DNA | 2015 |
Carbapenem-resistant Klebsiella pneumoniae urinary tract infection following solid organ transplantation.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cohort Studies; Drug Resistance, Bacterial; Female; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Length of Stay; Logistic Models; Male; Microbial Sensitivity Tests; Middle Aged; Ohio; Organ Transplantation; Retrospective Studies; Treatment Outcome; Urinary Tract Infections | 2015 |
First report in China of Enterobacteriaceae clinical isolates coharboring blaNDM-1 and blaIMP-4 drug resistance genes.
Topics: Adolescent; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; China; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Hospitals; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Plasmids; Quinolones; Thienamycins | 2015 |
A prediction tool for nosocomial multi-drug Resistant Gram-Negative Bacilli infections in critically ill patients - prospective observational study.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Carbapenems; Cohort Studies; Critical Illness; Cross Infection; Decision Support Techniques; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Intensive Care Units; Kidney Failure, Chronic; Klebsiella Infections; Klebsiella pneumoniae; Length of Stay; Logistic Models; Male; Middle Aged; Pneumonia, Bacterial; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Renal Dialysis; Risk Factors; Surgical Procedures, Operative; Systemic Inflammatory Response Syndrome; Urinary Tract Infections | 2014 |
Tigecycline for treatment of carbapenem-resistant Klebsiella pneumoniae infections after liver transplantation in the intensive care unit: a 3-year study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Female; Follow-Up Studies; Greece; Humans; Incidence; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Liver Transplantation; Male; Middle Aged; Minocycline; Pilot Projects; Prospective Studies; Risk Factors; Tigecycline; Time Factors; Treatment Outcome | 2014 |
Characterisation of the first ongoing outbreak due to KPC-3-producing Klebsiella pneumoniae (ST512) in Spain.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Disease Outbreaks; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Hospitals; Humans; Italy; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Multilocus Sequence Typing; Plasmids; Sequence Analysis, DNA; Spain | 2014 |
Characteristics, risk factors and outcomes of carbapenem-resistant Klebsiella pneumoniae infections in the intensive care unit.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; APACHE; Bacteremia; Carbapenems; Case-Control Studies; Drug Resistance, Multiple, Bacterial; Female; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Retrospective Studies; Risk Factors | 2015 |
Characterization of resistance genes in 68 ESBL-producing Klebsiella pneumonia in Lebanon.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cefepime; Cephalosporins; Colony Count, Microbial; Disk Diffusion Antimicrobial Tests; Drug Resistance, Multiple, Bacterial; Genes, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Lebanon; Microbial Sensitivity Tests; Organ Specificity; Substrate Specificity | 2014 |
High prevalence of carbapenem resistance among plasmid-mediated AmpC β-lactamase-producing Klebsiella pneumoniae during outbreaks in liver transplantation units.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Case-Control Studies; Disease Outbreaks; DNA, Bacterial; Female; Hospitals, University; Humans; Infection Control; Japan; Klebsiella Infections; Klebsiella pneumoniae; Liver Transplantation; Male; Middle Aged; Multilocus Sequence Typing; Plasmids; Polymerase Chain Reaction; Young Adult | 2015 |
Successful containment of carbapenem-resistant Enterobacteriaceae by strict contact precautions without active surveillance.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Containment of Biohazards; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Hospitals, Teaching; Humans; Imipenem; Incidence; Infection Control; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Phenotype; Prevalence; Prospective Studies; Republic of Korea; Retrospective Studies; Thienamycins | 2014 |
Impact of therapy and strain type on outcomes in urinary tract infections caused by carbapenem-resistant Klebsiella pneumoniae.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Cohort Studies; Female; Genotype; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Molecular Typing; Prospective Studies; Treatment Outcome; Urinary Tract Infections | 2015 |
Effects of various antibiotics alone or in combination with doripenem against Klebsiella pneumoniae strains isolated in an intensive care unit.
Topics: Carbapenems; Colistin; Doripenem; Dose-Response Relationship, Drug; Drug Combinations; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Levofloxacin; Minocycline; Rifampin; Tigecycline; Tobramycin | 2014 |
Doripenem MICs and ompK36 porin genotypes of sequence type 258, KPC-producing Klebsiella pneumoniae may predict responses to carbapenem-colistin combination therapy among patients with bacteremia.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; Carbapenems; Colistin; Doripenem; Drug Therapy, Combination; Female; Genotype; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Porins; Retrospective Studies | 2015 |
Risk factors of carbapenem-resistant Klebsiella pneumoniae infection: a serious threat in ICUs.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Automation; Carbapenems; Child; Child, Preschool; Cross Infection; Drug Resistance, Bacterial; Female; Humans; Infant; Infant, Newborn; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Multivariate Analysis; Retrospective Studies; Risk Factors; Software; Young Adult | 2015 |
Therapeutic strategy for pandrug-resistant Klebsiella pneumoniae severe infections: short-course treatment with colistin increases the in vivo and in vitro activity of double carbapenem regimen.
Topics: Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2015 |
[Isolation of a carbapenem-resistant K1 serotype Klebsiella pneumonia strain and the study of resistance mechanism].
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Multilocus Sequence Typing; Plasmids; Pneumonia; Virulence | 2014 |
Evaluating state-specific antibiotic resistance measures derived from central line-associated bloodstream infections, national healthcare safety network, 2011.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacteremia; Carbapenems; Catheter-Related Infections; Child; Child, Preschool; Disease Notification; Drug Resistance, Bacterial; Female; Humans; Incidence; Infant; Intensive Care Units; Klebsiella Infections; Klebsiella oxytoca; Klebsiella pneumoniae; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Public Health Surveillance; Risk Adjustment; Staphylococcal Infections; United States; Young Adult | 2015 |
Bloodstream infections among carriers of carbapenem-resistant Klebsiella pneumoniae: etiology, incidence and predictors.
Topics: Aged; Aged, 80 and over; Bacteremia; Carbapenems; Carrier State; Case-Control Studies; Drug Resistance, Bacterial; Female; Humans; Israel; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Retrospective Studies | 2015 |
Is the monoclonal spread of the ST258, KPC-3-producing clone being replaced in southern Italy by the dissemination of multiple clones of carbapenem-nonsusceptible, KPC-3-producing Klebsiella pneumoniae?
Topics: Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Humans; Italy; Klebsiella Infections; Klebsiella pneumoniae | 2015 |
No carbapenem resistance in pneumonia caused by Klebsiella species.
Topics: Aged; Carbapenems; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Female; Humans; Klebsiella Infections; Male; Pneumonia, Bacterial; Retrospective Studies | 2015 |
Spread of KPC-producing carbapenem-resistant Enterobacteriaceae: the importance of super-spreaders and rectal KPC concentration.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Carrier State; Cross Infection; Disease Transmission, Infectious; Environmental Microbiology; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Rectum | 2015 |
In vitro emergence of carbapenem resistance in extended-spectrum β-lactamase-producing Klebsiella pneumoniae clinical isolates.
Topics: Adult; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Mutation; Selection, Genetic | 2015 |
Risk factors for carbapenem-resistant Klebsiella pneumoniae infection/colonization and predictors of mortality: a retrospective study.
Topics: Adult; Aged; Anti-Bacterial Agents; Carbapenems; Case-Control Studies; China; Cross Infection; Drug Resistance, Bacterial; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Multilocus Sequence Typing; Odds Ratio; Retrospective Studies; Risk Factors; Tracheostomy | 2015 |
Is combination therapy for carbapenem-resistant Klebsiella pneumoniae the new standard of care?
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Drug Therapy, Combination; Humans; Klebsiella Infections; Klebsiella pneumoniae; Randomized Controlled Trials as Topic | 2015 |
Risk factors for infection with carbapenem-resistant Klebsiella pneumoniae after liver transplantation: the importance of pre- and posttransplant colonization.
Topics: Adult; Aged; Carbapenems; Carrier State; Cohort Studies; Colony Count, Microbial; Drug Resistance, Bacterial; Female; Humans; Incidence; Klebsiella Infections; Klebsiella pneumoniae; Liver Transplantation; Male; Mass Screening; Middle Aged; Models, Statistical; Multivariate Analysis; Prospective Studies; Risk Factors; Time Factors | 2015 |
Detection of blaIMP4 and blaNDM1 harboring Klebsiella pneumoniae isolates in a university hospital in Malaysia.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cross-Sectional Studies; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Gene Expression; Hospitals, University; Humans; Klebsiella Infections; Klebsiella pneumoniae; Malaysia; Microbial Sensitivity Tests; Molecular Typing | 2015 |
Outbreak of multidrug resistant NDM-1-producing Klebsiella pneumoniae from a neonatal unit in Shandong Province, China.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; China; Disease Outbreaks; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Humans; Infant; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Multilocus Sequence Typing; Neonatal Screening | 2015 |
Carbapenem-resistant Klebsiella pneumoniae meningitis: A case report.
Topics: Anti-Bacterial Agents; Carbapenems; Catheters; Drug Resistance, Bacterial; Equipment Contamination; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Meningitis, Bacterial; Middle Aged; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Ventriculoperitoneal Shunt | 2016 |
Management of carbapenem resistant Klebsiella pneumoniae infections in stem cell transplant recipients: an Italian multidisciplinary consensus statement.
Topics: Allografts; Carbapenems; Consensus; Drug Resistance; Hematologic Neoplasms; Humans; Italy; Klebsiella Infections; Klebsiella pneumoniae; Male; Stem Cell Transplantation | 2015 |
Piscidin is highly active against carbapenem-resistant Acinetobacter baumannii and NDM-1-producing Klebsiella pneumonia in a systemic Septicaemia infection mouse model.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Bacterial Proteins; Behavior, Animal; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Fish Proteins; Klebsiella Infections; Klebsiella pneumoniae; Male; Mice, Inbred C57BL; Microbial Sensitivity Tests; Protein Isoforms; Recombinant Proteins; Sepsis; Survival Analysis; Tilapia | 2015 |
[Controlling infection and spread of carbapenems-resistant Klebsiella pneumoniae among burn patients].
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Burns; Carbapenems; Drug Resistance, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Minocycline; Tigecycline | 2015 |
Structural Basis for Different Substrate Profiles of Two Closely Related Class D β-Lactamases and Their Inhibition by Halogens.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Catalytic Domain; Ceftazidime; Cephalosporins; Enterobacter cloacae; Enterobacteriaceae Infections; Enzyme Inhibitors; Humans; Iodides; Klebsiella Infections; Klebsiella pneumoniae; Molecular Docking Simulation; Protein Conformation | 2015 |
Tigecycline for carbapenem-resistant Klebsiella pneumoniae infections in the intensive care unit.
Topics: Aged; Carbapenems; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Minocycline; Tigecycline | 2015 |
Effect of Resistance Mechanisms on the Inoculum Effect of Carbapenem in Klebsiella pneumoniae Isolates with Borderline Carbapenem Resistance.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2015 |
Residence in Skilled Nursing Facilities Is Associated with Tigecycline Nonsusceptibility in Carbapenem-Resistant Klebsiella pneumoniae.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Drug Resistance, Multiple, Bacterial; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Minocycline; Prospective Studies; Risk Factors; Skilled Nursing Facilities; Tigecycline; Time Factors | 2015 |
Characterization of pKP-M1144, a Novel ColE1-Like Plasmid Encoding IMP-8, GES-5, and BEL-1 β-Lactamases, from a Klebsiella pneumoniae Sequence Type 252 Isolate.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Portugal | 2015 |
In Vitro Activity of Imipenem and Colistin against a Carbapenem-Resistant Klebsiella pneumoniae Isolate Coproducing SHV-31, CMY-2, and DHA-1.
Topics: Bacterial Proteins; beta-Lactamases; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Hip; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Porins | 2015 |
Emergence of Carbapenem-Resistant Klebsiella pneumoniae: Progressive Spread and Four-Year Period of Observation in a Cardiac Surgery Division.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; beta-Lactamases; Carbapenems; Child; Child, Preschool; Colistin; Drug Resistance, Bacterial; Female; High-Throughput Nucleotide Sequencing; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged | 2015 |
Prevalence study on carbapenemase-producing Escherichia coli and Klebsiella pneumoniae isolates in Czech hospitals--results from Czech Part of European Survey on Carbapenemase--Producing Enterobacteriaceae (EuSCAPE).
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; beta-Lactamases; Carbapenems; Cross-Sectional Studies; Czech Republic; Escherichia coli; Escherichia coli Infections; Geography; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Multilocus Sequence Typing; Prevalence; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Ukraine | 2015 |
Cefoxitin as a carbapenem-sparing antibiotic for infections caused by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cefoxitin; Escherichia coli; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Treatment Outcome; Young Adult | 2015 |
Risk factors and outcomes of carbapenem-resistant Klebsiella pneumoniae infections in liver transplant recipients.
Topics: Carbapenems; Drug Resistance, Bacterial; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Liver Transplantation; Male; Middle Aged; New York City; Postoperative Complications; Retrospective Studies; Risk Factors | 2015 |
Clinical and molecular characteristics of multi-clone carbapenem-resistant hypervirulent (hypermucoviscous) Klebsiella pneumoniae isolates in a tertiary hospital in Beijing, China.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Beijing; Carbapenems; China; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Retrospective Studies; Tertiary Care Centers; Virulence | 2015 |
Containment of carbapenem resistance rates of Klebsiella pneumoniae and Acinetobacter baumannii in a Greek hospital with a concomitant increase in colistin, gentamicin and tigecycline resistance.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Colistin; Containment of Biohazards; Cross Infection; Drug Resistance, Multiple, Bacterial; Gentamicins; Greece; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Minocycline; Tertiary Care Centers; Tigecycline | 2015 |
An Update of the Evolving Epidemic of blaKPC Carrying Klebsiella pneumoniae in Sicily, Italy, 2014: Emergence of Multiple Non-ST258 Clones.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Clone Cells; Colistin; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Epidemiological Monitoring; Fluoroquinolones; Gene Expression; Hospitals; Humans; Incidence; Italy; Klebsiella Infections; Klebsiella pneumoniae; Membrane Proteins; Multilocus Sequence Typing; Mutation; Plasmids | 2015 |
Managing a nosocomial outbreak of carbapenem-resistant Klebsiella pneumoniae: an early Australian hospital experience.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Australia; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cross Infection; Disease Outbreaks; Female; Hospital Mortality; Humans; Infection Control; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Young Adult | 2015 |
Determining the resistance of carbapenem-resistant Klebsiella pneumoniae to common disinfectants and elucidating the underlying resistance mechanisms.
Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Cross Infection; Disinfectants; Drug Resistance, Bacterial; Hospitals; Humans; Immunocompromised Host; Klebsiella Infections; Klebsiella pneumoniae; Treatment Outcome | 2015 |
Community-Acquired Pyelonephritis in Pregnancy Caused by KPC-Producing Klebsiella pneumoniae.
Topics: Adult; Anti-Bacterial Agents; Bacterial Proteins; Carbapenems; Community-Acquired Infections; Female; Humans; Infant; Klebsiella Infections; Klebsiella pneumoniae; Pregnancy; Pyelonephritis | 2015 |
Impact of carbapenem resistance on epidemiology and outcomes of nonbacteremic Klebsiella pneumoniae infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Pneumonia, Bacterial; Retrospective Studies; Risk Factors; Treatment Outcome; Urinary Tract Infections; Young Adult | 2015 |
Molecular characterization of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella spp. isolates in Mongolia.
Topics: Amikacin; Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactamases; Carbapenems; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Fluoroquinolones; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Mongolia; Plasmids; Polymerase Chain Reaction | 2016 |
KPC-2-producing Klebsiella pneumoniae in a hospital in the Midwest region of Brazil.
Topics: Anti-Bacterial Agents; beta-Lactamases; Brazil; Carbapenems; DNA, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Polymerase Chain Reaction; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Tertiary Care Centers | 2015 |
Clonal dissemination of multilocus sequence type ST15 KPC-2-producing Klebsiella pneumoniae in Bulgaria.
Topics: Anti-Bacterial Agents; beta-Lactamases; Bulgaria; Carbapenems; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Multilocus Sequence Typing; Plasmids; Random Amplified Polymorphic DNA Technique | 2015 |
Emergence of a hypervirulent carbapenem-resistant Klebsiella pneumoniae isolate from clinical infections in China.
Topics: Adolescent; Aged; Aged, 80 and over; Animals; Anti-Bacterial Agents; Carbapenems; China; Drug Resistance, Multiple, Bacterial; Female; Genotype; Humans; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Lethal Dose 50; Male; Medical Records; Mice; Multilocus Sequence Typing; Retrospective Studies; Serogroup; Virulence | 2015 |
Attributable mortality of carbapenem-resistant Klebsiella pneumoniae infections in a prospective matched cohort study in Italy, 2012-2013.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Female; Hospitals; Humans; Italy; Klebsiella Infections; Klebsiella pneumoniae; Male; Prospective Studies; Survival Analysis | 2016 |
Distinct but Spatially Overlapping Intestinal Niches for Vancomycin-Resistant Enterococcus faecium and Carbapenem-Resistant Klebsiella pneumoniae.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Carbapenems; Colony Count, Microbial; Drug Resistance, Bacterial; Enteritis; Enterococcus faecium; Fecal Microbiota Transplantation; Feces; Female; Gastrointestinal Microbiome; Gram-Positive Bacterial Infections; Host-Pathogen Interactions; In Situ Hybridization, Fluorescence; Intestinal Mucosa; Klebsiella Infections; Klebsiella pneumoniae; Mice, Inbred C57BL; Microbial Interactions; Specific Pathogen-Free Organisms; Vancomycin-Resistant Enterococci | 2015 |
Carbapenem-resistant and carbapenem-susceptible isogenic isolates of Klebsiella pneumoniae ST101 causing infection in a tertiary hospital.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cross Infection; Disease Outbreaks; Electrophoresis, Gel, Pulsed-Field; Female; Genomic Instability; Genotype; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Typing; Plasmids; Retrospective Studies; Tertiary Care Centers | 2015 |
Risk factors and outcomes of carbapenem-resistant Klebsiella pneumoniae infections in liver transplant recipients.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Liver Transplantation; Microbial Sensitivity Tests; Risk Factors | 2016 |
Epidemiology and outcomes of carbapenem-resistant Klebsiella pneumoniae bacteriuria in kidney transplant recipients.
Topics: Anti-Bacterial Agents; Bacteriuria; Carbapenems; Case-Control Studies; Drug Resistance, Bacterial; Humans; Kidney Transplantation; Klebsiella Infections; Klebsiella pneumoniae; Odds Ratio; Risk Factors; Treatment Outcome | 2015 |
Distribution of β-lactamase genes among carbapenem-resistant Klebsiella pneumoniae strains isolated from patients in Turkey.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; DNA, Bacterial; Drug Resistance, Bacterial; Genotype; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Polymerase Chain Reaction; Sequence Analysis, DNA; Turkey | 2015 |
Emergence of Carbapenemase Producing Klebsiella Pneumonia and Spread of KPC-2 and KPC-17 in Taiwan: A Nationwide Study from 2011 to 2013.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; DNA, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Epidemiology; Taiwan | 2015 |
Successful Treatment of Carbapenemase-Producing Pandrug-Resistant Klebsiella pneumoniae Bacteremia.
Topics: Anti-Bacterial Agents; Antiviral Agents; Azabicyclo Compounds; Bacteremia; Bacterial Proteins; beta-Lactamases; Carbapenems; Ceftazidime; Colectomy; Colistin; Drug Combinations; Drug Resistance, Multiple, Bacterial; Female; Ganciclovir; Humans; Immunosuppressive Agents; Intestine, Small; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Middle Aged; Minocycline; Thienamycins; Tigecycline; Trimethoprim, Sulfamethoxazole Drug Combination; Valganciclovir | 2015 |
Comparative effectiveness of flomoxef versus carbapenems in the treatment of bacteraemia due to extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella pneumoniae with emphasis on minimum inhibitory concentration of flomoxef: a retrospectiv
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Case-Control Studies; Cephalosporins; Escherichia coli; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Treatment Outcome | 2015 |
Genetic Characterization of Carbapenem-Resistant Enterobacteriaceae and the Spread of Carbapenem-Resistant Klebsiella pneumonia ST340 at a University Hospital in Thailand.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Child; Child, Preschool; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Hospitals, University; Humans; Infant; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Epidemiology; Thailand; Young Adult | 2015 |
In vitro evaluation of dual carbapenem combinations against carbapenemase-producing Enterobacteriaceae.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Interactions; Escherichia coli; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2016 |
Fluoroquinolone therapy for bloodstream infections caused by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Humans; Klebsiella Infections; Klebsiella pneumoniae; Middle Aged; Retrospective Studies; Survival Analysis; Treatment Outcome; Young Adult | 2017 |
Emergence of ST147 Klebsiella pneumoniae Producing OXA-204 Carbapenemase in a University Hospital, Tunisia.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Gene Expression; Hospitals, University; Humans; Isoenzymes; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Multilocus Sequence Typing; Plasmids; Sequence Analysis, DNA; Tunisia | 2016 |
First outbreak of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae isolates in Constantine, Algeria.
Topics: Adult; Algeria; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Child; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged | 2015 |
The Epidemiology of Carbapenem-Resistant Klebsiella pneumoniae Colonization and Infection among Long-Term Acute Care Hospital Residents.
Topics: Aged; Anti-Bacterial Agents; Carbapenems; Carrier State; Case-Control Studies; Drug Resistance, Bacterial; Fecal Incontinence; Female; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Metronidazole; Middle Aged; Organ Transplantation; Respiration, Artificial; Risk Factors; Stem Cell Transplantation; Thienamycins; Time Factors; Vancomycin | 2016 |
Trends in the annual incidence of carbapenem-resistant Klebsiella pneumoniae bloodstream infections: a 8-year retrospective study in a large teaching hospital in northern Italy.
Topics: Aged; Aged, 80 and over; Bacteremia; Carbapenems; Female; Hospitals, Teaching; Humans; Intensive Care Units; Italy; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Retrospective Studies | 2015 |
Aminoglycoside therapy for childhood urinary tract infection due to extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella pneumoniae.
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Escherichia coli Infections; Female; Humans; Infant; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Pyelonephritis; Republic of Korea; Retrospective Studies; Treatment Outcome; Urinary Tract Infections; Uropathogenic Escherichia coli | 2015 |
MALDI-TOF mass spectrometry and blakpc gene phylogenetic analysis of an outbreak of carbapenem-resistant K. pneumoniae strains.
Topics: Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Disease Outbreaks; Drug Resistance, Bacterial; Genotype; Humans; Italy; Klebsiella Infections; Klebsiella pneumoniae; Multilocus Sequence Typing; Phylogeny; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Tandem Mass Spectrometry | 2015 |
A Two-Year Surveillance in Five Colombian Tertiary Care Hospitals Reveals High Frequency of Non-CG258 Clones of Carbapenem-Resistant Klebsiella pneumoniae with Distinct Clinical Characteristics.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Clone Cells; Colombia; Cross-Sectional Studies; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Epidemiological Monitoring; Female; Gene Expression; Gene Transfer, Horizontal; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Epidemiology; Multilocus Sequence Typing; Phylogeny; Plasmids; Tertiary Care Centers | 2016 |
Double Copies of bla(KPC-3)::Tn4401a on an IncX3 Plasmid in Klebsiella pneumoniae Successful Clone ST512 from Italy.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Clone Cells; DNA Transposable Elements; Drug Resistance, Multiple, Bacterial; Gene Dosage; Gene Expression Regulation, Bacterial; Italy; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Open Reading Frames; Plasmids | 2016 |
Ertapenem-Containing Double-Carbapenem Therapy for Treatment of Infections Caused by Carbapenem-Resistant Klebsiella pneumoniae.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Carbapenems; Ertapenem; Female; Humans; Intraabdominal Infections; Klebsiella Infections; Klebsiella pneumoniae; Length of Stay; Male; Middle Aged; Pneumonia, Bacterial; Survival Analysis; Treatment Outcome; Urinary Tract Infections | 2016 |
Klebsiella oxytoca-producing IMP-1 Detected as the First Strain of Carbapenem-resistant Enterobacteriaceae in Our Hospital.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cross Infection; Hospitals; Humans; Inosine Monophosphate; Klebsiella Infections; Klebsiella oxytoca; Microbial Sensitivity Tests; Middle Aged | 2015 |
Clinical Characteristics of Carbapenem-resistant Klebsiella pneumoniae Infections in Ill and Colonized Children in Colombia.
Topics: beta-Lactam Resistance; Carbapenems; Carrier State; Child; Child, Preschool; Colombia; Cross-Sectional Studies; Female; Humans; Infant; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Retrospective Studies; Tertiary Care Centers | 2016 |
Emergence of Carbapenem-Resistant Serotype K1 Hypervirulent Klebsiella pneumoniae Strains in China.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Carbohydrate Epimerases; China; Female; Genotype; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Multilocus Sequence Typing; Plasmids; Serogroup; Survival Analysis; Virulence | 2016 |
Outbreak of KPC-3 Producing Carbapenem-Resistant Klebsiella pneumoniae in a US Pediatric Hospital.
Topics: Adolescent; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Child; Child, Preschool; Cross Infection; Disease Outbreaks; Drug Resistance, Bacterial; Female; Hospitals, Pediatric; Humans; Infant; Klebsiella Infections; Klebsiella pneumoniae; Male; Multilocus Sequence Typing; Polymerase Chain Reaction; United States | 2015 |
Outcomes and Risk Factors for Mortality among Patients Treated with Carbapenems for Klebsiella spp. Bacteremia.
Topics: Aged; Bacteremia; Carbapenems; Drug Resistance, Bacterial; Female; Humans; Klebsiella Infections; Length of Stay; Male; Middle Aged; Risk Factors; Severity of Illness Index; Treatment Outcome | 2015 |
Screening of nursing home residents for colonization with carbapenem-resistant Enterobacteriaceae admitted to acute care hospitals: Incidence and risk factors.
Topics: Adult; Aged; Aged, 80 and over; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Case-Control Studies; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Feces; Female; Hospitalization; Humans; Incidence; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Nursing Homes; Rhode Island; Risk Factors; Young Adult | 2016 |
Carbapenem-resistant Klebsiella pneumoniae isolates from Egypt containing blaNDM-1 on IncR plasmids and its association with rmtF.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Drug Resistance, Microbial; Egypt; Electrophoresis, Gel, Pulsed-Field; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Sequence Data; Multilocus Sequence Typing; Plasmids; Sequence Analysis, DNA | 2016 |
Emergence of tigecycline- and carbapenem-nonsusceptible Klebsiella pneumoniae ST11 clone in patients without exposure to tigecycline.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Female; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Male; Methyltransferases; Microbial Sensitivity Tests; Middle Aged; Minocycline; Multilocus Sequence Typing; Polymerase Chain Reaction; Tigecycline; Young Adult | 2016 |
KPC-Producing Klebsiella pneumoniae Isolates in Croatia: A Nationwide Survey.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Croatia; Disk Diffusion Antimicrobial Tests; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Gene Expression Regulation, Bacterial; Health Surveys; Humans; Incidence; Klebsiella Infections; Klebsiella pneumoniae; Molecular Epidemiology; Multilocus Sequence Typing; Plasmids; Polymerase Chain Reaction; Sequence Analysis, DNA | 2016 |
Klebsiella pneumoniae Isolate from a New York City Hospital Belonging to Sequence Type 258 and Carrying blaKPC-2 and blaVIM-4.
Topics: Adult; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Female; Hospitals, Urban; Humans; Klebsiella Infections; Klebsiella pneumoniae; Membrane Transport Proteins; Microbial Sensitivity Tests; New York City; Plasmids; Porins; Young Adult | 2016 |
Antibacterial Properties of Tebipenem Pivoxil Tablet, a New Oral Carbapenem Preparation against a Variety of Pathogenic Bacteria in Vitro and in Vivo.
Topics: Animals; Anti-Bacterial Agents; Carbapenems; Escherichia coli; Escherichia coli Infections; Female; Klebsiella Infections; Klebsiella pneumoniae; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Survival Analysis; Tablets | 2016 |
Phagocytosis and Killing of Carbapenem-Resistant ST258 Klebsiella pneumoniae by Human Neutrophils.
Topics: Animals; Bacterial Typing Techniques; Carbapenems; Drug Resistance, Bacterial; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Multilocus Sequence Typing; Neutrophils; Phagocytosis; Rabbits; Reactive Oxygen Species | 2016 |
Molecular characterisation and epidemiological investigation of an outbreak of blaOXA-181 carbapenemase-producing isolates of Klebsiella pneumoniae in South Africa.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Disease Outbreaks; Electrophoresis, Gel, Pulsed-Field; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Polymerase Chain Reaction; Prospective Studies; South Africa | 2015 |
Carbapenem-Resistant Klebsiella pneumoniae: Results of a Laboratory Surveillance Program in an Italian General Hospital (August 2014-January 2015) : Surveillance of Carbapenem-resistant Klebsiella pneumoniae.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Child; Child, Preschool; Cross Infection; Drug Resistance, Bacterial; Female; Humans; Infant; Italy; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Phylogeny; Young Adult | 2016 |
Survey of Carbapenemase-Producing Enterobacteriaceae in Companion Dogs in Madrid, Spain.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Dogs; Epidemiological Monitoring; Feces; Gene Expression; Humans; Integrons; Klebsiella Infections; Klebsiella pneumoniae; Pets; Plasmids; Prevalence; Spain | 2016 |
Risk factors and outcomes of carbapenem-resistant Klebsiella pneumoniae infections in liver transplant recipients.
Topics: Anti-Bacterial Agents; Carbapenems; Humans; Klebsiella Infections; Klebsiella pneumoniae; Liver Transplantation; Risk Factors | 2016 |
DETECTION OF NEW DELHI METALLO-BETA-LACTAMASE-1-PRODUCING KLEBSIELLA PNEUMONIAE AT A GENERAL HOSPITAL IN THAILAND.
Topics: Bacterial Proteins; beta-Lactamases; Carbapenems; Disk Diffusion Antimicrobial Tests; Hospitals, General; Humans; Klebsiella Infections; Klebsiella pneumoniae; Multiplex Polymerase Chain Reaction; Thailand | 2015 |
OXA-48 Producing Klebsiella pneumoniae in a Household Contact of a Previously Infected Patient: Person-to-Person Transmission or Coincidental Community Acquisition?
Topics: Adolescent; Anti-Bacterial Agents; Belgium; beta-Lactamases; Carbapenems; Community-Acquired Infections; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Family Characteristics; Female; Gene Expression; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Multilocus Sequence Typing; Plasmids; Sequence Analysis, DNA | 2016 |
[Progress on the current status and therapy of the carbapenem-resistant Klebsiella pneumoniae infection].
Topics: Carbapenems; Drug Resistance, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae | 2016 |
Risk factors associated with the transmission of carbapenem-resistant Enterobacteriaceae via contaminated duodenoscopes.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bile Duct Neoplasms; Carbapenems; Carrier State; Case-Control Studies; Child; Cholangiocarcinoma; Cholangiopancreatography, Endoscopic Retrograde; Drug Resistance, Bacterial; Duodenoscopes; Enterobacteriaceae; Enterobacteriaceae Infections; Equipment Contamination; Female; Hospitalization; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Odds Ratio; Retrospective Studies; Risk Factors; Stents; Young Adult | 2016 |
Fecal Carriage of Extended-Spectrum β-Lactamases in Healthy Humans, Poultry, and Wild Birds in León, Nicaragua-A Shared Pool of bla
Topics: Animals; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Carrier State; Clone Cells; Columbidae; Epidemiological Monitoring; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Falconiformes; Feces; Gene Expression Regulation, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Multilocus Sequence Typing; Nicaragua; Poultry; Sequence Analysis, DNA | 2016 |
Can carbapenem-resistant enterobacteriaceae susceptibility results obtained from surveillance cultures predict the susceptibility of a clinical carbapenem-resistant enterobacteriaceae?
Topics: Anti-Bacterial Agents; Carbapenems; Carrier State; Cohort Studies; Drug Resistance, Bacterial; Epidemiological Monitoring; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2016 |
A retrospective study of risk factors for carbapenem-resistant Klebsiella pneumoniae acquisition among ICU patients.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Case-Control Studies; Cross Infection; Female; Hospitals, Teaching; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Risk Factors; Tertiary Care Centers | 2016 |
The investigation of oxacillinase/metallo-beta-lactamase genes and clonal analysis in carbapenem-resistant Klebsiella pneumoniae.
Topics: Acinetobacter baumannii; Aged; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Clonal Evolution; Drug Resistance, Multiple, Bacterial; Female; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Turkey | 2016 |
Emergence of Klebsiella pneumoniae ST273 Carrying bla
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Female; Gene Expression; Genotype; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Molecular Epidemiology; Multilocus Sequence Typing; Multiplex Polymerase Chain Reaction; Philippines; Plasmids; Young Adult | 2016 |
High-level carbapenem-resistant OXA-48-producing Klebsiella pneumoniae with a novel OmpK36 variant and low-level, carbapenem-resistant, non-porin-deficient, OXA-181-producing Escherichia coli from Thailand.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; DNA Transposable Elements; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Fatal Outcome; Female; Genotype; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Molecular Typing; Porins; Thailand; Young Adult | 2016 |
Carbapenemase-producing Klebsiella pneumoniae: a major clinical challenge.
Topics: Azabicyclo Compounds; Bacterial Proteins; beta-Lactamases; Carbapenems; Ceftazidime; Drug Resistance, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Metronidazole; Middle Aged; Pancreatic Diseases; Teicoplanin | 2016 |
Appropriateness of empirical therapy in carbapenem-resistant Klebsiella pneumoniae intensive care unit acquired infection: role of surveillance cultures.
Topics: Adult; Aged; Anti-Bacterial Agents; Carbapenems; Cross Infection; Female; Humans; Inappropriate Prescribing; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Prospective Studies; Public Health Surveillance | 2016 |
Surveillance of antibiotic susceptibility in a Swedish Burn Center 1994-2012.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Anti-Bacterial Agents; Bacteremia; Burn Units; Burns; Carbapenems; Drug Resistance, Bacterial; Female; Gram-Negative Bacterial Infections; Humans; Klebsiella; Klebsiella Infections; Linear Models; Logistic Models; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections; Staphylococcal Infections; Sweden; Urinary Tract Infections; Wound Infection; Young Adult | 2016 |
Whole-Genome Comparative Analysis of Two Carbapenem-Resistant ST-258 Klebsiella pneumoniae Strains Isolated during a North-Eastern Ohio Outbreak: Differences within the High Heterogeneity Zones.
Topics: Anti-Bacterial Agents; Carbapenems; Cross Infection; Disease Outbreaks; Drug Resistance, Bacterial; Genetic Heterogeneity; Genome, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae | 2016 |
Epidemiology of carbapenem-resistant Klebsiella pneumoniae colonization: a surveillance study at a Turkish university hospital from 2009 to 2013.
Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Carrier State; Epidemiological Monitoring; Female; Hospitals, University; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Tertiary Care Centers; Turkey; Young Adult | 2016 |
Environmental sampling protocol devised and implemented to resolve a nosocomial outbreak due to carbapenem-resistant Klebsiella oxytoca.
Topics: Anti-Bacterial Agents; Bacteriological Techniques; beta-Lactam Resistance; Carbapenems; Cross Infection; Disease Outbreaks; Environmental Microbiology; Humans; Klebsiella Infections; Klebsiella oxytoca; Specimen Handling | 2016 |
Characterization of KPC-encoding plasmids from two endemic settings, Greece and Italy.
Topics: Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Endemic Diseases; Epidemics; Escherichia coli; Greece; Humans; Italy; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Multilocus Sequence Typing; Plasmids; Polymorphism, Restriction Fragment Length; Sequence Analysis, DNA | 2016 |
Rise and fall of KPC-producing Klebsiella pneumoniae in New York City.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Catheters; Cross Infection; Disease Outbreaks; DNA, Bacterial; Hospitals; Humans; Infection Control; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; New York City; Surveys and Questionnaires | 2016 |
Risk factors for infections due to carbapenem-resistant Klebsiella pneumoniae after open heart surgery.
Topics: Aged; beta-Lactam Resistance; Carbapenems; Cardiac Surgical Procedures; Female; Hospital Mortality; Humans; Italy; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Retrospective Studies; Risk Factors; Surgical Wound Infection; Survival Rate | 2016 |
mcr-1.2, a New mcr Variant Carried on a Transferable Plasmid from a Colistin-Resistant KPC Carbapenemase-Producing Klebsiella pneumoniae Strain of Sequence Type 512.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Child; China; Colistin; Drug Resistance, Bacterial; Escherichia coli; Estonia; Genetic Variation; Humans; Klebsiella Infections; Klebsiella pneumoniae; Plasmids; South Africa | 2016 |
Bloodstream infections caused by Klebsiella pneumoniae in onco-hematological patients: clinical impact of carbapenem resistance in a multicentre prospective survey.
Topics: Antibiotic Prophylaxis; Bacteremia; Carbapenems; Cohort Studies; Drug Resistance, Microbial; Female; Hematologic Neoplasms; Humans; Italy; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Prognosis; Proportional Hazards Models; Prospective Studies; Registries | 2016 |
In vitro activity of tigecycline in combination with rifampin, doripenem or ceftazidime against carbapenem-resistant Klebsiella pneumoniae bloodstream isolates.
Topics: Anti-Bacterial Agents; Carbapenems; Ceftazidime; Doripenem; Drug Resistance, Bacterial; Drug Synergism; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Minocycline; Rifampin; Tigecycline | 2017 |
Emergence of Multidrug-Resistant New Delhi Metallo-β-Lactamase-1-Producing Klebsiella pneumoniae in Egypt.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Egypt; Female; Gene Expression; Gene Transfer, Horizontal; Humans; Integrons; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Phylogeny; Plasmids | 2017 |
Using carbapenems for carbapenem-resistant Klebsiella pneumoniae-Are we flogging a dead (work)horse antibiotic?
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Horses; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Thienamycins | 2017 |
blaOXA-48 carrying clonal colistin resistant-carbapenem resistant Klebsiella pneumoniae in neonate intensive care unit, India.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cluster Analysis; Colistin; Cross Infection; Drug Resistance, Bacterial; Genotype; Humans; India; Infant, Newborn; Intensive Care Units, Neonatal; Klebsiella Infections; Klebsiella pneumoniae; Molecular Typing | 2016 |
Polymyxin B Resistance in Carbapenem-Resistant Klebsiella pneumoniae, São Paulo, Brazil.
Topics: Anti-Bacterial Agents; Brazil; Carbapenems; Drug Resistance, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Multilocus Sequence Typing; Polymyxin B; Population Surveillance | 2016 |
Metallo-beta-lactamase producing Escherichia coli and Klebsiella pneumoniae: A rising threat for hospitalized children.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Child; Child, Hospitalized; Escherichia coli; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Pakistan | 2016 |
ST147 NDM-1-producing Klebsiella pneumoniae spread in two Tunisian hospitals.
Topics: Adult; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Female; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Retrospective Studies; Tunisia; Urinary Tract Infections; Young Adult | 2017 |
Carbapenem-Resistant Klebsiella pneumoniae influences the outcome of early infections in liver transplant recipients.
Topics: Adult; Aged; Anti-Bacterial Agents; Carbapenems; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Humans; Italy; Klebsiella Infections; Klebsiella pneumoniae; Liver Transplantation; Male; Middle Aged; Mycoses; Retrospective Studies; Risk Factors; Surgical Wound Infection; Urinary Tract Infections | 2016 |
A cluster of KPC-2 and VIM-2-producing Klebsiella pneumoniae ST833 isolates from the pediatric service of a Venezuelan Hospital.
Topics: Bacterial Proteins; beta-Lactamases; Carbapenems; Child; Child, Preschool; Cross Infection; Drug Resistance, Bacterial; Female; Hospitals; Humans; Infant; Infant, Newborn; Integrons; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Molecular Epidemiology; Multilocus Sequence Typing; Pediatrics; Venezuela | 2016 |
Open Conversion after Aortic Endograft Infection Caused by Colistin-Resistant, Carbapenemase-Producing Klebsiella pneumoniae.
Topics: Anti-Bacterial Agents; Aortic Aneurysm, Abdominal; Aortography; Bacterial Proteins; beta-Lactamases; Blood Vessel Prosthesis; Blood Vessel Prosthesis Implantation; Carbapenems; Colistin; Computed Tomography Angiography; Device Removal; Drug Resistance, Bacterial; Endovascular Procedures; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Prosthesis-Related Infections; Treatment Outcome | 2016 |
Double-carbapenem regimen, alone or in combination with colistin, in the treatment of infections caused by carbapenem-resistant Klebsiella pneumoniae (CR-Kp).
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Colistin; Humans; Klebsiella Infections; Klebsiella pneumoniae | 2017 |
Mother-To-Child Transmission of KPC Carbapenemase-Producing Klebsiella Pneumoniae at Birth.
Topics: Adult; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Female; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Pregnancy | 2017 |
eComment. Diagnostic intricacies and fortuitous treatment approaches for carbapenem-resistant Klebsiella pneumoniae.
Topics: Anti-Bacterial Agents; Carbapenems; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2016 |
eReply. Diagnostic intricacies and fortuitous treatment approaches for carbapenem-resistant Klebsiella pneumoniae.
Topics: Anti-Bacterial Agents; Carbapenems; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2016 |
Previous bloodstream infections due to other pathogens as predictors of carbapenem-resistant Klebsiella pneumoniae bacteraemia in colonized patients: results from a retrospective multicentre study.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; Carbapenems; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Retrospective Studies; Risk Factors | 2017 |
Colistin Resistance in Carbapenem-Resistant Klebsiella pneumoniae: Laboratory Detection and Impact on Mortality.
Topics: Aged; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Colistin; Comorbidity; Female; Humans; Kaplan-Meier Estimate; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Phylogeny; Proportional Hazards Models | 2017 |
Epidemiology and biomolecular characterization of carbapenem-resistant
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Drug Resistance, Bacterial; Female; Humans; Italy; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Multilocus Sequence Typing; Retrospective Studies | 2016 |
Emergence of sequence type 11 Klebsiella pneumoniae coproducing NDM-1 and VIM-1 metallo-β-lactamases in a Greek hospital.
Topics: Bacterial Proteins; beta-Lactamases; Carbapenems; Greece; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2017 |
Evidence of transmission of an NDM-5-producing Klebsiella pneumoniae in a healthcare facility in New Zealand.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Disease Outbreaks; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Middle Aged; New Zealand | 2017 |
Epidemiology of Carbapenem-Resistant Klebsiella pneumoniae in a Network of Long-Term Acute Care Hospitals.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Comorbidity; Cross Infection; Drug Resistance, Bacterial; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Population Surveillance; United States; Young Adult | 2017 |
Detection of GES-5 Carbapenemase in Klebsiella pneumoniae, a Newcomer in France.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Chromosome Mapping; France; Gene Expression; Genome, Bacterial; Humans; Integrons; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Plasmids; Thailand | 2017 |
Strain-specific transmission in an outbreak of ESBL-producing Enterobacteriaceae in the hemato-oncology care unit: a cohort study.
Topics: Adult; Aged; beta-Lactamases; Carbapenems; Cohort Studies; Disease Outbreaks; Electrophoresis, Gel, Pulsed-Field; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Female; Hospital Units; Humans; Japan; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Typing; Polymerase Chain Reaction; Young Adult | 2017 |
E152A substitution drastically affects NDM-5 activity.
Topics: Amino Acid Substitution; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenems; Catalytic Domain; Drug Resistance, Multiple, Bacterial; Escherichia coli; Glutamic Acid; Hydrolysis; Kinetics; Klebsiella Infections; Klebsiella pneumoniae; Mutation | 2017 |
Prospective study analyzing risk factors and characteristics of healthcare-associated infections in a Urology ward.
Topics: Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Catheters, Indwelling; Cross Infection; Cystectomy; Drug Resistance, Microbial; Enterococcus; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Hospital Units; Humans; Immunosuppression Therapy; Incidence; Klebsiella; Klebsiella Infections; Male; Middle Aged; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Risk Factors; Surgical Wound Infection; Urinary Catheters; Urinary Tract Infections; Urology; Vancomycin | 2017 |
[Clonal relationship and detection of blaKPC gene in strains of Klebsiella pneumoniae resistant to carbapenems, at a hospital in Venezuela].
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Clone Cells; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Polymerase Chain Reaction; Venezuela | 2016 |
Colistin- and carbapenem-resistant Klebsiella oxytoca harboring bla
Topics: Adult; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Blood; Blood Culture; Carbapenems; Colistin; Drug Resistance, Bacterial; Female; Humans; Klebsiella Infections; Klebsiella oxytoca; Membrane Proteins; Mutagenesis, Insertional; Plasmids | 2017 |
Nosocomial transmission of carbapenem-resistant Klebsiella pneumoniae elucidated by single-nucleotide variation analysis: a case investigation.
Topics: Aged, 80 and over; beta-Lactam Resistance; Carbapenems; Cross Infection; Genotyping Techniques; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Molecular Epidemiology; Molecular Typing | 2017 |
Factors associated with carriage of carbapenem-non-susceptible Enterobacteriaceaein North-Eastern France and outcomes of infected patients.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Carrier State; Case-Control Studies; Cross Infection; Enterobacter cloacae; Enterobacteriaceae Infections; Female; France; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Risk Factors | 2017 |
Carbapenem MICs in Escherichia coli and Klebsiella Species Producing Extended-Spectrum β-Lactamases in Critical Care Patients from 2001 to 2009.
Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Critical Care; Doripenem; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Gene Expression; Genotype; Humans; Imipenem; Klebsiella; Klebsiella Infections; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Thienamycins; United States | 2017 |
Extended spectrum beta lactamase producing organisms causing urinary tract infections in Sri Lanka and their antibiotic susceptibility pattern -A hospital based cross sectional study.
Topics: Anti-Infective Agents; beta-Lactamases; Carbapenems; Cross Infection; Cross-Sectional Studies; Escherichia coli; Escherichia coli Infections; Female; Hospitals, Teaching; Humans; Incidence; Klebsiella; Klebsiella Infections; Male; Microbial Sensitivity Tests; Middle Aged; Prevalence; Sri Lanka; Urinary Tract Infections | 2017 |
Double-carbapenem combination as salvage therapy for untreatable infections by KPC-2-producing Klebsiella pneumoniae.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Catheter-Related Infections; Female; Greece; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Middle Aged; Prospective Studies; Salvage Therapy; Thienamycins; Treatment Outcome; Urinary Tract Infections; Young Adult | 2017 |
Does Second Place Count? Lessons from a Major Discrepancy Between Carbapenem-Resistant Klebsiella pneumoniae and Carbapenem-Resistant Enterobacter cloacae in a One-Year Follow-Up Study.
Topics: Brazil; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Enterobacter cloacae; Enterobacteriaceae Infections; Follow-Up Studies; Humans; Klebsiella Infections; Klebsiella pneumoniae; Retrospective Studies; Tertiary Care Centers | 2017 |
Carbapenem-resistant Klebsiella pneumoniae in high-risk haematological patients: factors favouring spread, risk factors and outcome of carbapenem-resistant Klebsiella pneumoniae bacteremias.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Carbapenems; Community-Acquired Infections; Drug Resistance, Bacterial; Female; Hematologic Neoplasms; Hospitals, Teaching; Humans; Infection Control; Italy; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Retrospective Studies; Risk Factors; Treatment Outcome | 2017 |
Spread of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae isolates in Istanbul, Turkey.
Topics: Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Models, Genetic; Turkey | 2008 |
Predictors of mortality from community-onset bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Community-Acquired Infections; Escherichia coli; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Predictive Value of Tests | 2008 |
Evaluation of CHROMagar KPC for rapid detection of carbapenem-resistant Enterobacteriaceae.
Topics: Bacteriological Techniques; beta-Lactam Resistance; Carbapenems; Culture Media; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Polymerase Chain Reaction; Sensitivity and Specificity | 2008 |
Plasmid-encoded carbapenem-hydrolyzing beta-lactamase OXA-48 in an imipenem-susceptible Klebsiella pneumoniae strain from Belgium.
Topics: Adult; Anti-Bacterial Agents; Belgium; beta-Lactamases; beta-Lactams; Carbapenems; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Plasmids | 2008 |
Use of active surveillance cultures to detect asymptomatic colonization with carbapenem-resistant Klebsiella pneumoniae in intensive care unit patients.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Carrier State; Cross Infection; Culture Media; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; New York City; Population Surveillance | 2008 |
Oxacillinase-mediated resistance to carbapenems in Klebsiella pneumoniae from Lebanon.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Child; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Lebanon; Microbial Sensitivity Tests | 2008 |
Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies.
Topics: Aged; Anti-Infective Agents; Carbapenems; Case-Control Studies; Drug Resistance, Bacterial; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; New York City; Risk Factors; Treatment Outcome | 2008 |
First report on a hyperepidemic clone of KPC-3-producing Klebsiella pneumoniae in Israel genetically related to a strain causing outbreaks in the United States.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Disease Outbreaks; Drug Resistance, Bacterial; Israel; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Reverse Transcriptase Polymerase Chain Reaction; United States | 2009 |
A VIM-1 metallo-beta-lactamase-producing Klebsiella pneumoniae clinical isolate in an acute hospital in Germany.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Gene Order; Genes, Bacterial; Germany; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Plasmids | 2009 |
Emergence of clonally related Klebsiella pneumoniae isolates of sequence type 258 producing plasmid-mediated KPC carbapenemase in Norway and Sweden.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Blotting, Southern; Carbapenems; DNA Fingerprinting; DNA Transposable Elements; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Norway; Plasmids; Sequence Analysis, DNA; Sweden | 2009 |
Prospective observational study of the impact of VIM-1 metallo-beta-lactamase on the outcome of patients with Klebsiella pneumoniae bloodstream infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Female; Greece; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Young Adult | 2009 |
Cluster of bloodstream infections caused by KPC-2 carbapenemase-producing Klebsiella pneumoniae in Manhattan.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Bacterial Typing Techniques; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cluster Analysis; Cross Infection; DNA Fingerprinting; DNA, Bacterial; Female; Genotype; Hospitals; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; New York City; Polymyxin B; Ribotyping; Sequence Analysis, DNA | 2009 |
Fatal cross infection by carbapenem-resistant Klebsiella in two liver transplant recipients.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Fatal Outcome; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Liver Transplantation; Male; Middle Aged | 2009 |
Genetic organization of transposase regions surrounding blaKPC carbapenemase genes on plasmids from Klebsiella strains isolated in a New York City hospital.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; DNA Transposable Elements; Drug Resistance, Bacterial; Hospitals, Urban; Humans; Isoenzymes; Klebsiella Infections; Klebsiella oxytoca; Klebsiella pneumoniae; Microbial Sensitivity Tests; New York City; Plasmids; Transposases | 2009 |
Decreased susceptibility to polymyxin B during treatment for carbapenem-resistant Klebsiella pneumoniae infection.
Topics: Ascitic Fluid; Blood; Carbapenems; Cerebrospinal Fluid; Drug Resistance, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Polymyxin B; United States | 2009 |
Success of an infection control program to reduce the spread of carbapenem-resistant Klebsiella pneumoniae.
Topics: Anti-Bacterial Agents; Carbapenems; Culture Media; Drug Resistance, Bacterial; Hospitals, Urban; Humans; Incidence; Infection Control; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; New York City; Population Surveillance; Program Evaluation; Rectum | 2009 |
Carbapenem-resistant Klebsiella pneumoniae endocarditis in a young adult. Successful treatment with gentamicin and colistin.
Topics: Adolescent; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Colistin; Drug Therapy, Combination; Endocarditis, Bacterial; Gentamicins; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Treatment Outcome | 2009 |
Oscar the cat, carbapenem-resistant Klebsiella pneumoniae, and attributable mortality.
Topics: Animals; Anti-Bacterial Agents; Carbapenems; Cats; Drug Resistance, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Nursing Homes; Predictive Value of Tests; Rhode Island; Virulence | 2009 |
Klebsiella pneumoniae Carbapenemase, Canada.
Topics: Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Canada; Carbapenems; Fatal Outcome; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Sputum; Urine | 2009 |
KPC-2-producing Klebsiella pneumoniae infections in Greek hospitals are mainly due to a hyperepidemic clone.
Topics: Amidohydrolases; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Disease Outbreaks; DNA, Bacterial; Drug Resistance, Bacterial; Genotype; Greece; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Population Surveillance | 2009 |
Klebsiella pneumoniae Carbapenemase-producing Enterobacteriaceae, Northeast Florida.
Topics: Adult; Aged; Aged, 80 and over; Bacterial Proteins; beta-Lactamases; Carbapenems; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Florida; Genotype; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Young Adult | 2009 |
Carbapenem resistance among Klebsiella pneumoniae isolates: risk factors, molecular characteristics, and susceptibility patterns.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Female; Humans; Israel; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Prevalence; Risk Factors | 2009 |
Re: A VIM-1-metallo-beta-lactamase-producing Klebsiella pneumoniae clinical isolate in an acute hospital in Germany.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Germany; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2009 |
Emergence of carbapenem-non-susceptible extended-spectrum beta-lactamase-producing Klebsiella pneumoniae isolates at the university hospital of Tübingen, Germany.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Electrophoresis, Polyacrylamide Gel; Germany; Humans; Klebsiella Infections; Klebsiella pneumoniae; Mass Spectrometry; Porins | 2009 |
Carbapenem resistance in Canada.
Topics: Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Canada; Carbapenems; Humans; Klebsiella Infections; Klebsiella pneumoniae | 2009 |
Contribution of OmpK36 to carbapenem susceptibility in KPC-producing Klebsiella pneumoniae.
Topics: Bacterial Proteins; Base Sequence; beta-Lactam Resistance; beta-Lactamases; Carbapenems; DNA Primers; DNA, Bacterial; Gene Expression; Genes, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Molecular Sequence Data; Porins | 2009 |
Klebsiellapneumoniae isolates possessing KPC beta-lactamase in Israel, Puerto Rico, Colombia and Greece.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Colombia; Drug Resistance, Bacterial; Greece; Humans; Israel; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Minocycline; Population Surveillance; Puerto Rico; Tigecycline | 2009 |
Characterization of Klebsiella pneumoniae producing SHV-12 and DHA-1 beta-lactamases accompanied by carbapenem resistance during hospitalization in a chronic care ward in Japan.
Topics: Aged; Aged, 80 and over; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Hospitalization; Hospitals, General; Humans; Japan; Klebsiella Infections; Klebsiella pneumoniae | 2009 |
Attributable mortality rate for carbapenem-resistant Klebsiella pneumoniae bacteremia.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Carbapenems; Case-Control Studies; Drug Resistance, Bacterial; Female; Hospital Mortality; Hospitals, Teaching; Humans; Israel; Klebsiella Infections; Klebsiella pneumoniae; Male; Matched-Pair Analysis; Microbial Sensitivity Tests; Middle Aged | 2009 |
Combination of IMP-4 metallo-beta-lactamase production and porin deficiency causes carbapenem resistance in a Klebsiella oxytoca clinical isolate.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; China; Conjugation, Genetic; Electrophoresis, Polyacrylamide Gel; Escherichia coli; Gene Transfer, Horizontal; Hospitals; Humans; Isoelectric Focusing; Klebsiella Infections; Klebsiella oxytoca; Microbial Sensitivity Tests; Plasmids; Porins; Sequence Analysis, DNA | 2009 |
Carriage rate of carbapenem-resistant Klebsiella pneumoniae in hospitalised patients during a national outbreak.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactam Resistance; Carbapenems; Carrier State; Case-Control Studies; Child; Child, Preschool; Disease Outbreaks; DNA Fingerprinting; Electrophoresis, Gel, Pulsed-Field; Female; Humans; Infant; Infant, Newborn; Israel; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Predictive Value of Tests; Prevalence; Rectum; Risk Factors; Sensitivity and Specificity; Young Adult | 2010 |
The spread of Klebsiella pneumoniae carbapenemases: a tale of strains, plasmids, and transposons.
Topics: Bacterial Proteins; beta-Lactamases; Carbapenems; DNA Transposable Elements; Drug Resistance, Bacterial; Escherichia coli; Gene Transfer, Horizontal; Humans; Klebsiella Infections; Klebsiella pneumoniae; Plasmids; Polymerase Chain Reaction; Serratia marcescens | 2009 |
Interspecies spread of Klebsiella pneumoniae carbapenemase gene in a single patient.
Topics: Adult; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Escherichia coli; Female; Gene Transfer, Horizontal; Humans; Klebsiella Infections; Klebsiella pneumoniae; Plasmids; Polymerase Chain Reaction; Serratia marcescens | 2009 |
Plasmid pKpQIL encoding KPC-3 and TEM-1 confers carbapenem resistance in an extremely drug-resistant epidemic Klebsiella pneumoniae strain.
Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Bacterial Proteins; beta-Lactamases; Carbapenems; Disease Outbreaks; DNA Transposable Elements; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Humans; Israel; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Plasmids; Polymerase Chain Reaction | 2010 |
Genesis of a KPC-producing Klebsiella pneumoniae after in vivo transfer from an imported Greek strain.
Topics: Aged; beta-Lactamases; Carbapenems; Catheterization; Cross Infection; Drug Resistance, Bacterial; France; Greece; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Male; Transformation, Bacterial | 2010 |
Successful control of an outbreak of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae at a long-term acute care hospital.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Chlorhexidine; Culture Media; Disease Outbreaks; Hospitals; Humans; Infection Control; Klebsiella Infections; Klebsiella pneumoniae; Long-Term Care; Microbial Sensitivity Tests; Patient Isolation; Population Surveillance; Prevalence | 2010 |
In vitro activities of fosfomycin and carbapenem combinations against carbapenem non-susceptible Escherichia coli and Klebsiella pneumoniae.
Topics: Anti-Bacterial Agents; Carbapenems; Drug Resistance, Bacterial; Drug Synergism; Escherichia coli; Escherichia coli Infections; Fosfomycin; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2010 |
Outbreak of carbapenem-resistant Klebsiella pneumoniae in Puerto Rico associated with a novel carbapenemase variant.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Case-Control Studies; Disease Outbreaks; Drug Resistance, Bacterial; Female; Genetic Variation; Hospitals, Teaching; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Puerto Rico; Risk Factors | 2010 |
Molecular epidemiology, sequence types, and plasmid analyses of KPC-producing Klebsiella pneumoniae strains in Israel.
Topics: Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Humans; Israel; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Epidemiology; Phylogeny; Plasmids; Polymerase Chain Reaction | 2010 |
Carbapenem-resistant Klebsiella pneumoniae bacteremia: factors correlated with clinical and microbiologic outcomes.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; Carbapenems; Cohort Studies; Female; Humans; Infection Control; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Retrospective Studies; Shock, Septic; Treatment Outcome | 2010 |
Plasmid-mediated carbapenem-hydrolysing OXA-48 beta-lactamase in Klebsiella pneumoniae from Tunisia.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Plasmids; Tunisia | 2010 |
In vitro double and triple bactericidal activities of doripenem, polymyxin B, and rifampin against multidrug-resistant Acinetobacter baumannii, Pseudomonas aeruginosa, Klebsiella pneumoniae, and Escherichia coli.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Doripenem; Drug Combinations; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; In Vitro Techniques; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Polymyxin B; Pseudomonas aeruginosa; Pseudomonas Infections; Rifampin | 2010 |
Potential role of active surveillance in the control of a hospital-wide outbreak of carbapenem-resistant Klebsiella pneumoniae infection.
Topics: Carbapenems; Communicable Disease Control; Cross Infection; Disease Outbreaks; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Hospital Mortality; Hospitals, Teaching; Humans; Israel; Klebsiella Infections; Klebsiella pneumoniae; Population Surveillance | 2010 |
Endoscopy-associated transmission of carbapenem-resistant Klebsiella pneumoniae producing KPC-2 beta-lactamase.
Topics: Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cross Infection; Endoscopy; Humans; Klebsiella Infections; Klebsiella pneumoniae | 2010 |
Emergence of a colistin-resistant KPC-2-producing Klebsiella pneumoniae ST258 clone in Hungary.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; beta-Lactamases; Carbapenems; Cluster Analysis; Colistin; DNA Fingerprinting; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Genotype; Humans; Hungary; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Polymerase Chain Reaction | 2010 |
Incidence and antimicrobial susceptibility of Escherichia coli and Klebsiella pneumoniae with extended-spectrum beta-lactamases in community- and hospital-associated intra-abdominal infections in Europe: results of the 2008 Study for Monitoring Antimicrob
Topics: Abdomen; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cross Infection; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae | 2010 |
[Molecular epidemiology of carbapenem-resistant Klebsiella pneumoniae strains isolated between 2004-2007 in Ankara University Hospital, Turkey].
Topics: beta-Lactam Resistance; Carbapenems; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Hospitals, University; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Restriction Mapping; Turkey | 2010 |
Emergence of bla KPC-3-Tn4401a associated with a pKPN3/4-like plasmid within ST384 and ST388 Klebsiella pneumoniae clones in Spain.
Topics: Adolescent; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; DNA Transposable Elements; DNA, Bacterial; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Nucleic Acid Hybridization; Plasmids; Polymerase Chain Reaction; Restriction Mapping; Sequence Analysis, DNA; Spain | 2010 |
Carbapenem-resistant Acinetobacter baumannii and Klebsiella pneumoniae across a hospital system: impact of post-acute care facilities on dissemination.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactam Resistance; Carbapenems; Child; Cross Infection; DNA Fingerprinting; DNA, Bacterial; Female; Genes, Bacterial; Genotype; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Epidemiology; Molecular Sequence Data; Ohio; Sequence Analysis, DNA; Young Adult | 2010 |
Development of high-level carbapenem resistance in Klebsiella pneumoniae among patients with prolonged hospitalization and carbapenem exposure.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Drug Resistance, Bacterial; Female; Hospitalization; Humans; Klebsiella Infections; Klebsiella pneumoniae; Length of Stay; Male; Microbial Sensitivity Tests; Middle Aged; Taiwan | 2010 |
Carbapenem-nonsusceptible strains of Klebsiella pneumoniae producing SHV-5 and/or DHA-1 beta-lactamases in a Czech hospital.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; beta-Lactamases; Carbapenems; Czech Republic; Drug Resistance, Bacterial; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2010 |
First detection of oxacillinase-mediated resistance to carbapenems in Klebsiella pneumoniae from Morocco.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Morocco | 2010 |
In vivo efficacy of simulated human dosing regimens of prolonged-infusion doripenem against carbapenemase- producing Klebsiella pneumoniae.
Topics: Animals; Anti-Bacterial Agents; Carbapenems; Doripenem; Female; Humans; Immunocompetence; Immunocompromised Host; Klebsiella Infections; Klebsiella pneumoniae; Mice; Mice, Inbred ICR; Thigh | 2010 |
Hospital outbreak caused by Klebsiella pneumoniae producing KPC-2 beta-lactamase resistant to colistin.
Topics: Adult; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Colistin; Cross Infection; Disease Outbreaks; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Female; Genotype; Greece; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Polymerase Chain Reaction | 2010 |
[Carbapenemases in enterobacteriaceae].
Topics: Asia; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance; Enterobacteriaceae; Enterobacteriaceae Infections; Europe; Greece; Israel; Klebsiella Infections; Klebsiella pneumoniae; Prevalence | 2010 |
Carbapenem Heteroresistance in VIM-1-producing Klebsiella pneumoniae isolates belonging to the same clone: consequences for routine susceptibility testing.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; beta-Lactamases; Carbapenems; DNA Fingerprinting; Genetic Variation; Genotype; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Phenotype | 2010 |
[Carbapenem-resistant Klebsiella pneumoniae following foreign travel].
Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Mutation; Travel | 2010 |
Emergence of carbapenem resistance due to porin loss in an extended-spectrum β-lactamase (ESBL)-producing Klebsiella pneumoniae strain during meropenem therapy.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Electrophoresis, Polyacrylamide Gel; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Middle Aged; Porins; Thienamycins | 2010 |
Multiclonal emergence of carbapenem-resistant Klebsiella pneumoniae in Tuscany, Italy.
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactam Resistance; beta-Lactamases; Carbapenems; DNA Fingerprinting; Electrophoresis, Gel, Pulsed-Field; Genotype; Humans; Italy; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Epidemiology; Phenotype | 2010 |
Recurrent healthcare-associated community-onset infections due to Klebsiella pneumoniae producing VIM-1 metallo-beta-lactamase.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Community-Acquired Infections; Cross Infection; Electrophoresis, Gel, Pulsed-Field; Female; Greece; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Plasmids; Polymerase Chain Reaction; Recurrence; Sequence Analysis, DNA; Urinary Tract Infections | 2010 |
Carabapenem-resistant bacteria a looming threat in Canada.
Topics: Canada; Carbapenems; Disease Outbreaks; Drug Resistance, Bacterial; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Risk Assessment | 2010 |
A carbapenem-resistant Klebsiella pneumoniae isolate harboring KPC-1 from Italy.
Topics: Aged, 80 and over; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Female; Humans; Italy; Klebsiella Infections; Klebsiella pneumoniae | 2010 |
Changing epidemiology of carbapenem-resistant Enterobacteriaceae carriage during an outbreak of carbapenem-resistant Klebsiella pneumoniae.
Topics: beta-Lactam Resistance; Carbapenems; Carrier State; Disease Outbreaks; Enterobacteriaceae; Humans; Klebsiella Infections; Klebsiella pneumoniae | 2010 |
Bloodstream infections caused by metallo-β-lactamase/Klebsiella pneumoniae carbapenemase-producing K. pneumoniae among intensive care unit patients in Greece: risk factors for infection and impact of type of resistance on outcomes.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; APACHE; Bacteremia; Bacterial Proteins; beta-Lactamases; Carbapenems; Case-Control Studies; Cross Infection; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Female; Greece; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Male; Metalloproteins; Middle Aged; Multivariate Analysis; Polymerase Chain Reaction; Risk Factors; Treatment Outcome; Young Adult | 2010 |
[Carbapenem resistance in gram-negative bacteria].
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Carrier State; Colony Count, Microbial; Cross Infection; Humans; Klebsiella Infections; Klebsiella pneumoniae; Prevalence | 2010 |
Genetic characterization of ESBL producing strains of Klebsiella pneumoniae from Tehran hospitals.
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactamases; Carbapenems; Cluster Analysis; Cross Infection; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Genotype; Hospitals; Humans; Iran; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Typing; Polymerase Chain Reaction; Polymorphism, Genetic | 2010 |
SCT in patients with carbapenem resistant Klebsiella pneumoniae: a single center experience with oral gentamicin for the eradication of carrier state.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Carbapenems; Cohort Studies; Drug Resistance, Bacterial; Female; Gastrointestinal Tract; Gentamicins; Hematologic Diseases; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Pilot Projects; Stem Cell Transplantation | 2011 |
Resistance status and evolution trends of Klebsiella pneumoniae isolates in a university hospital in Greece: ineffectiveness of carbapenems and increasing resistance to colistin.
Topics: Anti-Bacterial Agents; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Greece; Hospitals, University; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2010 |
Detection of NDM-1-producing Klebsiella pneumoniae in Kenya.
Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Humans; Kenya; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Polymerase Chain Reaction | 2011 |
Outbreak of colistin-resistant, carbapenem-resistant Klebsiella pneumoniae in metropolitan Detroit, Michigan.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Colistin; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Female; Genotype; Hospitals, University; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Michigan; Microbial Sensitivity Tests; Polymerase Chain Reaction | 2011 |
[Fatal pneumonia caused by carbapenem resistant Klebsiella pneumoniae].
Topics: Carbapenems; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Fatal Outcome; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Bacterial | 2010 |
Comparative effects of carbapenems on bacterial load and host immune response in a Klebsiella pneumoniae murine pneumonia model.
Topics: Animals; Anti-Bacterial Agents; Bacterial Load; beta-Lactamases; Carbapenems; Cytokines; Disease Models, Animal; Doripenem; Female; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Lung; Meropenem; Mice; Mice, Inbred C3H; Microbial Sensitivity Tests; Pneumonia, Bacterial; Thienamycins; Treatment Outcome | 2011 |
First identified case of VIM-producing carbapenem-resistant Klebsiella pneumoniae in the Republic of Ireland associated with fatal outcome.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Encephalitis, Herpes Simplex; Fatal Outcome; Female; Humans; Ireland; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Middle Aged; Sequence Analysis | 2010 |
Plasmid-mediated carbapenem-hydrolysing β-lactamase KPC-2 in a Klebsiella pneumoniae isolate from Switzerland.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Genes, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Plasmids; Switzerland | 2011 |
Detection of an Ambler class D OXA-48-type β-lactamase in a Klebsiella pneumoniae strain in The Netherlands.
Topics: beta-Lactam Resistance; beta-Lactamases; Carbapenems; Fatal Outcome; Humans; India; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Netherlands; Pneumonia, Bacterial; Travel | 2011 |
New Delhi metallo-β-lactamase and multidrug resistance: a global SOS?
Topics: Anti-Bacterial Agents; Australia; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Female; Humans; India; Klebsiella Infections; Klebsiella pneumoniae; Urinary Tract Infections | 2011 |
Carbapenem resistance in Klebsiella pneumoniae due to the New Delhi Metallo-β-lactamase.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Australia; Bacterial Typing Techniques; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Female; Humans; India; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Multilocus Sequence Typing; Urinary Tract Infections | 2011 |
Risk factors for the acquisition of nosocomial infection with carbapenem-resistant Klebsiella pneumoniae.
Topics: Age Factors; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Case-Control Studies; Chi-Square Distribution; Confidence Intervals; Cross Infection; Drug Resistance, Bacterial; Ertapenem; Female; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Length of Stay; Logistic Models; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Odds Ratio; Risk Factors; Thienamycins | 2011 |
New Delhi metallo-beta-lactamase, Ontario, Canada.
Topics: Adult; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Canada; Carbapenems; Female; Humans; India; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Ontario; Travel; Urinary Tract Infections | 2011 |
Containment of a country-wide outbreak of carbapenem-resistant Klebsiella pneumoniae in Israeli hospitals via a nationally implemented intervention.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Cross Infection; Disease Outbreaks; Health Policy; Hospitals; Humans; Incidence; Infection Control; Israel; Klebsiella Infections; Klebsiella pneumoniae | 2011 |
Phenotypic and genotypic screening and clonal analysis of carbapenem-resistant Klebsiella pneumoniae at a single hospital.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; DNA, Bacterial; Doripenem; Electrophoresis, Gel, Pulsed-Field; Ertapenem; Genotype; Hospitals, Urban; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Phylogeny; Polymerase Chain Reaction; Sensitivity and Specificity; Thienamycins; United States | 2011 |
[Investigation of the susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. strains to ertapenem and other carbapenems].
Topics: Amikacin; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Ertapenem; Escherichia coli; Escherichia coli Infections; Humans; Imipenem; Klebsiella Infections; Klebsiella oxytoca; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Thienamycins | 2011 |
Outbreak of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae isolates in France.
Topics: beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; France; Humans; Klebsiella Infections; Klebsiella pneumoniae | 2011 |
Rapid increase of carbapenemase-producing Klebsiella pneumoniae strains in a large Italian hospital: surveillance period 1 March - 30 September 2010.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Hospital Bed Capacity, 500 and over; Hospitalization; Hospitals, University; Humans; Incidence; Italy; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Phenotype; Polymerase Chain Reaction; Population Surveillance | 2011 |
Transfer of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae from Turkey to France.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Female; France; Humans; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Pregnancy; Pregnancy Complications, Infectious; Turkey | 2011 |
Outbreak of Klebsiella pneumoniae carbapenemase 2-producing K. pneumoniae with high qnr prevalence in a Chinese hospital.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; China; Drug Resistance, Bacterial; Gene Expression Regulation, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae | 2011 |
Treatment and outcomes in carbapenem-resistant Klebsiella pneumoniae bloodstream infections.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Minocycline; Prognosis; Retrospective Studies; Tigecycline; Treatment Outcome | 2011 |
Carbapenem therapy for bacteremia due to extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella pneumoniae.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; beta-Lactams; Carbapenems; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Middle Aged; Thienamycins; Treatment Outcome | 2011 |
Plasmid comparison and molecular analysis of Klebsiella pneumoniae harbouring bla(KPC) from New York City and Toronto.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Bacterial Typing Techniques; beta-Lactam Resistance; beta-Lactamases; Canada; Carbapenems; Electrophoresis, Gel, Pulsed-Field; Female; Gene Transfer, Horizontal; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Epidemiology; Molecular Typing; Multilocus Sequence Typing; New York City; Plasmids; Transformation, Bacterial | 2011 |
Double-carbapenem therapy for carbapenemase-producing Klebsiella pneumoniae.
Topics: Animals; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Therapy, Combination; Female; Klebsiella Infections; Klebsiella pneumoniae; Mice; Mice, Inbred ICR | 2011 |
Extended spectrum beta lactamase producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes.
Topics: Adult; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Microbial; Escherichia coli; Escherichia coli Infections; Female; Hospitalization; Hospitals, University; Humans; India; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Prevalence; Risk Factors; Treatment Outcome; Young Adult | 2010 |
Molecular and epidemiological analysis of nosocomial carbapenem-resistant Klebsiella spp. using repetitive extragenic palindromic-polymerase chain reaction and matrix-assisted laser desorption/ionization-time of flight.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Female; Humans; Klebsiella; Klebsiella Infections; Male; Microbial Sensitivity Tests; Middle Aged; Polymerase Chain Reaction; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2011 |
Institutional control measures to curtail the epidemic spread of carbapenem-resistant Klebsiella pneumoniae: a 4-year perspective.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Carrier State; Cross Infection; Epidemics; Hospitals, University; Humans; Infection Control; Israel; Klebsiella Infections; Klebsiella pneumoniae; Patient Isolation; Population Surveillance; Prospective Studies | 2011 |
Does it ever make sense to treat a bacterial infection with a drug against which the responsible pathogen possesses a resistance mechanism?
Topics: Animals; Anti-Bacterial Agents; Antitubercular Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Methicillin-Resistant Staphylococcus aureus; Mycobacterium tuberculosis; Staphylococcal Infections; Staphylococcus aureus | 2011 |
Molecular detection and epidemiology of extended-spectrum beta-lactamase genes prevalent in clinical isolates of Klebsiella pneumoniae and E coli from Trinidad and Tobago.
Topics: Aminoglycosides; beta-Lactamases; Carbapenems; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Phenotype; Polymerase Chain Reaction; Trinidad and Tobago | 2010 |
Outcome of carbapenem resistant Klebsiella pneumoniae bloodstream infections.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Sepsis | 2012 |
Klebsiella pneumoniae: development of a mixed population of carbapenem and tigecycline resistance during antimicrobial therapy in a kidney transplant patient.
Topics: Aged; Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; beta-Lactamases; Carbapenems; Chromosome Mapping; Cross Infection; Drug Resistance, Multiple, Bacterial; Humans; Kidney Transplantation; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Minocycline; Sequence Analysis, DNA; Tigecycline; Urinary Tract Infections | 2012 |
Molecular analysis of population structure and antibiotic resistance of Klebsiella isolates from a three-year surveillance program in Florence hospitals, Italy.
Topics: Amplified Fragment Length Polymorphism Analysis; Carbapenems; Disease Outbreaks; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Humans; Italy; Klebsiella; Klebsiella Infections; Molecular Typing | 2012 |
Spread of carbapenem-resistant Klebsiella pneumoniae in a tertiary hospital in Sao Paulo, Brazil.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; Brazil; Carbapenems; Child; Child, Preschool; Cross Infection; Disease Outbreaks; Female; Genotype; Hospitals, Teaching; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Young Adult | 2011 |
First isolation and outbreak of OXA-48-producing Klebsiella pneumoniae in an Irish hospital, March to June 2011.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cross Infection; Disease Outbreaks; Female; Hospitals, University; Humans; Intensive Care Units; Ireland; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Polymerase Chain Reaction; Treatment Outcome | 2011 |
OmpK26, a novel porin associated with carbapenem resistance in Klebsiella pneumoniae.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Base Sequence; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Gene Knockout Techniques; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Sequence Data; Porins; Sequence Alignment; Sequence Analysis, DNA | 2011 |
Carbapenem-resistant Klebsiella pneumoniae in post-acute-care facilities in Israel.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Carrier State; Case-Control Studies; Child; Cross-Sectional Studies; Female; Humans; Infection Control; Israel; Klebsiella Infections; Klebsiella pneumoniae; Length of Stay; Male; Middle Aged; Prevalence; Risk Factors; Skilled Nursing Facilities; Young Adult | 2011 |
An effective intervention to limit the spread of an epidemic carbapenem-resistant Klebsiella pneumoniae strain in an acute care setting: from theory to practice.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Cross Infection; Epidemics; Hospitals, University; Humans; Incidence; Infection Control; Israel; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Program Evaluation | 2011 |
Containment of an outbreak of KPC-3-producing Klebsiella pneumoniae in Italy.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cluster Analysis; Cross Infection; Disease Outbreaks; Electrophoresis, Gel, Pulsed-Field; Humans; Infection Control; Intensive Care Units; Italy; Klebsiella Infections; Klebsiella pneumoniae; Molecular Typing | 2011 |
Risk factors for developing clinical infection with carbapenem-resistant Klebsiella pneumoniae in hospital patients initially only colonized with carbapenem-resistant K pneumoniae.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Case-Control Studies; Cross Infection; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Risk Factors | 2012 |
Carbapenem-hydrolyzing class D β-lactamase OXA-48 in Klebsiella pneumoniae isolates from Tunisia.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Plasmids; Tunisia; Urine | 2012 |
Emergence of NDM-1-producing Klebsiella pneumoniae in Morocco.
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cluster Analysis; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Genotype; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Morocco; Multilocus Sequence Typing; Plasmids; Polymerase Chain Reaction; Sequence Analysis, DNA | 2011 |
Novel KPC variant from a carbapenem-resistant strain of Klebsiella pneumoniae in a Chinese hospital.
Topics: Aged, 80 and over; beta-Lactamases; Carbapenems; China; Databases, Nucleic Acid; DNA Primers; Drug Resistance, Multiple, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests | 2011 |
Resistance to carbapenems in sequence type 11 Klebsiella pneumoniae is related to DHA-1 and loss of OmpK35 and/or OmpK36.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Proteins; Carbapenems; Cluster Analysis; DNA, Bacterial; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Electrophoresis, Polyacrylamide Gel; Female; Genotype; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Molecular Typing; Polymerase Chain Reaction; Porins; Proteome; Republic of Korea; Sequence Analysis, DNA | 2012 |
Identification of a plasmid-borne blaIMP-11 gene in clinical isolates of Escherichia coli and Klebsiella pneumoniae.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cluster Analysis; Escherichia coli; Escherichia coli Infections; Gene Transfer, Horizontal; Humans; Infant; Infant, Newborn; Integrons; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Phylogeny; Plasmids; Sequence Analysis, DNA; Sequence Homology | 2012 |
The characteristics of VIM-1-producing Klebsiella pneumoniae from South Africa.
Topics: Aged; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Multilocus Sequence Typing; Polymerase Chain Reaction; South Africa | 2012 |
Comparative effectiveness of aminoglycosides, polymyxin B, and tigecycline for clearance of carbapenem-resistant Klebsiella pneumoniae from urine.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Cohort Studies; Drug Resistance, Bacterial; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Minocycline; Polymyxin B; Retrospective Studies; Tigecycline; Treatment Outcome; Urinary Tract Infections; Urine; Young Adult | 2011 |
IMP-producing carbapenem-resistant Klebsiella pneumoniae in the United States.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cluster Analysis; DNA Fingerprinting; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Genotype; Humans; Infant; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Male; Molecular Typing; Plasmids; Polymerase Chain Reaction; Sequence Analysis, DNA; United States | 2011 |
Nosocomial outbreak of VIM-1-producing Klebsiella pneumoniae isolates of multilocus sequence type 15: molecular basis, clinical risk factors, and outcome.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Case-Control Studies; Cross Infection; Disease Outbreaks; DNA Fingerprinting; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Risk Factors; Spain; Survival Rate; Treatment Outcome | 2012 |
A multifaceted intervention strategy for eradication of a hospital-wide outbreak caused by carbapenem-resistant Klebsiella pneumoniae in Southern Israel.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Feces; Female; Humans; Infection Control; Israel; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Middle Aged; Nursing Homes; Patient Isolation; Thienamycins; Young Adult | 2011 |
Genetic features of the widespread plasmid coding for the carbapenemase OXA-48.
Topics: Africa, Northern; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; Base Sequence; beta-Lactam Resistance; beta-Lactamases; Carbapenems; DNA Transposable Elements; DNA, Bacterial; Europe; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Middle East; Molecular Sequence Data; Plasmids | 2012 |
Europe launches 12 point plan to tackle antimicrobial resistance.
Topics: Animals; Carbapenems; Drug Resistance, Bacterial; Drug Utilization Review; European Union; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Sentinel Surveillance | 2011 |
Coexistence of blaOXA-48 and aac(6')-Ib-cr genes in Klebsiella pneumoniae isolates from Istanbul, Turkey.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Gene Transfer Techniques; Genes, Bacterial; Genes, MDR; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Ofloxacin; Plasmids; Turkey | 2011 |
Research into new antibiotics is not the answer to resistance.
Topics: Animals; Carbapenems; Cesarean Section; Drug Resistance, Bacterial; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Pregnancy | 2011 |
Organ transplantation from a donor colonized with a multidrug-resistant organism: a case report.
Topics: Adolescent; Bacteremia; Carbapenems; Drug Resistance, Multiple, Bacterial; Fatal Outcome; Humans; Kidney Transplantation; Klebsiella Infections; Klebsiella pneumoniae; Liver Transplantation; Lung Transplantation; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Bacterial; Tissue and Organ Harvesting; Tissue Donors; Young Adult | 2012 |
Efficacy of doripenem against Escherichia coli and Klebsiella pneumoniae in experimental meningitis.
Topics: Animals; Anti-Bacterial Agents; Bacterial Load; Carbapenems; Cefepime; Cephalosporins; Disease Models, Animal; Doripenem; Escherichia coli; Escherichia coli Infections; Klebsiella Infections; Klebsiella pneumoniae; Meningitis, Bacterial; Rabbits; Treatment Outcome | 2012 |
Partial excision of blaKPC from Tn4401 in carbapenem-resistant Klebsiella pneumoniae.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; beta-Lactamases; Carbapenems; DNA Transposable Elements; Escherichia coli; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Sequence Data; Multilocus Sequence Typing; Polymerase Chain Reaction; Sequence Deletion | 2012 |
Mechanism of resistance of a highly carbapenem-resistant Klebsiella oxytoca isolate and comparison of susceptibility to five carbapenems.
Topics: Aged; Anti-Bacterial Agents; Carbapenems; Clavulanic Acid; Drug Resistance, Multiple, Bacterial; Female; Humans; Klebsiella Infections; Klebsiella oxytoca; Microbial Sensitivity Tests | 2012 |
The epidemiology of the first described carbapenem-resistant Klebsiella pneumoniae outbreak in a tertiary care hospital in Saudi Arabia: how far do we go?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Cluster Analysis; Cross Infection; Disease Outbreaks; Electrophoresis, Gel, Pulsed-Field; Female; Genotype; Humans; Infection Control; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Molecular Typing; Prospective Studies; Retrospective Studies; Risk Factors; Saudi Arabia; Survival Analysis; Tertiary Care Centers; Young Adult | 2012 |
Epidemiology of carbapenem resistant Klebsiella pneumoniae colonization in an intensive care unit.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Cohort Studies; Female; Humans; Incidence; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Prospective Studies; Rectum; Risk Factors | 2012 |
Characterization of carbapenem-nonsusceptible Klebsiella pneumoniae bloodstream isolates at a Taiwanese hospital: clinical impacts of lowered breakpoints for carbapenems.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Bacterial Outer Membrane Proteins; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Electrophoresis, Polyacrylamide Gel; Female; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Risk Factors; Taiwan | 2012 |
Acquisition of carbapenem resistance in multiresistant Klebsiella pneumoniae strains harbouring blaCTX-M-15, qnrS1 and aac(6')-Ib-cr genes.
Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Carbapenems; Drug Resistance, Multiple, Bacterial; Electrophoresis, Polyacrylamide Gel; Female; Genes, Bacterial; Humans; Infant; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Mutation; Porins; Thienamycins | 2012 |
A carbapenem-resistant Klebsiella pneumoniae epidemic clone in Jerusalem: sequence type 512 carrying a plasmid encoding aac(6')-Ib.
Topics: Acetyltransferases; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Cluster Analysis; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Genotype; Hospitals; Humans; Israel; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Sequence Data; Multilocus Sequence Typing; Plasmids; Polymerase Chain Reaction; Restriction Mapping; Sequence Analysis, DNA | 2012 |
Isolation of NDM-1-producing Klebsiella pnemoniae in Ireland, July 2011.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Female; Humans; India; Infant; Ireland; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Polymerase Chain Reaction; Sequence Analysis, DNA; Travel | 2012 |
Emergence and outbreak of carbapenemase-producing KPC-3 Klebsiella pneumoniae in Spain, September 2009 to February 2010: control measures.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Feces; Female; Humans; Infection Control; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Patient Isolation; Polymerase Chain Reaction; Spain; Young Adult | 2012 |
Mortality associated with carbapenem-resistant Klebsiella pneumoniae infections in liver transplant recipients.
Topics: Adult; Aged; Anti-Bacterial Agents; Carbapenems; Drug Resistance, Bacterial; Female; Humans; Kaplan-Meier Estimate; Klebsiella Infections; Klebsiella pneumoniae; Liver Transplantation; Male; Middle Aged; Multivariate Analysis; New York City; Proportional Hazards Models; Retrospective Studies; Risk Assessment; Risk Factors; Survival Rate; Time Factors; Treatment Outcome; Young Adult | 2012 |
"Silent" dissemination of Klebsiella pneumoniae isolates bearing K. pneumoniae carbapenemase in a long-term care facility for children and young adults in Northeast Ohio.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Child; Child, Preschool; DNA, Bacterial; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Long-Term Care; Male; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Ohio; Oligonucleotide Array Sequence Analysis; Plasmids; Polymerase Chain Reaction; Sequence Analysis, DNA; Young Adult | 2012 |
Comparison of two carbapenem-resistant Klebsiella pneumoniae clones: from a contained outbreak in a paediatric population and from a national epidemic.
Topics: Adult; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Child; Child, Preschool; Disease Outbreaks; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Genotype; Humans; Infant; Israel; Klebsiella Infections; Klebsiella pneumoniae; Male; Multilocus Sequence Typing; Plasmids; Polymerase Chain Reaction; Restriction Mapping; Sequence Analysis, DNA | 2012 |
A permission system for carbapenem use reduced incidence of drug-resistant bacteria and cost of antimicrobials at a general hospital in Japan.
Topics: Anti-Bacterial Agents; Carbapenems; Cost-Benefit Analysis; Drug Costs; Drug Resistance, Bacterial; Drug Utilization; Escherichia coli Infections; Feasibility Studies; Hospital Costs; Hospitals, General; Humans; Inappropriate Prescribing; Infection Control; Japan; Klebsiella Infections; Medical Order Entry Systems; Pharmacy Service, Hospital; Practice Patterns, Physicians'; Program Evaluation; Pseudomonas Infections; Retrospective Studies; Time Factors | 2012 |
OXA-163-producing Klebsiella pneumoniae in Cairo, Egypt, in 2009 and 2010.
Topics: Adult; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cephalosporins; DNA, Bacterial; Egypt; Female; Humans; Hydrolysis; Klebsiella Infections; Klebsiella pneumoniae; Male; Molecular Sequence Data; Sequence Analysis, DNA | 2012 |
Sequence type 101 (ST101) as the predominant carbapenem-non-susceptible Klebsiella pneumoniae clone in an acute general hospital in Italy.
Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Hospitals, General; Humans; Imipenem; Italy; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2012 |
A rapid low-cost real-time PCR for the detection of Klebsiella pneumonia carbapenemase genes.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Genes, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Polymerase Chain Reaction; Real-Time Polymerase Chain Reaction; Sensitivity and Specificity; Sequence Analysis, DNA; Time Factors | 2012 |
Urinary tract infection caused by carbapenem-resistant K. pneumoniae and P. aeruginosa.
Topics: Aged; Anastomosis, Surgical; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Humans; Infection Control; Klebsiella Infections; Klebsiella pneumoniae; Male; Nephrolithiasis; Pseudomonas aeruginosa; Pseudomonas Infections; Risk Factors; Treatment Outcome; Urinary Bladder; Urinary Bladder Neoplasms; Urinary Tract Infections | 2011 |
Detection of carbapenem-resistant Escherichia coli and Klebsiella pneumoniae producing NDM-1 in Lebanon.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; DNA, Bacterial; Escherichia coli; Escherichia coli Infections; Genes, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Lebanon | 2012 |
Persistent carbapenem-resistant Klebsiella pneumoniae bacteremia in a patient with acute lymphoblastic leukemia.
Topics: Bacteremia; beta-Lactam Resistance; Carbapenems; Catheter-Related Infections; Catheterization, Central Venous; Drug Resistance, Multiple; Fatal Outcome; Female; Humans; Immunocompromised Host; Klebsiella Infections; Klebsiella pneumoniae; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2012 |
[First isolation of KPC in Chile: from Italy to a public hospital in Santiago].
Topics: Adult; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Chile; Humans; Italy; Klebsiella Infections; Klebsiella pneumoniae; Lymphoma, Non-Hodgkin; Male; Microbial Sensitivity Tests | 2012 |
Phenotypic detection of Klebsiella pneumoniae carbapenemase among burns patients: first report from Iran.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Burns; Carbapenems; Child; Child, Preschool; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Female; Humans; Infant; Iran; Klebsiella; Klebsiella Infections; Male; Microbial Sensitivity Tests; Middle Aged; Phenotype; Young Adult | 2013 |
Spontaneous bacterial peritonitis due to carbapenemase-producing Klebsiella pneumoniae: the last therapeutic challenge.
Topics: beta-Lactam Resistance; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Fatty Liver; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Peritonitis | 2012 |
Carbapenem-resistant Enterobacteriaceae containing New Delhi metallo-beta-lactamase in two patients - Rhode Island, March 2012.
Topics: beta-Lactamases; Cambodia; Carbapenems; Cross Infection; Drug Resistance, Multiple; Female; Humans; Infection Control; Klebsiella Infections; Klebsiella pneumoniae; Rhode Island; Travel | 2012 |
Carbapenem-resistant Klebsiella pneumoniae is associated with poor outcome in hemodialysis patients.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Case-Control Studies; Female; Follow-Up Studies; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Prospective Studies; Renal Dialysis; Renal Insufficiency; Risk Factors; Survival Analysis; Treatment Outcome | 2012 |
Use of meropenem Adatabs dissolved in MacConkey agar for screening NDM-1 positive Enterobacteriaceae in faecal surveillance cultures.
Topics: Adult; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Culture Media; Drug Stability; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Middle Aged; Thienamycins | 2012 |
Klebsiella pneumoniae Carbapenemase-producing enterobacteria in hospital, Singapore.
Topics: Aged, 80 and over; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; DNA, Bacterial; Enterobacteriaceae; Female; Hospitals, University; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Sequence Analysis, DNA; Singapore | 2012 |
Carbapenem non-susceptible Klebsiella pneumoniae from Micronet network hospitals, Italy, 2009 to 2012.
Topics: Anti-Bacterial Agents; Carbapenems; Drug Resistance, Bacterial; Hospitals; Humans; Imipenem; Italy; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Sentinel Surveillance; Thienamycins | 2012 |
Ongoing spread of colistin-resistant Klebsiella pneumoniae in different wards of an acute general hospital, Italy, June to December 2011.
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactamases; Carbapenems; Colistin; Cross Infection; Disease Outbreaks; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Hospitals, General; Humans; Intensive Care Units; Italy; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Multilocus Sequence Typing; Patients' Rooms; Polymerase Chain Reaction | 2012 |
Tracking a hospital outbreak of carbapenem-resistant Klebsiella pneumoniae with whole-genome sequencing.
Topics: Adult; Aged; Carbapenems; Colistin; Contact Tracing; Cross Infection; Disease Outbreaks; Drug Resistance, Bacterial; Female; Genome, Bacterial; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Molecular Sequence Data; Mutation; Polymorphism, Single Nucleotide; Sequence Analysis, DNA; United States; Young Adult | 2012 |
Mortality associated with carbapenem-resistant Klebsiella pneumoniae infections in liver transplant recipients.
Topics: Anti-Bacterial Agents; Carbapenems; Drug Resistance, Bacterial; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Liver Transplantation; Male | 2012 |
Discrepancy between effects of carbapenems and flomoxef in treating nosocomial hemodialysis access-related bacteremia secondary to extended spectrum beta-lactamase producing Klebsiella pneumoniae in patients on maintenance hemodialysis.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Cephalosporins; Cross Infection; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Renal Dialysis; Retrospective Studies; Survival Analysis; Treatment Outcome | 2012 |
Outbreak of carbapenem-resistant enterobacteriaceae at a long-term acute care hospital: sustained reductions in transmission through active surveillance and targeted interventions.
Topics: Adult; Aged; Aged, 80 and over; beta-Lactam Resistance; Carbapenems; Disease Outbreaks; Emergency Service, Hospital; Epidemiologic Studies; Female; Florida; Humans; Klebsiella Infections; Klebsiella pneumoniae; Long-Term Care; Male; Middle Aged; Poisson Distribution; Population Surveillance | 2012 |
KPC-9, a novel carbapenemase from clinical specimens in Israel.
Topics: Amino Acid Sequence; Amino Acid Substitution; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Ceftazidime; Escherichia coli; Escherichia coli Infections; Humans; Israel; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids | 2012 |
Molecular characterization of the bla(KPC-2) gene in clinical isolates of carbapenem-resistant Klebsiella pneumoniae from the pediatric wards of a Chinese hospital.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Child; Child, Preschool; China; Cross Infection; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Gene Transfer, Horizontal; Genes, Bacterial; Genotype; Hospitals, Pediatric; Humans; Infant; Klebsiella Infections; Klebsiella pneumoniae; Male; Methyltransferases; Microbial Sensitivity Tests; Plasmids | 2012 |
Few therapy options available for carbapenem-resistant Klebsiella.
Topics: Anti-Bacterial Agents; Carbapenems; Drug Resistance, Multiple, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae | 2012 |
Outbreak of carbapenem-resistant enterobacteriaceae containing blaNDM-1, Ontario, Canada.
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Female; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Ontario; Rectum | 2012 |
First report of KPC-producing Klebsiella pneumoniae in Croatia.
Topics: Aged; Bacterial Proteins; beta-Lactamases; Carbapenems; Croatia; Drug Resistance, Multiple, Bacterial; Fatal Outcome; Hematoma, Subdural; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Meningitis, Bacterial; Postoperative Complications | 2012 |
To battle deadly infections, clinicians draw on both new and old tools.
Topics: Carbapenems; Disease Outbreaks; DNA, Bacterial; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Genome-Wide Association Study; Humans; Klebsiella Infections; Klebsiella pneumoniae; National Institutes of Health (U.S.); Sequence Analysis, DNA; Time Factors; United States | 2012 |
[Experience with tigecycline compassionate use in pediatric patients infected with carbapenem resistant Klebsiella pneumoniae].
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Child, Preschool; Compassionate Use Trials; Fatal Outcome; Female; Humans; Infant; Klebsiella Infections; Klebsiella pneumoniae; Male; Minocycline; Retrospective Studies; Tigecycline | 2012 |
Carbapenem-resistant Escherichia coli and Klebsiella pneumoniae strains containing New Delhi metallo-beta-lactamase isolated from two patients in Vietnam.
Topics: beta-Lactam Resistance; beta-Lactamases; Carbapenems; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Vietnam | 2013 |
Transfer from high-acuity long-term care facilities is associated with carriage of Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae: a multihospital study.
Topics: Aged; Aged, 80 and over; Bacterial Proteins; beta-Lactamases; Carbapenems; Carrier State; Case-Control Studies; Chicago; Community-Acquired Infections; Confidence Intervals; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Multilocus Sequence Typing; Odds Ratio; Prevalence; Propensity Score; Rectum; Respiration, Artificial; Skilled Nursing Facilities | 2012 |
Multidrug resistance genes, including bla(KPC) and bla(CTX)-M-2, among Klebsiella pneumoniae isolated in Recife, Brazil.
Topics: Bacterial Proteins; beta-Lactamases; Brazil; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Genes, MDR; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Plasmids; Polymerase Chain Reaction | 2012 |
Carbapenem-resistant Klebsiella pneumoniae harbouring blaKPC-3 and blaVIM-2 from central Italy.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Humans; Italy; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Molecular Sequence Data | 2013 |
Carbapenem-sparing antibiotic regimens for infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae in intensive care unit.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Colistin; Drug Therapy, Combination; Female; Gentamicins; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Minocycline; Retrospective Studies; Tigecycline; Treatment Outcome | 2013 |
Early identification and control of carbapenemase-producing Klebsiella pneumoniae, originating from contaminated endoscopic equipment.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Disease Outbreaks; Drug Resistance, Bacterial; Endoscopy; Equipment Contamination; Female; Humans; Infection Control; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged | 2013 |
[Comparison of ertapenem-EMB Agar with traditional methods for screening carbapenem-resistant Klebsiella pneumoniae from rectal swabs].
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Culture Media; Doripenem; Drug Resistance, Bacterial; Ertapenem; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Multiplex Polymerase Chain Reaction; Rectum; Sensitivity and Specificity; Thienamycins; Time Factors | 2012 |
Genome sequence of OXA-48 carbapenemase-producing Klebsiella pneumoniae KpO3210.
Topics: Bacterial Proteins; beta-Lactamases; beta-Lactams; Blood; Carbapenems; Disease Outbreaks; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Genome, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Sequence Data; Sequence Analysis, DNA | 2012 |
Infections caused by carbapenem-resistant Gram-negative pathogens in hospitalized children.
Topics: Acinetobacter; Acinetobacter Infections; Adolescent; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Child; Child, Hospitalized; Child, Preschool; Cross Infection; Female; Gram-Negative Bacterial Infections; Humans; Infant; Infant, Newborn; Klebsiella; Klebsiella Infections; Male; Pseudomonas; Pseudomonas Infections; Survival Analysis | 2013 |
Carbapenem-hydrolyzing oxacillinase-48 and oxacillinase-181 in Canada, 2011.
Topics: Aged; Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactam Resistance; beta-Lactamases; Canada; Carbapenems; Electrophoresis, Gel, Pulsed-Field; Humans; Isoenzymes; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Plasmids | 2013 |
Risk factors for bacteriuria with carbapenem-resistant Klebsiella pneumoniae and its impact on mortality: a case-control study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacteriuria; beta-Lactam Resistance; Carbapenems; Case-Control Studies; Colistin; Confidence Intervals; Female; Hospital Mortality; Humans; Intensive Care Units; Kaplan-Meier Estimate; Klebsiella Infections; Klebsiella pneumoniae; Length of Stay; Male; Middle Aged; Odds Ratio; Proportional Hazards Models; Retrospective Studies; Risk Factors; Treatment Outcome; Urinary Catheters; Young Adult | 2013 |
Population-based incidence of carbapenem-resistant Klebsiella pneumoniae along the continuum of care, Los Angeles County.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; beta-Lactam Resistance; Carbapenems; Child; Child, Preschool; Continuity of Patient Care; Cross Infection; Disease Outbreaks; Emergency Service, Hospital; Female; Humans; Incidence; Infant; Klebsiella Infections; Klebsiella pneumoniae; Los Angeles; Male; Middle Aged; Population Surveillance; Skilled Nursing Facilities; Young Adult | 2013 |
Complete sequence of a bla(KPC-2)-harboring IncFII(K1) plasmid from a Klebsiella pneumoniae sequence type 258 strain.
Topics: Anti-Bacterial Agents; Base Sequence; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cross Infection; Humans; Klebsiella Infections; Klebsiella pneumoniae; Molecular Sequence Data; New York; Plasmids; Sequence Analysis, DNA; Sequence Homology, Nucleic Acid | 2013 |
Rectal swabs are suitable for quantifying the carriage load of KPC-producing carbapenem-resistant Enterobacteriaceae.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Colon; Feces; Humans; Klebsiella Infections; Klebsiella pneumoniae; Real-Time Polymerase Chain Reaction; RNA, Ribosomal, 16S; Specimen Handling | 2013 |
The modified Hodge test for identification of Klebsiella pneumoniae carbapenemase producing isolates.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Burns; Carbapenems; Drug Resistance, Multiple, Bacterial; Female; Humans; Klebsiella; Klebsiella Infections; Male | 2013 |
Response to letter to the editor: 'The modified Hodge test for identification of Klebsiella pneumoniae carbapenemase producing isolates'.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Burns; Carbapenems; Drug Resistance, Multiple, Bacterial; Female; Humans; Klebsiella; Klebsiella Infections; Male | 2013 |
The characteristics of Klebsiella pneumoniae that produce KPC-2 imported from Greece.
Topics: Adhesins, Bacterial; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Fimbriae Proteins; Gentamicins; Greece; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Travel; Virulence Factors | 2013 |
Impact of carbapenem resistance on the outcome of patients' hospital-acquired bacteraemia caused by Klebsiella pneumoniae.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacteremia; beta-Lactam Resistance; Carbapenems; Case-Control Studies; Cross Infection; Female; Humans; Israel; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Retrospective Studies; Survival Analysis; Treatment Outcome; Young Adult | 2013 |
A hospital-based matched case-control study to identify clinical outcome and risk factors associated with carbapenem-resistant Klebsiella pneumoniae infection.
Topics: Anti-Bacterial Agents; Carbapenems; Case-Control Studies; Cross Infection; Drug Resistance, Bacterial; Hospital Mortality; Humans; Klebsiella Infections; Klebsiella pneumoniae; Risk Factors | 2013 |
Extended-spectrum beta-lactamases in clinical isolates of Escherichia coli and Klebsiella spp. in a Singapore hospital: clinical spectrum.
Topics: Aged; beta-Lactamases; Carbapenems; Escherichia coli; Escherichia coli Infections; Female; Humans; Klebsiella; Klebsiella Infections; Male; Microbial Sensitivity Tests; Middle Aged | 2004 |
Outbreak of Klebsiella pneumoniae producing a new carbapenem-hydrolyzing class A beta-lactamase, KPC-3, in a New York Medical Center.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Disease Outbreaks; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Glucosyltransferases; Humans; Isoelectric Focusing; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Sequence Data; New York City; Plasmids; Reverse Transcriptase Polymerase Chain Reaction | 2004 |
Activity of cefepime and carbapenems in experimental pneumonia caused by porin-deficient Klebsiella pneumoniae producing FOX-5 beta-lactamase.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cefepime; Cephalosporins; Colony Count, Microbial; Guinea Pigs; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Lung; Meropenem; Microbial Sensitivity Tests; Pneumonia, Bacterial; Porins; Thienamycins; Treatment Outcome | 2005 |
Infections of cefotaxime-resistant and cefmetazole-susceptible Escherichia coli and Klebsiella pneumoniae in children.
Topics: Adolescent; Anti-Bacterial Agents; Bacteremia; Carbapenems; Catheterization; Cefmetazole; Cefotaxime; Child; Child, Preschool; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Heart Defects, Congenital; Humans; Immunologic Deficiency Syndromes; Infant; Inpatients; Klebsiella Infections; Klebsiella pneumoniae; Male; Neoplasms; Premature Birth; Taiwan | 2005 |
Emergence of KPC-possessing Klebsiella pneumoniae in Brooklyn, New York: epidemiology and recommendations for detection.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Health Planning Guidelines; Humans; Klebsiella Infections; Klebsiella pneumoniae; Laboratories; Microbial Sensitivity Tests; Microbiology; New York City | 2005 |
Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City: a new threat to our antibiotic armamentarium.
Topics: beta-Lactam Resistance; Carbapenems; Carrier State; Cross Infection; Disease Outbreaks; Humans; Klebsiella Infections; Klebsiella pneumoniae; New York City; Prevalence; Ribotyping | 2005 |
Outbreaks in distinct regions due to a single Klebsiella pneumoniae clone carrying a bla VIM-1 metallo-{beta}-lactamase gene.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Disease Outbreaks; Greece; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2005 |
Evaluation of techniques for detection of carbapenem-resistant Klebsiella pneumoniae in stool surveillance cultures.
Topics: Bacteriological Techniques; Carbapenems; Culture Media; Drug Resistance, Bacterial; Evaluation Studies as Topic; Feces; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2005 |
Clinical features of nosocomial infections by extended-spectrum beta-lactamase-producing Enterobacteriaceae in neonatal intensive care units.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cross Infection; Enterobacteriaceae Infections; Escherichia coli Infections; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Klebsiella Infections; Klebsiella pneumoniae; Retrospective Studies; Risk Factors; Taiwan; Treatment Outcome | 2005 |
[Isolation of multi-resistant carbapenemase-producing Pseudomonas aeruginosa (VIM-2) and extended-spectrum beta-lactamase-producing Klebsiella pneumoniae (SHV-2) in a perianal ulcer in a patient with hematological disease].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Burkitt Lymphoma; Carbapenems; Drug Resistance, Multiple, Bacterial; Female; Fissure in Ano; Humans; Immunocompromised Host; Klebsiella Infections; Klebsiella pneumoniae; Pseudomonas aeruginosa; Pseudomonas Infections | 2005 |
Health and economic outcomes of the detection of Klebsiella pneumoniae-produced extended-spectrum beta-lactamase (ESBL) in a hospital with high prevalence of this infection.
Topics: Academic Medical Centers; Adult; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Brazil; Carbapenems; Cephalosporins; Cohort Studies; Costs and Cost Analysis; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Retrospective Studies; Treatment Outcome | 2006 |
First detection of the plasmid-mediated class A carbapenemase KPC-2 in clinical isolates of Klebsiella pneumoniae from South America.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Humans; Isoelectric Point; Klebsiella Infections; Klebsiella pneumoniae; Molecular Sequence Data; Open Reading Frames; Plasmids; South America | 2006 |
Prior use of carbapenems may be a significant risk factor for extended-spectrum beta-lactamase-producing Escherichia coli or Klebsiella spp. in patients with bacteraemia.
Topics: Adult; Aged; Bacteremia; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance; Escherichia coli; Escherichia coli Infections; Female; Humans; Klebsiella; Klebsiella Infections; Male; Middle Aged; Retrospective Studies; Risk Factors | 2006 |
Treatment of ESBL-producing Klebsiella pneumoniae bacteraemia with carbapenems or flomoxef: a retrospective study and laboratory analysis of the isolates.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacteremia; beta-Lactamases; Carbapenems; Cephalosporins; Child; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Treatment Outcome | 2006 |
High-level carbapenem resistance in a Klebsiella pneumoniae clinical isolate is due to the combination of bla(ACT-1) beta-lactamase production, porin OmpK35/36 insertional inactivation, and down-regulation of the phosphate transport porin phoe.
Topics: Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Down-Regulation; Gene Deletion; Gene Expression Regulation, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Phosphate Transport Proteins; Porins | 2006 |
[Problems of prevalance and resistance of nosocomial Klebsiella pneumonia in hospitals of Russia].
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Russia | 2005 |
Comparative in vitro killing of carbapenems and aztreonam against Klebsiella pneumoniae producing VIM-1 metallo-beta-lactamase.
Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Greece; Humans; In Vitro Techniques; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2007 |
Emergence of KPC-2 and KPC-3 in carbapenem-resistant Klebsiella pneumoniae strains in an Israeli hospital.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Hospitals; Humans; Israel; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Epidemiology | 2007 |
Risk factors of carbapenem-resistant Klebsiella pneumoniae infections: a matched case control study.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Case-Control Studies; Drug Resistance, Bacterial; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Risk Factors | 2007 |
Outbreak of carbapenem-resistant Klebsiella pneumoniae producing KPC-3 in a tertiary medical centre in Israel.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Disease Outbreaks; Hospitals, University; Humans; Israel; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Polymerase Chain Reaction; Random Amplified Polymorphic DNA Technique; Sequence Analysis, DNA | 2007 |
Ongoing epidemic of blaVIM-1-positive Klebsiella pneumoniae in Athens, Greece: a prospective survey.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Greece; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Prospective Studies | 2008 |
Plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC-2 in Klebsiella pneumoniae isolate from Greece.
Topics: Adult; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Female; Greece; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Plasmids | 2008 |
Bloodstream infections caused by multidrug-resistant Klebsiella pneumoniae producing the carbapenem-hydrolysing VIM-1 metallo-beta-lactamase: first Italian outbreak.
Topics: Bacteremia; beta-Lactamases; Carbapenems; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Hospitals, University; Humans; Italy; Klebsiella Infections; Klebsiella pneumoniae | 2008 |
Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Case-Control Studies; Drug Resistance, Bacterial; Female; Hospitalization; Humans; Israel; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Predictive Value of Tests; Risk Factors | 2008 |
Carbapenem-resistant isolates of Klebsiella pneumoniae in China and detection of a conjugative plasmid (blaKPC-2 plus qnrB4) and a blaIMP-4 gene.
Topics: Adult; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; China; Conjugation, Genetic; Drug Resistance, Bacterial; Escherichia coli K12; Female; Fluoroquinolones; Humans; Infant; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Plasmids | 2008 |
Extended-spectrum beta-lactamases in ceftazidime-resistant Escherichia coli and Klebsiella pneumoniae isolates in Turkish hospitals.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Ceftazidime; DNA, Bacterial; Escherichia coli; Escherichia coli Infections; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Polymerase Chain Reaction; Turkey | 2007 |
Carbapenem-hydrolyzing oxacillinase, OXA-48, persists in Klebsiella pneumoniae in Istanbul, Turkey.
Topics: beta-Lactam Resistance; beta-Lactamases; Carbapenems; Humans; Hydrolysis; Klebsiella Infections; Klebsiella pneumoniae; Turkey | 2008 |
[Antibiotic susceptibility and molecular mechanisms of cephalosporins resistance in Klebsiella isolates from patients with hospital-acquired infections].
Topics: Anti-Bacterial Agents; Carbapenems; Cephalosporin Resistance; Cross Infection; Humans; Imipenem; Klebsiella; Klebsiella Infections; Meropenem; Thienamycins | 2006 |
Carbapenem-resistant Escherichia coli and Klebsiella pneumoniae isolates from Turkey with OXA-48-like carbapenemases and outer membrane protein loss.
Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Porins; Reverse Transcriptase Polymerase Chain Reaction; Transformation, Bacterial; Turkey | 2008 |
Detection of the Klebsiella pneumoniae carbapenemase type 2 Carbapenem-hydrolyzing enzyme in clinical isolates of Citrobacter freundii and K. oxytoca carrying a common plasmid.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Citrobacter freundii; Enterobacteriaceae Infections; Humans; Klebsiella Infections; Klebsiella oxytoca; Klebsiella pneumoniae; Microbial Sensitivity Tests; Nucleic Acid Hybridization; Plasmids; Restriction Mapping | 2008 |
Antibiotic resistance and production of extended-spectrum beta-lactamases amongst Klebsiella spp. from intensive care units in Europe.
Topics: Ampicillin; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Ceftazidime; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Drug Therapy, Combination; Enzyme Inhibitors; Europe; Humans; Intensive Care Units; Klebsiella; Klebsiella Infections; Microbial Sensitivity Tests; Monobactams; Penicillanic Acid; Piperacillin; Tazobactam | 1996 |
Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC beta-lactamase, and the foss of an outer membrane protein.
Topics: Amino Acid Sequence; Bacterial Outer Membrane Proteins; beta-Lactam Resistance; beta-Lactamases; Blotting, Southern; Carbapenems; Disease Outbreaks; DNA, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Infant; Isoelectric Focusing; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids | 1997 |
Outer membrane profiles of clonally related Klebsiella pneumoniae isolates from clinical samples and activities of cephalosporins and carbapenems.
Topics: Bacterial Typing Techniques; beta-Lactamases; Carbapenems; Cefoxitin; Cephalosporins; Cephamycins; Cross Infection; Disease Outbreaks; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Porins; Spain | 1998 |
Urinary tract infection in neurogenic bladder.
Topics: Acute Disease; Anti-Infective Agents, Urinary; Carbapenems; Cephalosporins; Chronic Disease; Epididymitis; Escherichia coli Infections; Female; Fever; Gram-Negative Bacterial Infections; Humans; Klebsiella Infections; Male; Prostatitis; Pseudomonas Infections; Pyelonephritis; Urinary Bladder; Urinary Bladder, Neurogenic; Urinary Catheterization; Urinary Tract Infections | 2001 |